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Abstract	
Introduction	
One	option	for	repair	of	abdominal	aortic	aneurysms	with	inadequate	length	of	
infrarenal	 neck	 is	 fenestrated	 Endovascular	 Aneurysm	 Repair.	 Significant	
complications	 may	 be	 caused	 by	 stent-graft	 migration	 and	 component	
distraction	 which	 are	 both	 resisted	 by	 fixation	 force	 and	 provoked	 by	
haemodynamic	distraction	force.		
The	 hypotheses	 tested	 in	 this	 thesis	 are	 that	 larger	 angulation	 of	 vessels	 is	
associated	 with	 greater	 distraction	 force	 and	 that	 greater	 distraction	 force	 is	
associated	with	higher	incidence	of	migration	and	component	distraction.		
Method	
Interobserver	variation	of	a	new	method	of	angle	measurement	was	compared	
with	 the	 standard	 method	 currently	 in	 use	 in	 our	 unit.	 Computer	 models	 of	
complete	 fenestrated	 stent-grafts	 and	 their	 individual	 components	 (proximal	
body,	 distal	 body	 and	 limb	 extensions)	 were	 then	 constructed	 based	 on	 the	
postoperative	computed	tomography	scans	of	54	patients.	Computational	Fluid	
Dynamic	analysis	in	steady	state	was	used	to	quantify	the	distraction	force	acting	
on	each	device.	Blood	pressure	was	kept	constant	at	160mmHg	and	the	impact	
of	 morphological	 features	 upon	 distraction	 force	 was	 assessed.	 To	 test	 the	
second	hypothesis,	patient-specific	blood	pressures	were	used	 to	obtain	 in	 situ	
distraction	 forces	 that	 were	 then	 related	 to	 the	 incidence	 of	 migration	 and	
component	distraction.	
Results	
There	were	no	significant	differences	between	the	old	and	new	methods	of	angle	
measurement	(p=.723,	WSR).		
Inlet	cross-sectional	area	(XSA)	exhibited	a	strong,	positive	correlation	with	total	
RDF	in	complete	stent-grafts,	proximal	body	and	distal	body	components.	Outlet	
		v	
angulation	≥45°	was	significantly	associated	with	greater	 total	RDF	 in	complete	
stent-grafts	 and	 limb	 extension	 components	 (Median	 total	 RDF	 in	 complete	
stent-grafts	 with	 angle	 <45°	 =	 2.6N	 vs	 6.2N	 in	 those	 ≥45°,	 p<.001.	 Limb	
extensions:	1.4N	vs	2.1N,	p=.004,	MWU).		
There	was	no	significant	difference	between	total	RDF	acting	on	the	proximal	or	
distal	 bodies	 that	 underwent	migration	 or	 component	 distraction	 versus	 those	
that	 did	 not.	 Limb	 extensions	 that	were	 observed	 to	migrate	were	 exposed	 to	
significantly	greater	 total	RDF	compared	to	those	that	did	not	migrate	 (Median	
total	RDF	2.9N,	range	2.7-6.3N	versus	1.6N,	range	0.4-3.8N,	p=.003,	MWU).		
Conclusions	
For	 a	 given	 blood	 pressure	 XSA	 was	 the	 most	 important	 morphological	
determinant	 of	 total	 RDF.	 Outlet	 angulation	 of	 complete	 stent-grafts	 and	 limb	
extensions	was	associated	with	significantly	greater	total	RDF.	In	limb	extensions,	
greater	distraction	force	was	significantly	associated	with	migration.	The	results	
suggest	caution	when	planning	distal	seal	in	ectatic	iliac	vessels.	
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1 	Abdominal	Aortic	Aneurysms	(AAA)	
Aneurysms	are	dilatations	of	localised	segments	of	the	arterial	system.	The	most	
common	type	of	 large	vessel	aneurysm	is	an	abdominal	aortic	aneurysm	(AAA).	
Macroscopically	AAAs	 involve	all	 layers	of	 the	arterial	wall	and	usually	 taper	at	
both	ends,	they	are	therefore	described	as	‘true’,	‘fusiform’	aneurysms.	95%	are	
infrarenal	arising	distal	to	the	renal	arteries	as	illustrated	in	Figure	1.1	(1).	
	
Figure	1.1	Infrarenal	abdominal	aortic	aneurysm.		
Image	from	Stanford	Health	Care	(2)	
	
1.1 Epidemiology	
AAA	disease	is	more	common	in	men	where	the	prevalence	is	4.9%	of	those	aged	
65-74	 years	 (3).	 It	 was	 the	 direct	 cause	 of	 3535	 deaths	 in	 England	 and	Wales	
during	2013	(4).		
	
1.2 Aetiology	and	pathogenesis	
AAAs	are	sometimes	attributed	to	atherosclerosis.	The	main	risk	factors	are	the	
same	for	both	diseases	(smoking,	hypertension,	hypercholesterolaemia,	age	and	
male	sex	(5))	but	the	true	aetiology	of	AAA	disease	 is	 likely	to	be	multifactorial	
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with	 complex	 interaction	 between	 environmental	 and	 genetic	 factors.	 	 Matrix	
metalloproteinases	 (MMPs)	 have	 been	 implicated	 in	 the	 degradation	 of	 the	
aortic	wall	 and	a	 transition	at	one	 locus	of	 the	MMP9	gene	may	provide	 some	
explanation	of	the	strong	link	to	the	increased	incidence	observed	with	a	positive	
family	history	(6).	
AAA	disease	is	characterised	by	loss	of	elastin	and	smooth	muscle	cells	from	the	
aortic	media.	Inflammation	leads	to	excessive	collagen	deposition	and	thickening	
of	 the	 arterial	wall	 (7).	 These	 abnormalities	 reduce	 the	 tensile	 strength	 of	 the	
vessel	to	withstand	the	forces	imposed	by	arterial	blood	pressure.	The	structural	
changes	 associated	with	Marfan’s	 and	 Ehlers-Danlos	 syndromes	may	 have	 the	
same	 end	 result	 in	 terms	 of	 aortic	 wall	 weakening	 and	 dilatation	 but	 remain	
separate	clinical	entities.	
	
1.3 Clinical	presentation	
AAA	 is	 usually	 asymptomatic.	 The	 natural	 history	 is	 of	 gradual	 expansion	 and	
eventual	rupture	which	classically	presents	as	severe	abdominal	or	back	pain	and	
hypovolaemic	shock.	At	this	point	mortality	approaches	80-90%	(8).	
	
1.4 Screening	
Screening	for	AAA	with	an	abdominal	ultrasound	scan	significantly	reduces	both	
the	 rate	 of	 aneurysm	 rupture	 (9)	 and	 all-cause	mortality	 (3).	 It	 has	 also	 been	
proven	to	be	cost	effective	(10)	and	the	NHS	Abdominal	Aortic	Aneurysm	Screen	
Programme	 (NAAASP)	 has	 now	 been	 introduced	 throughout	 the	 UK	 to	 offer	
ultrasound	 imaging	 to	 all	 men	 aged	 65	 years.	 The	 initial	 yield	 rate	 of	 this	
screening	 programme	 appears	 to	 be	 less	 than	 was	 originally	 forecast	 (11),	
possibly	 due	 to	more	 recent	 primary	 care	 emphasis	 on	 blood	 pressure	 control	
		
3	
Chapter	1:	AAA	
and	smoking	cessation	(12)	as	well	as	increased	use	of	cross-sectional	imaging	by	
other	medical	specialities.	
	
1.5 Treatment	threshold	
No	benefit	has	been	found	from	repair	of	AAA	<55mm	(13)	therefore	following	
diagnosis	most	patients	enter	a	 surveillance	programme.	As	 the	AAA	nears	 the	
treatment	 threshold	 of	 55mm	 a	 computed	 tomography	 (CT)	 scan	 is	 usually	
performed	 to	 identify	 whether	 it	 is	 anatomically	 suitable	 for	 endovascular	 or	
open	 repair.	 This	 treatment	 threshold	 is	 based	 on	 comparison	 of	 the	 risk	 of	
rupture	 with	 the	 risk	 of	 open	 repair.	 At	 40-55mm	 diameter	 a	 AAA	 has	
approximately	 0.6%	 risk	 of	 rupture	 per	 year	 (13)	 and	 2.7-5.8%	 operative	
mortality	from	elective	repair	(13,	14).	For	AAA	of	up	to	60mm	diameter	the	risk	
of	 rupture	 is	10.3%	(15)	with	no	 increase	 in	mortality	 from	elective	repair	 (2.1-
6.3%)	(13,	14).	
	
1.6 Open	repair	
The	 aim	 of	 open	 AAA	 repair	 is	 to	 replace	 the	 aneurysmal	 segment	 with	 a	
synthetic	 Dacron	 graft.	 	 Adequate	 access	 is	 usually	 achieved	 with	 a	 midline	
laparotomy	 or	 large	 transverse	 abdominal	 incision.	 The	 small	 bowel	 is	 packed	
into	the	right	side	of	the	abdomen	and	the	aneurysm	is	identified	at	the	base	of	
its	 mesentery.	 Mobilisation	 of	 the	 duodenum	 and	 dissection	 through	 the	
connective	 tissue	 in	 front	 of	 the	 infrarenal	 aorta	 is	 undertaken	 to	 expose	 a	
segment	of	normal	aorta	on	which	to	apply	a	cross	clamp.		This	normal	segment	
of	aorta	or	‘aneurysm	neck’	is	also	used	as	the	site	for	the	proximal	anastomosis.	
Inadequate	 length	 of	 infrarenal	 neck	 obviates	 the	 need	 to	 either	 clamp	 above	
one	or	both	renal	arteries	or	in	some	cases	above	all	of	the	visceral	vessels.	The	
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more	 proximal	 the	 anastomosis,	 the	 more	 complex	 the	 dissection	 and	
reconstruction	becomes	and	the	more	potential	morbidity	is	introduced.	
Depending	on	whether	the	aneurysm	extends	into	the	iliac	vessels	or	is	confined	
to	 the	 abdominal	 aorta	 a	 tube	 or	 bifurcated	 graft	 is	 anastomosed	 to	 normal	
arterial	tissue	using	an	’inlay’	technique	with	a	continuous	monofilament	suture	
as	is	shown	schematically	in	Figure	1.2.	
	
Figure	1.2	Inlay	repair	of	abdominal	aortic	aneurysm	with	Dacron	tube	graft.	
Image	adapted	from	Kirk	and	Winslet	(16)		
	
 Mortality	and	morbidity	of	open	repair	
In	2008,	Vascunet	(a	collaboration	of	European	Vascular	registries)	reported	7.5%	
mortality	 for	elective	AAA	repair.	This	 compared	unfavourably	with	most	other	
countries	 and	 prompted	 the	 introduction	 of	 a	 AAA	 Quality	 Improvement	
Programme,	 the	 aim	 of	 which	 was	 to	 reduce	 mortality	 to	 3.5%	 by	 2013	 (17).	
National	 Vascular	 Database	 (NVD)	 figures	 from	 2013	 estimated	 elective	
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infrarenal	AAA	mortality	had	fallen	to	2.4%	with	significant	 improvements	seen	
in	 data	 governance	 (18).	 The	 incidence	 of	 the	 more	 common	 postoperative	
complications	 include	 chest	 infection	 (36.8%),	 impaired	 renal	 function	 (11.2%)	
with	6.0%	requiring	some	form	of	renal	replacement	therapy,	respiratory	failure	
(8.4%),	 myocardial	 infarction	 (MI,	 7.5%),	 cardiac	 failure	 (5.5%),	 major	
haemorrhage	(4.8%),	wound	infection	(4.7%),	bowel	ischaemia	(2.4%)	and	lower	
limb	 ischaemia	 (3.5%).	 Graft	 infection	 is	 a	 rare	 (0.8%)	 but	 potentially	 fatal	
complication	of	open	repair	(19).	
	
1.7 Endovascular	Aneurysm	Repair	(EVAR)	
An	 alternative	 to	 open	 repair	 is	 Endovascular	 Aneurysm	 Repair	 (EVAR).	 First	
described	by	Parodi	in	1991	(20)	EVAR	involves	introduction	of	a	stent-graft	into	
the	aorta	via	small	 incisions	in	the	groin	through	which	the	femoral	arteries	are	
accessed.	 The	 device	 itself	 usually	 consists	 of	 a	 stainless	 steel	 or	 nitinol	 stent	
framework	sutured	or	bonded	to	a	polyester	(Dacron)	or	polytetrafluoroethylene	
(PTFE)	graft	fabric.	The	aneurysm	is	relined	as	shown	in	Figure	1.3	using	one	or	
more	modular	stent-graft	components	and	is	excluded	from	the	circulation.	
	
Figure	1.3	Endovascular	aneurysm	repair	performed	with	a	standard	Zenith	
stent-graft.	Image	from	Cook	Medical	Inc.	(21)	
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The	 principles	 of	 this	 technique	 have	 remained	 unchanged	 throughout	 more	
than	 20	 years	 of	 stent-graft	 development.	 Successful	 endovascular	 repair	
requires	adequate	access	vessels	and	sufficient	length	of	normal	artery	proximal	
and	distal	to	the	aneurysm	in	which	to	achieve	a	seal	(see	Figure	1.3).	‘Seal’	is	the	
haemostatic	apposition	of	graft	 fabric	 to	 the	vessel	wall	achieved	via	 the	radial	
force	of	the	metal	stents.	
As	devices	have	evolved	so	morphological	restrictions	have	been	overcome.	An	
infrarenal	neck	 length	of	10mm	and	a	common	 iliac	artery	 length	of	15mm	are	
now	 adequate	 for	 proximal	 and	 distal	 seal	 with	 the	 Endurant	 stent-graft	
(Medtronic	 Inc.,	 Minneapolis,	 USA).	 The	 Aorfix	 (Lombard	 Medical	 PLC,	
Oxfordshire,	UK)	can	be	deployed	in	vessels	with	up	to	90°	angulation	and	lower	
profile	 devices	 like	 the	 Zenith	 LP	 (Cook	 Medical	 Inc.	 Bloomington,	 USA)	 with	
reduced	diameter	delivery	systems	allow	access	via	more	challenging	ilio-femoral	
vessels.	Overall,	modern	standard	EVAR	devices	can	now	be	used	in	up	to	63%	of	
cases	of	AAA	(22).	
 Mortality	and	morbidity	of	EVAR	
In	2006,	132	(29%)	AAA	repairs	in	the	UK	were	performed	with	EVAR	versus	1580	
(44%)	in	2008	(19).	The	increasing	use	of	EVAR	is	likely	to	be	a	contributory	factor	
to	 the	 reduction	 in	overall	mortality	 for	elective	AAA	repair	 in	 the	UK	over	 the	
last	ten	years.	
The	EVAR	trial	reported	a	significantly	lower	30	day	mortality	from	EVAR	vs	open	
repair	(1.8%	vs	4.3%,	p=.02)	(23)	and	similar	initial	results	were	observed	in	two	
other	large	scale	randomised	controlled	trials	(24,	25).	Only	the	French	ACE	trial	
failed	 to	 show	 any	 difference	 between	 EVAR	 and	 open	 repair	 (26).	 The	 early	
survival	 benefit	 seen	 in	 the	 EVAR	 trial	 was	 eventually	 lost	 due	 in	 part	 to	 the	
incidence	of	late	rupture	in	the	endovascular	group	(23).	
EVAR	 is	not	associated	with	 lower	 rates	of	non-fatal	MI,	 stroke	or	 renal	 failure	
despite	 it	 being	 inherently	 less	 invasive	 than	 open	 repair	 (23).	 Its	 main	
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disadvantage	 is	 the	 incidence	 of	 graft-related	 adverse	 events	 (GRAE,	 section	
2.8.3)	 and	 the	 need	 for	 secondary	 intervention	 which	 are	 both	 significantly	
higher	following	EVAR	(12.6	and	5.1	events	per	100	person	years	respectively)	as	
compared	with	open	repair	 (2.5	and	1.7	events	per	100	person	years,	p<.0001)	
(23).	 This	higher	 incidence	necessitates	 a	 long-term	 surveillance	programme	of	
imaging	 to	 ensure	 the	 aneurysm	 remains	 excluded	 from	 the	 circulation	 and	 to	
recognise	 early	 changes	 associated	 with	 graft	 failure	 before	 clinical	
consequences	occur.	A	recent	health	economic	analysis	suggested	that	because	
of	 these	 disadvantages	 EVAR	may	 not	 currently	 be	 cost-effective	 based	 on	UK	
standards	(27).	
 Follow-up	
There	 has	 been	 a	 move	 away	 from	 contrast-enhanced	 CT	 imaging	 in	 the	
surveillance	of	standard	stent-grafts	in	order	to	reduce	both	radiation	exposure	–	
estimated	to	account	for	one	solid	tumour	per	year	in	large	volume	EVAR	centres	
(28)	 –	 and	 contrast	 induced	 nephropathy	 (incidence	 of	 1.25-11%	 following	
intravenous	contrast	use)	(29).	One	approach	is	to	use	non-contrast	enhanced	CT	
which	 eliminates	 the	 risk	 of	 nephropathy	 and	 reduces	 radiation	exposure	 (30).	
An	alternative	is	duplex	surveillance	(31).	In	each	case,	changes	in	aneurysm	sac	
volume	 or	 diameter	 trigger	 further	 evaluation	 with	 contrast-enhanced	 CT	 to	
assess	for	endoleak	and	to	check	stent-graft	and	seal-zone	integrity.		
More	 recently	 Contrast-Enhanced	 Ultrasound	 (CEUS)	 has	 been	 shown	 to	 have	
similar	 accuracy	 to	 contrast-enhanced	CT	 for	 the	detection	of	 endoleak	 (32).	 It	
may	 therefore	 have	 an	 adjunctive	 role	 in	 EVAR	 follow-up	 (33).	 It	 does	 not	
however	provide	a	structural	assessment	of	stent-graft	or	seal-zone	integrity.		
 Complications	
The	main	complications	that	follow-up	protocols	are	designed	to	detect	are:	
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 Endoleak	
White	et	al.	(34)	defined	endoleak	as:	
“...a	condition	defined	by	the	persistence	of	blood	flow	outside	the	lumen	of	
the	[stent-]	graft	but	within	an	aneurysm	sac	or	adjacent	vascular	segment	
being	treated	by	the	[stent-]	graft”	(34).	
The	current	standard	classification	system	was	published	the	following	year	(35)	
and	is	represented	pictorially	in	Figure	1.4.	
Type	 I	 endoleak:	 blood	 flow	 into	 the	 aneurysm	 at	 the	 proximal	 or	 distal	 seal-
zones.	Later	further	classified	as	Ia:	proximal	or	Ib:	distal.	Type	I	endoleaks	carry	
a	high	 risk	of	 aneurysm	expansion	and	 subsequent	 rupture,	 they	are	 therefore	
treated	 aggressively	 whenever	 possible	 with	 endovascular	 extension	 or	 open	
reintervention.	
	
Figure	1.4	Endoleak	Classification.		
Image	from	Brunicardi	et	al.	(36)	
	
Type	II	endoleak:	retrograde	flow	into	the	aneurysm	from	patent	aortic	branches	
i.e.	 lumbar	 arteries	 or	 inferior	mesenteric	 artery	 (IMA).	 Controversy	 still	 exists	
about	 the	 significance	of	 type	 II	endoleaks	but	most	are	 treated	conservatively	
unless	associated	with	continual	increases	in	AAA	diameter	(37).	
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Type	 III	 endoleak:	 blood	 flow	 into	 the	 aneurysm	 from	 the	 junction	 between	
stent-graft	components	or	from	defects	in	the	graft	fabric.	Later	classified	as	IIIa:	
junctional	or	 IIIb:	 fabric	defect.	Diagnosis	of	 type	 IIIb	endoleak	 is	often	difficult	
but	 reintervention	 in	 the	 form	of	 relining	or	 conversion	 to	open	 repair	may	be	
required	to	prevent	AAA	expansion	and	rupture	(38).	
Type	IV	endoleak:	blood	flow	into	the	aneurysm	through	the	normal	porosity	of	
the	 stent-graft	 fabric	 in	 the	 immediate	 postoperative	 period.	 In	 practice	 the	
incidence	 of	 this	 type	 of	 endoleak	 is	 now	 very	 low	 due	 to	 the	 availability	 of	
modern	low	porosity	fabrics.	
Type	V	endoleak	or	endotension	are	 terms	 that	have	been	proposed	 since	 the	
initial	 White	 et	 al.	 classification	 to	 describe	 a	 pressurised	 aneurysm	 following	
EVAR	in	the	absence	of	demonstrable	flow	outside	of	the	stent-graft	(39,	40).	
 Migration	
Migration	 is	 thought	 to	 be	 the	 commonest	mode	 of	 failure	 following	 standard	
EVAR	(41).	Definitions	of	migration	include	movement	of	the	stent-graft	>10mm	
relative	to	an	anatomical	landmark,	movement	>5mm	or	any	degree	of	migration	
leading	to	symptoms	or	requiring	therapy	(40,	42).		Migration	can	describe	distal	
movement	of	 the	proximal	 seal-zone	or	 proximal	movement	of	 the	distal	 seal-
zone,	 both	 of	 which	 have	 the	 potential	 for	 type	 I	 endoleak	 with	 the	 risk	 of	
aneurysm	 expansion	 and	 rupture.	 Distally	 there	 are	 the	 added	 risks	 of	 limb	
kinking	and	occlusion.		
Migration	 is	 provoked	 by	 haemodynamic	 distraction	 force	 and	 resisted	 by	 the	
fixation	force	of	each	stent-graft	component	(43,	44).	The	radial	force	of	sealing	
stents	and	the	presence	of	barbs	or	stented	fenestrations	contribute	to	fixation	
force,	 whilst	 vessel-related	 factors	 such	 as	 atherosclerotic	 disease,	 thrombus,	
angulation	and	progressive	dilation	may	adversely	affect	the	adequacy	of	fixation	
(45-52).	
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 Limb	occlusion	
Proximal	 migration	 of	 the	 iliac	 limb	 component	 may	 induce	 kinking.	 Severe	
kinking	may	cause	a	reduction	in	vessel	cross-sectional	area	with	haemodynamic	
changes	 such	 as	 increases	 in	 peak	 systolic	 velocity	 that	 can	 be	 diagnosed	 on	
duplex	 scanning.	 Limb	 kinking	may	 progress	 to	 thrombosis	 and	 occlusion	with	
clinical	implications	of	lower	limb	ischaemia.	
	
1.8 Aneurysms	not	suitable	for	EVAR	
Despite	many	technological	advances	in	stent-graft	design,	approximately	a	third	
of	 AAA	 patients	 may	 still	 be	 anatomically	 unsuitable	 for	 standard	 EVAR.	 The	
majority	 of	 these	 (76%)	 are	 ‘juxtarenal’	 aneurysms	 with	 inadequate	 infrarenal	
neck	length	for	proximal	seal	(22).		
 Juxtarenal	aneurysms	
Juxtarenal	 aneurysms	 involve	 the	 infrarenal	 aorta	 adjacent	 to	 or	 including	 the	
lower	 margin	 of	 the	 lowest	 renal	 artery	 ostium	 (53).	 The	 exact	 definition	 has	
evolved	 with	 the	 expanding	 indications	 for	 standard	 EVAR	 and	 can	 differ	
between	 publications	 (54).	 Generally	 a	 juxtarenal	 aneurysm	 is	 not	 suitable	 for	
repair	 with	 a	 standard	 EVAR	 device	 due	 to	 an	 inadequate	 length	 of	 infrarenal	
neck	and	therefore	another	treatment	option	must	be	found.	Choices	include:	
1. Conservative	management.	The	aim	of	any	aneurysm	repair	 is	 to	prolong	
life	 by	 preventing	 rupture.	 If	 life	 expectancy	 is	 limited	 due	 to	 other	
significant	 co-morbidities	 then	 repair	 may	 be	 futile	 and	 may	 actually	
become	 the	cause	of	death	 if	attempted.	 In	 these	 situations	an	 informed	
decision	 not	 to	 treat	 made	 in	 partnership	 with	 the	 patient	 may	 be	
appropriate.	
2. Standard	EVAR	outside	of	the	manufacturer’s	instructions	for	use	(so	called	
‘off	 label’	 use).	 This	 may	 be	 associated	 with	 higher	 incidence	 of	 type	 I	
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endoleak	at	one	year	(55)	and	graft	thrombosis	(45)	although	other	studies	
show	no	difference	in	outcome	(56).		
3. Open	repair	with	infrarenal	cross	clamp	or	the	associated	higher	morbidity	
of	interrenal/suprarenal	cross	clamping	and	renal	re-implantation	(57).	
4. Complex	 endovascular	 techniques	 such	 as	 fenestrated	 Endovascular	
Anuerysm	Repair	 (fEVAR).	 This	 approach	 is	 described	 in	 detail	 in	 chapter	
two.		
	
1.9 Summary	
AAA	disease	 affects	 4.9%	of	men	 aged	65-74	 years.	 Screening	 and	 appropriate	
elective	treatment	can	prevent	rupture	thus	avoiding	a	mortality	of	80%.	In	the	
UK	 increasing	 numbers	 of	 elective	 aneurysm	 repairs	 are	 being	 performed	 by	
endovascular	 techniques.	Although	 this	 reduces	30	day	mortality	 from	4.3%	 to	
1.8%,	 these	 benefits	 are	 lost	 in	 the	 long-term	 due	 to	 late	 stent-graft	 failure.	
Postoperative	 surveillance	 programmes	 are	 designed	 to	 recognise	 the	 signs	 of	
this	early	and	allow	secondary	intervention	to	be	carried	out.	A	third	of	all	AAA	
are	 not	 suitable	 for	 the	 standard	 endovascular	 approach	 and	 one	 option	 for	
these	patients	is	a	fenestrated	Endovascular	Aneurysm	Repair	(fEVAR).		
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2 Fenestrated	Endovascular	Aneurysm	Repair	(fEVAR)	
2.1 Introduction		
fEVAR	provides	an	endovascular	option	for	the	treatment	of	AAA	with	necks	that	
are	unsuitable	for	standard	EVAR.	The	first	two	cases	were	described	by	Park	et	
al.	 in	 1996	 (58)	 who	 used	 stainless	 steel	 and	 PTFE	 stent-grafts	 with	 a	 single	
‘home-made’	 fenestration	 for	 the	 inferior	 mesenteric	 artery	 and	 right	 renal	
artery.	 One	 year	 later	 the	 Perth	 Endovascular	 Group	 were	 deploying	 the	 first	
customised	fenestrated	versions	of	the	Zenith	stent-graft	manufactured	by	Cook	
Medical	 Inc.	 (Bloomington,	 USA)	 (59).	 	 The	 Zenith	 fenestrated	 stent-graft	 has	
become	 the	 most	 commonly	 used	 fenestrated	 device	 worldwide	 and	 shares	
many	 features	 with	 its	 standard	 counterpart.	 The	 three-piece	modular	 system	
(Figure	2.1)	consists	of	a	proximal	fenestrated	body	(A),	a	distal	bifurcated	body	
(B)	and	at	least	one	iliac	limb	extension	(C).	These	components	will	subsequently	
be	referred	to	as	‘proximal	body’,	‘distal	body’	and	‘limb	extension’.	
	
Figure	2.1	Zenith	Fenestrated	Stent-graft.	A:	Proximal	body,	B:	Distal	body,	C:	
Limb	extension.	Image	adapted	from	Cook	Medical	Inc.	(60)	
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2.2 Stent-graft	configuration	
All	 three	 components	 of	 the	 Zenith	 fenestrated	 stent-graft	 are	made	with	 the	
same	full	thickness	woven	polyester	fabric	(Dacron)	that	is	used	in	the	standard	
version.	The	fabric	is	sutured	to	self-expanding	Gianturco	stainless	steel	z-stents	
using	 both	 polyester	 and	 polypropylene	 suture	 material.	 The	 bare	 metal	
suprarenal	stents	have	the	same	barbs	as	the	standard	infrarenal	device	placed	
at	 3mm	 increments	 around	 the	 radius	 however	 they	 are	 situated	 on	 the	
additional	proximal	body	component	rather	than	the	bifurcated	component.		
 Proximal	body		
The	 tubular	proximal	body	component	has	custom	made	 fenestrations	cut	 into	
the	Dacron	fabric	to	maintain	flow	to	the	visceral	vessels.	Each	fenestration	is	re-
enforced	 with	 a	 nitinol	 ring	 and	 is	 bounded	 by	 2mm	 high	 gold	 radiopaque	
markers	 (GM)	 at	 the	 12,	 3,	 6	 and	 9	 o’clock	 positions	 as	 shown	 in	 Figure	 2.2.	
Fenestrations	can	be	large	(8,	10	or	12mm	diameter)	or	small	(6	or	8mm	high	x	
6mm	wide)	and	are	located	around	the	circumference	of	the	proximal	body	seal-
zone	 as	 defined	 by	 radial	 clock	 face	 position	 and	 distance	 from	 the	 proximal	
fabric	edge.		
	
Figure	2.2	Fenestration	(left)	and	Scallop	(right).	GM:	Gold	radiopaque	Marker.	
Image	adapted	from	Cook	Medical	Inc.	(60)	
	
Visceral	vessels	less	than	10mm	away	from	the	intended	position	of	the	proximal	
fabric	edge	can	usually	be	accommodated	by	a	 scallop.	Scallops	are	 ‘U’-shaped	
fabric	 defects	 bounded	 by	 three	 radiopaque	 markers	 as	 shown	 in	 Figure	 2.2.	
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Without	nitinol	re-enforcement,	fenestrations	and	scallops	may	not	fully	deploy	
with	the	rest	of	the	stent-graft.	The	fenestrations	would	therefore	be	difficult	to	
cannulate	and	the	scallop	may	continue	to	slowly	open	to	its	full	extent	with	the	
risk	 of	 fabric	 ‘shuttering’	 across	 target	 vessels.	 The	 mean	 number	 of	
fenestrations	per	patient	 in	 available	 case	 series	 is	 2.5	with	 the	most	 common	
configuration	being	a	scallop	for	 the	superior	mesenteric	artery	 (SMA)	and	two	
small	 fenestrations	 for	 the	 renal	 arteries	 (59,	 61-68).	 Earlier	 publications	
generally	describe	fewer	fenestrations	per	patient.	Semmens’	series	of	fEVAR	in	
Western	Australia	for	instance	recruited	patients	from	as	early	as	1997	and	used	
single	fenestration	devices	in	43.1%	of	patients	(59).	
Proximal	seal	is	achieved	in	the	visceral	segment	with	one,	or	more	usually	two	
self-expanding	 sealing	 stents	 located	 inside	 the	 graft	material	 and	 available	 in	
diameters	from	24	to	36mm	in	2mm	increments.	Oversizing	by	10%	is	standard.	
Proximal	bodies	are	available	 in	 lengths	 from	94	 to	137mm	but	all	now	have	a	
distal	diameter	of	22mm	to	accommodate	the	24mm	diameter	proximal	end	of	
the	distal,	bifurcated	body	component.	The	distal	diameter	of	the	proximal	body	
was	changed	from	24mm	to	22mm	in	2005	possibly	following	the	experience	of	
the	American	centres	where	16	adjunctive	stents/stent-grafts	were	needed	in	a	
total	 of	 119	 fEVARs	 (13.4%)	 to	 treat	 type	 IIIa	 endoleaks	 between	 the	 proximal	
and	 distal	 bodies	 (64).	 The	 relative	weakness	 of	 this	 junction	was	 intended	 to	
allow	some	inter-component	distraction	so	that	not	all	of	the	distraction	forces	
experienced	at	 the	bifurcation	were	 transmitted	 to	 the	proximal	body.	The	net	
effect	of	this	modification	was	to	strengthen	the	junction	between	the	proximal	
and	distal	body.		
Diameter	 reducing	 ties	 allow	 the	 proximal	 body	 to	 be	 constrained	 to	
approximately	 30%	 of	 its	 full	 diameter	 during	 deployment.	 This	 feature	 is	
illustrated	 in	Figure	2.3	and	enables	manipulation	of	the	component	within	the	
visceral	aorta	for	alignment	of	fenestrations	with	their	intended	target	vessels.	It	
also	 preserves	 blood	 flow	 around	 the	 proximal	 body	 during	 the	 often	 time	
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consuming	 step	 of	 target	 vessel	 cannulation	 (69,	 70).	 Removal	 of	 the	 stainless	
steel	wire	from	the	centre	of	the	ties	allows	the	proximal	body	to	expand	to	its	
full	extent.		
	
Figure	2.3	Posterior	view	of	a	proximal	fenestrated	body	with	diameter	
reducing	ties	to	all	stents	(blue).	Close	up	shows	stainless	steel	wire	(yellow).	
Image	adapted	from	Oderich	et	al.	(70)	
	
 Distal	body	
The	 distal	 bifurcated	 component	 has	 a	 variable	 body	 length	 (76-124mm),	
ipsilateral	 limb	 length	 (28-62mm)	 and	 ipsilateral	 limb	 diameter	 (12-24mm).	
Overlap	within	the	proximal	body	should	be	at	least	36mm	or	two	stent	lengths	
although	 54mm	 (three	 stents)	 is	 preferable	 and	 offers	 more	 resistance	 to	
component	 distraction.	 	 The	 contralateral	 gate	 is	 the	 segment	 intended	 for	
overlap	 with	 the	 iliac	 limb	 extension.	 It	 is	 a	 standard	 23mm	 long	 by	 12mm	
diameter	and	 is	marked	by	a	 radiopaque	 ‘tick’	 to	aid	accurate	deployment	and	
catheterisation.	
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 Limb	extensions	
Iliac	limb	extensions	are	available	in	lengths	of	39-122mm	and	distal	diameters	of	
9-24mm	to	allow	ipsi	or	contralateral	extension	into	the	common	or	external	iliac	
artery.	The	recommended	22mm	overlap	with	the	contralateral	gate	is	built	into	
the	sizing	therefore	a	 limb	extension	of	39mm	is	actually	61mm	in	total	 length.	
Distal	seal	is	achieved	via	the	radial	force	of	one	sealing	stent.	
A	 three-piece	modular	 design	 enables	 application	of	 this	 technology	 to	 a	 large	
variation	 of	 aorto-iliac	 anatomy.	 Figure	 2.4	 shows	 the	 three	 stent-graft	
components	 combined	 to	 exclude	 a	 juxtarenal	 aneurysm	 from	 the	 circulation	
while	 maintaining	 flow	 to	 the	 SMA	 (scallop)	 and	 renal	 arteries	 (stented	
fenestrations).	
	
Figure	2.4	A	juxtarenal	aneurysm	treated	with	a	Zenith	Fenestrated	Stent-graft.	
Image	from	Cook	Medical	Inc.	(60)	
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2.3 Indications	for	use	(fEVAR)	
 Neck	length		
The	 Zenith	 fenestrated	 stent-graft	 is	 one	 option	 for	 AAAs	 with	 a	 diameter	 of	
55mm	 or	 above	 that	 are	 not	 suitable	 for	 standard	 EVAR.	 One	 survey	 of	 	 UK	
vascular	 surgeons	 involved	 in	 a	 fEVAR	 programme	 reported	 that	 even	 in	 the	
presence	 of	 adverse	 neck	 features	 such	 as	 short	 length,	 conicity,	 excess	
angulation	and	thrombus	lining	most	would	still	chose	standard	EVAR	outside	of	
the	 manufactures	 instructions	 for	 used	 (IFU).	 The	 same	 survey	 reported	 that	
fEVAR	was	supported	in	AAAs	not	at	all	suitable	for	standard	EVAR	due	to	short	
or	no	infrarenal	neck.	In	these	types	of	more	complex	aneurysms	the	consensus	
for	 fEVAR	 was	 stronger	 in	 patients	 under	 85	 years	 of	 age	 and	 in	 aneurysms	
greater	than	60mm	diameter	(71).		
For	 fEVAR	within	 IFU	the	manufacturers	specify	 that	 the	 infrarenal	neck	should	
be	 non-aneurysmal	 and	 at	 least	 4mm	 long	 (72).	 The	 average	 neck	 length	 of	
patients	receiving	fEVAR	worldwide	is	6.9mm	(range	0-14.4)	based	on	five	series	
of	a	total	346	patients	(48,	62,	64,	65,	67).		
 Neck	diameter	and	angulation	
Neck	 diameter	 should	 be	 19-31mm	 as	 measured	 from	 the	 outer	 wall	 of	 the	
vessel	 and	 there	 should	 be	 no	 angulation	 in	 excess	 of	 45°	 including	 the	 angle	
between	 the	 flow	axis	of	 the	 suprarenal	 aorta	and	 the	AAA	neck	and	between	
the	 neck	 and	 the	 aneurysm	 itself.	 Excess	 angulation	 greatly	 increases	 the	
difficulty	of	orientation	and	cannulation	of	the	fenestrations.	
 Iliac	arteries	
Distal	 seal-zones	 must	 be	 at	 least	 30mm	 in	 length	 and	 9-21mm	 diameter	
(ipsilateral)	or	7-21mm	diameter	(contralateral)	as	measured	from	the	outer	wall	
of	the	vessel.	Adequate	femoral	and	iliac	artery	access	is	a	prerequisite	although	
		
18	
Chapter	2:	fEVAR	
access	 vessel	 issues	 (stenosis,	 angulation	 or	 aneurysmal	 enlargement)	 only	
preclude	less	than	4%	of	AAA	patients	from	endovascular	treatment	(22).	
 Benefits	
fEVAR	is	a	useful	option	for	hostile	abdomens,	i.e.	those	with	stomas	or	scarring	
from	previous	surgery.	Access	via	groin	incisions	avoids	the	need	to	re-enter	the	
abdominal	 cavity	 and	 traverse	 complex	 peritoneal	 adhesions.	 Avoiding	 the	
physiological	 insult	 of	 a	 large	 laparotomy	 may	 also	 be	 beneficial	 when	 the	
patient	has	significant	cardio-respiratory	co-morbidity.	
 Contraindications	
Physical	 limitations	 upon	 what	 can	 be	 manufactured	 may	 provide	
contraindication	 to	 fEVAR.	 For	 instance	 the	 necessary	 arrangement	 of	
fenestrations	when	visceral	vessels	are	 in	close	proximity	to	each	other	may	be	
impossible	 to	 incorporate	 into	 the	 stent-graft	 design.	 Other	 contraindications	
include	sensitivity	to	any	of	the	materials	used	in	the	manufacture	of	the	stent-
graft	or	introduction	system	and	systemic	or	local	infection	likely	to	increase	the	
chance	of	 stent-graft	 infection.	 In	 clinical	practice	 this	 latter	 contraindication	 is	
sometimes	 overlooked	 and	 stent-grafts	 can	 be	 used	 to	 stabilise	 mycotic	
aneurysms	following	rupture	(73).	
 Other	considerations	
In	addition	to	the	manufacturers	indications	the	high	cost	of	the	device	(average	
£17,000	 per	 fEVAR)	 demands	 careful	 case	 by	 case	 evaluation	 based	 upon	 a	
reasonable	life	expectancy	and	an	unacceptably	high	risk	from	open	AAA	repair.		
An	initial	cost	effectiveness	analysis	has	reported	a	two-fold	higher	total	cost	at	
30	days	associated	with	fEVAR	in	comparison	with	open	repair	(74).	
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2.4 Planning	
Accurate	 assessment	 of	 aneurysm	 morphology	 is	 essential	 before	 fEVAR	 is	
undertaken.	This	 requires	high	 resolution	cross-sectional	 imaging	usually	 in	 the	
form	 of	 a	 helical	 computerised	 tomography	 (CT).	 Axial	 images	 can	 be	
reconstructed	 to	 provide	 three-dimensional	 (3D)	 images	 that	 can	 then	 be	
manipulated	using	a	suitable	workstation.	This	process	enables	measurements	to	
be	taken	in	the	correct	planes	and	allows	the	surgeon	to	build-up	a	mental	image	
of	 the	 spatial	 arrangement	 of	 the	 aneurysm	and	major	 vessels	 that	 should	 aid	
deployment	and	cannulation.	Although	the	2011	guidelines	on	the	management	
of	AAA	from	the	European	Society	for	Vascular	Surgery	(75)	did	not	recommend	
the	use	of	a	3D	workstation,	weak	evidence	does	suggest	that	it	may	reduce	the	
incidence	 of	 type	 I	 endoleak	 following	 standard	 EVAR	 (76).	 In	 the	 planning	 of	
fenestrated	EVAR	the	3D	workstation	becomes	a	vital	tool	to	define	the	position	
of	 the	 visceral	 vessels.	 A	 planning	 pro	 forma	 (Appendix	 8.1)	 is	 supplied	 by	 the	
manufacturer	 and	 is	 used	 to	 standardise	 the	 information	 gathering	 and	device	
selection	process.		
Custom-made	 fenestrated	 stent-grafts	 take	 approximately	 six	 weeks	 to	
manufacture	 and	 supply	 which	 precludes	 the	 treatment	 of	 haemodynamically	
stable	 ruptures	 and	 conveys	 a	 theoretical	 risk	 of	 rupture	 whilst	 awaiting	
treatment.	Recently	 ‘off-the-shelf’	 devices	have	been	 introduced	 to	 reduce	 the	
time	 between	 planning	 and	 deployment.	 The	 Zenith	 p-branch	 device	 is	 an	 off-
the-shelf	proximal	fenestrated	body	that	is	available	in	two	configurations	and	is	
potentially	 applicable	 to	 more	 than	 70%	 of	 patients	 requiring	 fEVAR	 (77,	 78).	
Early	results	are	comparable	with	the	custom-made	devices.	The	planning	stage	
involves	the	same	measurement	of	vessel	diameters	and	lengths	but	the	visceral	
target	vessels	are	then	assessed	in	terms	of	their	relative	geometry	to	the	SMA	
and	are	plotted	on	a	sizing	sheet	to	determine	whether	p-branch	option	A	or	B	is	
more	 suitable.	 The	 sizing	 sheet	 is	 a	 two-dimensional	 projection	 of	 the	 visceral	
segment/seal-zone	of	the	proximal	body	and	is	shown	in	Figure	2.5.	
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Figure	2.5	Zenith	p-branch	sizing	sheet.	Image	from	Kitagawa	et	al.	(77)	
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2.5 Deployment	
 Anaesthesia	
fEVAR	can	be	performed	under	general,	 regional,	or	 local	 anaesthesia.	General	
anaesthesia	 is	 the	standard	approach	 in	Europe	as	 it	 removes	 the	potential	 for	
any	 patient	 movement	 during	 the	 precise	 deployment	 of	 stent-graft	
components.	Of	11	major	publications	reporting	on	fEVAR	(48,	59,	61-68,	79,	80),	
four	 contained	 details	 of	 the	 anaesthetic	 regimen.	 Three	 European	 series	
included	a	 total	of	279	patients	 treated	under	general	 (n=221),	 regional	 (n=43)	
and	 local	 (n=13)	 anaesthesia	 (two	 unknown)	 (61,	 65,	 67).	 The	 only	 US	 series	
revealed	a	4:1	preference	for	regional	anaesthesia	(64).	
 Access	
Bilateral	 femoral	 artery	 access	 is	 obtained	 by	 either	 open	 cut	 down	 or	
percutaneously	with	 ultrasound	 guidance.	 Percutaneous	 access	 requires	 either	
prior	 placement	 of	 a	 suture-mediated	 closure	 device,	 i.e.	 Perclose	 ProGlide	
(Abbott	 Vascular,	 USA)	 (81)	 or	 post	 procedural	 surgical	 closure	 of	 the	
arteriotomy.	An	alternative	to	direct	surgical	closure	of	the	arteriotomy	is	fascial	
closure.	This	involves	closure	of	the	fascia	lata/femoral	sheath	superficial	to	the	
femoral	artery	and	just	distal	to	the	inguinal	ligament	with	a	purse	string	(82).	It	
can	 be	 completed	 through	 a	 25-50mm	 skin	 incision	 and	 obviates	 the	 need	 to	
dissect	close	to	the	artery	which	makes	any	subsequent	groin	access	easier.	
Although	the	proximal	body	can	be	deployed	from	either	groin	depending	on	the	
patient’s	anatomy	the	following	description	uses	the	right	groin	as	the	ipsilateral	
side.	
 Ipsilateral	
Ipsilateral	femoral	artery	puncture	is	usually	performed	with	an	18-gauge	needle	
through	which	an	0.035mm	wire	 is	advanced	 into	 the	external	 iliac	artery.	The	
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needle	 is	 exchanged	 for	 a	9Fr	 sheath	via	which	a	 soft	 tipped	guidewire	 can	be	
inserted	under	fluoroscopy	screening	until	it	lies	in	the	proximal	aorta.	A	catheter	
is	advanced	over	the	wire	and	the	initial	wire	is	exchanged	for	an	extra-stiff	wire	
(Lunderquist,	 Cook	 Medical	 Inc.,	 Bloomington,	 USA)	 before	 the	 catheter	 is	
removed.	 These	 steps	 ensure	 safe	 introduction	 of	 the	 extra-stiff	wire	with	 the	
minimum	of	vessel	wall	trauma.	The	extra-stiff	wire	 is	necessary	to	support	the	
stent-graft	delivery	system.	
 Contralateral	
A	similar	guidewire	and	needle	exchange	is	used	on	the	contralateral	side	before	
the	 access	 sheath	 is	 exchanged	 for	 a	 20Fr	 DrySeal	 sheath	 (W.	 L.	 Gore	 &	
Associates,	 Inc.,	 USA)	 via	 which	 the	 multiple	 target	 vessel	 catheters	 can	 be	
introduced.	A	further	puncture	and	5Fr	sheath	is	used	to	deliver	an	angiography	
catheter	to	the	level	of	L1	(i.e.	at	the	level	of	the	visceral	vessels).		
5000units	 of	 unfractionated	 heparin	 is	 administered	 intravenously	 before	 any	
endovascular	manipulation	is	commenced	and	Activated	Partial	Thromboplastin	
Time	(APTT)	can	be	checked	during	the	procedure	to	allow	further	boluses	to	be	
administered	if	necessary	(83).			
 Proximal	body	and	target	vessel	stents	
The	9Fr	sheath	 is	removed	from	the	 ispilateral	 femoral	artery	and	the	proximal	
body	on	its	delivery	system	is	inserted	over	the	extra-stiff	Lunderquist	guidewire.	
The	 device	 is	 orientated	 for	 height	 and	 rotation	 based	 the	 gold	 radiopaque	
markers	 and	 then	 positioned	 in	 relation	 to	 a	 pre-selected	 index	 visceral	 vessel	
with	 that	 vessel	 profiled	 appropriately	 (usually	 the	 SMA	 with	 the	 image	
intensifier/C-arm	 positioned	 laterally).	 Once	 a	 satisfactory	 position	 has	 been	
achieved	 the	 proximal	 body	 is	 unsheathed	 and	 the	 angiogram	 is	 repeated	 to	
confirm	 accurate	 alignment	 of	 the	 visceral	 fenestrations.	 This	 stage	 is	
represented	 pictorially	 in	 Figure	 2.6A.	 In	 practice	 the	 fenestrations	 are	 aligned	
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with	 the	 superior	 aspect	 of	 the	 respective	 target	 vessels	 anticipating	 a	 little	
caudal	movement	when	the	barbs	of	the	bare	metal	stent	engage	fully	with	the	
aortic	wall.	
	
Figure	2.6	Deployment	of	proximal	body	and	target	vessel	stents.	TC:	Top	Cap.	
Image	adapted	from	Cook	Medical	Inc.	(72)	
	
The	 first	 visceral	 vessel	 is	 cannulated	 through	 its	 fenestration	 via	 the	
contralateral	 groin	 using	 a	 Glidewire	 (Terumo	 Medical	 Corp.,	 USA).	 A	 further	
wire-catheter	 exchange	 usually	 with	 a	 Rosen	 wire	 (Cook	 Medical	 Inc.,	
Bloomington,	 USA)	 for	 renal	 arteries	 or	 Amplatz	 Super	 Stiff	 wire	 (Boston	
Scientific,	France)	 for	the	SMA	creates	a	stable	platform	for	 introduction	of	the	
long	7Fr	sheath.	A	small	volume	of	contrast	confirms	correct	positioning	of	 the	
sheath	in	the	vessel	ostium	and	the	balloon	expandable	stent	is	then	introduced	
(but	 not	 deployed)	with	 5mm	of	 its	 length	 remaining	within	 the	 aortic	 lumen.	
Once	 this	 procedure	 has	 been	 performed	 for	 all	 target	 vessels	 the	 diameter	
reducing	 ties	 and	 top	 cap	 of	 the	 delivery	 system	 (TC)	 can	 be	 released	 to	 fully	
deploy	 the	 proximal	 body	 and	 restore	 normal	 blood	 flow	 to	 the	 limbs	 (Figure	
2.6B).	The	top	cap	is	retrieved	and	carefully	pulled	down	away	from	the	visceral	
		
24	
Chapter	2:	fEVAR	
segment	to	allow	more	room	for	deployment	of	the	visceral	stents.		The	C-arm	is	
manoeuvred	 to	 provide	 a	 perpendicular	 view	 of	 the	 first	 target	 vessel	 based	
upon	 the	 appearance	 of	 its	 gold	 radiopaque	 markers	 and	 the	 corresponding	
target	vessel	stent	is	deployed.	An	oversized	balloon	is	used	to	create	a	flange	in	
the	intra-aortic	portion	of	the	stent	and	seal	the	new	vessel	ostium.	This	process	
is	represented	in	Figure	2.6C	with	the	end	result	shown	in	Figure	2.7.			
	
Figure	2.7	Flange	(F)	created	in	aortic	lumen	portion	of	target	vessel	stent.	
Image	adapted	from	Moore	et	al.	(83)	
	
A	 selective	angiogram	 is	performed	 to	confirm	no	disruption	of	blood	 flow	has	
occurred	and	the	procedure	is	repeated	for	the	other	target	vessels.	
 Distal	body	and	limb	extension	
After	 removal	 of	 the	 target	 vessel	 access	wires	 and	 catheters	 the	 angiography	
catheter	 is	pulled	back	and	another	angiogram	is	 taken	to	mark	the	position	of	
the	aortic	bifurcation.	The	proximal	body	delivery	system	is	then	exchanged	for	
that	of	the	distal	body	component.	It	is	orientated	so	that	the	contralateral	gate	
(CG)	 indicated	 by	 the	 radiopaque	 tick	 marker	 lies	 just	 proximal	 to	 the	
contralateral	 common	 iliac	 artery	 origin	 as	 shown	 in	 Figure	 2.8.	 The	 proximal	
extent	of	the	distal	body	is	positioned	inside	the	proximal	body	with	two	to	three	
stents’	overlap,	although	–	in	practice	–	the	maximum	available	length	of	overlap	
is	 desirable.	 Repeat	 angiogram	 confirms	 the	 position	 of	 the	 ipsilateral	 limb	 in	
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relation	 to	 the	 internal	 iliac	 artery	 origin	 before	 the	 sheath	 is	 withdrawn	 to	
deploy	 the	 contralateral	 gate.	 The	 proximal	 stent	 (PS)	 remains	 constrained	 as	
shown	in	Figure	2.8A.	
	
Figure	2.8	Deployment	of	distal	body	and	limb	extension.	PS:	Proximal	Stent,	
CG:	Contralateral	Gate,	GSS:	Graft	Sealing	Sites.	
	Image	adapted	from	Cook	Medical	Inc.	(72)	
	
The	 contralateral	 gate	 is	 cannulated	 from	 the	 contralateral	 side.	 Due	 to	 the	
proximal	 constraint	of	 the	distal	body	 it	 should	not	be	possible	 to	advance	 the	
guidewire	 beyond	 this	 point	 (see	 Figure	 2.8B).	 Further	 confirmation	 can	 be	
obtained	by	either	rotating	a	catheter	within	the	body	of	the	graft,	taking	further	
angiographic	 images	or	 inflating	a	balloon	partially	 inside	the	contralateral	gate	
and	observing	the	pear	shape	this	causes.	The	proximal	stent	of	the	distal	body	is	
then	deployed	and	the	contralateral	wire	and	catheter	are	advanced	proximally.	
The	 C-arm	 is	 moved	 caudally	 and	 obliquely	 to	 the	 right	 to	 give	 perpendicular	
images	of	the	contralateral	common	iliac	artery.	The	position	of	the	contralateral	
internal	 iliac	 artery	 is	 confirmed	with	 a	 further	 angiogram.	 The	 limb	 extension	
delivery	system	is	advanced	into	the	contralateral	gate	of	the	distal	body	to	give	
at	least	22mm	overlap	before	deployment.			
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Balloon	 dilatation	 has	 been	 shown	 to	 significantly	 improve	 the	 fixation	 of	 the	
proximal	and	distal	 seal-zones	 (84),	 therefore	after	completing	 the	deployment	
by	releasing	the	ipsilateral	limb	of	the	distal	body	a	moulding	balloon	is	used	to	
secure	all	of	the	graft	sealing	sites	(GSS,	Figure	2.8C).	These	include	the	proximal	
body	 seal-zone,	 proximal	 body/distal	 body	 junction,	 distal	 body/limb	extension	
junction,	distal	ipsilateral	seal-zone	and	distal	contralateral	seal-zone.	
A	completion	angiogram	is	taken	at	the	level	of	the	SMA	to	confirm	target	vessel	
patency	 and	 exclude	 type	 I/III	 endoleak	 before	 all	 wires	 and	 catheters	 are	
removed.	The	groins	are	then	closed	in	the	most	appropriate	way	as	outlined	in	
section	2.5.2.	
	
2.6 Intraoperative	details	
Published	 fEVAR	 results	 reveal	 a	mean	 procedural	 time	 of	 232mins	 (range	 80-
720)	(61-65,	67,	68,	79).	The	large	variability	was	probably	due	to	some	extent	on	
the	experience	of	 the	operating	surgeon	or	 interventionalist	but	also	may	have	
depended	heavily	upon	the	complexity	of	case	which	ranged	from	single	tubular	
components	and	one	scallop	to	multiple	limb	extensions	and	four	fenestrations.	
Mean	 fluoroscopy	 time	 was	 47mins	 (range	 1-230)	 and	 mean	 contrast	 volume	
used	 was	 180mls	 (range	 40-450)	 (61,	 63,	 64,	 67,	 68).	 Again	 this	 reflects	 the	
varying	complexity	of	fEVAR	with	the	series	that	reported	the	lowest	contrast	use	
also	 reporting	 the	 lowest	 ratio	 of	 fenestrations	 per	 patient	 (mean	 contrast	
volume	used	96.3mls	+/-	46.3,	 ratio	of	 fenestrations	per	patient	1.9)	 (68).	 	The	
mean	blood	loss	was	535mls	(range	50-7000)	(62-64,	67,	79)	which	highlights	the	
potential	 for	 significant	complications	 such	as	 rupture	of	 stenosed	 iliac	arteries	
(4.5%	of	patients	in	one	series)	(61)	or	perforation	of	target	vessels.	
There	 was	 considerable	 variation	 between	 studies	 in	 terms	 of	 the	 number	 of	
adjunctive	procedures	performed.	One	Swedish	 series	 reported	more	 than	one	
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adjunctive	 procedure	 per	 patient	 including	 18	 proximal	 extensions	 or	 cuffs	 for	
type	 I	 endoleak	 in	 a	 cohort	 of	 52	 patients	 (48).	 The	 most	 recent	 multicentre	
study	reported	a	16.5%	rate	of	adjunctive	procedures	with	only	three	extensions	
or	cuffs	for	type	I	endoleak	(79).		
	
2.7 Follow-up	
Although	 duplex	 alone	 can	 be	 used	 for	 follow-up	 of	 standard	 EVAR,	 the	
anatomical	complexities	of	fenestrated	endovascular	repair	means	that	contrast-
enhanced	 CT	 remains	 the	 gold	 standard.	 The	 current	 surveillance	 protocol	 for	
our	unit	comprises	a	baseline	abdominal	x-ray	postoperatively	and	then	a	duplex,	
contrast	 enhanced	 CT	 and	 venous	 blood	 sampling	 for	 estimated	 glomerular	
filtration	 rate	 (eGFR)	 at	 one	 month.	 Clinical	 review	 is	 usually	 performed	 at	
approximately	six	weeks	with	these	results.	A	further	duplex,	contrast	enhanced	
CT	and	eGFR	are	performed	at	six	months	and	the	patient	then	enters	a	yearly	
surveillance	programme	with	abdominal	x-ray,	duplex,	contrast-enhanced	CT	and	
eGFR.	Contrast	Enhanced	Ultrasound	(CEUS)	is	used	selectively	to	obtain	further	
characterisation	of	endoleaks	incompletely	diagnosed	at	CT	(32,	33).	
	
2.8 Complications	
The	 fEVAR	 follow-up	 regimen	 is	 designed	 to	 identify	 all	 of	 the	 complications	
previously	 detailed	 for	 standard	 EVAR	 and	 described	 in	 section	 1.7.3	 with	 the	
following	additions:	
 Migration	and	target	vessel	compromise	
The	 implications	of	migration	could	be	considered	to	be	more	severe	 following	
fEVAR	compared	with	standard	EVAR.	Target	vessel	loss	may	lead	to	renal	failure	
or	 bowel	 ischaemia	 as	well	 as	 type	 I	 endoleak	with	 the	 potential	 risks	 of	 AAA	
		
28	
Chapter	2:	fEVAR	
expansion	and	rupture.	Even	small	amounts	of	caudal	migration	of	the	proximal	
body	risks	 impingement	of	the	superior	aspect	of	the	re-enforced	fenestrations	
upon	the	visceral	stents	leading	to	stenosis	and	in	severe	cases	stent	fracture	or	
occlusion	 (67).	 Technical	 difficulties	 during	 deployment	 or	 unforeseen	
interactions	with	the	native	aorta	may	both	lead	to	stent	distortion	(85)	however	
small	 amounts	 of	 radial	 misalignment	 of	 fenestrations	 may	 be	 well	 tolerated	
without	adverse	effect	 (86).	Compromise	of	scalloped	target	vessels	may	result	
from	 shuttering	 of	 the	 scallop	 across	 the	 vessel	 as	 a	 result	 of	 planning	 or	
deployment	error	(85,	87).	
 Endoleak	and	component	distraction	
Type	IIIa	endoleak	is	possible	at	more	sites	than	with	standard	EVAR	due	to	the	
greater	modularity	of	the	fenestrated	device.	The	junction	between	target	vessel	
stents	and	the	proximal	body,	between	proximal	and	distal	bodies	as	well	as	the	
distal	body	and	 iliac	 limb	extension	are	all	 potential	 sites	 for	endoleak.	CT	and	
plain	 film	 images	 are	 therefore	 examined	 for	 any	 evidence	 of	 component	
distraction	 and	 CT	 and	 duplex	 are	 used	 to	 assess	 for	 any	 endoleak	 originating	
from	these	junctions.	
 Graft-related	adverse	events	
Following	 fenestrated	 endovascular	 aneurysm	 repair	 the	 term	 ‘graft-related	
adverse	events’	(GRAE)	refers	to	migration,	component	distraction	target	vessel	
compromise	type	I	and	III	endoleak,	or	limb	stenosis.	
	
2.9 Results	to	date	
Apart	from	the	aforementioned	single	or	multicentre	series	of	fEVAR	there	have	
also	 been	 nine	 review	 articles	 summarising	 the	worldwide	 experience	 (54,	 88-
95).	The	most	 recent	systematic	 review	from	Queen	Mary	Hospital,	Hong	Kong	
includes	817	patients	(less	than	a	third	of	the	estimated	number	of	fenestrated	
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stent-grafts	 deployed	 worldwide)	 (93).	 Fifty	 six	 of	 these	 patients	 received	
Ventana	 (Endologix	 Inc.,	 Irvine,	 USA)	 or	 Anaconda	 (Vascutek,	 Inchinnan,	
Scotland)	 fenestrated	 devices	 (93).	 By	 including	 the	 multicentre	 GLOBALSTAR	
initiative	 (79)	 and	 excluding	 potential	 duplication	 of	 patients	 (66,	 96-100)	 the	
number	of	reported	outcomes	for	the	Zenith	fenestrated	stent-graft	totals	1028	
(59,	 61-65,	 67,	 68,	 79,	 80).	 The	 overall	median	 follow-up	 remains	 less	 than	 20	
months	(range	0-94).	Since	the	initial	review	of	fEVAR	outcomes	was	performed	
for	 inclusion	 in	 this	 thesis	 there	 have	been	 two	 small	 single	 centre	 series	with	
less	 than	 ten	 fEVAR	 patients	 in	 each	 (101,	 102),	 and	 two	 others	where	 fEVAR	
outcomes	 were	 reported	 alongside	 open	 repair	 or	 alternative	 endovascular	
techniques	 (103,	 104).	 The	 Swedish	 and	 French	 series	 (61,	 105)	 have	 been	
expanded	by	100	patients	(106)	and	updated	(107)	and	outcomes	from	another	
139	patients	treated	at	the	Cleveland	Clinic,	Ohio,	USA	have	also	been	published	
(108).	 The	 following	 review	 of	 outcomes	 is	 based	 on	 the	 original	 combined	
cohort	from	ten	publications	(59,	61-65,	67,	68,	79,	80).		
 30-day	Outcomes	
 Mortality	
Overall	cumulative	30-day	mortality	was	23	patients	from	1028	(2.2%	range	0.8-
3.7%).	 Five	 more	 patients	 died	 during	 the	 initial	 admission	 after	 30	 days	
therefore	 the	 global	 cumulative	 perioperative	 mortality	 for	 fEVAR	 was	 2.6%	
(range	 0.8-4.4%).	 Causes	 of	 death	 included	 distal	 embolisation,	 mesenteric	
ischaemia,	 multisystem	 organ	 failure	 (one	 case	 following	major	 bleeding	 from	
access	vessel	 rupture	and	one	following	conversion	to	open	repair),	myocardial	
infarction,	major	 haemorrhage	 (from	a	 perforated	 kidney),	 pulmonary	 oedema	
and	possible	pulmonary	embolism.	
In	comparison	with	open	repair	of	juxtarenal	aneurysms,	a	recent	comprehensive	
systematic	 review	 and	 meta-analysis	 of	 1575	 open	 and	 751	 fEVAR	 patients	
reported	no	significant	difference	in	mortality	(4.1%	for	open	and	fEVAR,	p=.822)	
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despite	fEVAR	patients	being	significantly	older	with	a	significantly	higher	rate	of	
pre-existing	renal	and	respiratory	insufficiency,	cardiac	dysfunction	and	diabetes	
(94).	 It	must	be	recognised	however	that	a	significant	amount	of	heterogeneity	
exists	 even	 within	 AAAs	 regarded	 as	 juxtarenal.	 For	 example	 some	 juxtarenal	
aneurysms	unsuitable	for	standard	EVAR	may	be	suitable	for	open	repair	with	an	
infrarenal	clamp.	Others	require	 inter	or	suprarenal	or	even	supracoeliac	aortic	
cross	clamping.		
One	 direct	 comparison	 from	 a	 single	 centre	 study	 reported	 outcomes	 in	 107	
patients	 who	 underwent	 open	 repair	 or	 fEVAR.	 It	 showed	 a	 risk-adjusted	
absolute	 risk	 reduction	 of	 death	 of	 9.5%	 for	 fEVAR	 as	 compared	 with	 open	
surgery	(109).		
 Conversion	to	open	repair	
Only	 two	 patients	 in	 all	 fEVAR	 studies	 (0.2%)	 were	 reported	 as	 needing	 open	
conversion	 at	 the	 time	 of	 initial	 repair.	 The	 first	 was	 during	 treatment	 of	 a	
juxtarenal	 aneurysm	 above	 a	 previously	 placed	 standard	 infrarenal	 stent-graft	
where	difficulty	in	retrieving	the	top	cap	resulted	in	crushing	of	the	renal	stents.	
The	 patient	 spent	 eight	 days	 in	 ICU	 but	 was	 discharged	 at	 22	 days	 in	 ‘good’	
condition	 (67).	 The	 second	 was	 due	 to	 occlusion	 of	 the	 aortic	 bifurcation	
following	 successful	 deployment	 of	 the	 proximal	 body	 and	 renal	 stents.	 This	
patient	died	at	4-5	days	postoperatively	of	multisystem	organ	failure	(61).	
		
31	
Chapter	2:	fEVAR	
 Primary	success	and	primary	technical	success	
Four	studies	 reported	primary	success	defined	as	successful	deployment	of	 the	
stent-graft	 without	 surgical	 conversion,	 mortality	 or	 limb	 and	 target	 vessel	
occlusion	 (59,	62,	65,	79).	Only	 two	 studies	 reported	primary	 technical	 success	
which	in	addition	to	the	requirements	for	primary	success	included	the	absence	
of	limb	stenosis	and	type	I/III	endoleak	in	the	first	30	days	(63,	65,	68).	It	is	likely	
that	 some	 of	 the	 reported	 ‘primary’	 technical	 success	 also	 included	 ‘assisted’	
technical	 success	but	 this	 concept	was	not	mentioned	 in	any	study	despite	 the	
large	numbers	of	adjunctive	manoeuvres	used	in	some.	Overall	primary	success	
was	92.7%	and	primary	technical	success	90.7%.	
 Target	vessel	loss	
Overall	target	vessel	patency	was	2391	of	2435	target	vessels	(98.2%,	range	90.5-
100%).	Some	studies	reported	this	at	completion,	at	24	hours	or	at	30	days	(59,	
61,	62,	64,	65,	67,	68,	79).	
 Primary	Endoleak		
The	 lower	 ‘primary	 technical	 success’	 rate	 (90.7%)	 compared	 to	 the	 ‘primary	
success’	 rate	 (92.7%)	 was	 due	 to	 the	 incidence	 of	 type	 I/III	 endoleak	 at	
completion	 and	 during	 the	 first	 30	 days.	 In	 nine	 studies	 of	 a	 total	 921	 fEVAR	
patients	 there	were	41	 type	 I	 and	13	 type	 III	 endoleaks	diagnosed.	Some	were	
successfully	treated	with	adjunctive	manoeuvres	such	as	ballooning	and	palmaz	
stent/cuff	 deployment.	 Treatment	 of	 primary	 graft-related	 endoleak	 is	
summarised	 in	Table	2.1	 (59,	61-65,	67,	68,	79).	Whilst	 it	 cannot	be	confirmed	
that	all	endoleaks	occurred	in	separate	patients,	the	approximate	overall	rate	of	
primary	 graft-related	 endoleak	 following	 fEVAR	 was	 5.9%	 (range	 per	 series	 2-
10.1%).		
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Table	2.1	Summary	of	primary	graft-related	endoleak	
Endoleak	 n	 Treatment	 	
Type	Ia	 34	 8	Giant	Palmaz	stents	(1	requiring	further	
fenestrated	cuff	extension)	
1	open	conversion	at	9	months	
1	AAA	sac	embolization	
10	conservatively	treated	(7	resolved;	2	
persisted	requiring	1	fenestrated	cuff,	the	other	
refused	treatment;		1	unknown)	
14	treatment	unknown	(79)	
Type	Ib	 6	 1	IIA	coil	embolization	and	extension	to	EIA	
2	palmaz	stent	
3	treatment	unknown	(79)	
Other	 1	 persistent	type	Ia	from	standard	EVAR	following	
fenestrated	extension	(65).	Conservative	
treatment	with	complete	resolution	
Type	IIIa	renal	ostium	 5	 3	covered	target	vessel	stents	
2	treatment	unknown	
Type	IIIa	proximal-distal	
body	junction	
7	 1	extension	cuff	
2	giant	Palmaz	stents	(1	recurred	requiring	AUI	
+	cross	over	bypass)	
1	relining	
2	conservative	(both	resolved)	
1	treatment	unknown	
Type	IIIa	distal	body	-
limb	extension	junction	
1	 Treatment	unknown	
AUI:	Aorto-Uni	Iliac	stent-graft,	EIA:	External	iliac	artery,	IIA:	Internal	iliac	artery,	RA:	Renal	artery	
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Five	other	patients	with	seven	type	IIIa	endoleaks	from	the	Troisi	et	al.	(80)	series	
were	 not	 included	 in	 Table	 2.1.	 All	 were	 due	 to	 failure	 of	 target	 vessel	
cannulation	but	 it	was	not	 stated	whether	 these	endoleaks	were	present	upon	
completion	 angiography	or	were	 diagnosed	 at	 early	 follow-up.	 Because	 all	 five	
received	 secondary	 intervention	 between	 one	 and	 18	 months	 following	 the	
initial	 procedure	 they	 have	 been	 included	 in	 the	 secondary	 endoleak	 section	
2.9.2.3.	
 Renal	failure	
The	 likely	 causes	 of	 renal	 failure	 following	 fenestrated	 endovascular	 aneurysm	
repair	 include	 contrast	 induced	 nephropathy,	 embolisation,	 technical	 error	 or	
renal	 artery/renal	 stent	 stenosis	 and	 occlusion	 during	 follow-up.	 Renal	 failure	
occurred	in	14.1%	of	patients	with	1.8%	of	all	patients	requiring	dialysis	(59,	61-
65,	67,	68)	however	the	exact	definition	of	renal	failure	often	differed	between	
publications	 or	was	 absent	 entirely.	 Even	 the	 two	most	 recent	 studies	 to	 look	
specifically	 at	 the	 incidence	of	 renal	 failure	 following	 fenestrated	 endovascular	
aneurysm	repair	used	different	definitions	(>50%	or	>25%	increase	in	creatinine)	
(110,	111).	In	these	two	studies	dialysis	was	required	in	3%	and	5.9%	of	patients,	
temporarily	 in	 all	 but	one	 case.	Although	 the	 latter	 series	 included	38	patients	
treated	 with	 branched	 stent-grafts	 as	 well	 as	 187	 fenestrated	 devices,	 no	
significant	difference	was	found	in	terms	of	incidence	of	acute	renal	failure	(ARF)	
or	need	for	dialysis	between	the	two	groups.	Postoperative	ARF	was	significantly	
associated	 with	 preoperative	 chronic	 renal	 failure,	 metformin	 use	 and	 longer	
procedure	time	although	not	with	higher	volumes	of	contrast	(111).		
 Other	significant	morbidity	
2.9.1.7.1 Surgical	or	procedure	related:		
There	were	seven	cases	of	spinal	ischaemia	(cumulative	incidence	0.8%)	of	whom	
five	suffered	permanent	 loss	or	 reduction	 in	 function	 (59,	61,	79).	This	 is	much	
lower	 than	 the	 9.7%	 rate	 of	 paraplegia/paraparesis	 reported	 following	
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endovascular	 treatment	 of	 thoraco-abdominal	 aneurysms	 and	 is	 probably	 a	
result	of	 less	aorta	being	 lined	with	stent-graft	(112).	The	only	series	to	 include	
nine	 branched	 stent-grafts	 with	 fenestrated	 repairs	 reported	 no	 persistent	
neurological	complications	(80).	
Other	 procedural	 related	 complications	 included	 lower	 limb	 ischaemia	 from	
internal	 iliac	 artery	 coverage	 or	 limb	 extension	 occlusion/stenosis,	 non-fatal	
bowel	 ischaemia,	 additional	 wounds	 for	 access	 or	 control	 of	 haemorrhage,	
additional	 puncture	 sites	 (i.e.	 brachial),	 haematoma	 and	 pseudoaneurysm,	
peripheral	embolism,	wound	infection,	stent-graft	infection	and	seroma.	
2.9.1.7.2 Medical:		
Non-fatal	 myocardial	 infarction,	 acute	 coronary	 syndrome,	 atrial	 fibrillation,	
stroke/transient	 ischaemic	attack,	pneumonia,	urine	retention	and	urinary	tract	
infection	have	all	been	reported	following	fEVAR.	
 Early	reintervention	
Three	studies	reported	reintervention	rates	within	the	first	30	days	(64,	67,	79).	
Three	others	provided	enough	information	for	this	to	be	calculated	(61,	68,	80).	
Overall	51	of	841	patients	 (6.1%)	required	a	range	of	early	reinterventions	that	
included	 the	 aforementioned	 procedures	 for	 graft-related	 endoleak	 (see	 Table	
2.1);	 target	 vessel	 bypass	 for	 occlusion	 and	 stenosis;	 target	 vessel	 coil	
embolization	 for	 perforation;	 thromboembolectomy	 and	 peripheral	 bypass	 for	
acute	 ischaemia;	 laparotomy	 or	 diagnostic	 laparoscopy	 for	 concern	 regarding	
abdominal	 pathology;	 repair	 of	 brachial	 and	 femoral	 psuedoaneurysm;	
evacuation	 of	 haematoma;	 ureteric	 stent	 for	 hydronephrosis	 and	 cardiac	
pacemaker	insertion	for	bradycardia.	
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 Length	of	hospital	stay	
Overall	median	length	of	hospital	stay	was	five	days	(range	1-100	days).	Median	
ICU	stay	was	one	day	(range	0-38	days)	but	this	was	based	on	only	three	studies	
(482	patients)	(61,	62,	79).		
 Outcomes	during	follow-up	after	30	days	
Definitions	of	early,	short,	mid	and	long	term	follow-up	vary.	For	standard	EVAR	
‘early’	 has	 been	 defined	 as	 30	 days	 to	 one	 year,	 ‘short’	 as	 one	 to	 five	 years,	
‘midterm’	 as	 five	 to	 ten	 years	 and	 ‘long	 term’	 as	 more	 than	 ten	 years	 (113).	
Fenestrated	 repair	 however	 is	 a	 younger	 discipline	 therefore	 most	 authors	
described	early	reintervention	as	being	between	0	and	30	days	postoperatively.		
Median	 follow-up	 of	 15	 months	 (range	 2-53)	 has	 been	 described	 as	 midterm	
(61).	It	is	inevitable	that	as	experience	progresses	these	definitions	will	continue	
to	be	revised.	
 Mortality	after	30	days	
Eight	of	the	ten	studies	reported	mortality	after	30	days	(59,	61-64,	67,	68,	79).	
One	 other	 gave	 enough	 information	 for	 this	 to	 be	 calculated	 (65).	 Overall	
mortality	after	30	days	during	a	median	 follow	up	of	17.4	months	 (range	0-87)	
was	10.9%	(range	3.6-23.8%).		
The	only	AAA	related	deaths	during	this	follow-up	were	in	the	German	series	that	
included	63	patients	and	had	a	median	follow-up	of	14	months	(range	6-77)	(68).	
One	patient	died	 following	 rupture	at	 ten	months.	He	was	not	 suitable	 for	any	
intervention	due	to	comorbidities	and	whilst	the	rupture	was	attributed	to	type	I	
endoleak	 none	 was	 found	 either	 at	 six	 month	 follow-up	 or	 upon	 acute	
presentation.	The	other	AAA	related	death	was	due	to	an	aorto-duodenal	fistula	
at	72	months.	This	series	also	included	the	only	‘late’	conversion	to	open	repair	
performed	 successfully	 at	 nine	 months	 due	 to	 a	 persistent	 proximal	 type	 I	
endoleak	(68).		
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Five	 studies	 reported	 freedom	 from	all	mortality	 by	 Kaplan-Meier	 analysis	 (61,	
63,	67,	68,	79).	This	ranged	from	89%	at	36	months	(79)	to	58.5%	at	60	months	
(67).	The	latter	figure	from	the	Dutch	single	centre	study	was	based	on	only	14	
remaining	patients	at	risk	at	that	time	interval.		
 Target	vessel	loss	during	follow-up	
Of	 the	 2435	 target	 vessels	 patent	 following	 the	 primary	 procedure	 in	 nine	
studies,	 72	 (3%)	 occluded	during	 follow-up	 (59,	 61-65,	 67,	 68,	 79).	 Troisi	et	 al.	
described	 another	 five	 target	 vessel	 occlusions	 but	 did	 not	 state	 the	 overall	
number	of	target	vessels	in	their	107	patients.	Because	the	definition	of	primary	
target	vessel	patency	varied	(to	include	either	completion	imaging,	24	hour	or	30	
day	postoperative	periods)	a	more	accurate	indicator	of	target	vessel	loss	may	be	
Kaplan-Meier	 analysis	 over	 the	 longer	 term.	 Reported	 freedom	 from	 target	
vessel	 loss	was:	95%	at	36	months	 (79),	93%	at	60	months	 (67)	and	92%	at	77	
months	(68).	
More	recently	the	Dutch	group	has	published	target	vessel	follow-up	data	on	138	
fEVAR	patients	treated	between	2001	and	2011.	Four	year	patency	for	all	target	
vessels	was	91.9%.	For	stented	target	vessels	only	this	figure	was	88.6%.	It	was	
noted	that	after	2005	covered	stents	became	the	stent	of	choice	for	fenestrated	
target	vessels	as	opposed	to	the	uncovered	stents	more	commonly	used	prior	to	
this.	No	difference	in	patency	was	noted	between	the	two	types	of	stent.	Renal	
stent	 stenosis	 occurred	 more	 frequently	 in	 uncovered	 stents	 than	 in	 covered	
stents	 (p=.004)	 and	 uncovered	 stents	were	 significantly	more	 likely	 to	 fracture	
(10.3%	versus	1.2%	p=.01)	(114).	
Causes	 of	 target	 vessel	 compromise	 included	 proximal	 body	 migration,	 native	
vessel	 characteristics	 (i.e.	 progressive	 stenosis	 or	 unsatisfactory	 initial	 stent	
position	 due	 to	 acute	 vessel	 angulation)	 and	 iatrogenic	 causes	 (i.e.	 intentional	
coverage	of	a	target	vessel	to	abolish	a	type	III	endoleak	at	the	real	ostium).	
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Historically,	occlusions	were	observed	in	scalloped	target	vessels	(59).	A	possible	
mechanism	 for	 this	 was	 incomplete	 initial	 deployment	 of	 the	 scallop	 due	 to	
oversizing	of	 the	stent-graft.	Rotational	 forces	acting	upon	 it	would	 then	cause	
shuttering	of	the	fabric	across	the	target	vessel	ostium.	Stenting	of	scallops	was	a	
potential	protective	mechanism	but	the	need	for	this	was	superseded	by	nitinol	
re-enforcement	of	the	scallop	edge.	
 Secondary	endoleak	
The	reported	incidence	of	secondary	or	late	type	I/III	endoleak	was	low	in	most	
studies.		Troisi	et	al.	(80)	however	described	a	disproportionate	six	late	type	I	and	
10	 late	 type	 III	 endoleaks	 in	 their	 series.	 This	 was	 the	 only	 series	 to	 include	
branched	 (n=9),	 and	 hybrid	 repairs	 (n=2)	 as	 well	 as	 fenestrated	 stent-grafts	
(n=96).	The	initial	type	of	repair	was	specified	for	secondary	type	I	but	not	type	
III	endoleaks	(80).	
2.9.2.3.1 Secondary	type	I	endoleaks	
There	were	nine	proximal	 type	 I	 endoleaks	 reported	 in	a	 total	of	961	patients.	
One	was	 a	 recurrence	 at	 one	 year	 of	 a	 conservatively	 treated	 primary	 type	 Ia	
endoleak.	 It	was	 successfully	 treated	 the	 second	 time	with	 proximal	 extension	
and	re-stenting	of	the	left	renal	artery	(64).	Another	occurred	at	18	months	and	
led	to	an	increase	in	AAA	diameter.	This	was	treated	with	aortic	cuff	and	chimney	
stent	to	the	SMA	(61).	The	third	was	at	an	unknown	time	after	the	initial	fEVAR	
and	 was	 treated	 conservatively	 due	 to	 no	 observed	 changes	 in	 AAA	 diameter	
(48).		
Another	 six	 cases	 –	 all	 from	 the	 fenestrated	 patients	 included	 in	 Troisi	 et	 al’s	
series	(80)	–	were	associated	with	stent-graft	migration	and	renal	stent	fracture	
(two	 with	 bilateral	 fractures).	 Mean	 time	 to	 diagnosis	 of	 these	 six	 late	 type	 I	
endoleaks	 was	 two	 years	 following	 the	 initial	 procedure.	 Treatment	 and	
outcomes	are	described	in	Table	2.2.	
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One	 review	 examining	 type	 I	 endoleaks	 in	 fenestrated	 and	 branched	
endovascular	 aneurysm	 repairs	 showed	 that	 this	 complication	was	much	more	
likely	in	conical	visceral	sealing	zones	(i.e.	those	with	>10%	increase	in	diameter	
from	cranial	to	caudal.	Type	Ia	endoleak	was	associated	with	increased	aneurysm	
related	mortality	(115).		
2.9.2.3.2 Secondary	type	III	endoleaks	
Most	 type	 IIIa	endoleaks	were	between	renal	artery	 fenestrations	and	the	AAA	
sac.	Seven	of	these	were	due	to	initial	failure	of	cannulation	therefore	could	be	
considered	type	I	endoleaks.	One	was	sealed	at	six	months	with	loss	of	the	renal	
artery	(68),	another	was	treated	at	12	months	with	an	aortic	cuff	(61).	Two	were	
stented	 successfully	 at	 two	 and	 18	 months	 (80),	 the	 other	 three	 had	 failed	
attempts	 at	 stenting	 at	 one,	 two	 and	 four	 months	 and	 then	 required	 either	
coverage	with	a	stent-graft,	Amplatzer	plug	(St.	Jude	Medical,	USA)	embolization	
or	open	renal	artery	ligation	with	ilio-renal	bypass	(80).	
Six	type	IIIa	endoleaks	occurred	between	the	junction	of	the	renal	stent	and	the	
proximal	 body	 fenestration.	 One	 required	 re-stenting	 at	 13	 months	 following	
unsuccessful	 angioplasty	 11	 months	 earlier	 (79).	 	 The	 other	 five	 were	 due	 to	
dislocation	of	a	target	vessel	stent	(four	SMA	and	one	renal	artery).	These	were	
all	 successfully	 treated	with	 further	 stenting	at	 a	median	 time	of	eight	months	
following	the	primary	procedure	(range	2-14	months)	(80).	
Two	other	type	IIIa	endoleaks	occurred	between	the	proximal	and	distal	bodies,	
one	at	12	months	and	the	other	(a	complete	disconnection)	at	20	months.	Both	
were	treated	with	further	stent-grafts	(67,	68).	
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 Migration	
There	were	13	confirmed	cases	of	proximal	body	migration	in	8	of	the	10	series	
(48,	59,	62,	64,	65,	67,	68,	80).	Cumulative	incidence	of	migration	was	therefore	
2.3%	in	a	total	of	565	patients.	These	cases	are	summarised	in	Table	2.2.		
The	 Dutch	 series	 (67)	 described	 two	 other	 cases	 of	 suspected	 migration	 and	
Semmens	et	al.	 (59)	 reported	 four	cases	of	 target	vessel	 loss	due	 to	shuttering	
that	 they	 describe	 as	 rotational	 migration.	Migration	 was	 not	 reported	 in	 the	
French	series	(61)	and	although	Kristmundsson	et	al.	(63)	also	did	not	report	on	
migration,	 Chisci	et	 al.	 (48)	 reported	 no	migration	 in	 the	 same	 patient	 cohort.	
The	 GLOBASTAR	 database	 described	 freedom	 from	migration	 by	 Kaplan-Meier	
analysis	 of	 92%	 and	 88%	 at	 two	 and	 three	 years	 respectively	 (79).	 This	 was	
similar	to	the	92%	freedom	from	migration	at	three	years	reported	by	Troisi	et	al.	
(80).		
A	 core	 lab	 analysis	 of	 follow-up	 imaging	 from	 154	 fenestrated	 endovascular	
aneurysm	repairs	showed	that	migration	≥4mm	can	be	found	in	21%	of	proximal	
bodies	 (116).	 Median	 time	 to	 diagnosis	 varied	 greatly	 between	 one	 and	 88.7	
months	(median	11.8	months)	and	the	presence	of	migration	was	not	associated	
with	a	greater	incidence	of	graft-related	adverse	events	or	reintervention.	
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Table	2.2	Summary	of	proximal	body	migration		
Author	 Total	no.	of	
fEVAR	in	
series	
Migration	
(n)	
Extent	
(mm)	
Time	post	fEVAR	
(months)	
O’Neill	(64)	 119	 1	 3	 -	
Outcome:	Crushing	and	occlusion	of	renal	stent	successfully	re-stented	(117)	
Ziegler	(68)	 63	 2	 -	 <14		
(1	at	6	days)	
Outcome:	 One	 type	 IIIa	 endoleak	 (renal	 ostium).	 Both	 migrations	 resulted	 in	
target	vessel	occlusion	in	unsecured	fenestrations	
Scurr	(65)	 45	 2	 -	 -	
Outcome:	Deformation	and	angulation	of	target	vessel	stents	
Greenberg	
(118)	
30	 1	 6	 24	
Outcome:	Crushing	of	renal	stent	successfully	re-stented	
Verhoeven	
(67)	
100	 1	 <5	 24	
Outcome:	Renal	artery	occlusion	and	creatinine	rise	>30%	
Troisi	(80)	 96	 6	 -	 Mean	24	
Range	4-45	
Outcome:	6	graft-related	endoleaks	with	8	renal	stent	fractures.	
Successful	 treatment	 in	 3	 cases	 with	 balloon	 dilatation	 and	 renal	 stent.	
Unsuccessful	recanalization	of	renal	arteries	 in	3	cases	with	2	persistent	type	I	
endoleaks	and	3	patients	requiring	permanent	dialysis	 (1	despite	hepato-renal	
bypass).	
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 Component	Distraction	
Component	 distraction	 refers	 to	 the	movement	 of	 a	 component	 in	 relation	 to	
another	 into	which	 it	 has	 been	deployed.	 It	may	 eventually	 result	 in	 complete	
dislocation.	 Seven	examples	of	 component	distraction	were	 found	 in	 six	of	 the	
major	series	and	are	summarised	in	Table	2.3	(59,	64,	65,	67,	68,	80).		
Table	2.3	Summary	of	component	distraction	
Author	 Recruit-
ment	
period	
Total	
no.	in	
series	
Component	
distraction	
(n)	
Time	post	
fEVAR	
(months)	
Outcome	
O’Neill	
(64)	
2001-2005	 119	 1	 24	 Successful	
extension	cuff	
Semmens	
(59)	
1997-2004	 58	 2	 -	 Both	treated	
with	additional	
stent-graft	
when	<1	stent	
overlap	
	
Ziegler	
(68)	
1999-2006	 63	 2		
(1	with	type	
IIIa	
endoleak)	
<14	 Both	treated	
with	bridging	
stents	
Scurr	(65)	 2003-2006	 45	 1	 28	 Successful	
bridging	cuff	
	
Verhoeven	
(67)	
2001-2009	 100	 1		
(Complete	
dislocation)	
20	 Treated	with	
thoracic	stent-
graft	
	
Four	publications	made	no	mention	of	either	component	distraction,	dislocation	
or	 separation	 (61-63,	 79).	 The	 cumulative	 incidence	 of	 component	 distraction	
was	 therefore	 approximately	 1.5%	 of	 a	 total	 481	 patients.	 There	 were	 a	 very	
small	number	of	tubular	single-piece	and	custom-made	stent-grafts	deployed	in	
some	of	the	series	that	lacked	modularity	and	would	not	have	been	susceptible	
to	this	complication.		
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One	further	example	was	described	by	Resch	et	al.	(119)	in	2010	where	complete	
dislocation	of	the	distal	body	component	 led	to	type	IIIa	endoleak	and	rupture.	
This	patient	was	converted	to	open	repair	(119).		
An	analysis	 of	 component	movement	 and	distraction	 from	 the	Cleveland	Clinic	
was	published	 in	2008.	Many	of	the	patients	 included	would	have	been	part	of	
the	 O’Neill	 series	 (64)	 that	 initially	 reported	 only	 one	 example	 of	 this	
complication	(see	Table	2.3).	After	analysis	of	106	patients’	CT	images,	14	were	
found	 to	 have	 >10mm	 movement	 between	 components.	 Eight	 required	
secondary	 intervention	 including	 one	 open	 conversion	 due	 to	 rupture	 (120).	
Although	 there	were	an	unknown	number	of	branched	 stent-grafts	 included	 in	
the	 analysis,	 the	 results	 suggest	 that	 there	may	 be	 an	 underlying	 incidence	 of	
sub-clinical	component	distraction	higher	than	that	reported	in	the	clinical	series	
(120).	
O’Neill’s	series	(64)	was	one	of	only	two	to	recruit	all	patients	prior	to	2005	when	
the	distal	diameter	of	the	proximal	body	was	changed	by	the	manufacturer	from	
24mm	to	22mm.	The	proximal	diameter	of	the	distal	body	remained	24mm.	The	
aim	 was	 to	 reduce	 the	 chance	 of	 component	 distraction	 by	 creating	 a	 more	
secure	 fixation	between	 the	 two	components.	 Less	component	distraction	may	
be	expected	following	this	change.	
 Limb	complications	
2.9.2.6.1 Limb	migration	
Proximal	 migration	 of	 the	 limb	 extension	 was	 not	 reported	 in	 any	 of	 the	
publications	however	 the	core	 lab	analysis	by	England	et	al.	 (116)	 identified	34	
examples	of	iliac	limb	migration	≥4mm	in	a	total	of	259	limbs	(13%)	(116).	
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2.9.2.6.2 Limb	occlusion	
Seven	late	limb	occlusions	were	reported	in	four	of	the	series	(1.2%	cumulative	
incidence	by	patient)	(67,	68,	79,	80).	There	were	also	five	examples	within	the	
first	30	days	(61,	79,	80).	Removal	of	the	extra-stiff	wire	before	the	completion	
angiogram	 is	 performed	 is	 one	 way	 to	 ensure	 kinked	 or	 tortuous	 anatomy	 is	
identified	 early	 (80).	 In	 this	 setting	 judicious	use	of	 adjunctive	 stents	 has	 been	
shown	to	reduce	limb	occlusion	rates	(121).	Freedom	from	late	limb	occlusion	by	
Kaplan-Meier	analysis	was	96%	and	85%	at	two	and	three	years	respectively	(79).	
 Reintervention	
Three	series	reported	freedom	from	reintervention	by	Kaplan-Meier	analysis	(48,	
61,	68).	This	varied	between	81%	at	3	years	(61)	to	75.3%	at	over	six	years	(68).	
GLOBASTAR	 reported	 freedom	 from	 late	 secondary	 intervention	 (i.e.	 not	
including	reinterventions	within	the	first	30	days)	of	70%	at	three	years	(79).	
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2.10 Summary	
Fenestrated	 Endovascular	 Aneurysm	 Repair	 using	 the	 modular	 Zenith	
fenestrated	stent-graft	 is	an	alternative	 to	open	 juxtarenal	aneurysm	repair	 for	
patients	with	 suitable	 anatomy.	 It	 avoids	 the	 higher	 perioperative	mortality	 of	
open	surgery	and	obviates	the	need	to	negotiate	hostile	abdomens	with	multiple	
previous	operative	scars.	 It	does	however	require	long	term	radiological	follow-
up	 to	 ensure	 that	 the	 stent-graft	 components	 remain	 intact	 and	 continue	 to	
exclude	the	aneurysm	from	the	circulation.	Graft-related	adverse	events	such	as	
migration,	component	distraction,	type	I/III	endoleak,	target	vessel	compromise,	
and	 limb	 stenosis	 may	 all	 require	 reintervention	 to	 maintain	 the	 structural	
integrity	of	the	repair.	
The	 published	 clinical	 results	 in	 the	 short	 and	 medium	 term	 are	 favourable	
however	longer	term	results	are	not	available	and	this	lack	of	data	as	well	as	an	
awareness	of	 the	 financial	 costs	need	 to	be	 considered	when	advising	patients	
on	treatment	options.	
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3 Rationale	for	Investigations	
	
Migration	 of	 stent-graft	 components	 following	 fenestrated	 Endovascular	
Aneurysm	Repair	is	a	serious	complication	observed	in	up	to	12%	of	patients	at	
three	 years	 (79).	 Clinical	 sequelae	 of	 proximal	 body	 migration	 include	 target	
vessel	loss	leading	to	renal	failure	or	bowel	ischaemia	and	graft-related	endoleak	
that	 risks	 aneurysm	 expansion	 and	 rupture.	Movement	 of	 the	 distal	 body	 and	
migration	 of	 limb	 extensions	may	 lead	 to	 limb	 thrombosis,	 and	 type	 Ib	 or	 IIIa	
endoleak	with	the	subsequent	risk	of	AAA	expansion	and	rupture.		
Understanding	 what	 factors	 increase	 the	 chance	 of	 stent-graft	 migration	 may	
allow	 targeted	 intensive	 follow-up	 to	 be	 undertaken	 or	 guide	 the	 patient	 and	
surgeon	toward	an	alternative	choice	of	intervention	for	those	at	high	risk.		
	
	
3.1 Fixation	force	
	
Migration	 is	 resisted	 by	 the	 fixation	 force	 of	 a	 stent-graft	 component	 i.e.	 the	
force	holding	it	in	place	inside	the	vessel.	Two	main	factors	affect	fixation	force:		
1. The	physical	properties	of	the	stent-graft;	
2. The	characteristics	of	the	vessel	into	which	the	stent-graft	is	deployed.	
	
Physical	properties	include	adjunctive	fixation	aids	such	as	suprarenal	bare	metal	
stents,	 hooks,	 barbs	 or	 stented	 fenestrations	 as	well	 as	 the	 radial	 force	 of	 the	
sealing	stents	themselves.	 	Radial	 force	 is	determined	by	the	type	of	metal	and	
the	 configuration	of	 the	 stent.	 Incorporation	of	 the	 graft	 fabric	 into	 the	native	
vessel	 is	probably	 less	 important	 (122).	The	proportion	 to	which	 these	physical	
properties	contribute	to	 fixation	force	 is	difficult	 to	define	as	 few	commercially	
available	stent-grafts	differ	by	only	one	feature.		
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 Proximal	fixation	
The	most	relevant	comparison	of	proximal	fixation	force	was	made	by	Zhou	et	al.	
(123)	 who	 compared	 a	 standard	 Zenith	 stent-graft	 (Figure	 3.1D)	 with	 a	 one-
fenestration	proximal	body	deployed	in	wet,	pressurised	bovine	aorta	segments.	
Both	 had	 stainless	 steel	 gianturco	 design	 sealing	 stents,	 a	 stainless	 steel	 bare	
metal	 stent	 with	 barbs	 and	 the	 same	 Dacron	 fabric.	 The	 stent-grafts	 were	
distracted	 from	 the	 aortas	 using	 a	 force	 gauge.	 The	 addition	 of	 one	 stented	
fenestration	increased	the	overall	fixation	force	from	10.8N	+/-1.7N	to	28.2N	+/-
1.6N	(approximately	262%)	(123).		
	
Figure	3.1	Proximal	stent-graft	design.	A:	Excluder	(W.L.	Gore	&	Associates	Inc.,	
Flagstaff,	USA),	B:	Anaconda	(Vascutek,	Inchinnan,	Scotland),	C:	Endurant	
(Medtronic,	Minneapolis,	USA),	D:	Zenith	(Cook	Medical	Inc.,	Bloomington,	
USA),	E:	Talent	(Medtronic,	Minneapolis,	USA).	A-C	from	Bosman	et	al.	(124),	D-
E	adapted	from	respective	manufacturers	(125,	126)	
	
Resch	et	al.	 (127)	 reported	a	median	proximal	 fixation	 force	of	24N	 (23-26.5N)	
for	the	standard	Zenith	device	in	a	segment	of	human	cadaveric	aorta	but	other	
studies	 using	 the	 complete	 standard	 stent-graft	 as	 opposed	 to	 the	 truncated	
proximal	 end	 have	 yielded	 even	 higher	 results	 (46.7N	 +/-5.4N	 in	 ovine	 aorta	
(128)	and	39.3N	+/-1.6N	in	human	aorta	(84)).	These	results	suggest	that	secure	
iliac	 fixation	 and	 columnar	 stability	 also	 contribute	 to	 the	 strength	 of	 the	
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proximal	seal.	Experimental	data	using	stent-grafts	deployed	in	an	 in	vivo	ovine	
model	 support	 this	 finding	 (129),	as	do	clinical	 follow-up	studies	 from	Stanford	
University	 School	 of	 Medicine	 (130-132).	 Although	 forces	 greater	 than	 28.2N	
may	 be	 required	 to	 completely	 displace	 the	 proximal	 body	 of	 a	 Zenith	
fenestrated	 stent-graft,	 a	 lower	 initial	 fixation	 force	 of	 11.5N	 +/-1.5N	was	 also	
described	 (123).	When	 forces	 of	 this	magnitude	were	 applied	 to	 the	 proximal	
body	an	 initial	 phase	of	migration	 (<5mm)	was	observed	 that	 corresponded	 to	
full	 engagement	of	 the	barbs	with	 the	aortic	wall.	At	 this	point	overall	 fixation	
force	had	to	be	overcome	to	produce	further	movement.	Verhoeven	et	al.	 (67)	
considered	migration	 of	 <5mm	 to	 be	 the	 cause	 of	 at	 least	 two	 cases	 of	 target	
vessel	 compromise	 and	 experimental	 work	 has	 shown	 that	 the	 median	 force	
required	to	produce	stenosis	of	the	commonly	used	target	vessel	stent	 (Atrium	
Advanta	V12,	Maquet	Ltd.,	UK)	is	similar	to	this	initial	fixation	force.	When	9.3N	
of	 force	 (interquartile	 range,	 IQR	 0.9N)	 was	 applied	 perpendicular	 to	 the	 long	
axis	of	the	stent	a	50%	stenosis	resulted.	13.2N	(IQR	1.6N)	caused	a	75%	stenosis	
(133).		
The	 Endurant	 stent-graft	 (Figure	 3.1C,	 Medtronic,	 Minneapolis,	 USA)	 has	 a	
similar	m-shaped	 stent	 configuration	 to	 that	 of	 the	 z-shaped	 gianturco	 sealing	
stent	of	 the	Zenith	device.	 It	 also	has	a	bare	metal	 stent	with	barbs.	The	main	
difference	 is	 that	 the	 stents	 are	 made	 from	 an	 alloy	 of	 nickel	 and	 titanium	
(nitinol)	that	gives	more	flexibility	and	thermal	memory	than	stainless	steel.	It	is	
therefore	more	resistant	to	elastic	deformation	and	 is	more	 likely	to	re-expand	
to	 its	 initial	 shape	 than	 stainless	 steel	 under	 the	 same	 compressive	 force.	
Conversely	 it	 exerts	 less	 radial	 force	 on	 the	 internal	 surface	 of	 the	 vessel	 into	
which	 it	 is	 deployed	 (134).	 One	 experimental	 study	 in	 human	 cadaveric	 aorta	
found	that	the	Zenith	had	approximately	7.6N	(24%)	more	fixation	force	than	the	
Endurant	(39.3N	+/-1.6N	vs	31.8N	+/-	2.3N).	The	most	likely	reason	for	this	was	
the	different	properties	of	the	metals	(84).		
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Nitinol	without	barbs	has	a	lower	fixation	force.	This	was	shown	by	Linsen	et	al.	
(135)	 using	 a	 similar	 experimental	 set	 up	 to	 that	 of	 Zhou	 et	 al.	 (123).	 The	
proximal	 end	 of	 a	 standard	 Talent	 stent-graft	 (Figure	 3.1E,	 Medtronic,	
Minneapolis,	 USA)	 and	 a	modified,	 two-stented	 fenestration	 Talent	 stent-graft	
were	 both	 distracted	 from	human	 cadaveric	 aortas	with	 simulated	 aneurysms.	
The	 median	 fixation	 force	 was	 4.7N	 (range	 3.8-6.4N)	 and	 17N	 (14.8-19.7N)	
respectively	with	 some	of	 the	higher	 force	 generated	by	 the	 increased	 surface	
area	of	contact	afforded	by	using	the	visceral	aorta	as	a	seal-zone	(135).		
Further	evidence	for	the	beneficial	effect	of	barbs	comes	from	observing	the	lack	
of	engagement	that	excess	oversizing	causes.	 In	one	study	where	custom-made	
stent-grafts	 were	 imaged	 post	 deployment	 before	 distraction	 was	 performed,	
greater	 than	 30%	 oversizing	 resulted	 in	 only	 approximately	 a	 third	 of	 barbs	
penetrating	 the	 aortic	 wall.	 This	 compared	 with	 89%	 penetration	 with	 10%	
oversizing	and	led	to	41%	less	fixation	force	(136).	Sternbergh	et	al.	(137)	linked	
>30%	oversizing	to	a	significant	14-fold	 increase	 in	migration	as	compared	with	
<30%	 oversizing	 in	 the	 participants	 of	 the	 (standard)	 Zenith	 multicentre	 trial	
(137).	
The	 importance	of	stent	design	 is	best	 illustrated	by	comparing	the	nitinol	 fish-
mouth	 ring	 stents	 of	 the	 Anaconda	 stent-graft	 (Vascutek,	 Inchinnan,	 Scotland	
Figure	3.1B)	with	the	more	traditional	z/m-shaped	nitinol	of	the	Excluder	(W.	L.	
Gore	&	Associates	Inc.,	Flagstaff,	USA	Figure	3.1A).	Both	are	devoid	of	suprarenal	
fixation	and	both	have	small	barbs	near	the	proximal	extent	of	the	fabric	(woven	
polyester	and	PTFE	respectively).	The	anaconda	device	displayed	approximately	
13.6N	 (60%)	 more	 fixation	 force	 than	 the	 Excluder	 (84).	 The	 impact	 of	 stent	
design	on	radial	force	has	also	been	shown	on	a	smaller	scale	in	3mm	diameter	
coronary	stents	(138).		
By	contrast	to	the	magnitude	of	fixation	displayed	by	endovascular	stent-grafts,	a	
hand-sewn	 anastomosis	 as	 performed	 during	 open	 aneurysm	 repair	 has	 a	
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fixation	force	of	between	89.2N	and	150N	(127,	135).	At	this	force	the	aorta	was	
seen	to	tear	before	any	disruption	of	the	anastomosis	occurred.		
All	 of	 these	 experimental	 designs	 investigated	 fixation	 force	 under	 ideal	
deployment	 conditions.	 At	 worst	 there	 were	 small	 amounts	 of	 calcified	
atherosclerotic	 plaque	 in	 the	 human	 aortas	 used.	One	 pullout	 study	 examined	
the	 effect	 of	 10mm	 versus	 15mm	 of	 proximal	 neck	 length	 and	 showed	 that	
although	 fixation	 force	was	 less	with	 the	 shorter	 seal-zone,	 the	difference	was	
only	significant	 for	 the	Excluder	device	and	not	 for	 the	Ananconda	or	Endurant	
(124).	
A	 number	 of	 clinical	 follow-up	 studies	 have	 investigated	 the	 effect	 of	 adverse	
neck	morphology	 upon	 the	 consequences	 of	 poor	 fixation.	 Thrombus	 lining	 of	
the	 aneurysm	 neck	 might	 be	 expected	 to	 reduce	 the	 fixation	 force	 of	 the	
proximal	 stent-graft	 by	 interfering	with	 barb	 engagement	 and	 providing	 a	 less	
than	 stable	 surface	 for	 purchase	 of	 the	 sealing	 stents.	 This	 should	 result	 in	 a	
higher	rate	of	migration	however,	after	correction	for	the	type	of	stent-graft,	one	
analysis	 of	 396	 patients	 following	 standard	 EVAR	 showed	 no	 difference	 in	 the	
rate	of	migration	with	or	without	neck	thrombus	(139).	Although	outcomes	may	
not	 be	 affected	 in	 the	 early	 postoperative	 period	 (140),	 large	 diameter,	
angulated	necks	have	been	linked	to	a	higher	incidence	of	migration	(45,	46,	49,	
50,	 141)	 as	well	 as	more	 type	 I	 endoleak	 (46,	 50,	 51,	 141,	 142),	 postoperative	
complications	and	reinterventions	(48,	51,	52,	142)	in	the	longer	term.		
 Inter-component	fixation	
Two	 in	 vitro	 models	 using	 Zenith	 stent-grafts	 give	 some	 insight	 into	 the	
important	factors	affecting	the	inter-component	fixation	force.	In	the	absence	of	
barbs	 and	 without	 the	 influence	 of	 native	 vessel	 characteristics	 the	 most	
important	factor	at	this	junction	is	the	radial	force	of	the	stents.	Scurr	et	al.	(143)	
showed	 that	 with	 a	 two	 stent	 (35mm)	 overlap	 the	 distal	 body	 of	 a	 Zenith	
fenestrated	stent-graft	was	fixed	within	the	proximal	body	at	a	median	force	of	
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approximately	 6.5N	 (IQR	 4.8-7.2N)	 (143).	 Liffman	 et	 al.	 (144)	 showed	 that	 by	
bringing	more	surface	area	of	 the	 two	components	 into	contact	 (i.e.	 increasing	
the	overlap)	the	same	junction	could	be	stabilised	against	the	effects	of	pressure	
differences	in	a	pulsatile	flow	model	(144).		
The	strength	of	the	iliac	limb	and	contralateral	gate	fixation	was	reported	by	Cina	
et	al.	(145),	for	the	Zenith	device	this	was	approximately	3.5N	+/-0.1N.	This	force	
was	more	than	for	the	Excluder	(2.5N	+/-0.5N)	but	less	than	for	Talent	(6.3N	+/-
0.6N)	and	Anaconda	devices	(4.7N	+/-0.4N	to	13N	+/-	0.4N)	(145).		
 Distal	fixation	
In	a	pullout	study	in	cadaveric	human	vessels	the	similar	z/m	distal	stent	design	
of	 the	Endurant	 (Figure	3.2C),	and	Talent	 (E)	 resulted	 in	a	similar	distal	 fixation	
force	to	the	Zenith	(D)	despite	the	difference	in	materials	(9.7N	+/-0.4N	and	9.2N	
+/-1.3N	versus	9.6N	+/-1.5N)	(84).		
	
Figure	3.2	Distal	sealing	stent	design.	A:	Excluder	(146),	B:	Anaconda	(147),	C:	
Endurant	(148),	D:	Zenith	(125),	E:	Talent	(126)	
The	Excluder	(Figure	3.2A)	with	more	numerous	stents	and	the	anaconda	(B)	with	
circular	stents	had	greater	distal	 fixation	forces	of	10.5N	+/-0.4N	and	14.6N	+/-
0.7N	respectively.	
Previous	work	from	our	unit	has	shown	a	 link	between	the	 length	of	distal	seal	
(i.e.	 iliac	 engagement)	 and	 the	 incidence	 of	 distal	 endoleak,	 limb	 kinking	 and	
occlusion	 (149,	150).	Other	 studies	however	have	 shown	no	adverse	outcomes	
with	 other	 vessel	 characteristics	 that	 may	 affect	 fixation	 force	 such	 as	 large	
diameter	(151,	152)	and	a	greater	degree	of	iliac	angulation	(153).	
		
51	
Chapter	3:	Rationale	for	Investigations	
3.2 Distraction	force	
Haemodynamic	distraction	force	is	derived	from	blood	pressure	(normal	force	or	
stress)	and	blood	flow	(shear	stress).	The	overall	effect	of	distraction	force	is	to	
act	 against	 fixation	 force,	 provoking	 migration	 or	 movement	 of	 stent-graft	
components.	Quantification	of	the	effect	of	vessel	morphology	and	physiological	
factors	 upon	 in	 situ	 distraction	 force	 would	 improve	 understanding	 of	 this	
important	physical	 concept.	 Further	 to	 this,	 if	 in	 situ	 distraction	 force	 could	be	
linked	 to	 stent-graft	 movement	 then	 high-risk	morphology	 could	 be	 identified	
early	giving	the	clinician	an	option	to	arrange	more	intensive	follow	up	or	chose	
alternative	intervention.		
	
3.3 Determining	distraction	force	
Distraction	force	can	be	determined	using	three	main	techniques:		
1. Experimental	(desktop)	models	(144,	154-157);	
2. Analytical	(theoretical)	models	(43,	44,	158);	
3. Computational	Fluid	Dynamics	(CFD)	models	(41,	159-165).		
 Experimental	models	
Experimental	models	 enable	 the	 effects	 of	 pulsatile	 blood	 flow	 to	 be	 analysed	
(154)	 but	 even	 the	 construction	 of	 a	 rudimentary	 desktop	 model	 is	 time-
consuming	and	provides	little	patient-specific	information	about	the	forces	likely	
to	 be	 encountered	 in	 situ.	 Experimental	 models	 have	 been	 used	 to	 show	 the	
linear	 relationship	 between	 blood	 pressure	 and	 distraction	 force	 (154,	 155).	
Liffman	et	al.	(144)	used	them	to	show	the	effect	of	pulse	pressure	on	modular	
distraction	with	varying	lengths	of	overlap	and	Corbett	et	al.	(156)	documented	
the	 greater	 longitudinal	 force	 generated	 with	 increasing	 bifurcation	 angle	 and	
increasing	tortuosity	(i.e.	out-of-plane	limb	angulation).	
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 Analytical	models	
Analytical	or	 theoretical	models	provide	an	excellent	opportunity	 to	assess	 the	
impact	of	changing	one	variable	at	a	time	on	distraction	force.	Most	are	based	on	
simple	 ‘Bernoulli-type’	 approaches	 in	 combination	 with	 the	 principles	 of	
continuity	(conservation	of	mass)	and	linear	momentum	to	fluid	flow.		
The	 linear	momentum	equation	 is	a	 form	of	Newton’s	2nd	 law	of	motion	which	
states:	
“The	rate	of	change	of	momentum	is	parallel	and	directly	proportional	to	force,	is	
in	the	direction	of	that	force	and	is	inversely	proportional	to	its	mass”.	
If	momentum	remains	constant	the	net	forces	must	be	zero,	therefore	changes	
in	momentum	 can	 be	 used	 to	 calculate	 force.	 The	 following	 theoretical	model		
was	 used	 by	 Mohan	 et	 al.	 (44)	 to	 determine	 distraction	 force	 in	 a	 simple	
bifurcated	tube	representing	the	aorta	and	iliac	vessels.	
(3.1)	
	
The	main	 determinants	 of	 distraction	 force	 (fx)	 were:	 Inlet	 pressure	 (P1),	 inlet	
cross-sectional	 area	 (A1),	 blood	 density	 (ρ),	 inflow	 velocity	 (U1),	 outlet	 cross-
sectional	area	 (A2),	and	outlet	angle	 (θ).	Pressure	and	 inlet	cross-sectional	area	
had	a	 linear	 relationship	with	distraction	 force.	Outlet	angle	was	only	 found	 to	
increase	 distraction	 force	when	 greater	 than	 20°.	 Density	 and	 velocity	 of	 flow	
were	 relatively	 less	 important	 as	 the	 pressure	 terms	 dominate.	More	 complex	
analytical	 models	 have	 been	 used	 for	 determining	 distraction	 force	 (43,	 158).	
Some	include	terms	for	asymmetrical	flow	division	and	gravity	but	all	are	limited	
by	 only	 providing	 a	 one	 dimensional	 representation	 of	 flow	 in	 simplified	
bifurcated	geometries	at	one	particular	point	in	time	along	a	pulse	wave.	
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 Computational	Fluid	Dynamics	(CFD)	
Computational	Fluid	Dynamics	(CFD)	simulates	real	fluid	flow	by	using	numerical	
methods	to	solve	the	Navier-Stokes	equations.	The	Navier-Stokes	equations	are	
partial	 differential	 equations	 derived	 from	 Newton’s	 second	 law	 that	 describe	
the	 interrelationship	 between	 flow	 variables	 in	 Newtonian	 fluids	 (166).	 In	
relation	to	blood	flow	where	temperature	is	constant	and	flow	is	incompressible	
(i.e.	 density	 is	 constant)	 these	 equations	 may	 be	 simplified	 into	 the	 following	
continuity	equation	(3.2)	and	the	conservation	of	momentum	equation	(3.3)	
																																												(3.2)	
where	u,	v	and	w	represent	velocity	components	in	the	x,	y	and	z	axes.	
										(3.3)	
The	 conservation	 of	 momentum	 equation	 (3.3)	 relates	 inertial	 terms	 to	 the	
pressure	gradient	and	viscous	terms	in	three	directions.	ρ	represents	density,	p:	
pressure,	μ:	viscosity	and	t	is	time	
The	 CFD	 software	 first	 separates	 the	 fluid	 domain	 of	 the	 model	 into	 much	
smaller	 elements	 to	make	 it	 suitable	 for	 numerical	 evaluation.	 This	 process	 is	
called	discretisation.	Boundary	 conditions	 including	 velocity	 at	 the	model	 inlet,	
		
Inertia	 	 	 	 	 Pressure	 						 	 	 	 Viscous	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 Gradient	
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pressure	 (at	 steady	 state),	 fluid	 viscosity,	 density,	 temperature	 and	 flow	
weighting	are	set.	The	walls	of	the	model	are	assumed	to	be	rigid	with	zero	flow	
velocity	(the	so-called	 ‘no-slip’	condition).	The	above	equations	are	then	solved	
simultaneously	 and	 repeatedly	 for	 each	 element.	 When	 the	 software	 has	
achieved	 an	 acceptable	 level	 of	 error	 the	model	 can	be	 interrogated	 to	 return	
values	for	the	forces	acting	on	different	parts	of	the	wall.		
 Application	to	vascular	surgery	
Rudimentary	CFD	was	being	used	in	medical	research	during	the	1960s	when	Ray	
and	Davids	from	the	Department	of	Engineering	Mechanics	at	Pennsylvania	State	
University	constructed	a	computational	model	with	20	elements	to	examine	the	
effect	 of	 asymmetrical	 vessel	 cross-section	 on	 shear	 stress	 (167).	 Early	
applications	to	vascular	surgery	involved	the	modelling	of	turbulence	and	shear	
stress	as	risk	factors	for	developing	atherosclerosis	(168)	or	in	the	quantification	
of	AAA	wall	shear	stress	as	a	predictor	of	expansion	and	rupture	(169-171).	
Idealised	 models	 of	 stent-grafts	 –	 where	 real-life	 anatomy	 is	 simplified	 and	
represented	by	two	or	three-dimensional	models	with	curvature	in	one	plane	–	
provide	an	opportunity	to	make	stepwise	changes	to	morphological	parameters	
and	 assess	 the	 impact	 upon	 distraction	 force.	 Results	 of	 such	 CFD	 studies	
demonstrated	a	linear	relationship	between	greater	distraction	force	and	larger	
proximal	 diameter	 (43,	 158,	 172),	 larger	 proximal:distal	 diameter	 ratios	 and	
larger	 bifurcation	 angle	 in	 standard	 stent-grafts	 (163).	 ‘Neck	 angle’	was	 poorly	
defined	but	was	found	to	influence	distraction	force	more	in	the	lateral	direction	
than	 in	 the	 antero-posterior	 direction	 (163,	 172).	 One	 study	 has	 included	 an	
assessment	 of	 distraction	 force	 acting	 on	 an	 idealised	 complete	 fenestrated	
stent-graft	model.	Forces	of	7.36N	were	observed	at	peak	systole	(159).	
More	 recent	 developments	 in	 computer	 processing	 power	 and	 the	 ability	 to	
produce	 computer	 models	 of	 patient-specific	 geometries	 from	 cross-sectional	
imaging	in	a	relatively	short	time	(173-175)	have	enabled	virtual	replicas	of	life-
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like	anatomy	to	be	solved	by	CFD.	This	has	enabled	in	situ	distraction	forces	to	be	
determined	without	the	need	for	intricate	physical	models	or	elaborate	desktop	
flow	circuits.	
CFD	analysis	of	patient-specific	geometry	has	been	used	to	describe	the	effect	of	
inlet	 diameter	 (41)	 as	 well	 as	 inlet	 cross-sectional	 area	 (161,	 165)	 upon	
distraction	 force.	Other	morphological	parameters	 found	 to	be	associated	with	
greater	 distraction	 force	 include	 smaller	 outlet	 diameter,	 larger	 inlet:outlet	
diameter	 ratio	 (172),	 larger	 neck	 angulation	 (160,	 161,	 163,	 165,	 172),	 iliac	
angulation	 (160,	 172),	 bifurcation	 angle	 (163),	 and	 curvature	 (160,	 164).	 The	
largest	of	 these	studies	reported	no	significant	association	between	 inlet:outlet	
cross-sectional	 area	 ratio	 or	 iliac	 angulation	 and	 the	 magnitude	 of	 distraction	
force	 (165).	 All	 ten	 stent-graft	 models	 in	 this	 analysis	 were	 standard	 EVAR	
devices.	 Only	 one	 study	 considered	 distraction	 force	 in	 patient-specific	
fenestrated	Anaconda	stent-graft	models	(161).	This	was	a	pulsatile	flow	analysis	
that	 considered	 the	 complete	 stent-graft	 as	 one	 piece.	 	 No	 studies	 have	
investigated	 distraction	 forces	 in	 Zenith	 fenestrated	 stent-grafts	 or	 considered	
the	stent-graft	in	terms	of	its	individual	components.	
 Other	findings	with	CFD	
Crossed	 iliac	 limbs	 (the	 so	 called	 ‘ballerina’	position	of	 stent-graft	deployment)	
has	not	been	shown	to	increase	the	distraction	force	acting	upon	the	stent-graft	
(176).	A	minor	beneficial	effect	has	been	noted	with	tapering	of	stent-graft	limbs	
as	 opposed	 to	 sudden	 diameter	 changes	 (177)	 and	 some	 variation	 has	 been	
noted	depending	on	the	position	of	the	bifurcation	(164).	
Incorporation	of	the	mechanical	properties	of	the	stent-graft	and	aneurysm	into	
simulations	 has	 shown	 the	 possible	 protective	 effects	 of	 type	 II	 endoleak	 in	
reducing	 distraction	 force	 (41,	 162).	 It	 has	 also	 shown	 that	 compliance	 of	 the	
stent-graft	 had	 only	 a	 negligible	 effect	 upon	 distraction	 force	 and	 therefore	
supports	 the	assumption	of	 rigid,	 ‘no-slip’	walls	 for	 the	boundary	 conditions	of	
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fluid	 simulations	 (158,	 178).	 Prior	 to	 stent-graft	 deployment	 the	 compliance	of	
the	 native	 vessel	may	 be	more	 important.	 The	 analytical	model	 developed	 by	
Morris	 et	 al.	 (158,	 178)	 suggested	 an	 approximate	 15%	 increase	 in	 distraction	
force	at	peak	systole	between	a	 low	compliance	model	of	an	elderly	aorta	and	
the	high	compliance	of	a	young	aorta	(158,	178).		
A	steeper	inflection	of	the	blood	pressure	waveform	was	associated	with	greater	
distraction	 force	 (172)	 but	 velocity	 profile	was	 not	 found	 to	 have	 a	 significant	
effect	(179).	
	
3.4 Summary	
Stent-graft	 migration	 is	 resisted	 by	 fixation	 force	 and	 provoked	 by	
haemodynamic	distraction	 force.	Experimental,	analytical	and	CFD	studies	have	
associated	the	following	factors	with	greater	distraction	force:	
1. Large	inlet	cross-sectional	area/diameter;	
2. Hypertension;	
3. Small	outlet	cross-sectional	area;	
4. Large	proximal:distal	diameter	ratio;	
5. Large	bifurcation	angle;	
6. Large	proximal	neck	angulation;	
7. Greater	vessel	curvature.	
Less	 important	 contributors	 include:	 high	 volume	 flow	 rate,	 high	 viscosity	 and	
blood	 density.	 Analytical	 models	 do	 not	 allow	 consideration	 of	 complex	
geometries	and	experimental	models	are	 time-consuming	and	costly	 to	 set	up.	
Once	 suitably	 validated,	 CFD	 is	 the	 ideal	 method	 to	 evaluate	 the	 effect	 of	
angulation	 on	 distraction	 force	 in	 patient-specific	 geometries.	 Although	 CFD	
methods	have	been	described	 for	 the	 evaluation	of	 distraction	 force	 acting	on	
standard	 stent-grafts	 and	 complete	 fenestrated	 stent-grafts,	 no	 studies	 have	
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quantified	distraction	force	for	patient-specific	stent-graft	components.	A	study	
of	 this	 kind	 would	 provide	 greater	 understanding	 of	 the	 contribution	 of	
morphological	 factors	 upon	 the	 distraction	 force.	 In	 addition	 to	 this	 if	 the	
intuitive	 link	 between	 distraction	 force	 and	migration	 can	 be	 proven	 it	 would	
justify	targeted	intensive	follow-up	of	at-risk	stent-grafts	or	help	the	clinician	to	
avoid	placing	stent-grafts	in	high-risk	anatomy.	
	
3.5 Project	overview	
This	 thesis	 will	 use	 Computational	 Fluid	 Dynamic	 analysis	 in	 steady	 state	 to	
quantify	 in	 situ	 distraction	 force	 for	 59	 complete	 fenestrated	 stent-grafts	 and	
their	individual	components.		
In	part	one	blood	pressure	will	be	kept	constant	at	160mmHg	to	represent	peak	
systole	 in	a	hypertensive	patient	and	morphological	 features	will	 be	defined	 in	
order	 to	 assess	 their	 impact	 on	 distraction	 force.	 In	 part	 two,	 patient-specific	
blood	pressures	will	be	used	to	obtain	in	situ	distraction	forces	that	will	then	be	
related	to	the	incidence	of	migration	and	component	distraction.	
	
3.6 Hypotheses	
In	fenestrated	Endovascular	Aneurysm	Repair:	
1. Larger	angulation	of	vessels	is	associated	with	greater	distraction	force;	
2. Greater	distraction	force	is	associated	with	higher	incidence	of	migration	
and	component	distraction.	
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3.7 Limitations	
One	 limitation	 of	 a	 CFD	 approach	 is	 that	 a	 number	 of	 factors	 will	 change	
between	 models	 which	 may	 make	 elucidation	 of	 the	 effect	 of	 one	 particular	
feature	 more	 difficult.	 Blood	 will	 be	 modelled	 as	 a	 Newtonian	 fluid.	 This	 is	 a	
reasonable	 assumption	 for	 the	 large	 vessels	 and	 high	 velocity	 flows	 present	 in	
the	aorto-iliac	territory	(180).	
The	effect	of	the	blood	pressure	waveform	will	not	be	assessed	as	pulsatile	flow	
will	 not	 be	 modelled.	 	 The	 effect	 of	 endoleak	 (high	 AAA	 sac	 pressure)	 and	
aorta/stent-graft	 compliance	 will	 also	 not	 be	 assessed	 as	 this	 requires	
simultaneous	 modelling	 of	 tissue	 mechanical	 properties.	
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4 Measurement	of	Vessel	Angulation	
4.1 Abstract	
 Introduction	
In	order	to	quantify	the	effect	of	aorto-iliac	angulation	upon	distraction	force	it	is	
first	necessary	 to	describe	a	 reproducible	and	accurate	method	by	which	angle	
measurements	 can	 be	 obtained.	No	 standardised	method	 for	measurement	 of	
vessel	 angulation	 currently	 exists.	 The	 aim	 of	 this	 chapter	 was	 to	 develop	 a	
method	 of	 angle	 measurement	 that	 would	 be	 useful	 when	 assessing	 the	 link	
between	vessel	angulation	and	distraction	force.		The	interobserver	variation	of	
the	new	method	was	then	compared	with	the	standard	method	currently	in	use	
in	our	unit	for	measuring	vessel	angulation	during	the	EVAR	planning	process.		
 Method	
Interobserver	variation	in	the	measurement	of	the	angle	between	the	suprarenal	
aorta	 and	 the	 infrarenal	 neck	 (α	 angle)	 was	 assessed	 between	 five	 observers	
using	sagittal	or	coronal	 reconstructed	 images	of	CT	scans	 in	 the	arterial	phase	
on	 the	 Leonardo	 workstation	 (Siemmens	 AG,	 Germany).	 A	 protocol	 for	 a	 new	
method	 of	 angle	 measurement	 was	 drawn	 up	 with	 reference	 to	 existing	
literature	 and	 was	 used	 by	 the	 same	 five	 observers	 to	 measure	 the	 same	 α	
angles	 from	 three-dimensional	 models	 created	 using	 ScanIP	 software	
(Simpleware	 Ltd,	 UK).	 Results	 were	 compared	 using	 Wilcoxon	 matched-pair	
Signed-Rank	 test	 (WSR)	 and	 Friedman’s	 Two-way	 Analysis	 of	 Variance	 (FTAV).	
The	application	of	the	protocol	was	also	qualitatively	assessed.		
 Results	
The	 overall	median	 α	 angle	measured	with	 Leonardo	was	 17°	 (range	 0-56°)	 vs	
19.6°	 (range	 1.4-55.8°)	 for	 ScanIP,	 p=.723	 (WSR).	 There	 were	 no	 significant	
differences	between	the	two	methods	of	angle	measurement.	FTAV	revealed	no	
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significant	 differences	 in	 α	 angle	 measurement	 between	 observers	 using	
Leonardo	(p=.154)	or	ScanIP	(p=.171).	Qualitative	analysis	of	the	results	revealed	
that	 although	 there	 were	 no	 differences	 in	 the	 values	 recorded,	 there	 were	
major	 differences	 in	 interpretation	 and	 application	 of	 the	 protocol	 between	
methods	and	between	observers.	
 Conclusions	
Variation	between	observers	measuring	α	angle	was	not	improved	by	the	use	of	
the	 new	 method.	 It	 was	 however	 at	 least	 as	 good	 as	 the	 current	 method	 in	
common	use	and	can	be	used	 to	describe	angles	within	 the	aorto-iliac	arteries	
for	the	purpose	of	relating	them	to	haemodynamic	forces.	
	 	
		
61	
Chapter	4:	Measurement	of	Vessel	Angulation	
4.2 Introduction	
Standard	 geometric	 terminology	 can	 be	 used	 to	 define	 important	 features	
involved	in	the	measurement	of	an	angle	(see	Figure	4.1):	
Ray:	One	of	a	pair	of	lines	that	make	up	an	angle.	Technically	a	ray	is	a	line	with	
infinite	length	but	as	‘leg’	is	the	alternative	term	it	has	been	used	here	to	avoid	
confusion	with	the	anatomical	term	‘limb’.		
Vertex:	the	point	at	which	the	two	rays	converge.	The	‘pivot	point’	of	the	angle	
being	measured.	
Endpoint:	the	extent	of	each	ray	away	from	the	vertex.	
Supplementary	 angle:	 describes	 position	 of	 the	 second	 ray	 in	 terms	 of	 its	
deviation	 from	 the	 direction	 of	 the	 first	 assuming	 that	 the	 first	 ray	 runs	 from	
endpoint	to	vertex.		
	
	
Figure	4.1	Geometric	terminology	applied	to	β	angle	of	the	aorta	
:	Endpoint	of	ray,						:	Vertex,	β:	Supplementary	β	angle	
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For	accurate	angle	measurement	it	is	essential	that	rays	follow	a	Central	Luminal	
Line	 (CLL).	 This	 eliminates	 error	 caused	 by	 variation	 in	 the	 aortic	 wall	 or	
thrombus	lining	(See	Figure	4.2).	
	
Figure	4.2	Importance	of	central	luminal	line:	Angle	measurement	using	either	
aortic	wall	leads	to	different	results		
	
The	position	of	ray	endpoints	may	also	significantly	affect	the	magnitude	of	the	
angle	being	measured	(see	Figure	4.3).		
	
	
Figure	4.3	Importance	of	ray	endpoints:	The	choice	of	mid	common	iliac	artery	
or	bifurcation	as	the	position	for	distal	endpoint	leads	to	different	results	
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 Methods	for	measuring	angulation	in	aorto-iliac	arteries	
Angulation	of	the	aneurysm	neck	is	one	of	the	morphological	features	commonly	
associated	with	poor	outcome	after	EVAR	and	most	 stent-graft	 Instructions	 for	
Use	(IFU)	include	a	recommended	range	for	at	least	one	angle	within	the	aorto-
iliac	territory.	Despite	this	recommendation	there	is	no	standard	method	for	the	
measurement	 of	 aorto-iliac	 angulation.	 The	 2002	 EVAR	 reporting	 standards	
document	contained	no	definition	of	angles	or	measurement	method	(40)	but	a	
related	publication	defined	four	angles	(α,	β,	θ	and	φ)	and	recommended	the	use	
of	 spatially	 correct	 3D	 images	 from	 which	 to	 take	 measurements	 (181).	 The	
definitions	were	as	follows	(see	Figure	4.4):	
α	angle:	between	the	flow	axis	of	the	suprarenal	aorta	and	the	infrarenal	neck.		
β	angle:	between	the	flow	axis	of	the	infrarenal	neck	and	the	aneurysm.	
Φ/φ	angle:	the	most	acute	angle	in	the	aorta	(Φ)	and	iliac	arteries	(φ).	
	
Figure	4.4	α,	β	and	φ	angle.	From	Chaikof	et	al.	(181)	
(L1	and	L2	are	CLL	and	straight-line	distances	used	to	determine	the	iliac	tortuosity	index)	
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It	should	be	noted	that	in	this	publication	the	angles	were	‘internal’	rather	than	
‘supplementary’	 as	 is	more	 commonly	 used.	 The	 ‘internal’	 angle	 describes	 the	
difference	 between	 the	 position	 of	 first	 and	 second	 ray	 as	 if	 rotation	 had	
occurred	 around	 the	 vertex	 rather	 than	 as	 a	 deviation	 from	 the	 axis	 of	 blood	
flow.	The	sum	of	the	internal	and	supplementary	angles	is	always	180°.	
Many	other	published	 studies	dealing	with	 angulation	 refer	 to	one	or	other	of	
these	angles	but	provide	little	further	detail	on	how	measurements	were	actually	
obtained.	Most	of	these	studies	have	methodological	deficiencies	in	one	or	more	
of	the	following	areas:	
1. Angle	 terminology:	 Different	 terms	 used	 for	 the	 same	 angles,	 lack	 of	 clear	
definition	of	the	angles	measured	or	method	used	(45,	50,	141,	142,	182-184);	
2. Comprehensiveness	versus	applicability:	Methods	that	attempt	to	describe	all	
angulation	 within	 a	 complex	 vessel	 (185-187)	 are	 usually	 too	 rigid	 to	 allow	
application	to	variations	in	aorto-iliac	anatomy;	
3. Reproducibility:	 the	 less	 precise	 a	 method	 is	 in	 describing	 exactly	 how	 to	
manipulate	 images	 and	 measure	 an	 angle	 the	 less	 reproducible	 the	 results	
become	(182).	
 Proposed	improvements	
Terminology	 can	 be	 improved	 by	 using	 standard	 terms.	 Guidelines	 should	 be	
both	specific	and	to	some	degree	adaptable.	
All	 angle	 measurements	 considered	 so	 far	 have	 relied	 upon	 placing	 an	 angle	
measuring	tool	(i.e.	a	physical	or	electronic	protractor)	onto	a	projection	of	a	3D	
image.	 If	 the	 image	has	not	been	manipulated	 to	show	the	desired	angle	 in	 its	
maximum	 projection	 (i.e.	 the	 plane	 in	 which	 the	 angle	 appears	 as	 large	 as	
possible)	 then	 an	 incorrect	 measurement	 is	 inevitable	 despite	 accurate	
application	 of	 the	 measuring	 tool.	 3D	 calipers	 that	 can	 be	 applied	 to	 the	 CLL	
independent	of	 the	projection	 in	which	 the	angle	 is	being	 viewed	 is	 a	 function	
available	 in	 ScanIP	 (Simpleware	 Ltd,	 UK).	 The	 approach	 requires	 3D	 image	
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reconstruction	with	CLLs	as	opposed	to	coronal	and	sagittal	cross-sectional	views	
(188,	 189)	 but	 it	 may	 reduce	 the	 need	 for	 and	 variability	 caused	 by	 pre-
measurement	image	manipulation.	
 Aim	
The	 aim	 of	 this	 chapter	was	 to	 develop	 a	method	 of	 angle	measurement	 that	
would	 be	 useful	 when	 assessing	 the	 link	 between	 vessel	 angulation	 and	
distraction	force.		Interobserver	variation	of	this	new	method	was	assessed	and	
compared	 with	 the	 current	 method	 of	 angle	 measurement	 used	 for	 EVAR	
planning	in	Liverpool	Vascular	and	Endovascular	Service	(LiVES).	
	
	
4.3 Method	
 Preparation	of	images	
Ten	 patients	 who	 received	 standard	 EVAR	 were	 chosen	 at	 random	 from	 a	
departmental	 database.	 Each	 patient’s	 pre-intervention	 arterial	 phase	 CT	 scan	
was	 anonymised	 and	 imported	 into	 a	 commercially	 available	 image	 processing	
software	 (ScanIP,	 Simpleware	 Ltd,	 UK).	 Images	 were	 cropped	 to	 include	 the	
aorto-iliac	 segment	 from	 diaphragm	 to	 just	 distal	 to	 the	 common	 iliac	 artery	
bifurcation.		
The	 lumen	 and	 thrombus	were	 segmented	based	on	pixel	 greyscale	 density	 to	
obtain	 two	Regions	of	 Interest	 (ROIs,	 red:	 lumen,	purple:	 thrombus,	 see	Figure	
4.5).	 The	 lumen	 ROI	 was	 duplicated	 and	 a	 skeletalisation	 filter	 was	 applied	 to	
reduce	it	to	the	pixel	furthest	from	the	vessel	wall	in	each	axial	slice	thus	yielding	
a	CLL	(green	ROI,	Figure	4.5).		
The	 same	 CT	 scans	 were	 downloaded	 onto	 the	 Leonardo	 (Siemmens	 AG,	
Germany)	3D	workstation	and	anonymised.	
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Figure	4.5	Reconstructed	image	of	a	patient-specific	AAA.	Red	ROI:	lumen,	
purple:	thrombus,	green:	CLL	
	
 Angle	measurement	
α	 angles	 were	 measured	 by	 five	 observers	 using	 both	 ScanIP	 and	 Leonardo	
workstation.	 All	 observers	 had	 previous	 experience	 of	 EVAR	 planning	with	 the	
Leonardo	workstation.	Three	were	researchers	enrolled	in	MD	or	PhD	programs	
with	 LiVES	 and	 the	 University	 of	 Liverpool,	 the	 other	 two	 were	 Specialist	
Registrars	in	Vascular	Surgery.	
 ScanIP	method	
Observers	were	 given	 three	 test	 cases	 to	 get	 used	 to	 the	 software.	 They	were	
then	asked	to	follow	the	protocol	detailed	in	Appendix	8.2	and	measure	α	angle	
using	3D	calipers	applied	to	the	CLL.	
α	angle	was	defined	as	the	angle	between	the	axis	of	blood	flow	in	the	neck	of	
the	aneurysm	(at	the	seal-zone	of	the	planned	standard	EVAR)	in	relation	to	that	
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of	the	aorta	 immediately	proximal	to	this.	The	vertex	was	defined	as	the	major	
angulation	of	CLL	nearest	the	lowest	renal	artery.	Proximal	endpoint	was	defined	
as	where	the	CLL	of	the	superior	mesenteric	artery	joins	the	aortic	CLL	and	distal	
endpoint	was	the	most	distal	point	of	the	CLL	along	the	neck	of	the	aneurysm	or	
the	next	major	angle	vertex.	The	protocol	was	designed	to	prescribe	the	setting	
of	endpoints	and	vertex	whilst	leaving	some	room	for	application	to	variations	in	
aneurysm	morphology.	An	advisor	was	available	for	technical	software	issues	but	
not	to	give	any	advice	regarding	application	of	the	protocol.	
 Leonardo	method	
Observers	measured	the	same	angles	on	the	Leonardo	workstation	with	at	least	
24hrs	 rest	 between	 each	 method.	 This	 workstation	 uses	 axial	 CT	 slices	 to	
reconstruct	 coronal	 and	 sagittal	 images	 that	 can	 be	 manipulated	 in	 different	
planes	 to	provide	projections	of	 the	aortic	 lumen.	Observers	were	asked	 to	do	
this	 in	 the	usual	way	as	 for	EVAR	planning.	No	CLL	was	available	 therefore	 the	
angle	measuring	 tool	 (a	 two-dimensional	 electronic	 caliper)	 had	 to	 be	 applied	
over	 an	 estimated	 CLL	 on	 the	manipulated	 image	 in	 either	 sagittal	 or	 coronal	
plane	that	projected	the	largest	angle.	
 Statistical	analysis	
Variation	 between	 methods	 was	 assessed	 by	 comparing	 paired	 angle	
measurements	using	Wilcoxon	matched-pair	Signed-Rank	test	(WSR).	Observers	
were	compared	using	Friedman’s	Two-way	Analysis	of	Variance.	
	
	 	
		
68	
Chapter	4:	Measurement	of	Vessel	Angulation	
4.4 Results	
Five	observers	measured	α	angle	in	ten	aneurysms	(see	Table	4.1).	Observer	four	
failed	to	record	α	angle	for	aneurysm	nine	with	ScanIP	and	observer	five	failed	to	
record	α	angle	for	aneurysm	two	with	ScanIP	and	aneurysm	three	with	Leonardo.	
	
Table	4.1	α	angle	measurements	in	degrees	made	by	each	observer	
Observer	
EVAR	
1	 2	 3	 4	 5	 6	 7	 8	 9	 10	
1	 Leo	 52	 5	 22	 34	 13	 8	 52	 9	 18	 8	
ScanIP	 17.5	 22.9	 17.7	 16.3	 21.8	 13.1	 16.5	 7.6	 31.2	 11.4	
2	 Leo	 12	 5	 16	 38	 23	 18	 49	 3	 28	 11	
ScanIP	 45.5	 19.5	 24	 25.5	 22.5	 23	 55.8	 1.4	 28.5	 10.7	
3	 Leo	 45	 24	 16	 45	 28	 30	 56	 0	 31	 7	
ScanIP	 45.4	 19.3	 18.4	 31.1	 20.2	 25.6	 53.1	 7.9	 24.6	 14	
4	 Leo	 13	 21	 9	 36	 18	 17	 14	 7	 12	 12	
ScanIP	 12.9	 21.6	 4.1	 20.5	 26.4	 13.9	 18.5	 5.3	 	-	 24.4	
5	 Leo	 54	 10	 	-	 37	 17	 20	 13	 10	 34	 15	
ScanIP	 15.3	 	-	 3.2	 23.4	 30.8	 8.9	 19.6	 8.3	 26.4	 10.3	
	
	
 Analysis	by	method	
The	 overall	 median	 α	 angle	 measured	 with	 Leonardo	 was	 17°	 (range	 0-56°)	
versus	19.6°	 (range	1.4-55.8°)	 for	 ScanIP.	 There	were	no	 significant	differences	
between	 the	values	obtained	using	either	 two	methods	of	angle	measurement	
p=.723	(WSR).	
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 Analysis	by	observer	
Paired	 data	 was	 also	 analysed	 between	 observers	 using	 Friedman’s	 Two-way	
Analysis	of	Variance.	This	is	similar	to	Kruskal-Wallis	test	in	that	it	compares	the	
distribution	of	multiple	groups	of	non-parametric	data	for	significant	differences	
but	can	be	used	when	the	observations	are	 linked.	 In	 this	case	 there	were	 five	
groups	with	ten	linked	observations	for	each	method.	There	were	no	significant	
differences	in	α	angle	measurement	between	observers	using	Leonardo	(p=.154)	
or	ScanIP	(p=.171).	
 Qualitative	analysis	of	images	
Even	though	there	was	no	statistically	significant	difference	in	α	angles	measured	
by	 the	 five	 observers	 using	 the	 two	 techniques,	 examination	 of	 the	 pictures	
recorded	at	 the	 time	of	angle	measurement	 showed	variation	 in	application	of	
the	protocol.	 In	 case	one,	using	 the	Leonardo	method,	observers	 two	and	 four	
chose	to	position	the	vertex	at	the	level	of	the	lowest	renal	artery	on	the	sagittal	
image	 and	measure	 the	 slight	 anterior	 angulation	 just	 distal	 to	 that	 point	 (see	
Figure	4.6A).		
	
Figure	4.6	Case	1.	Two	different	α	angles	measured	using	different	images	on	
the	Leonardo	workstation	(A:	12°,	B:	54°)	
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Observers	 one,	 three	 and	 five	 chose	 to	 use	 the	 coronal	 image	 and	 measure	
lateral	angulation	(see	Figure	4.6B).	Case	one	α	angle	using	Leonardo	therefore	
varied	from	12-13°	to	45-54°.	The	same	two	ways	of	applying	the	protocol	were	
also	seen	with	the	ScanIP	method	(see	Figure	4.7).		
	
	
Figure	4.7	Case	1.	Two	different	α	angles	measured	using	ScanIP	(A:	17°,	B:	45°)	
Only	observers	three	and	four	consistently	measured	the	same	α	angle	with	both	
methods	 in	 case	 one.	 Observers	 one,	 four	 and	 five	 chose	 to	 use	 the	 exact	
position	at	which	the	CLL	of	the	lowest	renal	artery	meets	the	CLL	of	the	visceral	
aorta	as	the	vertex	(as	shown	in	Figure	4.7A)	whereas	observers	two	and	three	
chose	the	more	obvious	vertex	just	distal	to	this	point	(Figure	4.7B).	The	resulting	
α	angle	for	case	one	measured	using	ScanIP	was	either	approximately	17°	or	45°.		
Case	 four	 illustrates	 how	 even	 when	 the	 same	 angle	 is	 measured,	 different	
methods	of	image	manipulation	with	the	Leonardo	method	can	lead	to	variation	
in	 the	 resulting	 α	 angle	 (see	 Figure	 4.8).	 The	 lower	 levels	 of	 magnification	 in	
images	A	and	C	compared	with	B	may	have	contributed	some	of	 the	variation.	
The	3D	 calipers	 in	 ScanIP	 that	 automatically	 adhere	 to	 the	CLL	 and	 reduce	 the	
need	for	and	variation	caused	by	image	manipulation	were	expected	to	improve	
the	 reproducibility	 of	 α	 angle	 measurement.	 However,	 even	 when	 the	 ScanIP	
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protocol	was	applied	 in	a	consistent	manner,	slight	differences	 in	 the	choice	of	
vertex	position	or	ray	endpoints	led	to	a	variation	of	16	to	31°	(see	Figure	4.9).	
	
Figure	4.8	Case	4.	The	same	α	angle	measured	using	different	magnification	
with	the	Leonardo	workstation	(A:	34°,	B:	38°,	C:	45°)	
	
	
Figure	4.9	Case	4.	Variation	in	α	angle	measured	using	ScanIP	(A:	16°,	B:	23°,	C:	
31°)	
	
	
4.5 Discussion	
The	 complex	 morphology	 of	 the	 aorta	 makes	 the	 measurement	 of	 angulation	
difficult.	 No	 standardised	 method	 exists	 despite	 the	 inclusion	 of	 maximum	
angulation	 within	 the	 instructions	 for	 use	 of	 all	 commercially	 available	 stent-
grafts.	 An	 ideal	 method	 is	 consistent	 in	 terminology,	 applicable	 to	 anatomical	
variation	 and	 reproducible	 both	 in	 terms	 of	 image	 manipulation	 and	 actual	
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measurement	 technique.	 In	 this	 chapter	 a	 proposed	 new	 method	 of	 angle	
measurement	(ScanIP)	was	assessed	against	the	current	method	used	in	our	unit	
(Leonardo).	 The	 new	 method	 included	 the	 use	 of	 three-dimensional	
reconstructed	 images,	 a	 central	 luminal	 line	 and	 three-dimensional	 calipers	 to	
reduce	variability	caused	by	image	manipulation	and	measurement	technique.	It	
was	 written	 using	 standardised	 terms	 as	 a	 prescriptive	 protocol	 to	 improve	
overall	reproducibility	whilst	still	allowing	for	applicability	to	variation	in	normal	
anatomy.		
Overall	 there	 were	 no	 statistically	 significant	 differences	 between	 α	 angles	
measured	 with	 Leonardo	 compared	 with	 those	 measured	 with	 ScanIP.	 There	
were	also	no	 significant	differences	between	observers	using	either	of	 the	 two	
methods.	 The	 results	 show	non-inferiority	 of	 the	 ScanIP	method	 and	 justify	 its	
use	as	a	means	to	measure	aortic	angulation.	
Examining	 the	 measurements	 qualitatively	 in	 section	 4.4.3	 revealed	 some	
variation	in	the	application	of	protocol.	This	possibly	contributed	to	the	absence	
of	 the	expected	reduction	 in	variation	that	was	anticipated	with	 the	use	of	 the	
ScanIP	method	with	 its	prescriptive	protocol,	3D	reconstructed	images,	CLL	and	
3D	calipers.	Feedback	training	before	another	round	of	angle	measurement	using	
ten	different	aneurysms	may	have	reduced	variability	but	was	beyond	the	scope	
of	the	current	study.		
In	relating	the	current	results	to	the	measurement	of	angulation	in	the	aorto-iliac	
vessels	 after	 fenestrated	 endovascular	 aneurysm	 repair	 for	 the	 purpose	 of	
determining	an	association	with	distraction	force	the	following	points	should	be	
considered:	
1. One	 observer	 will	 be	 making	 the	 measurements	 providing	 no	 potential	 for	
interobserver	variation.	
2. A	less	prescriptive	approach	to	describing	the	angles	to	be	measured	may	be	
appropriate	since	this	was	not	shown	to	improve	variability.	
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3. Theoretical	models	include	the	angle	of	outlets	in	reference	to	the	angle	of	the	
inlet	 therefore	 this	 needs	 to	 be	measured	 for	 the	 complete	 fenestrated	 stent-
graft	and	 for	each	component	 in	 turn.	Previous	work	 from	this	unit	has	 shown	
that	 the	 iliac	 vessels	 become	 significantly	 less	 tortuous	 following	 stent-graft	
deployment	 (190).	 This	 should	 improve	 the	 reproducibility	 of	 angle	
measurement	 as	 calipers	 are	 much	 easier	 to	 fit	 to	 straight	 lines	 rather	 than	
curves.	
4. To	 enable	 comparison	 of	 Computational	 Fluid	 Dynamic	 (CFD)	 results	 with	
analytical	models	 all	 angles	will	 need	 to	 be	measured	 in	 two	 separate	 planes.	
This	will	be	the	only	way	to	ensure	the	three-dimensional	arrangement	of	limbs	
in	 a	 bifurcated	 component	 can	 be	 accurately	 determined	 in	 relation	 to	 each	
other.	One	angle	measurement	as	obtained	using	the	ScanIP	technique	detailed	
above	does	not	enable	this.	Two,	two-dimensional	angles	will	therefore	need	to	
be	 measured	 for	 each	 vessel	 angulation.	 Measuring	 angles	 in	 this	 way	 will	
require	 a	 simple	 and	 reproducible	method	 of	 image	manipulation	 to	 eliminate	
possible	confounding	factors.		
The	 eventual	 method	 devised	 for	 angle	 measurement	 for	 the	 purpose	 of	
distraction	force	analysis	is	detailed	in	chapter	five.	α	angle	was	retained	as	the	
angle	describing	the	axis	of	blood	flow	into	the	proximal	part	of	the	stent-graft.	It	
was	adapted	for	use	in	fEVAR	so	that	α	angle	became	the	angle	between	the	axis	
of	blood	flow	in	the	seal-zone	of	the	proximal	body	component	in	relation	to	the	
abdominal	aorta	immediately	above.		Other	angles	measured	include:	
‘β	angle’	–	adapted	 from	the	Society	 for	Vascular	Surgery	publication	 to	define	
the	 axis	 of	 blood	 flow	 in	 the	 distal	 body	 component	 in	 relation	 to	 the	 visceral	
aorta	 (181).	 This	 is	 an	 approximation	 of	 the	 aneurysm	 angle	 in	 standard	 EVAR	
planning.	
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‘θ	angle’	-	defines	the	axis	of	blood	flow	at	the	outlet	of	a	component	in	relation	
to	 its	 inlet.	 All	 rays	were	 required	 to	 be	 at	 least	 as	 long	 as	 the	 corresponding	
sealing	stent.	
	
	
4.6 Conclusion	
Variability	 in	 measurement	 of	 α	 angle	 was	 not	 improved	 with	 the	 use	 of	 a	
prescriptive	 protocol,	 3D	 reconstructed	 images,	 CLL	 and	 3D	 calipers.	 This	
approach	is	however	at	least	as	good	as	the	current	method	in	common	use	and	
has	been	developed	further	to	define	angles	within	the	aorto-iliac	arteries	for	the	
purpose	 of	 investigating	 the	 association	 between	 morphological	 features	 and	
distraction	force.		
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5 Determining	Distraction	Force	for	Individual	Components	
of	the	Fenestrated	Stent-graft	with	Particular	Reference	to	
Morphological	Features	
5.1 Abstract	
 Background	
Secure	 fixation	 of	 endovascular	 stent-grafts	 is	 essential	 for	 successful	
endovascular	 aneurysm	 repair.	 Haemodynamic	 distraction	 forces	 act	 against	
fixation	 force	 to	 encourage	migration	 that	may	 lead	 to	 stent-graft	 failure.	 The	
aim	of	 this	 chapter	was	 to	 quantify	 distraction	 forces	 acting	 on	 all	 fenestrated	
stent-graft	 components	 and	 determine	 which	 morphological	 factors	 were	
associated	with	greater	force.	
 Method	
Computer	models	 of	 54	 fenestrated	 stent-grafts	were	 constructed	using	 image	
processing	software	(ScanIP,	Simpleware	Ltd).	The	models	were	exported	into	a	
finite-volume	solver	(FLUENT	v6.2,	ANSYS	Inc.)	for	computational	fluid	dynamics	
analysis	using	boundary	conditions	representative	of	peak	systole	in	a	patient	at	
rest.	 Distraction	 force	 results	 were	 obtained	 in	 three	 directions	 and	 used	 to	
calculate	 total	 Resultant	 Distraction	 Force	 (RDF).	 Cross-sectional	 area	 was	
measured	and	correlated	with	total	RDF.	Complete	stent-grafts	and	components	
were	grouped	according	to	angulation	≥45°	or	<45°	and	total	RDF	was	compared	
by	non-parametric	methods	(Mann-Whitney	U,	MWU).	
 Results	
Median	 total	 Resultant	 Distraction	 Force	 (RDF)	 acting	 on	 the	 complete	 stent-
grafts	was	6.0N	 (range	0.3-17.7N),	on	proximal	bodies:	4.8N	 (range	1.3-15.7N),	
distal	bodies	5.6N	(range	1.0-8.0N)	and	limb	extensions	1.7N	(range	0.6-8.4N).		
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Inlet	cross-sectional	area	(XSA)	exhibited	a	strong,	positive	correlation	with	total	
RDF	 in	 complete	 stent-grafts,	 proximal	 body	 and	 distal	 body	 components	
(Spearman’s	 Rho	 0.814,	 0.883,	 0.802	 respectively).	 Outlet	 XSA	 exhibited	 a	
similarly	strong,	positive	correlation	with	total	RDF	in	limb	extension	components	
(Spearman’s	Rho	0.822).		
Outlet	angulation	≥45°	was	significantly	associated	with	greater	total	RDF	in	the	
most	 angulated	 groups	 i.e.	 complete	 stent-grafts	 and	 limb	 extension	
components	(Median	total	RDF	 in	complete	stent-grafts	with	angle	<45°	=	2.6N	
vs	6.2N	 in	those	≥45°,	p<.001,	MWU.	Median	total	RDF	 in	 limb	extensions	with	
angle	<45°	=	1.4N	vs	2.1N	in	those	≥45°,	p=.004,	MWU).	
 Conclusion	
This	 chapter	 demonstrates	 a	 technique	 to	 obtain	 distraction	 force	 results	 for	
individual	 components	 of	 a	 fenestrated	 stent-graft	 using	 CT	 images	 and	
computational	fluid	dynamics.	
For	 a	 given	 blood	 pressure	 cross-sectional	 area	 was	 the	 most	 important	
morphological	determinant	of	total	resultant	distraction	force.	Angulation	within	
the	aorta	was	not	 large	enough	 to	 significantly	 influence	distraction	 force.	 Iliac	
angulation	 affecting	 outlet	 angles	 of	 complete	 stent-grafts	 and	 limb	 extension	
components	was	associated	with	significantly	greater	 total	 resultant	distraction	
force.	
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5.2 Introduction	
Fenestrated	endovascular	aneurysm	repair	provides	a	less	invasive	alternative	to	
open	 surgery	 in	abdominal	aortic	aneurysms	 that	are	not	 suitable	 for	 standard	
EVAR.	The	Zenith	fenestrated	stent-graft	(Cook	Medical	Inc.,	Bloomington,	USA)	
has	 a	 modular	 design	 that	 comprises	 a	 customisable	 proximal	 body	 with	
fenestrations	 for	 visceral	 vessels,	 a	 bifurcated	 distal	 body	 and	 at	 least	 one	
tubular	 limb	extension.	 Secure	 fixation	of	 all	 components	within	 the	aorta	 and	
iliac	arteries	is	essential	for	successful	repair.		
Clinical	 studies	of	 standard	 stent-grafts	have	 linked	 large	diameter,	 conical	and	
highly	 angulated	 aneurysm	 necks	 to	 migration,	 type	 I	 endoleak	 and	 increased	
rates	of	 secondary	 interventions	 (45,	46,	48-52,	115,	142).	A	possible	cause	 for	
this	is	the	adverse	effect	that	these	unfavourable	morphological	features	have	on	
stent-graft	 fixation.	 In	 addition	 to	 the	 impact	 on	 fixation	 force,	 unfavourable	
morphology	may	 also	 increase	 haemodynamic	 distraction	 forces	 acting	 against	
fixation	 force	 in	 situ	 (43,	 158,	 163,	 172).	 Haemodynamic	 distraction	 forces	 are	
generated	by	blood	pressure	and	blood	 flow	and	may	 lead	 to	migration	of	 the	
stent-graft.	If	distraction	force	overcomes	fixation	force	in	a	fenestrated	proximal	
body,	migration	 carries	 the	 added	 risk	 of	 visceral	 vessel	 loss	 as	well	 as	 type	 Ia	
endoleak,	aneurysm	expansion	and	subsequent	rupture.	Component	distraction	
involving	 the	 distal	 body	 may	 lead	 to	 type	 IIIa	 endoleak	 and	 limb	 extension	
migration	 risks	 type	 Ib	 endoleak.	 Both	 types	of	 endoleak	may	ultimately	 cause	
aneurysm	expansion	and	rupture.	
Chapter	three	outlined	the	evidence	linking	morphological	features	with	greater	
distraction	 forces.	 Whilst	 larger	 proximal	 cross-sectional	 area	 was	 firmly	
associated	with	greater	distraction	 force,	 the	effect	of	angles	was	 less	obvious.		
Analytical	models	suggest	that	the	 larger	the	angle	of	bifurcation	 in	a	Y-shaped	
tube,	 the	greater	 the	 forces	are	acting	on	that	 tube	(44).	This	effect	may	be	as	
much	 as	 a	 52%	 increase	 in	 distraction	 force	 in	 stent-grafts	 with	 a	 bifurcation	
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angle	 of	 80°	 compared	 with	 10°	 (158).	 Computational	 fluid	 dynamics	 (CFD)	
studies	 in	 idealised	 stent-graft	 geometries	 have	 also	 shown	 the	 link	 between	
large	bifurcation	angles	and	greater	forces	but	the	effect	of	other	angles	within	
the	stent-graft	territory	is	less	well	defined	(163,	165).	
No	previous	in	silico	study	has	determined	distraction	forces	for	individual	stent-
graft	 components.	 This	 concept	 may	 be	 more	 relevant	 when	 considering	 a	
fenestrated	 stent-graft	 as	 opposed	 to	 a	 standard	 stent-graft	 due	 to	 its	 greater	
modularity.		
	
5.3 Aim	
The	aim	of	this	chapter	is	to	use	CFD	to	determine	distraction	force	at	constant	
blood	pressure	for	each	component	of	54	fenestrated	stent-grafts	with	particular	
reference	 to	 morphological	 features	 such	 as	 cross-sectional	 area	 and	 vessel	
angulation.		
	
5.4 Hypothesis	1	
Larger	vessel	angulation	is	associated	with	greater	distraction	force.	
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5.5 Methods	
 Model	construction	
Construction	 of	 computer	 models	 consisted	 of	 three	 distinct	 phases:	 Image	
acquisition,	 image	 manipulation	 (segmentation),	 and	 model	 construction	
(meshing).	
 Image	acquisition	
Arterial	phase	postoperative	CT	scans	in	Digital	Imaging	and	Communications	in	
Medicine	 (DICOM)	 format	 were	 imported	 into	 a	 commercially	 available	 image	
processing	 software	 (ScanIP,	 Simpleware	 Ltd).	 Axial	 slices	 were	 selected	 and	
cropped	in	anterio-posterior	and	 lateral	directions	to	 include	the	distal	thoracic	
aorta	 to	 the	 external	 iliac	 artery	 and	 at	 least	 the	 first	 order	 divisions	 of	 the	
visceral	 vessels.	 Two	 copies	 of	 these	 cropped	 axial	 slices	 were	 imported	 into	
ScanIP.	Each	was	given	different	windowing	(W)	and	level	(L)	settings	in	order	to	
provide	sharper	detail	of	either	the	vessel	 lumen	(W:L	900:300)	or	the	stainless	
steel	stent	framework	(W:L	4000:400).	
 Image	manipulation	(Segmentation)	
Definition:	 the	 partitioning	 of	 a	 region	 of	 interest	 (ROI)	 from	 a	 background	
image.		
5.5.1.2.1 Segmentation	of	lumen	
Using	 the	900:300	background	 images,	pixel	greyscale	density	 in	 the	aorto-iliac	
lumen	 was	 sampled	 along	 its	 longitudinal	 axis.	 All	 pixels	 within	 the	 sampled	
greyscale	range	were	then	segmented.		
The	segmented	lumen	was	smoothed	and	re-filled	to	remove	unconnected	pixels	
of	 similar	 density	 in	 the	 surrounding	 tissues.	 Metal	 artefacts	 caused	 by	
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radiopaque	markers	and	visceral	 stents	 (as	shown	 in	Figure	5.1)	were	removed	
by	manually	segmenting	pixels	on	sequential	axial	images.		
	
Figure	5.1	Axial	image	of	900:300	background	at	the	level	of	the	renal	arteries	
showing	metal	artefact	(M)	caused	by	gold	radiopaque	marker	(G).	Lumen	
represented	by	red	ROI	
Some	 CT	 scans	 had	 different	 axial	 slice	 thickness,	 therefore	 all	 images	 were	
resampled	with	a	pixel	size	of	0.4mm	in	x,	y	and	z	axes.	The	lumen	was	smoothed	
again	and	pixel	greyscale	density	was	sampled	in	transverse	section	of	the	distal	
thoracic	 aorta	 to	 ensure	 the	 remaining	 ROI	 was	 a	 true	 representation	 of	 the	
arterial	contrast	volume	and	therefore	also	of	the	vessel	lumen.		
5.5.1.2.2 Segmentation	of	model	outlets	
Using	a	 cuboidal	3D	editing	 tool,	 an	artificial	 region	of	 interest	was	 segmented	
towards	the	distal	extent	of	every	outflow	vessel	(shown	as	multi-coloured	parts	
in	Figure	5.2	over	page).	The	proximal	surface	was	created	perpendicular	 to	 its	
outflow	vessel	and	the	contact	between	that	surface	and	the	lumen	ROI	(shown	
in	red	in	Figure	5.2)	was	assigned	as	‘outlet’.	
5.5.1.2.3 Segmentation	of	radiopaque	markers	and	stents	
Pixels	 with	 greyscale	 density	 220-255	 were	 segmented	 from	 the	 4000:400	
background	 images	 to	 represent	 the	 radiopaque	markers.	Greyscale	 density	 of	
the	 stainless	 steel	 stents	was	 sampled	 from	the	same	background	 to	create	an	
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ROI	representative	of	the	stent	framework.	The	average	range	of	pixel	greyscales	
in	this	ROI	was	approximately	140-220.	
	
Figure	5.2	3D	rendering	of	lumen	(red)	showing	all	outlet	regions	of	interest	
(multi-coloured	parts)	
	
5.5.1.2.4 Segmentation	of	graft	fabric	
The	 lumen	 ROI	 was	 duplicated	 and	 dilated	 by	 two	 pixels	 in	 each	 direction	 to	
create	a	larger	copy.	The	original	lumen	was	subtracted	from	it	to	give	a	new	ROI	
that	 completely	 enveloped	 the	 lumen.	 This	 formed	 the	basis	 of	 the	 stent-graft	
fabric	and	further	editing	was	then	performed	to	create	separate	ROIs	for	each	
component	 based	on	 the	 position	 of	 stents	 and	 radiopaque	 gold	markers.	 The	
proximal	body,	distal	body	and	 limb	extension	ROIs	 that	 this	process	produced	
are	shown	in	Figure	5.3.	In	those	stent-grafts	where	the	ipsilateral	limb	remained	
in	close	apposition	 to	 the	contralateral	 limb	some	manual	deletion	of	 the	graft	
fabric	ROI	was	necessary	to	separate	the	 limbs	and	complete	the	segmentation	
of	the	limb	extension.	
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Figure	5.3	3D	rendering	of	fenestrated	stent-graft	components	
A:	Proximal	body	(blue).	Inlet:	Upper	margin	of	proximal	gold	radiopaque	fabric	markers	
(PGM).	Outlet:	lower	margin	of	distal	gold	radiopaque	marker	(DGM).	ROI	cropped	
perpendicular	to	stent	rows	(white	arcs)	in	each	case.	Fenestrations	‘cut’	according	to	
position	of	gold	radiopaque	markers	(S:	scallop	for	superior	mesenteric	artery,	F1:	small	
fenestration	for	left	renal	artery).	
B:	Distal	body	(green).	Inlet:	Upper	margin	of	proximal	gold	radiopaque	marker	(PGM)	
with	ROI	cropped	perpendicular	to	1st	sealing	stent	(white	arc).	Outlets:	lower	extent	of	
the	radiopaque	‘tick’	marker	(TM)	perpendicular	to	the	last	stent	of	the	contralateral	
gate	and	perpendicular	to	the	distal	sealing	stent	of	the	ipsilateral	limb	(white	arcs).		
C:	Limb	extension	(orange):	Inlet	-	Perpendicular	to	the	upper	extent	of	the	proximal	
sealing	stent	(PS).	Outlet	-	perpendicular	to	the	lower	extent	of	the	distal	sealing	stent	
(DS).	
Lumen	shown	in	red.	Arrows	indicate	directions	in	which	force	results	were	obtained:	x	
(red	arrow),	y	(green	arrow),	z	(blue	arrow).	
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5.5.1.2.5 Combining	ROI	
Because	 the	 CFD	 software	 could	 not	 recognise	 overlapping	 stent-graft	
components,	 the	 technique	 above	 required	 four	 separate	 models	 of	 each	
patient’s	 lumen	 (i.e.	 one	model	 each	 for	 proximal	 body,	 distal	 body	 and	 limb	
extension	 plus	 a	 complete	 stent-graft	 model).	 A	 different	 technique	 was	 used	
after	 the	 first	 20	 patients	 in	 order	 to	 make	 the	 process	 more	 efficient:	 By	
creating	ROIs	 to	 represent	 the	overlapping	parts	and	by	 then	subtracting	 them	
from	each	other	it	was	possible	to	represent	the	complete	stent-graft	or	any	of	
its	 constituent	 components	 on	 the	 same	 lumen	 model.	 Figure	 5.4	 shows	 the	
arrangement	 of	 these	 ROIs	 for	 one	 fenestrated	 stent-graft.	 Appendix	 8.3	
compares	 both	 methods	 and	 confirms	 that	 this	 did	 not	 affect	 the	 distraction	
force	results.	
	
Figure	5.4	Regions	of	interest	combine	to	represent	the	complete	stent-graft	or	
constituent	components	upon	the	same	lumen	model.	Complete	stent-graft:		
ROI	1,	2,	3,	4,	5,	6;	Proximal	body:	ROI	1,	2,	3;	Distal	body:	ROI	2,	3,	4,	6;	Limb	
extension:	ROI	3,	4,	5	
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 Meshing	
Definition:	 The	 construction	 of	 a	 three-dimensional	 model	 from	 the	 pre-
segmented	 regions	 of	 interest	 using	 smaller	 tetrahedral	 building	 blocks	 or	
elements.		
Computer	 models	 were	 constructed	 from	 the	 segmented	 regions	 of	 interest	
using	 a	 free	 mesh	 algorithm.	 This	 algorithm	 automatically	 choses	 small	
tetrahedral	elements	to	preserve	fine	detail	and	uses	large	tetrahedral	elements	
to	reduce	complexity	and	therefore	file	size	in	areas	where	detail	is	not	required	
(i.e.	 the	 centre	 of	 the	 lumen).	 Mesh	 complexity	 was	 pre-set	 by	 selecting	 the	
‘compound	 coarseness’.	 Following	 a	 series	 of	 preliminary	 experiments	 (see	
appendix	 8.4)	 compound	 coarseness	 of	 -20	 was	 chosen.	 This	 gave	 tetrahedral	
elements	with	a	minimum	edge	length	of	0.76mm	and	maximum	of	1.84mm.	The	
average	number	of	elements	per	model	was	approximately	1.4million.		
 Assigning	model	boundary	conditions	
5.5.1.4.1 Fluid	region	and	wall	
Only	the	region	of	 interest	representing	the	 lumen	was	used	to	create	a	three-
dimensional	meshed	volume.	This	volume	was	designated	as	‘fluid’.	The	volume	
of	 the	 stent-graft	 components	ROIs	was	not	used	 in	 the	meshing	process;	only	
the	 surface	 area	 contact	 between	 the	 component	 and	 the	 lumen	 ROI	 was	
included	and	assigned	as	 ‘wall’.	All	walls	were	considered	 to	be	 rigid	with	 zero	
flow	velocity	(i.e.	‘no-slip’	conditions).	
5.5.1.4.2 Inlets	and	outlets	
The	 proximal	 extent	 of	 the	 lumen	 was	 assigned	 as	 the	 model	 ‘inlet’.	 Model	
outlets	were	assigned	to	 the	surface	area	of	contact	between	 lumen	and	cubic	
outlet	ROIs	created	for	all	patent	major	aortic	branches	(as	shown	in	Figure	5.2).	
This	 included	 separate	 outlets	 for	 coeliac	 axis	 (CA),	 superior	mesenteric	 artery	
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(SMA),	left	and	right	renal	artery	(RA),	left	and	right	common	iliac	(CIA)	or	-	when	
the	 distal	 extent	 of	 the	 stent-graft	 was	 close	 to	 the	 bifurcation	 -	 internal	 and	
external	iliac	artery	(IIA/EIA).	
 Computational	Fluid	Dynamics	(CFD)	
Models	were	exported	into	a	finite-volume	solver	(FLUENT	v6.2,	ANSYS	Inc.)	for	
simulation	of	blood	flow	at	steady-state	using	laminar	flow.	CFD	uses	numerical	
methods	to	solve	the	Navier-Stokes	equations	which	are	the	governing	equations	
of	 fluid	motion.	 These	 equations	 are	 described	 in	more	 detail	 in	 section	 3.3.3	
Computational	Fluid	Dynamics	(CFD).		
 Assigning	simulation	boundary	conditions	
5.5.2.1.1 Fluid	domain	and	Inlet	conditions	
Blood	 was	 represented	 by	 a	 Newtonian	 fluid	 with	 viscosity	 0.0033Pa.s	 and	
density	1098	kg/m3.	Boundary	conditions	were	representative	of	peak	systole	in	
a	hypertensive	patient	at	rest.	Inlet	pressure	of	the	model	was	set	at	160mmHg.	
Inlet	volume	flow	rate	was	chosen	to	represent	peak	systole	in	the	supracoeliac	
aorta	 at	 rest	 (1.323x10-4	 m3/s)	 (191).	 Velocity	 was	 calculated	 by	 dividing	 the	
volume	 flow	 rate	 by	 the	 orthogonal	 cross-sectional	 area	 of	 the	most	 proximal	
extent	of	the	lumen.		
5.5.2.1.2 Outlet	conditions	
Outlet	weighting	was	assigned	to	outlet	vessels	to	represent	the	division	of	blood	
flow	at	rest	(192).	The	CA	received	33%	of	supracoeliac	blood	flow,	SMA:	7.4%,	
RAs:	 14.8%	 equally	 divided	 between	 left	 and	 right,	 EIAs:	 15.7%	 each	 and	 IIAs:	
6.7%	each.	If	one	visceral	artery	was	occluded	its	flow	weighting	was	given	to	the	
contralateral	 patent	 vessel.	 In	 the	 case	 of	 aorto	 uni-iliac	 repair	 all	 infrarenal	
blood	flow	was	assigned	to	the	patent	limb.	
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 Validation	
Prior	 validation	 of	 this	 method	 of	 blood	 flow	 simulation	 was	 carried	 out	 by	
comparison	with	analytical	and	pulsatile	flow	experimental	models	of	simplified	
geometries:	
 Method	
5.5.3.1.1 CFD	model:	Modelling,	meshing	and	flow	simulation	
A	 computer	 model	 of	 a	 simplified	 bifurcated	 stent-graft	 was	 created	 by	 using	
ScanCAD	–	a	computer	aided	design	software	from	Simpleware	Ltd	–	to	combine	
three	 cylindrical	 shapes	 representing	 the	 aorto-iliac	 lumen.	 Dimensions	 were	
chosen	 to	 recreate	 the	desktop	experimental	model	used	by	Zhou	et	al.	 (154).	
The	main	body	diameter	was	30mm,	length	150mm;	Iliac	 limb	diameter:	12mm	
with	length:	150mm.	Iliac	angulation	was	30°	for	each	limb	in	the	same	plane	(i.e.	
bifurcation	angle:	60°).	 	The	bifurcated	ROI	were	exported	 into	ScanIP	where	a	
3D	 computer	model	 (Figure	 5.5)	was	 constructed	 using	 a	 free	mesh	 algorithm	
without	 any	 further	 smoothing	 so	 as	 to	preserve	 the	original	 dimensions.	 Inlet	
and	outlets	were	assigned	in	the	same	way	as	described	in	section	5.5.1.4.		
	
Figure	5.5	Simplified	bifurcated	model	used	in	validation	simulations	
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The	finished	model	was	imported	into	FLUENT	v6.3	(ANSYS	Inc.,	USA)	for	finite-
volume	 analysis.	 Blood	 was	 represented	 by	 a	 Newtonian	 fluid	 with	 viscosity	
0.0033Pa.s	 and	 density	 1098kg/m3.	 A	 separate	 steady	 state	 simulation	 was	
performed	to	reflect	the	boundary	conditions	found	at	each	0.1	second	interval	
along	 the	 normal	 pulse	 wave	 used	 by	 Zhou	 et	 al.	 (154).	 Flow	 and	 pressure	
waveforms	are	shown	in	Figure	5.6.	This	approach	enabled	comparison	between	
CFD	 and	 desktop	 experimental	 model	 as	 well	 as	 the	 intended	 comparison	
between	CFD	and	 analytical	model.	 Equal	 flow	weighting	was	 given	 to	 each	of	
the	 two	 outlets	 since	 the	 model	 was	 symmetrical.	 No-slip	 conditions	 were	
imposed	at	 the	wall	 i.e.	 the	 surface	area	of	 contact	between	 lumen	and	 stent-
graft.	
	
Figure	5.6	Normal	flow	(Q)	and	pressure	waveforms.		
Adapted	from	Zhou	et	al.	(154)		
Distraction	 force	 results	 were	 obtained	 in	 three	 directions	 but	 only	 the	
longitudinal	 (z)	 forces	were	 significant	because	 the	 iliac	 limb	angulation	was	 in	
one	plane	only	and	the	simplified	model	was	symmetrical.		
5.5.3.1.2 Analytical	model	
Equation	 3.1	was	written	 into	Mathcad	 (PTC,	USA)	 and	was	 used	 to	 solve	 uni-
directional	distraction	force	for	the	same	boundary	conditions	as	the	CFD	model.	
U1	 (Inlet	velocity	m3/s)	was	calculated	 from	Q	 (volume	 flow	rate	L/min)	and	A1	
(Inlet	cross-sectional	area	m2)	using	the	following	equation:	
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	 	 																																																	(5.1)	
The	angle	of	the	iliac	limb	from	the	axis	of	the	main	body	in	degrees	(θa=30°)	was	
converted	into	radians	(θ)	using	the	following	equation:	 	
																																																(5.2)	
5.5.3.1.3 Desktop	experimental	model	
Results	for	the	experimental	model	with	pulsatile	flow	were	obtained	from	the	
original	thesis	(193).	
 Validation	results		
There	were	no	axial	forces	generated	in	the	x	and	y	directions.	All	forces	acted	in	
the	 longitudinal	 (z)	 plane.	 Table	 5.1	 shows	 the	 contribution	 of	 pressure	 and	
viscous	forces	to	total	 force.	Pressure	forces	were	dominant.	The	magnitude	of	
viscous	force	was	always	less	than	0.1%	of	the	total	force.	
Table	5.1	Longitudinal	distraction	force	results	for	the	simplified	bifurcated	
model		
Time	(secs)	 Pressure	Force	(N)	 Viscous	Force	(N)	 Total	Force	(N)	
0	 3.832	 0.000	 3.832	
0.1	 7.591	 -0.001	 7.590	
0.2	 10.328	 -0.002	 10.326	
0.3	 7.262	 -0.003	 7.259	
0.4	 3.467	 -0.002	 3.465	
0.5	 3.577	 -0.002	 3.575	
0.6	 3.833	 -0.001	 3.832	
0.7	 3.613	 -0.001	 3.613	
0.8	 3.562	 0.000	 3.562	
0.9	 3.599	 0.000	 3.599	
1	 3.758	 0.000	 3.758	
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Total	 force	 was	 compared	 with	 results	 of	 the	 analytical	 model	 obtained	 using	
Mathcad	 and	 the	 desktop	 experimental	 model	 data	 of	 Zhou	 et	 al.	 (193).	 The	
comparison	 shown	 in	 Figure	 5.7	 confirmed	 good	 agreement	 between	 all	 three	
methods.	
	
Figure	5.7	Comparison	between	distraction	force	(DF)	results	obtained	via	three	
different	methods	at	0.1	second	intervals	along	a	pulse	wave	
	
The	results	of	this	benchmarking	show	that	CFD	and	analytical	models	agree	to	
better	 than	 2%.	 Some	 of	 this	 difference	was	 thought	 to	 be	 due	 to	 the	 lack	 of	
viscous	 flow	 terms	 in	 the	 analytical	 model	 but	 inspection	 of	 the	 CFD	 results	
reveal	 that	viscous	 forces	are	negligible	 in	comparison	with	those	derived	from	
blood	pressure.	When	CFD	results	were	compared	to	distraction	forces	obtained	
using	 the	 experimental	 desktop	 model	 of	 the	 same	 bifurcated	 tube	 under	
physiological	pulsatile	 flow	conditions	the	difference	was	always	 less	than	10%.		
Thus	 time	 dependent	 effects	 on	 distraction	 force	 are	 small	 compared	 to	 the	
other	variables.	The	agreement	between	the	three	approaches	 justifies	the	use	
of	steady	state	CFD	analysis	in	the	current	study.		
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 Format	of	results	
Distraction	 force	results	 for	 the	patient-specific	models	were	obtained	for	each	
stent-graft	and	their	individual	components	in	three	directions:	‘z’	–	axial	forces	
in	 the	 caudal	 direction;	 ‘x’	 –	 right	 lateral	 and	 ‘y’	 –	 posterior	 forces	 (see	 Figure	
5.3).	 Unlike	 the	 simple	 bifurcated	 model	 used	 in	 the	 validation	 these	 models	
were	asymmetrical	 and	exhibited	angulation	 in	more	 than	one	plane	 therefore	
the	 x,	 y	 and	 z	 forces	 were	 used	 to	 calculate	 total	 Resultant	 Distraction	 Force	
(RDF)	using	the	formula	where	F	represents	total	force	in	a	particular	direction:	
	
(5.3)	
The	term	 ‘out-of-plane	 forces’	was	used	to	 refer	 to	 the	contribution	of	x	and	y	
directional	 force	 to	 the	 magnitude	 of	 total	 RDF.	 Total	 RDF	 comprised	 forces	
derived	from	blood	pressure	and	blood	flow	(viscous	friction).	
 Measurement	of	morphological	features	
 Cross-sectional	area		
Lumen	cross-sectional	area	(XSA)	at	the	inlet	and	outlet	of	all	components	with	
the	exception	of	the	limb	extension	inlet	was	obtained	from	FLUENT	v6.2	(ANSYS	
Inc.)	by	creating	a	plane	through	the	lumen	(Figure	5.8).		
	
Figure	5.8	A:	Plane	created	at	the	inlet	of	a	component.	B:	Inlet	cross-sectional	
area	shown	in	green.	
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This	method	was	not	possible	for	the	inlet	to	the	limb	extension	components	due	
to	 the	 close	 proximity	 of	 the	 two	 limbs	 at	 the	 bifurcation.	 For	 this	 inlet	 the	
average	diameter	as	measured	in	ScanIP	was	used	to	calculate	the	approximate	
inlet	 XSA.	 For	bifurcated	 components	outlet	 XSA	was	 the	 sum	of	 left	 and	 right	
outlets.	Inlet:Outlet	area	ratio	was	calculated	by	dividing	the	inlet	XSA	with	that	
of	the	(combined)	outlet.		
 Angle	measurement	
Angle	measurement	was	 performed	 in	 ScanIP.	 A	 CLL	was	 created	 to	 guide	 the	
placement	 of	 a	 computerised	 caliper.	 Angles	 within	 each	 lumen	 model	 were	
measured	in	coronal	and	sagittal	elevation	by	applying	two-dimensional	calipers	
onto	 the	 three-dimensional	 image.	 This	 gave	 two	 data	 points	 for	 each	 angle.	
Although	it	was	possible	to	apply	a	3D	version	of	the	calipers	to	the	CLL	to	obtain	
one	data	point	per	angle	this	would	not	have	provided	any	information	regarding	
the	 position	 of	 one	 limb	 in	 relation	 to	 the	 other	 when	 considering	 bifurcated	
components.	Calipers	were	applied	over	as	much	length	of	CLL	as	possible	with	
each	one	covering	at	least	the	length	of	the	respective	sealing	stent.	Three	types	
of	angle	were	measured	 in	both	coronal	elevation	 (as	viewed	 from	an	anterior	
position)	and	sagittal	elevation	(as	viewed	from	the	patients’	left,	see	Figure	5.9):	
α	angle:	the	angle	between	the	axis	of	blood	flow	at	the	proximal	body	inlet	from	
that	of	the	aorta	immediately	above.		
β	angle:	the	angle	between	the	axis	of	blood	flow	in	the	aneurysm	lumen	from	
that	 of	 the	 visceral	 aorta.	Due	 to	 the	 effect	 of	 the	 stent-graft	 upon	 the	 native	
vessels	the	β	angle	was	usually	observed	at	the	junction	between	proximal	and	
distal	 bodies	 and	 was	 therefore	 a	 postoperative	 approximation	 of	 the	 angle	
between	the	aneurysm	neck	and	the	 long	axis	of	 the	aneurysm	as	described	 in	
the	IFU	document.	
θ	Angle:	the	angle	between	the	axis	of	blood	flow	at	the	outlet	of	a	component	
in	relation	to	its	inlet.	
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Bifurcation	 angle	 (the	 angle	 between	 two	 outlets	 of	 a	 bifurcated	 body	 or	
complete	stent-graft	in	each	plane)	was	calculated	by	taking	the	sum	of	left	and	
right	θ	angles.	Largest	angle	refers	to	the	largest	angle	observed	in	either	coronal	
or	sagittal	elevation.		
α,	 β	 and	θ	 angulation	 in	 a	 clockwise	direction	was	 initially	 assigned	a	negative	
value	 and	 counter-clockwise	 a	 positive	 value.	 Subsequent	 comparison	 was	
limited	to	magnitude	only	and	therefore	all	values	were	considered	as	positive.	
	
	
Figure	5.9	Angle	measurement	of	one	distal	body	in	coronal	and	sagittal	
elevation.	PB:	Proximal	extent	of	proximal	body	component.	θl:	Left	outlet	
angle	(demonstrated	in	sagittal	elevation	only),	θr:	Right	outlet	angle	
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 Inclusion	criteria	
All	 patients	 who	 received	 fenestrated	 endovascular	 aneurysm	 repair	 at	 Royal	
Liverpool	 University	 Hospital	 between	 January	 2006	 and	 October	 2011	 were	
included	 in	 the	 study.	 Prior	 to	 2006	 images	 were	 not	 stored	 in	 the	 on-line	
repository	 but	 in	 hard	 copy	 or	 on	 compact	 discs	 which	 made	 retrieval	 and	
conversion	to	DICOM	format	difficult.		
Ethical	 approval	 for	 the	 use	 of	 medical	 images	 and	 demographic	 data	 was	
granted	by	the	North	West	–	Liverpool	East	Research	Ethics	Committee.		
 Exclusion	criteria	
Patients	without	postoperative	arterial	phase	contrast	enhanced	CT	scans	were	
excluded.	Individual	components	where	stents	or	gold	radiopaque	markers	were	
not	visible	or	obscured	such	that	the	inlet	or	outlet	could	not	be	identified	were	
also	excluded.		
 Statistical	analysis	
The	correlation	between	XSA,	actual	component	diameter	and	RDF	was	assessed	
using	Spearman’s	correlation	coefficient	(Spearman’s	rho,	ρ).	Paired	comparison	
between	 angulation	 or	 components	 within	 the	 same	 fEVAR	 were	 performed	
using	 Wilcoxon	 Signed	 Rank	 test	 (WSR).	 Complete	 stent-grafts	 and	 their	
individual	 components	 were	 grouped	 according	 to	 the	 presence	 of	 α,	 β,	 θ	 or	
bifurcation	angles	<45°	or	≥45°	 in	either	 sagittal	or	 coronal	plane.	Total	RDF	 in	
each	group	was	compared	by	Mann-Whitney	U	test	(MWU).		
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5.6 Results	
59	 patients	 were	 treated	 with	 fenestrated	 endovascular	 aneurysm	 repair	
between	January	2006	and	October	2011.	Four	patients	were	excluded	due	to	no	
postoperative	 CTs	 being	 available.	 A	 further	 patient	 had	 no	 postoperative	
imaging	 with	 arterial	 phase	 contrast.	 Five	 limb	 extensions	 from	 two	 separate	
patients	 were	 excluded	 because	 the	 inlet	 or	 outlet	 could	 not	 be	 positively	
identified.	
 Morphological	features	
Appendix	8.5	details	all	morphological	data	for	each	complete	stent-graft	and	all	
individual	components.		Table	5.2	summaries	this	data.	
	Table	5.2	Summary	of	morphological	features	for	complete	stent-grafts	and	
components	
Component	
Complete	
Stent-graft	
Proximal	
Body	 Distal	Body	
Limb	
Extension	
n	 54	 54	 52	 62	
Inlet	XSA	(mm2)	 349.5		(111-907)	
349.5		
(111-907)	
380.5		
(160-501)	
68.5		
(44-104)	
Outlet	XSA	
(mm2)	 97	(25-400)	 78	(35-356)	 74	(23-393)	 100	(25-400)	
Combined	
Outlet	XSA	
(mm2)	
198.5	
(78-793)	
163.5		
(57-356)	
156		
(40-434)	 -	
Inlet:Outlet	
area	ratio	
1.62	
(0.63-5.07)	
1.95		
(0.77-15.91)	
2.29		
(0.72-9.98)	
0.71		
(0.17-2.86)	
θ	angle	 48°	(1-140)	 17°	(0-69)	 21°	(0-89)	 38°	(2-116)	
n	(<45°/≥45°)	 4/50	 45/9	 25/27	 24/38	
Bifurcation	
Angle	 35°	(0-167)	 -	 25.5°	(0-85)	 -	
n	(<45°/≥45°)	 7/44◊	 -	 36/14ѱ	 -	
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Values	given	as	median	with	range	in	parentheses.	n:	number,	Inlet	XSA:	Inlet	cross-sectional	
area	post	deployment	(mm2),	Outlet	XSA:	Outlet	cross-sectional	area	post	deployment	(mm2),	
Inlet:Outlet	area	ratio	(ratio	of	Inlet	cross-sectional	area:Outlet	cross-sectional	area)	Largest	θ	
angle:	Largest	outlet	angle	in	either	coronal	or	sagittal	elevation,	Largest	Bifurcation	angle:	
Largest	Bifurcation	angle	in	either	coronal	or	sagittal	elevation,	◊:	total	n=51	due	to	1	tube	graft	
and	2	ipsilateral	limb	occlusions	where	no	bifurcation	angle	could	be	measured,	ѱ:	total	n=50	
due	to	2	ipsilateral	limb	occlusions.	
	
 Complete	stent-grafts	
5.6.1.1.1 Cross-sectional	area	
The	 inlet	 of	 the	 complete	 stent-graft	 in	 all	 cases	was	 the	 inlet	 of	 the	 proximal	
body	component.	Fourty	eight	of	the	54	complete	stent-grafts	had	an	inlet	XSA	
larger	 than	 the	combined	outlet	XSA,	only	 six	had	outlets	with	 larger	XSA	 than	
the	 inlet	 (i.e.	 Inlet:Outlet	 area	 ratios	 less	 than	 1).	 Overall	 median	 Inlet:Outlet	
area	ratio	was	1.62	(range	0.63-5.07).		
5.6.1.1.2 Angulation	
There	were	no	α	angles	greater	than	45°	and	there	was	no	significant	differences	
between	α	 angles	measured	 in	 coronal	 or	 sagittal	 elevation	 (median	 coronal	α	
angle	8°,	range	0-31°	versus	8°,	range	0-38,	p=.704,	WSR).	Four	of	the	54	fEVARs	
had	β	angles	greater	than	the	maximum	45°	stated	in	the	IFU.	β	angulation	was	
significantly	 greater	 in	 the	 coronal	 elevation	 (i.e.	 lateral	 angulation)	 than	 in	
sagittal	elevation	(antero-posterior	angulation)	with	a	median	coronal	β	angle	of	
13°,	range	0-58°	versus	11°,	range	0-42°,	p=.021	(WSR).	
Outlet	 angulation	 of	 complete	 stent-grafts	 in	 the	 coronal	 elevation	 (i.e.	 lateral	
angulation)	was	significantly	less	than	in	the	sagittal	elevation	(antero-posterior)	
in	both	left	(p=.000)	and	right	limbs	(p=.006,	WSR).	Median	coronal	outlet	angle	
was	 31°,	 range	 1-83°(left),	 and	 40°,	 4-97°(right)	 versus	 median	 sagittal	 outlet	
angle	58°,	3-140°(left),	and	56°,	12-120°(right).	The	degree	of	limb	angulation	in	
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sagittal	 elevation	 between	 the	 limbs	 did	 not	 differ	 significantly	 (p=.440,	WSR).	
This	 is	perhaps	due	to	the	similar	posterior	course	taken	by	both	common	 iliac	
arteries	as	 they	enter	 the	pelvis	and	 is	supported	by	the	 finding	of	significantly	
lower	bifurcation	angle	in	this	elevation	(sagittal	bifurcation	angle:	11°,	range	0-
93°	versus	78°	coronal	bifurcation	angle,	range	4-167,	p=.000,	WSR).		There	was	a	
significant	 difference	 between	 left	 and	 right	 outlet	 angulation	 in	 coronal	
elevation	 (p=.003,	 WSR)	 which	 suggests	 that	 the	 iliac	 arteries	 had	 a	 more	
variable	lateral	-	as	compared	to	posterior	-	course.	
 Proximal	bodies	
5.6.1.2.1 Diameter	and	cross-sectional	area	
Proximal	bodies	were	manufactured	with	proximal	diameter	 (D1)	of	24,	26,	28,	
30,	32	and	36mm	(Figure	5.10).	In	this	cohort	one	custom-made	device	with	a	D1	
of	40mm	was	used	(fEVAR	55,	Appendix	8.5.2).		
	
Figure	5.10	Proximal	body	configuration.	
Adapted	from	Cook	Medical	Inc.	(72)	
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Median	D1	of	 the	proximal	bodies	used	 for	CFD	analysis	was	30mm	(range	24-
40mm)	 and	median	 post-deployment	 inlet	 cross-sectional	 area	measured	 from	
the	 computer	 models	 was	 349.5mm2	 (range	 111-907mm2).	 Post-deployment	
inlet	 cross-sectional	 area	 correlated	 strongly	 with	 pre-deployment	 proximal	
diameter	(Spearman’s	rho,	ρ	0.757,	p<.01).	This	agreement	suggests	a	consistent	
amount	 of	 oversizing	 was	 used	 in	 the	 planning	 stages	 and	 may	 also	 indicate	
consistency	of	 the	model	construction	process.	The	distal	diameter	of	proximal	
bodies	 was	 usually	 22mm	 although	 fEVAR	 51	 (tube	 graft	 only)	 had	 a	 distal	
diameter	of	38mm.	Two	other	non-standard	devices	were	used:	One	had	a	distal	
diameter	 30mm	 (fEVAR	 28),	 the	 other	 was	 a	 custom-made	 single-piece	
bifurcated	fenestrated	stent-graft	(fEVAR	7).	The	median	combined	outlet	cross-
sectional	 area	 was	 163.5mm2,	 range	 57-356mm2	 which	 corresponds	 to	 an	
equivalent	circular	diameter	of	14.2mm.	The	lower	than	expected	value	(i.e.	less	
than	22mm	shown	in	Figure	5.10)	was	due	to	the	flow	divider	(bifurcation)	of	the	
distal	 body	 being	 placed	 above	 the	 distal	 extent	 of	 the	 proximal	 body	 in	most	
cases	 in	order	 to	maximise	component	overlap.	 In	situ	 this	gave	most	proximal	
bodies	two	functional	outlets	as	seen	in	fEVAR	36	(Figure	5.11A).		
	
Figure	5.11	Two	different	proximal	body	components	(blue)	showing	the	distal	
body	flow	divider	(FD)	above	(A)	and	below	(B)	the	distal	extent	of	the	proximal	
body	component.	Red:	lumen	
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The	flow	divider	was	distal	to	the	proximal	body	fabric	in	only	five	of	the	fEVARs.	
One	of	these	was	fEVAR	37	shown	in	Figure	5.11B.	A	further	two	cases	had	one	
functional	outlet	due	to	an	occluded	stent-graft	 limb	and	one	other	due	to	the	
repair	 being	 performed	 with	 the	 tubular	 proximal	 body	 component	 only.	 The	
proximal	body	of	fEVAR	55	had	one	functional	outlet	that	was	very	close	to	the	
flow	 divider.	 	 The	 CLL	 was	 observed	 to	 have	 already	 bifurcated	 at	 the	 distal	
extent	 of	 the	 fabric	 and	 adherence	 to	 the	 protocol	 for	 angle	 measurement	
therefore	produced	four	angle	data	points	(two	for	each	CLL).		
5.6.1.2.2 Angulation	
Median	 coronal	 and	 sagittal	 outlet	 angulation	 of	 the	 left	 functional	 outlet	was	
14°	 (range	 0-45°)	 and	 24.4°	 (0-58°)	 respectively.	 The	 difference	 between	 these	
distributions	was	significant	(p=.007,	WSR)	but	this	difference	was	not	observed	
with	 the	 right	 functional	 outlet	 (median	 coronal	 and	 sagittal	 outlet	 angle	 16°,	
range	 0-69°	 and	 19°,	 range	 2-50°,	 p=.627,	 WSR).	 The	 left	 side	 was	 the	
contralateral	side	in	40	of	the	52	fEVARs	and	it	is	likely	that	the	presence	of	the	
limb	 extension	 at	 the	 level	 of	 the	 contralateral	 functional	 outlet	 influenced	 its	
position	causing	an	increase	in	angulation	towards	the	origin	of	the	iliac	vessels.	
5.6.1.2.3 Fenestrations	
Table	5.3	summaries	the	scallop	and	fenestration	configurations	of	all	54	fEVAR	
included	in	the	distraction	force	analysis.	fEVAR	were	numbered	in	chronological	
order	and	–	as	was	the	case	with	the	French	and	Swedish	series	(106)	–	a	trend	
to	more	complex	fEVAR	with	more	fenestrations	was	observed	in	the	later	cases.	
The	most	 commonly	used	configuration	was	one	 scallop	and	 two	 fenestrations	
(n=30).		
Table	5.3	Summary	of	scallop	and	fenestration	configurations	
Scallop	 0	 0	 0	 1	 1	 1	 1	
Fenestration	 2	 3	 4	 0	 1	 2	 3	
n	 1	 4	 2	 2	 4	 30	 11	
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5.6.1.2.4 Sealing	stents	and	proximal	body	length	
Usually	two	proximal	sealing	stents	were	used	but	fEVARs	6	and	24	included	only	
one	 sealing	 stent.	 Two	 other	 fEVARs	 (34	 and	 58)	 had	 three	 sealing	 stents.	
Proximal	bodies	were	available	 in	 lengths	between	76-137mm	 (BL1,	 see	Figure	
5.10).	Ten	longer	non-standard	lengths	were	used	(fEVAR	28,	37,	40,	51,	52,	53,	
55,	56,	58	and	59).		
 Distal	bodies	
5.6.1.3.1 Diameter	and	cross-sectional	area	
Standard	 distal	 body	 proximal	 diameter	was	 24mm	however	 one	 larger	 32mm	
device	 was	 used	 in	 conjunction	 with	 a	 30mm	 distal	 diameter	 proximal	 body	
(fEVAR	 28,	 see	 Appendix	 8.5.3).	 This	 device	 was	 also	manufactured	 with	 non-
standard	lengths	(DBL	and	DLL	shown	in	Figure	5.12).		
	
Figure	5.12	Distal	body	configuration.	
Adapted	from	Cook	Medical	Inc.	(72)	
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Median	 inlet	 cross-sectional	 area	 in	 the	 cohort	 of	 52	 distal	 bodies	 with	
postoperative	 imaging	 was	 380.5mm2	 (range	 160-501mm2),	 this	 was	 the	
equivalent	 of	 a	 22mm	 circular	 diameter.	 Contralateral	 gate	 diameter	 was	 a	
standard	12mm	in	all	devices.	The	median	contralateral	outlet	XSA	was	70.5mm2	
(9.5mm	circular	diameter),	range	23-100mm2.		
Forty	of	the	52	distal	bodies	were	deployed	from	the	right	groin.	The	ipsilateral	
limb	of	the	distal	body	component	was	available	in	diameters	of	12,	16,	20	and	
24mm.	One	 custom	made	distal	 body	with	an	 ipsilateral	 limb	diameter	 (D3)	of	
28mm	was	also	used	 in	 this	cohort	 to	achieve	distal	seal	 in	an	ectatic	common	
iliac	 artery	 (fEVAR	 56).	 The	median	 D3	 used	was	 16mm	 (range	 12-28mm)	 and	
median	 ipsilateral	 outlet	 XSA	 post-deployment	 was	 85.5mm2	 (range	 25-
393mm2).	 There	 was	 a	 moderate	 but	 significant	 positive	 correlation	 between	
these	two	distributions	(ρ	0.607,	p<.01).	
5.6.1.3.2 Sealing	stents	and	distal	body	length	
Distal	 body	 lengths	 (DBL)	 were	 either	 76,	 94,	 109	 or	 124mm.	 Only	 the	 76mm	
version	 had	 two	 sealing	 stents	 (SS,	 Figure	 5.12).	 All	 other	 lengths	 had	 three	
sealing	stents	as	standard.	 Ipsilateral	 limbs	 lengths	(DLL)	were	28,	45	or	62mm.	
This	enabled	distal	seal	to	be	achieved	at	the	chosen	site	in	common	iliac	arteries	
of	 varying	 lengths.	 Apart	 from	 fEVAR	 28,	 one	 other	 custom-made	 short	 distal	
body	with	slightly	 longer	DLL	was	used	 (fEVAR	49).	 In	 this	device	 the	short	DLL	
required	an	 internalised	contralateral	gate	 to	be	manufactured	 inside	 the	main	
distal	 body.	 In	 13	 cases	 the	 ipsilateral	 limb	 was	 extended	 further	 with	 a	 limb	
extension	(see	Appendix	8.5.4).	
5.6.1.3.3 Angulation	
Outlet	 angulation	 of	 the	 ipsilateral	 limb	 was	 significantly	 greater	 than	 the	
contralateral	gate	 in	both	coronal	and	sagittal	elevations	 (coronal:	median=28°,	
range	 0-85°	 versus	 6.5°,	 range	 0-58°,	 p=.000,	 and	 sagittal:	 39.5°,	 range	 7-89°	
versus	 17°,	 range	 2-49°,	 p=.000,	WSR).	 This	 greater	 angulation	was	 due	 to	 the	
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ipsilateral	 limb	being	deployed	 in	 the	 iliac	arteries	whilst	 the	usual	position	 for	
the	contralateral	gate	was	 just	proximal	 to	 the	aortic	bifurcation	and	therefore	
much	more	 in	 line	with	 the	 inlet.	As	with	 the	complete	stent-graft	models,	 the	
bifurcation	angle	was	significantly	greater	 in	the	coronal	elevation	(28.5°,	range	
0-85°	 versus	 25°,	 range	 2-60°,	 p=.035,	 WSR).	 Overall	 however	 the	 bifurcation	
angle	 in	 the	 distal	 body	models	was	 significantly	 smaller	 than	 in	 the	 complete	
stent-grafts	 in	both	 coronal	 and	 sagittal	 elevations.	Median	 coronal	bifurcation	
angle	for	distal	bodies	was	28.5°,	range	0-85°	versus	78°	in	complete	stent-grafts,	
range	 22-167°,	 p=.000	 and	 median	 sagittal	 bifurcation	 angle	 11°,	 range	 0-93°	
versus	25°,	range	2-60°,	p=.012,	WSR.	This	finding	was	also	a	consequence	of	the	
contralateral	 gate	 placement	 within	 the	 aortic	 lumen	 in	 the	 distal	 body	
component.	 In	 contrast,	 the	 configuration	of	 the	 complete	 stent-graft	 included	
the	contralateral	 limb	extension	and	therefore	had	both	outlets	within	the	 iliac	
arteries.	
 Limb	extensions	
5.6.1.4.1 Diameter	and	cross-sectional	area	
All	limb	extensions	had	a	proximal	diameter	of	12mm	to	achieve	seal	within	the	
contralateral	 gate	 of	 the	 distal	 body.	 All	 limb	 lengths	 (LL)	 in	 this	 cohort	 were	
between	56	and	107mm	(Figure	5.13).	Current	standard	LL	lengths	are	39,	56,	74,	
90,	107	and	122mm	although	this	changed	slightly	throughout	the	study	period.	
LL	was	not	inclusive	of	the	22mm	proximal	seal-zone.	
The	median	outlet	cross-sectional	area	for	limb	extensions	was	99mm2,	range	25-
400mm2.	This	correlated	well	with	the	distal	diameter	(median	D2	16mm,	range	
12-28mm,	ρ=.829,	P<.01).	The	standard	range	of	available	D2	diameters	was	9-
24mm.	Two	limb	extensions	were	custom	made	28mm	D2	devices	(fEVAR	25	and	
56,	see	Appendix	8.5.4).	
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Figure	5.13	Limb	extension	configuration.	
Adapted	from	Cook	Medical	Inc.	(72)	
	
5.6.1.4.2 Angulation	
Median	coronal	outlet	angle	was	41°	(range	2-116°).	Median	sagittal	outlet	angle	
was	 38°	 (range	 2-99°).	 There	 were	 no	 significant	 differences	 in	 the	 extent	 of	
angulation	between	these	two	elevations	(p=.141,	WSR).	
 Distraction	force		
Distraction	force	results	for	pressure	and	viscous	friction	forces	were	obtained	in	
x,	y	and	z	directions	and	used	to	calculate	total	resultant	distraction	force	(RDF).	
Appendix	8.6	details	the	x,	y	and	z	contributions	of	pressure	and	viscous	force	to	
total	RDF	for	the	complete	stent-grafts	and	individual	components	of	all	fEVARs.	
Median	 total	 RDF	 acting	 on	 the	 complete	 stent-grafts	 was	 6.0N	 (range	 0.3-
17.7N),	on	proximal	bodies	4.8N	(range	1.3-15.7N),	distal	bodies	5.6N	(range	1.0-
8.0N)	and	limb	extensions	1.7N	(range	0.6-8.4N).		
Pressure	 derived	 forces	 were	 the	 dominant	 contributor	 to	 total	 RDF.	 The	
contribution	 of	 viscous	 force	was	minimal:	Median	magnitude	 of	 viscous	 force	
was	only	0.46%	of	total	RDF	(range	0.05-11.76%)	and	was	inversely	proportional	
to	 the	overall	magnitude	of	 the	 total	RDF	 (ρ=-0.690,	p<.01)	 so	 that	 the	smaller	
the	total	RDF	the	greater	the	magnitude	of	viscous	friction.	
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Out-of-plane	 forces	 contributed	 a	median	 46%	 (range	 4-100%)	 of	 total	 RDF	 in	
complete	 stent-grafts,	44%	 (range	3-99%)	of	 total	RDF	 in	proximal	bodies,	51%	
(12-100%)	in	distal	bodies	and	94%	(36-100%)	in	limb	extensions.	
 Cross-sectional	area	and	total	RDF	
Inlet	XSA	showed	a	strong	positive	correlation	with	total	RDF	in	complete	stent-
grafts	(ρ=0.814),	proximal	bodies	(ρ=0.883)	and	distal	bodies	(ρ=0.802).	All	values	
were	significant	to	p<.01	(see	Figure	5.14).	
	
Figure	5.14	Correlation	between	inlet	cross-sectional	area	and	total	resultant	
distraction	force	
*Complete	stent-graft	not	included	as	inlet	cross-sectional	area	was	equivalent	of	proximal	body	
inlet	cross-sectional	area	
	
In	 the	 limb	 extension	 components	where	 the	 outlet	was	 predominantly	 larger	
than	the	inlet	(See	Table	5.2	Inlet:Outlet	area	ratio	0.71,	range	0.17-2.86)	there	
*	
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was	no	correlation	between	inlet	XSA	and	total	RDF	(ρ=0.179).	This	was	the	only	
component	for	which	outlet	XSA	correlated	significantly	with	total	RDF	(ρ=0.822,	
p<.01).	 Outlet	 XSA	 did	 not	 correlate	 with	 total	 RDF	 in	 any	 other	 component	
(ρ=0.153	 in	complete	stent-graft,	 -0.165	 in	proximal	bodies	and	 -0.107	 in	distal	
bodies).		
 Inlet:Outlet	area	ratio	
Inlet:Outlet	area	ratio	showed	a	moderate	positive	correlation	with	total	RDF	in	
complete	 stent-grafts,	 proximal	 and	 distal	 bodies	 (ρ=0.438,	 0.756	 and	 0.540,	
p<.01).	 In	 limb	 extensions	 the	 correlation	 between	 Inlet:Outlet	 area	 ratio	 and	
total	RDF	was	negative	(ρ=-0.756,	p<.01).	
 Angulation	and	total	RDF	
5.6.2.3.1 β	anglulation	
Four	of	the	54	aortas	had	β	angles	greater	than	or	equal	to	45°.	Median	total	RDF	
was	not	significantly	larger	in	these	complete	stent-grafts	(6.1N,	range	0.3-17.7N)	
versus	the	other	50	with	β	angle	less	than	45°	(median	total	RDF	3.2N,	range	2.9-
7.5N,	p=.166,	MWU).	Similarly	there	was	no	significant	difference	in	median	total	
RDF	 acting	 upon	 the	 proximal	 bodies	 components	 of	 these	 fEVARs	 between	 β	
angle	groups	(4.6N,	range	3.4-7.7N	for	β	angle	≥45°	versus	4.8N,	range	1.3-15.7N	
for	those	<45°,	p=.911,	MWU).		
5.6.2.3.2 θ	angulation	
Complete	 stent-grafts	 and	 components	 were	 also	 grouped	 according	 to	 the	
presence	 of	 outlet	 (θ)	 angle	 ≥45°	 or	 <45°	 (see	 Table	 5.2).	 There	 were	 no	
significant	differences	in	total	RDF	between	proximal	and	distal	bodies	in	either	
angulation	group.	This	finding	is	shown	in	the	box	and	whisker	plot	of	Figure	5.15	
where	median	total	RDF	for	proximal	bodies	with	a	θ	angle	≥45°	was	4.4N	(range	
2.2-7.9N)	 compared	 with	 4.8N	 (range	 1.3-15.7N)	 for	 those	 with	 θ	 angle	 <45°,	
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p=.954.	Distal	bodies	with	θ	angle	≥45°	had	a	median	 total	RDF	of	5.7N	 (range	
2.5-8.0N)	compared	with	5.3N	(range	1.0-7.3N)	for	those	<45°,	p=.862,	MWU.		
In	contrast,	Figure	5.15	also	shows	that	complete	stent	graft	and	limb	extensions	
in	the	≥45°	θ	angle	group	were	exposed	to	significantly	higher	forces	than	those	
with	θ	 angle	 <45°.	 For	 the	 complete	 stent-grafts	 the	difference	 in	median	RDF	
was	 6.2N	 (range	 2.2-17.2N)	 versus	 2.6N	 (range	 0.3-3.1N),	 p=.001	 and	 in	 limb	
extensions:	2.1N	(range	0.9-8.4N)	compared	with	1.4N	(range	0.6-4.6N),	p=.004,	
MWU).	 Outliers	 represent	 stent-grafts	 or	 components	 at	 the	 extreme	 ends	 of	
available	inlet/outlet	diameters	or	observed	cross-sectional	areas.	
	
Figure	5.15	Comparison	of	total	resultant	distraction	force	between	outlet	(θ)	
angle	groups	in	complete	stent-grafts	and	components.	
Boxes	represent	median	total	RDF	and	interquartile	range,	whiskers:	95%	confidence	interval,		
o:	outlier	at	95%	CI,	*:	outlier	at	99%CI,	†indicates	significance	to	p<.01,	MWU.	
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5.6.2.3.3 Bifurcation	angle	
Fourty	four	complete-stent-grafts	had	bifurcation	angles	≥45°.	These	stent-grafts	
were	exposed	to	a	median	total	RDF	of	6.1N	(range	2.2-11.8N).	Complete	stent-
grafts	with	bifurcation	angles	<45°	(n=7)	were	exposed	to	less	total	RDF	(median	
5.0N,	range	0.3-7.3N)	although	this	difference	did	not	reach	significance	(p=.312,	
MWU).	 Similarly	 there	was	 no	 significant	 differences	 between	 total	 RDF	 acting	
upon	 distal	 bodies	 with	 bifurcation	 angle	 ≥45°	 versus	 those	 with	 bifurcation	
angle	 <45°	 (median	 total	 RDF	 5.7N,	 range	 2.5-8.0	 vs.	 5.4N,	 range	 1.0-7.1N,	
p=.503,	MWU).	
	
5.7 Discussion	
Inlet	cross-sectional	area	displayed	the	strongest	correlation	with	total	resultant	
distraction	force	in	proximal	body	and	distal	body	components.	The	relationship	
was	linear.	This	finding	is	supported	by	one-dimensional	analytical	models	based	
on	 conservation	 of	 linear	momentum	 (43,	 44,	 158).	 Previous	 CFD	 studies	 have	
considered	 the	 stent-graft	 as	 a	 single	piece	 (41,	 161,	 163-165)	 or	 have	divided	
the	stent-graft	into	arbitrary	territories	and	in	doing	so	biased	results	depending	
on	the	cross-sectional	area	at	the	choice	of	inlet	position	(41).		
By	 considering	 each	 component	 separately	 we	 can	 compare	 total	 RDF	 with	
experimentally-derived	 fixation	 force.	 For	 a	 proximal	 body	 with	 one	 stented	
target	vessel	the	initial	fixation	force	was	approximately	11.5N	+/-1.5N	(123).	By	
contrast,	distal	bodies	rely	on	the	radial	force	of	sealing	stents	alone	and	have	a	
fixation	 force	 of	 approximately	 6.5N	 (4.8-7.2N)	 (143).	 The	 fixation	 force	 at	 the	
distal	 seal-zone	 of	 a	 limb	 extension	 is	 approximately	 9.6N	 +/-1.5N	 (84).	 In	 the	
current	steady-state	numerical	simulations	with	constant	pressure	of	160mmHg	
there	were	 two	 proximal	 bodies,	 11	 distal	 bodies	 and	 no	 limb	 extensions	 that	
were	exposed	to	distraction	forces	in	excess	of	their	known	fixation	force.		
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 Proximal	and	distal	body	
Fifty	one	of	the	52	distal	body	components	all	had	the	same	proximal	diameter	
(24mm)	for	docking	into	the	22mm	overlap	zone	of	the	proximal	body.	The	range	
in	 inlet	 XSA	 observed	 in	 these	 components	 was	 much	 narrower	 than	 for	 the	
proximal	 body	 components	 (160-501mm2	 vs	 111-907).	 A	 XSA	 of	 380mm2	
approximates	to	a	circular	lumen	diameter	of	22mm	therefore	distal	bodies	with	
smaller	XSA	may	have	been	deployed	 inside	the	22mm	portion	of	 the	proximal	
body.	In	aortas	with	a	visceral	segment	luminal	diameter	greater	than	22mm	the	
sealing	 stents	 of	 the	 proximal	 body	 expand	 to	 a	 greater	 diameter	 than	 the	
overlap	zone	to	approximate	with	the	vessel	intima.	Landing	a	portion	of	the	first	
distal	 body	 sealing	 stent	 in	 the	wider	 segment	may	 allow	 expansion	 up	 to	 the	
maximum	 diameter	 of	 24mm.	 This	 diameter	 approximates	 to	 an	 equivalent	
circular	 XSA	of	 452mm2	 although	 the	 actual	 luminal	 XSA	would	 be	 slightly	 less	
due	 to	 the	 thickness	 of	 the	 graft	 fabric	 (approximately	 0.14mm	 as	 measured	
using	a	micrometer).	Distal	body	XSA	in	excess	of	380mm2	were	therefore	most	
likely	due	to	intentional	maximisation	of	overlap.			
 Limb	extension	
When	migration	 of	 limb	 extension	 components	 occurs	 it	 is	 usually	 in	 a	 cranial	
direction.	This	has	been	demonstrated	experimentally	by	Volodos	et	al.	(157)	and	
by	core	lab	analysis	of	follow-up	images	(194).	The	latter	study	observed	an	8%	
incidence	of	migration	greater	than	4mm	at	36	months	follow-up.	By	considering	
total	 RDF	 for	 each	 component	 rather	 than	 for	 the	 stent-graft	 as	 a	 whole	 the	
reason	for	the	cranial	direction	of	migration	can	be	explained:	significantly	higher	
θ	angulation	in	the	limb	extensions	compared	with	the	proximal	bodies	(median	
38°	 vs.	 17°	 p<.01,	WSR)	 led	 to	 significantly	 higher	 contribution	 of	 out-of-plane	
forces	(94	vs.	44%,	p<.01,	WSR).	This	concept	is	illustrated	in	Figure	5.16B	where	
the	 ‘y’	axis	 force	 (green	arrow)	acting	on	 the	more	angulated	 limb	extension	 is	
almost	twice	the	magnitude	of	the	force	acting	axially	in	the	‘z’	axis	(blue	arrow)	
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compared	 with	 the	 much	 smaller	 ‘y’	 forces	 acting	 on	 the	 straighter	 proximal	
body	 component	 in	 Figure	 5.16A.	 The	 effect	 on	 total	 RDF	 for	 limb	 extension	
components	was	to	cause	it	to	act	in	a	more	antero-posterior	or	lateral	direction.	
In	 addition	 to	 the	 effect	 of	 angulation,	 a	 median	 Inlet:Outlet	 area	 ratio	 0.71	
confirmed	 that	 the	outlet	 of	 the	 limb	extension	 -	 designed	 for	 seal	within	 iliac	
arteries	of	outer	diameter	7-21mm	-	was	usually	larger	than	the	standard	12mm	
diameter	inlet.	The	effect	of	this	was	that	pressure	derived	forces	(and	therefore	
total	RDF)	were	 reversed	 in	 relation	 to	blood	 flow.	This	 is	also	shown	 in	Figure	
5.16B	where	total	RDF	is	seen	to	act	parallel	and	in	the	opposite	direction	to	the	
flow	of	blood	in	the	distal	part	of	the	limb	extension.	Under	these	conditions	the	
component	outlet	assumes	primary	importance	as	the	main	determinant	of	force	
magnitude.		
	
Figure	5.16	A:	Total	resultant	distraction	force	for	proximal	body	(blue)	acting	
in	predominantly	longitudinal	(z)	axis	versus	B:	Total	RDF	for	limb	extension	
(orange)	acting	more	anteriorly	and	against	the	direction	of	blood	flow			
Images	shown	in	sagittal	elevation.	x	direction	forces	not	shown.	A:	x=0.6N,	B:	x=0.2N.	
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 Angulation	
The	α	angle	was	above	the	graft	fabric	and	theoretically	should	have	no	impact	
on	 the	magnitude	of	 total	 RDF	however	Molony	et	 al.	 (165)	 and	Kandail	et	 al.	
(161)	 reported	 an	 association	 between	 anterio-posterior	 neck	 angulation	 and	
resultant	distraction	force	following	standard	EVAR.	An	explanation	may	be	that	
greater	 α	 angle	 may	 act	 as	 a	 surrogate	 marker	 for	 tortuosity	 which	 may	 also	
cause	 greater	 θ	 angulation.	 The	 effect	 of	 α	 angle	 upon	 total	 RDF	 was	 not	
assessed	in	this	analysis	since	all	were	less	than	45°.		
Complete	stent-grafts	and	limb	extension	components	were	the	only	groups	for	
which	θ	 angle	was	 significantly	 associated	with	 greater	 total	 RDF.	 There	was	 a	
good	 distribution	 of	 limb	 extensions	 between	 angle	 groups	 (n=24	 vs.	 38)	
however	there	were	only	four	complete	stent-grafts	with	outlet	angle	<45°	(see		
Table	5.2).	The	 lack	of	significance	when	θ	angle	and	total	RDF	were	compared	
for	 the	 other	 components	was	 probably	 as	 a	 result	 of	 smaller	 angulation.	 This	
assumption	is	supported	by	previous	analytical	and	CFD	analyses		that	show	little	
effect	upon	force	of	angulation	less	than	35°	(163).		
The	 effect	 of	 bifurcation	 angle	 on	 force	 has	 been	 quantified	 analytically	 (158,	
163,	 172).	 An	 average	 distal	 body	 (Inlet	 XSA	 380mm2,	 equivalent	 to	 22mm	
circular	diameter)	with	a	bifurcation	angle	of	80°	would	be	exposed	to	2N	more	
distraction	 force	than	the	same	size	component	with	a	bifurcation	angle	of	10°	
(158).	The	 lack	of	association	found	between	bifurcation	angle	and	total	RDF	in	
this	analysis	may	be	due	to	the	small	bifurcation	angles.	For	example	the	median	
largest	 bifurcation	 angle	was	 35°	 for	 complete	 stent-grafts	 and	 25.5°	 for	 distal	
bodies.	 The	 second	 value	 is	 predictably	 lower	 due	 to	 one	 of	 the	 distal	 body	
outlets	 (the	 contralateral	 gate)	 being	 situated	 within	 the	 aorta	 and	 therefore	
more	 in	 line	with	 the	 inlet.	 It	may	also	 in	part	be	due	 to	 the	 relatively	 greater	
importance	of	cross-sectional	area	as	a	determinant	of	force.	
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 Predicting	distraction	force	
Defining	 the	 relationship	between	morphological	 features	and	distraction	 force	
may	be	useful	 in	 the	planning	 stage	before	endovascular	aneurysm	repair.	 The	
ability	to	predict	distraction	force	using	easily	measured	morphological	features	
may	 allow	 the	 clinician	 to	 choose	 alternative	 treatment	 modalities	 or	 ensure	
close	 follow-up	 of	 those	 considered	 at	 a	 high	 risk	 of	 migration.	 	 It	 must	 be	
remembered	however	 that	 an	 angle	measured	using	 the	 CLL	 on	 a	 planning	 CT	
may	 not	 represent	 the	 eventual	 angle	 formed	 by	 the	 stent-graft	 after	
deployment.	Especially	in	tortuous	anatomy	the	stent-graft	may	take	what	could	
be	 considered	as	 the	 ‘racing	 line’.	 Its	mechanical	properties	and	chosen	 site	of	
deployment	would	 also	 govern	 how	much	 it	 conforms	 or	 deforms	 the	 original	
vessel	morphology.	
Based	 on	 the	 significant	 morphological	 features	 for	 complete	 stent-grafts	 and	
their	 individual	components,	a	regression	model	was	developed	to	predict	total	
resultant	distraction	force	(F)	at	constant	blood	pressure	(160mmHg).	
 Complete	stent-graft	
For	 Complete	 stent-grafts,	 inlet	 XSA	 (A1)	 alone	 predicted	 81%	 of	 total	 RDF.	
Inlet:Outlet	area	ratio	(A1/A2)	and	largest	θ	angle	(max[θ])	 in	sagittal	or	coronal	
elevation	were	also	both	independently	significant	(p=.001)	and	when	combined	
with	inlet	XSA	predicted	92%	of	total	RDF	(R2	0.922):	FSG	=	ASG	+	BSGA1	+	CSGA1	+	DSGmax[θ]		 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 			 			 	 	 	 	 	 	 	 	 	 																A2	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
(5.4)	
where	ASG=4.109N,	BSG=0.017N/mm2,	CSG=0.523N	and	DSG=0.043N/deg.	Inlet	XSA	
in	equation	5.4	refers	to	the	 lumen	XSA	at	the	 inlet	of	the	stent-graft	following	
deployment.	 This	 should	 correspond	 well	 with	 the	 lumen	 XSA	 at	 the	 chosen	
proximal	seal-zone	as	defined	on	the	planning	CT.	The	actual	circular	XSA	of	the	
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proximal	 body	 (πD12/4)	would	 only	 act	 as	 a	 surrogate	 for	 this	measurement	 if	
aortic	wall	thickness	was	uniform	and	consistent	oversizing	was	employed.		
 Proximal	body	
In	 proximal	 body	 components	 inlet	 XSA	 (A1)	 alone	predicted	84%	of	 total	 RDF.	
Inlet:Outlet	 area	 ratio	 (A1/A2)	 was	 also	 independently	 significant	 (p=.025)	 but	
only	 added	 another	 1%	 to	 the	 overall	 predictive	 value	 of	 the	 following	 simple	
regression	model	(R2	0.852):		FPB	=	APB	+	BPBA1	+	CPBA1																															A2	
(5.5)	
where	APB=-1.305N,	BPB=0.017N/mm2	and	CPB=0.239N.	 In	 regression	models	 for	
both	complete	stent-grafts	and	proximal	bodies	every	1mm2	increase	in	inlet	XSA	
caused	 an	 approximate	 0.017N	 increase	 in	 total	 RDF.	 For	 example	 a	 lumen	 of	
circular	diameter	30mm	has	a	cross-sectional	area	of	707mm2.	A	2mm	increase	
in	diameter	 leads	 to	a	cross-sectional	area	of	804mm2	 (an	 increase	of	97mm2).	
Using	 the	 simple	 linear	 regression	 model	 this	 would	 increase	 the	 distraction	
force	 acting	 on	 the	 complete	 stent-graft	 or	 proximal	 body	 by	 1.8N	 assuming	
everything	else	held	constant.	
 Distal	body	
Inlet	 XSA	 (A1)	 alone	 predicted	 74%	 of	 total	 RDF	 acting	 upon	 distal	 body	
components.	 Inlet:Outlet	 area	 ratio	 (A1/A2)	 was	 independently	 significant	
(p=.001)	and	although	results	above	did	not	show	any	difference	between	distal	
bodies	 with	 θ	 angle	 ≥45°	 compared	 with	 those	 <45°,	 the	 largest	 θ	 angle	 in	
sagittal	 or	 coronal	 elevation	 (max[θ])	 was	 also	 independently	 significant	
(p<.001).	Combined	they	contributed	to	a	model	that	predicted	89%	of	total	RDF	
(R2	0.886):		 FDB	=	ADB	+	BDBA1	+	CDBA1	+	DDBmax[θ]	A2	
(5.6)	
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where	ADB=-2.285N,	BDB=0.016N/mm2,	CDB=0.048N	and	DDB=0.004N/deg.	
	
 Limb	extension	
In	limb	extension	components	outlet	XSA	alone	(A2)	predicted	85%	of	total	RDF.	
Inlet:Outlet	 area	 ratio	 (A1/A2)	 and	 the	 largest	 θ	 angle	 (max[θ])	 were	 also	
independently	 significant	 and	 contributed	 to	 the	 most	 accurate	 simple	
regression	model	that	predicted	95%	of	total	RDF	(R2	0.953):	FLE	=	ALE	+	BLEA2	+	CLEA1	+	DLEmax[θ]	
                                      A2	
(5.7)	
where	ALE=-1.69N,	BLE=0.001N/mm2,	CLE=0.092N	and	DLE=0.002N/deg.	
	
	
5.8 Limitations	
Limitations	of	this	CFD	study	include	the	use	of	a	steady-state	blood	flow	rather	
than	pulsatile	flow.	Previous	experience	with	experimental	models	suggests	that	
results	are	less	than	10%	higher	at	any	given	time	along	a	pulse	wave	in	pulsatile	
flow	 models	 compared	 with	 steady-state	 models.	 The	 difference	 is	 largest	 at	
peak	 systole	 due	 to	 the	 inertial	 effect	 of	 the	 pressure	 waveform	 (154).	 The	
validation	experiment	described	earlier	in	this	chapter	(section	5.5.3)	justifies	the	
use	of	steady	state	blood	flow.	This	approach	was	also	used	for	practical	reasons	
as	 -	 compared	with	pulsatile	 flow	 -	 the	 simulations	 take	a	 tenth	of	 the	 time	 to	
complete.	
There	were	three	limitations	to	the	study	design	that	were	likely	to	have	caused	
only	 minimal	 effect	 on	 distraction	 force	 results	 due	 to	 the	 insignificant	
contribution	of	viscous	friction	force	(typically	<1%	of	total	RDF).	These	were	the	
use	 of	 a	 Newtonian	 fluid	 model	 which	 was	 only	 an	 approximation	 of	 in	 situ	
conditions	providing	a	 less	accurate	 representation	of	blood	 flow	 in	areas	with	
high	velocity	gradients;	the	assumption	that	all	forces	were	transmitted	through	
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the	 overlapping	 parts	 of	 the	 stent-graft	 (this	 was	 an	 oversimplification	 and	 in	
reality	only	pressure	 force	was	 likely	 to	be	 transmitted	 to	 those	 segments	of	a	
component	not	 in	direct	 contact	with	blood	 flow)	and	 the	exclusion	of	 visceral	
stents	 from	 the	 stent-graft	models	 due	 to	 limitations	 in	CT	 imaging	 resolution.	
Whilst	 visceral	 stents	 would	 have	 affected	 the	 fixation	 force	 of	 an	 individual	
proximal	body,	 their	 inclusion	would	only	have	 likely	 led	 to	more	 realistic	 local	
velocity	profiles	and	no	great	affect	upon	distraction	force	results.		
Use	 of	 a	 constant	 inlet	 pressure	 (160mmHg)	 was	 essential	 to	 investigate	 the	
effect	of	morphological	 features	upon	total	RDF	but	this	meant	that	the	results	
did	not	reflect	each	patient-specific	blood	pressure.	Pressure	derived	forces	were	
the	predominant	force	contributing	to	total	RDF.	A	selection	of	simulations	were	
carried	 out	 at	 140mmHg	where	 the	 20mmHg	 pressure	 difference	 led	 to	 lower	
total	RDF	by	a	factor	of	0.88	(i.e.	140/160).	These	findings	suggest	that	control	of	
hypertension	 should	 remain	 an	 important	 objective	 even	 after	 aneurysm	
exclusion.	
No	structural	characteristics	were	modelled	but	the	work	of	Molony	et	al.	(178)	
supported	 the	 rigid	 wall	 (‘no-slip’)	 assumption	 and	 suggested	 that	 including	
compliance	 of	 the	 stent-graft	 in	 simulations	 had	 little	 effect	 upon	 the	 forces	
measured	(178).	
There	 was	 a	 small	 error	 introduced	 by	 the	 large	 variation	 in	 anatomy	
experienced	 during	 the	 modelling	 process.	 Occasionally	 the	 use	 of	 gold	
radiopaque	markers	to	identify	inlets	or	outlets	led	to	larger	than	expected	cross-
sectional	 areas	 due	 to	 an	 overhang	 in	 the	 lumen	 (see	 Figure	 5.17).	 The	 distal	
body	illustrated	in	Figure	5.17B	had	an	inlet	XSA	501mm2	and	was	the	only	distal	
body	 component	 significantly	 larger	 than	 the	 predicted	 approximate	 452mm2	
XSA	(equivalent	to	24mm	circular	diameter).		The	affect	this	had	upon	distraction	
force	 can	 be	 estimated	 using	 equation	 5.7	 from	 the	 regression	 analysis.	 An	
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oversize	of	this	magnitude	 is	 likely	to	add	 less	than	0.8N	-	 in	this	case	11%	-	to	
the	total	RDF.		
	
Figure	5.17	Proximal	body	(blue)	and	distal	body	(green)	of	fEVAR	47	showing	
inconsistency	in	inlet	XSA	(*)	due	to	overhang	(OH)	secondary	to	modelling	
method.	GM	=	Gold	radiopaque	Marker		
Cross-sectional	 area	 of	 limb	 extension	 inlet	 was	 measured	 using	 a	 different	
technique	to	 that	used	with	other	 inlets	and	outlets.	This	was	due	to	 the	close	
proximity	of	the	other	limb	that	interfered	with	the	original	software	tool.	Some	
measurements	 were	 smaller	 than	 expected	 for	 an	 inlet	 with	 a	 standard	 outer	
diameter	of	12mm.	These	smaller	measurements	were	probably	due	to	the	small	
amount	 of	 constriction	 of	 the	 12mm	 seal-zone	 when	 deployed	 inside	 another	
12mm	 diameter	 contralateral	 gate	 and	 also	 the	 artefact	 from	 the	 high	
concentration	 of	 metal	 stents	 and	 radiopaque	 markers	 that	 may	 have	 led	 to	
under-representation	 of	 the	 lumen	 during	 the	 segmentation	 process.	 The	
observed	 median	 inlet	 XSA	 was	 68.5mm2,	 range	 44-104mm2.	 An	 internal	
diameter	 of	 11mm	 (which	 takes	 into	 account	 an	 estimated	 four	 graft	
thicknesses)	would	equate	to	a	circular	XSA	of	95mm2.		
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5.9 Conclusion	
This	 study	has	demonstrated	a	 technique	 to	obtain	distraction	 force	 results	 for	
individual	components	of	a	fenestrated	stent-graft	in	patient-specific	geometries	
using	 CT	 images	 and	 computational	 fluid	 dynamics.	 These	 simulations	 are	 the	
first	 to	 describe	 distraction	 force	 acting	 on	 the	 individual	 components	 of	 a	
fenestrated	stent-graft.	Given	the	potential	for	each	component	to	move	and	the	
importance	of	inlet	cross-sectional	area	in	determining	total	resultant	distraction	
force	this	approach	is	fundamental	to	achieving	meaningful	results.	
At	 a	 given	 blood	 pressure	 the	 most	 important	 morphological	 determinant	 of	
total	 resultant	 distraction	 force	 was	 cross-sectional	 area	 (inlet	 for	 complete	
stent-grafts,	 proximal	 and	 distal	 bodies,	 outlet	 for	 limb	 extensions).	 No	 angles	
within	the	aorta	were	large	enough	to	affect	the	total	resultant	distraction	force.	
Angulation	 ≥45°	 was	 associated	 with	 significantly	 greater	 force	 in	 complete	
stent-grafts	and	iliac	limb	extension	components.	Therefore	with	regards	to	the	
original	 hypothesis,	 larger	 vessel	 angulation	 such	 as	 that	 caused	 by	 the	 iliac	
vessels	 in	 relation	 to	 the	 aorta	 was	 associated	 with	 significantly	 greater	
distraction	 forces	 following	 fenestrated	 endovascular	 aneurysm	 repair.
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6 Relating	Distraction	Force	to	Migration	and	
Component	Distraction	
6.1 Abstract	
 Background	
Fixation	 force	 for	 proximal	 bodies,	 distal	 bodies	 and	 iliac	 limb	 extensions	 has	
been	determined	experimentally	under	ideal	deployment	conditions	at	11.5N	+/-
1.5N,	6.5N	 (4.8-7.2N)	and	9.6N	+/-1.5N	respectively	 (84,	123,	195).	The	second	
part	 of	 this	 thesis	 aims	 to	 quantify	 patient-specific	 distraction	 forces	 acting	
against	 fixation	 force	 for	 each	 component	 of	 the	 fenestrated	 stent-grafts	 and	
relate	this	to	the	incidence	of	migration	and	component	distraction.	
 Method	
Total	 resultant	 distraction	 force	 (RDF)	 results	 obtained	 in	 chapter	 five	 were	
corrected	 for	 patient-specific	 preoperative	blood	pressure.	 Core	 lab	 analysis	 of	
the	patient	cohort	had	already	been	performed	to	look	for	migration	of	proximal	
bodies	and	limb	extensions	(194).	Data	from	this	study	was	kindly	contributed	by	
the	lead	author.	
A	method	for	assessing	component	distraction	between	the	proximal	and	distal	
body	was	developed	 from	the	migration	analysis	method	detailed	 in	 the	above	
study.	 Stent-graft	 components	 were	 grouped	 according	 to	 the	 presence	 of	
movement	 ≥4mm	 and	 the	 difference	 in	 total	 RDF	 was	 analysed	 by	 non-
parametric	statistical	analysis	(Mann	Whitney	U	test,	MWU).	
 Results	
There	were	 nine	proximal	 bodies,	 three	distal	 bodies	 and	 four	 limb	extensions	
that	exhibited	movement	of	≥4mm	over	a	median	follow-up	period	of	25	months	
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(range	4-72).	 	All	 of	 these	 components	were	exposed	 to	distraction	 forces	 less	
than	the	experimentally	derived	fixation	force.	
There	was	no	significant	difference	between	total	RDF	acting	on	either	complete	
stent-grafts	 or	 proximal	 bodies	 in	 the	 migration	 and	 no	 migration	 groups	
(Median	 total	 RDF	 6.0N,	 range	 2.6-9.5N	 versus	 5.0N,	 2.1-13.1N,	 p=.295	 for	
complete	 stent-grafts;	 5.6N,	 range	 1.7-8.6N	 versus	 4.0N,	 1.3-11.6N,	 p=.338	 for	
proximal	bodies).	Likewise	there	was	no	significant	difference	between	total	RDF	
acting	 on	 either	 complete	 stent-grafts	 or	 distal	 bodies	 in	 the	 component	
distraction	and	no	component	distraction	groups	(Median	total	RDF	4.8N,	range	
4.2-5.1N	 versus	 5.5N,	 2.1-13.1N,	 p=.678	 for	 complete	 stent-grafts	 and	 4.3N,	
range	2.8-4.7N	vs	4.8N,	range	2.4-8.0N,	p=.235	for	distal	bodies).	
Limb	 extensions	 in	 the	 migration	 group	 were	 exposed	 to	 significantly	 greater	
total	RDF	compared	to	those	that	did	not	migrate	(Median	total	RDF	2.9N,	range	
2.7-6.3N	versus	1.6N,	range	0.4-3.8N,	p=.003).	Median	total	RDF	acting	upon	the	
complete	 stent-grafts	 in	 the	 limb	 migration	 group	 was	 6.0N,	 range	 2.4-13.1N	
versus	5.4N,	range	2.1-7.8N	for	the	no	migration	group.	This	difference	was	not	
significant	(p=.747).	
There	 was	 only	 one	 graft-related	 adverse	 event	 in	 all	 patients	 experiencing	
movement	of	a	stent-graft	component.	This	was	a	type	IIIa	endoloeak	from	the	
junction	 between	 the	 proximal	 body	 and	 left	 renal	 stent.	 It	 was	 treated	 at	 14	
months	postoperatively	with	angioplasty	of	the	renal	stent.			
 Conclusion	
Migration	 and	 component	 distraction	may	 occur	with	 distraction	 forces	 below	
the	experimentally	derived	fixation	force.	In	limb	extension	components	greater	
distraction	 force	 was	 significantly	 associated	 with	 cranial	 migration	 from	 the	
distal	seal-zone.	The	results	suggest	caution	when	planning	distal	seal	 in	ectatic	
iliac	vessels.	
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6.2 Introduction	
In	 Chapter	 five,	 total	 Resultant	 Distraction	 Force	 (RDF)	 was	 determined	 for	
individual	components	of	 the	 fenestrated	stent-graft	using	Computational	Fluid	
Dynamics	 (CFD).	 The	 contribution	 of	 morphological	 features	 such	 as	 cross-
sectional	 surface	 area	 and	 vessel	 angulation	 was	 quantified.	 Distraction	 force	
acting	upon	a	component	of	 the	stent-graft	 is	opposed	by	 the	 fixation	 force	of	
that	component.	Fixation	force	has	been	quantified	by	pullout	studies	in	porcine	
and	human	cadaveric	models	(84,	124,	127,	135,	143,	145).	
The	 Zenith	 proximal	 body	 with	 one	 visceral	 stent	 has	 an	 initial	 fixation	 force	
following	deployment	of	approximately	11.5N	+/-1.5N	(123).	The	radial	force	of	
the	 sealing	 stent(s),	 the	 barbs	 on	 the	 bare	metal	 stents	 and	 the	 visceral	 stent	
itself	all	contribute	to	this	 force.	 In	situations	where	distraction	force	 is	greater	
than	 fixation	 force,	 movement	 of	 the	 stent-graft	 may	 occur.	 In	 fenestrated	
endovascular	aneurysm	repair	caudal	migration	may	lead	to	stenosis	or	occlusion	
of	 target	vessels	as	well	as	compromise	of	 the	proximal	seal	with	 the	potential	
for	 type	 Ia	 endoleak	 and	 AAA	 rupture.	 The	 cumulative	 incidence	 of	 proximal	
body	migration	reported	in	worldwide	clinical	series	was	approximately	2.3%	(48,	
59,	62,	64,	65,	67,	68,	80)	but	early	subclinical	or	asymptomatic	migration	may	
occur	more	frequently.	One	recent	retrospective	core	lab	analysis	suggested	that	
proximal	body	migration	of	≥4mm	may	occur	 in	up	22%	of	cases	by	36	months	
(194).		
By	 contrast	 the	distal	body	of	 the	 stent-graft	 relies	upon	 the	 radial	 force	of	 its	
sealing	stents	alone	and	 is	 fixed	 inside	the	proximal	body	with	median	 force	of	
only	6.5N	(interquartile	range	4.8-7.2N)	(143).	Movement	between	the	distal	and	
proximal	 bodies	 (component	 distraction)	 may	 cause	 type	 IIIa	 endoleak,	 AAA	
expansion	 and	 subsequent	 rupture.	 The	 cumulative	 incidence	 of	 component	
distraction	in	reported	fEVAR	outcomes	is	approximately	1.5%	(59,	64,	65,	67,	68,	
80)	 however	 core	 lab	 analysis	 specifically	 for	 this	 complication	 has	 reported	
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movement	of	>10mm	in	13%	and	distraction	to	 less	 than	two	stents	overlap	 in	
7.5%	 (120).	 	 Interpretation	 of	 this	 is	made	more	 difficult	 by	 a	 redesign	 of	 the	
proximal	 body	 component	 in	 2005	 when	 the	 distal	 diameter	 was	 changed	 to	
22mm	 from	 24mm.	 The	 core	 lab	 analysis	 above	 was	 performed	 on	 106	
fenestrated	 stent-grafts	 deployed	before	2006	and	 therefore	most	would	have	
probably	been	 the	old	24/24mm	configuration.	All	 except	one	of	 the	43	 stent-
grafts	 in	 the	 current	 component	 distraction	 analysis	 are	 of	 the	 new	 22/24mm	
configuration	as	was	the	device	tested	by	Scurr	et	al.	(143).	
Limb	 extensions	 are	 fixed	 in	 the	 contralateral	 gate	 of	 the	 distal	 body	 with	
approximately	3.5N	of	fixation	force	(145)	but	since	migration	of	this	component	
is	usually	observed	from	the	distal	seal-zone	in	the	cephalid	direction,	the	distal	
fixation	force	in	the	iliac	vessels	of	approximately	9.6N	+/-1.5N	is	more	clinically	
relevant	(84).	Cephalid	migration	of	the	limb	extension	may	lead	to	kinking	and	
occlusion.	 The	 reported	 incidence	 of	 Zenith	 limb	 occlusion	 following	 standard	
EVAR	is	approximately	3-5%	(121).	This	figure	may	be	higher	in	those	deployed	in	
the	 external	 iliac	 artery	 (196).	 Since	 fEVAR	 uses	 the	 same	 Zenith	 limbs	 as	 the	
standard	repair	a	similar	incidence	may	be	expected	however	this	outcome	was	
not	reported	in	any	of	the	major	fEVAR	series	reviewed	in	chapter	two.	Proximal	
migration	of	the	iliac	limb	may	also	cause	loss	of	distal	seal,	type	Ib	endoleak	and	
subsequent	AAA	expansion	and	rupture.	
	
6.3 Aim	
The	aim	of	this	chapter	is	to	quantify	the	in	situ	distraction	force	acting	on	each	
complete	 stent-graft	 and	 its	 individual	 components.	 These	 forces	 will	 then	 be	
compared	 with	 the	 incidence	 of	 graft-related	 adverse	 events	 (GRAE)	 including	
migration,	 component	 distraction,	 type	 I	 and	 III	 endoleak	 and	 target	 vessel	
compromise.	
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6.4 Hypothesis	2	
Greater	 distraction	 force	 is	 associated	 with	 higher	 incidence	 of	 migration	 and	
component	distraction.	
	
	
6.5 Method	
	
 Calculating	forces	based	on	preoperative	systolic	blood	pressure	
Preoperative	systolic	blood	pressure	for	each	subject	was	used	to	calculate	the	in	
situ	distraction	force	for	each	patient	based	on	the	results	of	the	simulations	in	
chapter	five.	Previous	experimental	and	analytical	studies	have	indicated	that	the	
relationship	 between	 blood	 pressure	 and	 pressure	 derived	 distraction	 force	 is	
linear	(44,	155).	In	chapter	five,	distraction	force	results	were	obtained	for	a	peak	
systolic	blood	pressure	of	160mmHg	(21332Pa).	During	these	simulations,	results	
were	also	obtained	for	a	systolic	pressure	of	140mmHg	(18665Pa).	To	prove	the	
linear	relationship	between	pressure	and	pressure	derived	forces,	the	results	at	
18665Pa	were	transformed	by	equation	6.1	and	compared	with	actual	results	at	
21332Pa	from	chapter	five.		 FRDF2	=	FP1	x	P2	+	FV															P1	
(6.1)	
where	FRDF2	is	the	predicted	total	RDF	in	Newtons	at	21332Pa	(P2)	and	FP1	is	the	
pressure	 derived	 force	 at	 18665Pa	 (P1).	 Flow	 derived,	 viscous	 forces	 (FV)	 were	
constant	and	independent	of	pressure	forces.	They	were	therefore	added	to	the	
pressure	force	to	give	total	resultant	distraction	force.	
Table	6.1	shows	the	median	error	between	the	total	RDF	predicted	by	equation	
6.1	and	 the	actual	observed	 total	RDF	at	21332Pa	 for	 all	 complete	 stent-grafts	
and	components	included	in	chapter	five.	
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Table	6.1	Median	error	(%)	of	predicted	versus	observed	total	RDF	at	21332Pa	
	 Median	Error	(%)	 Range	(%)	
Complete	stent-grafts	 0.35	 0.04-2.86	
Proximal	bodies	 0.31	 0.03-2.79	
Distal	bodies	 0.31	 0.02-2.82	
Limb	extensions	 0.19	 0.01-2.82	
		
This	 error	was	 considered	 acceptable	 and	 equation	 6.1	was	 therefore	 used	 to	
translate	 force	 results	 at	 18665Pa	 into	 patient-specific	 total	 RDF	 for	 each	
complete	stent-graft	and	for	the	individual	components	as	follows:	
	 FIS	=	FP1	x	133.32PPO	+	PV	P1	
(6.2)	
where	FIS	=	in	situ	total	RDF	in	Newtons	and	PPO	=	preoperative	systolic	blood	pressure	in	
mmHg.		
	
 Analysis	of	component	distraction		
The	 method	 of	 England	 et	 al.	 (194)	 used	 in	 the	 analysis	 of	 proximal	 body	
migration	had	been	previously	validated	by	an	intra	and	interobserver	variability	
study	 (197).	 Using	 a	 computer	 generated	 central	 luminal	 line	 (CLL),	 electronic	
measuring	 tool	 and	 predefined	 anatomical	markers,	 accuracy	was	 observed	 to	
4mm.	 The	 method	 described	 here	 for	 analysis	 of	 component	 distraction	
preserves	as	many	of	the	features	used	in	this	migration	analysis	as	possible.		
 Image	acquisition	and	reconstruction	
The	 first	 and	 last	 available	 postoperative	 CT	 scans	 were	 loaded	 onto	 a	 3D	
workstation	 (Carestream	 PACS	 10.2,	 Kodak,	 Rochester,	 NY).	 An	 in-built	 vessel	
analysis	 tool	was	used	 to	generate	a	CLL	 from	above	 the	 stent-graft	 to	a	point	
along	 the	 ipsilateral	 limb	 beyond	 the	 distal	 extent	 of	 the	 proximal	 body.	 The	
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ipsilateral	limb	was	chosen	for	its	smoother	transition	past	the	flow	divider	than	
the	contralateral	gate.	Here	the	sudden	reduction	in	luminal	diameter	caused	by	
the	 proximal	 extent	 of	 the	 limb	 extension	 may	 cause	 sudden	 changes	 in	 the	
direction	of	the	generated	CLL.		
The	 Maximum	 Intensity	 Projection	 (MiPPR)	 sagittal	 image	 was	 thickened	 to	
25mm	 to	 more	 readily	 show	 the	 overall	 configuration	 of	 the	 stent-graft	 (see	
Figure	6.1B).	Crosshairs	were	moved	up	and	down	the	green	CLL	and	were	used	
to	mark	reference	points	as	they	appeared	in	the	axial	window	(Figure	6.1C).	The	
distance	between	reference	points	along	the	CLL	was	automatically	calculated	by	
the	software.	A	3D	overview	of	the	stent	graft	and	vessel	morphology	was	shown	
in	the	top	left	of	the	screen	(Figure	6.1A).	
	
Figure	6.1	Carestream	software	set	up	for	measurement	of	component	
distraction.	A:	3D	reconstruction,	B:	Sagittal	MiPPR,	C:	axial	window		
	
 Component	distraction	definition	
One	previous	 core	 lab	 analysis	 of	 106	 patients	 post	 fEVAR	defined	 component	
movement	 as	 any	 movement	 of	 >10mm	 (120).	 Component	 distraction	 was	
defined	as	movement	that	had	 led	to	 inadequate	overlap	 length	(less	than	two	
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stents	as	defined	by	 IFU)	or	clinical	 symptoms	or	 secondary	 intervention.	Since	
the	 current	 method	 is	 based	 upon	 a	 previously	 described	 migration	 analysis	
method	that	has	validated	accuracy	to	4mm,	the	term	component	distraction	 is	
used	here	to	describe	movement	of	≥4mm	of	 the	distal	body	 in	relation	to	the	
proximal	body.		
 Selection	of	reference	points	
For	 the	measurement	of	 proximal	migration,	 England	et	 al.	 (194)	 used	 the	CLL	
distance	 between	 the	 first	 axial	 slice	 where	 there	was	 clear	 separation	 of	 the	
SMA	from	the	aortic	wall	and	the	appearance	of	at	least	two	bare	metal	stents.	
Since	 the	measurement	 of	 component	 distraction	 relies	 upon	 determining	 the	
position	of	one	component	in	relation	to	another	it	was	not	necessary	to	include	
a	native	vascular	reference	point.	All	the	reference	points	were	therefore	stents	
or	markers	on	the	proximal	or	distal	body.	These	points	are	shown	in	Figure	6.2.	
	
Figure	6.2	Reference	points	on	the	Zenith	fenestrated	proximal	body	and	distal	
body	for	the	measurement	of	component	distraction.	
Image	adapted	from	Cook	medical	Inc.	(72)	
	
The	 most	 proximal	 reference	 point	 was	 the	 first	 appearance	 of	 at	 least	 two	
apices	of	the	suprarenal	bare	metal	stent	(A).	B	 is	the	anterior	gold	radiopaque	
markers	of	the	proximal	body.	C	 is	the	proximal	gold	radiopaque	marker	of	the	
distal	body	and	D	is	the	distal	gold	radiopaque	marker	of	the	proximal	body.	
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 Measurements		
Four	measurements	were	made	on	each	CT	scan.	 ‘First	appearance’	 in	all	cases	
refers	to	the	identification	of	a	reference	point	whilst	moving	through	the	images	
in	a	cranial	to	caudal	direction.		
6.5.2.4.1 Measurement	1	(M1)	
The	CLL	distance	between	the	first	appearance	of	at	least	two	struts	of	the	bare	
metal	stent	(A,	Figure	6.2	and	Figure	6.3)	to	the	first	appearance	of	the	proximal	
gold	radiopaque	marker	on	the	distal	body	(C).	This	measurement	was	included	
as	 it	 uses	one	of	 the	 reference	points	 from	 the	previous	proven	methodology.	
Dowdall	et	al.	 (120)	used	 the	 first	 contralateral	 gate	 radiopaque	marker	as	 the	
distal	 reference	point	but	the	extra	distance	between	these	points	may	 lead	to	
inaccuracy	 should	 there	 be	 any	 significant	 changes	 in	 aortic	 tortuosity	 or	
‘concertinering’	of	components.	Concertinering	refers	 to	 the	potential	 for	 the	z	
stents	to	move	closer	together	thus	closing	the	small	2mm	gaps	between	them	
as	 a	 result	 of	 changes	 to	 the	 native	 vessel	 or	 migration	 of	 one	 end	 of	 a	
component	 in	 relation	 to	 the	 other.	 The	 net	 result	 is	 a	 shortening	 of	 the	
component.	To	address	this	point	–	and	because	identification	of	the	maximum	
radiopacity	of	the	gold	markers	may	be	less	subjective	than	that	of	the	stents	–	a	
second	measurement	was	also	taken	(see	M2).	
6.5.2.4.2 Measurement	2	(M2)	
The	CLL	distance	between	the	first	appearance	of	the	most	proximal	of	the	three	
anterior	vertical	gold	markers	on	the	proximal	body	(B,	Figure	6.2	and	Figure	6.3)	
to	 the	 first	 appearance	 of	 the	 proximal	 gold	 radiopaque	marker	 on	 the	 distal	
body	 (C).	This	distance	was	much	shorter	 than	M1	and	 in	 some	cases	negative	
i.e.	when	the	distal	body	was	overlapped	to	the	lower	margin	of	the	lower	most	
fenestration,	 reference	 point	 C	 was	 actually	 proximal	 to	 point	 B.	 M2	 also	
quantified	 the	 amount	 of	 ‘non-appositional	 overlap’	 present	 between	 the	 two	
components.	The	proximal	of	the	three	vertical	markers	identified	the	transition	
		
125	
Chapter	6:	Distraction	Force,	Migration	and	Component	Distraction		
point	 between	 the	 seal-zone	 above	 that	 may	 be	 up	 to	 36mm	 in	 diameter	
depending	on	the	size	of	device	chosen	and	the	overlap	zone	below	where	the	
diameter	is	always	22mm.	Distal	body	sealing	stents	deployed	above	this	point	in	
large	 proximal	 body	 components	 may	 add	 little	 or	 no	 radial	 force	 to	 the	
component’s	 fixation.	 Conversely	 with	 enough	 clearance	 below	 the	 visceral	
vessels,	 allowing	 a	 distal	 body	 sealing	 stent	with	 a	 diameter	 of	 24mm	 to	 fully	
deploy	above	the	transition	point	may	lead	to	more	secure	fixation	since	it	would	
then	be	very	difficult	to	distract	it	back	down	the	22mm	overlap	zone.		
	
Figure	6.3	Axial	views	at	positions	A-D	(left)	and	MiPPR	(right)	showing	all	
reference	points	(indicated	by	red	arrows).	M1:	A-C,	M2:	B-C,	M3:	B-D,	M4:	C-D	
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6.5.2.4.3 Measurement	3	(M3)	
The	CLL	distance	between	the	first	appearance	of	the	most	proximal	of	the	three	
anterior	vertical	gold	markers	on	the	proximal	body	(B,	Figure	6.2	and	Figure	6.3)	
to	 the	 first	 appearance	 of	 the	 distal	 gold	 radiopaque	marker	 on	 the	 proximal	
body	 (D).	While	M3	 gave	 no	 information	 in	 terms	 of	 component	movement	 it	
was	 used	 to	 confirm	 that	 any	 changes	 in	 M4	 were	 indeed	 due	 to	 distraction	
rather	than	a	significant	reduction	in	tortuosity	or	concertinering.	
6.5.2.4.4 Measurement	4	(M4)	
The	CLL	distance	between	the	first	appearance	of	the	proximal	gold	radiopaque	
marker	on	the	distal	body	(C,	Figure	6.2	and	Figure	6.3)	to	the	first	appearance	of	
the	distal	gold	radiopaque	marker	on	the	proximal	body	(D).	M4	was	a	secondary	
measurement	of	movement	between	gold	markers	and	also	corresponded	to	the	
length	of	 ‘appositional	overlap’	between	the	proximal	and	distal	bodies.	This	as	
opposed	 to	 ‘non-appositional	 overlap’	 (see	M2)	 was	 the	 length	 of	 distal	 body	
physically	in	contact	with	the	22mm	diameter	overlap	zone	of	the	proximal	body.	
Each	measurement	 on	 the	 first	 postoperative	 CT	 scan	was	 compared	with	 the	
corresponding	 measurement	 on	 the	 last	 available	 CT	 scan	 and	 any	 difference	
≥4mm	 was	 investigated	 further	 by	 visual	 comparison	 of	 images.	 A	 change	 of	
≥4mm	 in	M2	measurements	was	 suggestive	of	 component	distraction	and	was	
confirmed	by	ensuring	there	were	no	significant	differences	in	CLL	morphology;	
by	a	≥4mm	change	in	M1	and	M4	and	a	<4mm	change	in	M3.	A	≥4mm	change	in	
M3	would	be	 suggestive	of	either	a	 change	 in	aortic	 tortuosity,	 inconsistencies	
with	CLL	generation	or	–	in	the	case	of	reduction	≥4mm	–	concertinering.	
	
 Inclusion	criteria	
Patients	were	required	to	have	an	initial	postoperative	CT	scan	and	at	least	one	
other	separate	surveillance	episode	with	CT	imaging.	Ethical	approval	for	the	use	
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of	 medical	 images	 and	 demographic	 data	 was	 granted	 by	 the	 North	 West	 –	
Liverpool	East	Research	Ethics	Committee.		
 Statistical	analysis	
Continuous	 data	was	 analysed	using	Mann	Whitney	U	 test	 (MWU),	 categorical	
data	with	Fisher’s	Exact	test.	
	
6.6 Results	
 Proximal	body	migration	
 Exclusions	
Of	54	patients	for	whom	flow	simulations	had	been	performed	43	had	an	initial	
postoperative	CT	plus	one	 further	surveillance	episode	with	CT	 imaging.	Eleven	
patients	were	excluded	due	to	only	having	one	available	postoperative	CT.	This	
was	either	due	to	follow-up	having	been	arranged	elsewhere	(n=6),	short	follow-
up	 with	 only	 one	 completed	 imaging	 episode	 (n=2),	 mortality	 prior	 to	 second	
imaging	 episode	 (n=2)	 or	 poor	 renal	 function	 excluding	 further	 follow-up	with	
contrast	enhanced	CT	(n=1).	
 Migration	analysis	
Central	 luminal	 line	 analysis	 identified	 nine	 cases	 of	migration	 ≥4mm	 (median	
distance	 migrated	 6.1mm,	 range	 4.1-12.5mm).	 There	 were	 34	 other	 proximal	
bodies	 in	the	‘no	migration’	group	with	a	median	migration	distance	of	1.7mm,	
range	 -3.2-3.8mm.	 Overall	 median	 time	 between	 imaging	 episodes	 was	 25	
months	(range	4-72).	
Demographics	were	obtained	from	departmental	records.	Both	groups	were	well	
matched	with	 the	exception	of	BMI	 (see	Table	6.2).	Although	 the	difference	 in	
BMI	reached	statistical	significance	(25	in	the	migration	group	versus	27.5	in	the	
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no	migration	group)	this	is	of	little	clinical	significance	since	both	are	considered	
‘overweight’	by	the	World	Health	Authority.	There	was	a	trend	toward	a	longer	
time	 between	 imaging	 episodes	 in	 the	 migration	 group	 but	 this	 was	 not	
significant.	
	
Table	6.2	Comparison	of	demographics	between	patients	with	proximal	body	
migration	versus	no	migration	
	 Migration	 No	Migration	 p	(MWU	except	
f:Fisher's	Exact)	
n	 9	 34	 	
Distance	Migrated,	mm	 6.1	
(4.1-12.5)	
1.8	
(-3.2-3.8)	
	
Gender	(M:F)	 8:1	 30:4	 0.723f	
Age	 76	
(65-86)	
76	
(62-85)	
0.942	
BMI	 25.0	
(22.6-34.3)	
27.5	
(19.7-40.9)	
0.046*	
Diabetes	 1	 3	 0.624f	
Ischaemic	heart	disease	 5	 20	 0.575f	
Heart	failure	 0	 1	 0.791f	
Hypertension	 4	 20	 0.345f	
Preoperative	systolic	blood	
pressure,	mmHg	
135	
(122-167)	
140	
(92-185)	
0.567	
Preoperative	pulse	rate,	beats	
per	minute	
68	
(50-90)	
70	
(53-118)	
0.385	
Chronic	renal	impairment	 2	 3	 0.277f	
Current	smoker	 3	 6	 0.463f	
Peripheral	vascular	disease	 1	 4	 0.723f	
ASA	(1/2/3/4)	 0/2/7/0	 1/10/23/0	 	
Imaging	interval,	months	 44	
(10-72)	
24	
(4-52)	
0.295	
Maximum	preoperative	AAA	
diameter	(mm)	
59	
(55-80)	
65	
(55-86)	
0.187	
XSA	of	lumen	at	proximal	body	
inlet	(mm2)	
389	
(209-659)	
347	
(214-907)	
0.418	
For	full	demographics	see	Appendix	8.8.	Continuous	variables	expressed	as	median	with	range	in	
parentheses,	n	given	for	categorical	variables,	ASA:	American	Society	of	Anaesthetists	grading,	
BMI:	Body	mass	index,	n=Number	of	patients,	XSA:	Cross-sectional	area,	*denotes	significance	to	
p<.05	
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 Total	resultant	distraction	force	(RDF)	
Median	total	RDF	acting	on	the	complete	stent-grafts	in	the	migration	group	was	
6.0N	 (range	 2.6-9.5N).	 This	 figure	 was	 higher	 than	 in	 the	 no	 migration	 group	
(Median	 5.0N,	 range	 2.1-13.1N)	 but	 did	 not	 reach	 statistical	 significance.	 A	
similar	trend	was	seen	between	proximal	bodies	in	each	group	(5.6N,	range	1.7-
8.6N	vs	4.0N,	range	1.3-11.6N)	(see	Figure	6.4).	
	
	
Figure	6.4	Comparison	of	total	RDF	between	migration	and	no	migration	groups	
Individual	distraction	force	results	for	complete	stent-grafts	and	proximal	bodies	
are	 detailed	 in	 Appendix	 8.7.1.	Migration	measurements	 and	 imaging	 intervals	
are	also	included.			
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 Clinical	sequelae	
Only	one	of	the	nine	patients	with	proximal	body	migration	developed	any	target	
vessel	problems.	This	was	an	ostial	 endoleak	between	 the	visceral	 stent	of	 the	
left	 renal	 artery	 and	 the	 main	 stent-graft	 of	 fEVAR	 53.	 It	 was	 treated	 with	
angioplasty	of	the	original	visceral	stent	at	14	months.	One	other	patient	(fEVAR	
45)	had	suspected	misalignment	of	the	SMA	scallop	and	was	investigated	with	a	
digital	 subtraction	 angiogram.	 No	 significant	 stenosis	 was	 found	 and	 no	
secondary	 intervention	 was	 performed.	 Appendix	 8.9	 details	 the	 clinical	
outcomes	for	all	patients	in	the	cohort.	
There	were	no	late	type	I	endoleaks	in	either	group.	Of	the	34	patients	in	the	no	
migration	group	there	were	two	ostial	type	IIIa	endoleaks	between	target	vessel	
stents	and	the	main	stent-graft	during	the	follow-up	period	(fEVARs	25	and	32).	
Three	visceral	vessels	occluded	without	clinical	consequences	(fEVARs	29,	36	and	
41),	one	associated	with	stent	fracture	and	another	with	stent	dislocation.	Three	
other	visceral	stents	remained	patent	but	were	noted	to	have	fractured	(fEVARs	
25,	 34	 and	52)	 and	one	other	had	dislocated	but	 also	 remained	patent	 (fEVAR	
25).	 	There	were	two	stenoses	in	scalloped	target	vessels	(the	right	renal	artery	
of	fEVAR	21	and	SMA	of	fEVAR	35).		
Of	 the	 patients	 not	 included	 in	 the	migration	 analysis	 (due	 to	 having	 only	 one	
available	postoperative	CT	scan)	one	developed	mesenteric	ischaemia	secondary	
to	an	SMA	stent	stenosis.	This	was	treated	unsuccessfully	by	angioplasty	at	one	
month	and	was	followed	by	right	external	iliac	artery	to	SMA	bypass	at	8	months.	
This	patient	(fEVAR	2)	was	lost	to	follow-up	in	another	region	at	28	months.	One	
other	 had	 a	 right	 renal	 stent	 stenosis	 treated	 by	 angioplasty	 within	 the	 first	
postoperative	month	(fEVAR	24).	
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 Proximal-distal	body	component	distraction	
 Exclusions	
One	 patient	 (fEVAR	 7)	 was	 excluded	 from	 the	 43	 patients	 included	 in	 the	
proximal	 body	 migration	 analysis.	 This	 device	 was	 a	 custom	 made	 hybrid	
proximal/distal	body	component	that	was	both	fenestrated	and	bifurcated.		
 Distraction	analysis	
Three	 cases	 of	 component	 distraction	 ≥4mm	 between	 the	 distal	 and	 proximal	
bodies	were	identified	(median	distance	5.6mm,	range	5.4-13.7mm).	There	were	
39	 other	 distal	 bodies	 in	 the	 ‘no	 component	 distraction’	 group	with	 a	median	
distance	 of	 0.4mm,	 range	 -3.2-3.0mm.	 Overall	 median	 time	 between	 imaging	
episodes	was	24	months	(range	4-52)	and	there	were	no	significant	demographic	
differences	 between	 groups	 (see	 Table	 6.3).	 Likewise	 there	 was	 no	 significant	
difference	between	 the	groups	 in	 terms	of	preoperative	AAA	diameter	or	 inlet	
cross-sectional	area	of	the	distal	body	component	post-deployment.	
The	 interval	change	between	M1,	2,	3	and	4	measurements	 for	each	patient	 is	
shown	in	Appendix	8.7.2	along	with	patient-specific	distraction	forces	acting	on	
each	distal	body	and	fenestrated	stent-graft	as	a	whole.		
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Table	6.3	Comparison	of	demographics	between	patients	with	proximal-distal	
body	component	distraction	versus	no	component	distraction	
	 Component	
Distraction	
No	Component	
Distraction	
p	(MWU	except	
f:Fisher's	Exact)	
n	 3	 39	 	
Distance	distracted,	mm		
Based	on	M2	measurements	
	
5.6		
(5.4-13.7)	
0.4		
(-3.2-3.0)	
	
Gender	(M:F)	 2:1	 35:4	 .323f	
Age	 76	
(62-78)	
76	
(64-86)	
.678	
BMI	 26.3	
(19.7-27.6)	
26.8		
(20.3-40.9)	
.371	
Diabetes	 0	 4	 1.000f	
Ischaemic	heart	disease	 1	 23	 .567f	
Heart	failure	 0	 1	 1.000f	
Hypertension	 0	 23	 .084f	
Preoperative	systolic	blood	
pressure,	mmHg	
117	
(92-180)	
140	
(100-185)	
.425	
Preoperative	pulse	rate,	beats	
per	minute	
65	
(62-90)	
70		
(50-118)	
.644	
Chronic	renal	impairment	 0	 5	 1.000f	
Current	smoker	 2	 7	 .111f	
Peripheral	vascular	disease	 0	 5	 1.000f	
ASA	(1/2/3/4)	 0/1/2/0	 1/11/27/0	 	
Imaging	interval,	months	 23	
(21-49)	
25	
(4-52)	
.577	
Maximum	preoperative	AAA	
diameter	(mm)	
59	
(57-62)	
64		
(55-86)	
.298	
XSA	of	lumen	at	proximal	body	
inlet	(mm2)	
340		
(272-414)	
382	
(194-501)	
.577	
For	full	demographics	see	Appendix	8.8.	Continuous	variables	expressed	as	median	with	range	in	
parentheses,	n	given	for	categorical	variables,	ASA:	American	Society	of	Anaesthetists	grading,	
BMI:	Body	mass	index,	n=Number	of	patients,	XSA:	Cross-sectional	area	
	
 Visual	image	comparison	for	all	measurement	differences	≥4mm	
Overall	 there	 were	 eight	 patients	 with	 ≥4mm	 change	 in	 M1,	 2	 or	 4	
measurements.	Visual	 image	comparison	showed	that	only	three	of	these	were	
true	cases	of	component	distraction.	
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6.6.2.3.1 Cases	where	true	component	distraction	was	ruled	out	
fEVAR	19	(M4:	-4.6mm):	No	component	distraction.	
Prior	 analysis	 of	 migration	 (see	 6.6.1)	 had	 shown	 that	 fEVAR	 19	 underwent	
4.1mm	 of	 proximal	 body	 migration	 between	 imaging	 intervals.	 This	 probably	
represented	full	engagement	of	the	barbs	into	the	aortic	wall	and	can	be	seen	in	
Figure	6.5	where	the	bare	metal	stents	expanded	and	moved	distally	in	relation	
to	the	superior	border	of	the	first	lumbar	vertebra	(a).		
	
Figure	6.5	First	and	last	available	images	for	fEVAR	19	
The	distance	between	the	proximal	gold	marker	(PGM)	of	the	distal	body	and	the	
distal	 gold	 marker	 (DGM)	 of	 the	 proximal	 body	 reduced	 by	 4.6mm	 but	 this	
probably	 represented	 the	 concertinering	 effect	 of	 the	 stents	 of	 both	 proximal	
and	distal	bodies	due	to	the	migration	above	rather	than	distraction	between	the	
two.	The	case	for	concertinering	is	supported	by	the	6.2mm	reduction	in	distance	
between	the	anterior	gold	markers	(AGM)	and	DGM	(i.e.	M3	measurement)	and	
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by	 the	 small	upward	movement	of	 the	PGM	 in	 relation	 to	AGM	seen	 in	 Figure	
6.5.	
fEVAR	21	(M1:	+6.6mm,	M4:	-5.3mm):	No	component	distraction.		
The	distance	between	the	appearance	of	two	bare	metal	stents	and	the	proximal	
gold	 marker	 (PGM)	 of	 the	 distal	 body	 increased	 by	 6.6mm	 between	 imaging	
intervals.	 The	 anterior	 curvature	 of	 the	 stent-graft	 increased	 over	 this	 time	
period	 which	 would	 have	 contributed	 to	 the	 increase	 in	 the	 CLL	 distance	
between	these	two	points	(see	Figure	6.6).		
	
Figure	6.6	First	and	last	available	images	for	fEVAR	21	
A	further	contributing	factor	was	a	3.0mm	increase	in	M2	distance,	i.e.	between	
the	anterior	gold	markers	(AGM)	of	the	proximal	body	and	PGM.	This	movement	
did	not	quite	 reach	 significance	and	although	 the	measurement	 technique	was	
not	validated	to	prove	such	small	movements,	visual	 inspection	of	these	points	
of	interest	does	suggest	a	small	amount	of	component	distraction.	The	distance	
between	 the	 PGM	 and	 distal	 gold	 marker	 (DGM)	 of	 the	 proximal	 body	 (M4	
distance)	reduced	by	5.3mm	over	the	same	imaging	 interval.	The	CLL	curvature	
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throughout	this	segment	did	not	change	and	the	seemingly	significant	difference	
in	 M4	 was	 probably	 as	 a	 result	 of	 the	 small	 amount	 (3.0mm)	 of	 component	
distraction	together	with	the	concertinering	effect	on	the	posterior	aspect	of	the	
stents	caused	by	the	observed	anterior	displacement	of	the	stent-graft.		
fEVAR	26	(M1:	+4.4mm):	No	component	distraction.		
This	stent-graft	exhibited	significant	(9.5mm)	proximal	body	migration	during	the	
imaging	 interval.	This	 can	be	seen	 in	Figure	6.7	where	 the	position	of	 the	bare	
metal	stent	moved	from	a	to	b	in	relation	to	the	vertebral	bodies	between	2008	
and	2012.		
	
Figure	6.7	First	and	last	available	images	for	fEVAR	26	
Despite	 significant	proximal	body	migration	 the	distance	between	 the	proximal	
bare	 metal	 stent	 and	 the	 proximal	 gold	 marker	 (PGM)	 increased	 by	 4.4mm.	
Continued	expansion	of	the	first	sealing	stent	may	have	contributed	to	this	and	
visual	inspection	of	images	suggests	that	the	PGM	of	the	distal	body	remained	at	
the	same	position	in	comparison	with	the	three	anterior	gold	markers	(AGM)	on	
the	proximal	body.	This	finding	combined	with	no	significant	change	in	M2	or	M4	
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distance	 confirmed	 the	 absence	 of	 component	 distraction.	 In	 this	 instance	 the	
proximal	and	distal	bodies	migrated	distally	en	mass.	
fEVAR	35	(M4:	-4.4mm):	No	component	distraction.	
The	M4	distance	between	the	proximal	gold	marker	(PGM)	of	the	distal	body	and	
distal	gold	marker	of	the	proximal	body	marker	(DGM)	in	fEVAR	35	decreased	by	
4.4mm	between	imaging	intervals	but	this	was	not	accompanied	by	a	significant	
change	 in	 M1	 or	 M2	 measurements	 (1.9	 and	 0.9mm	 respectively).	 A	 small	
amount	of	concertinering	of	the	stent-graft	may	have	contributed	to	the	change	
in	M4	measurement.	This	was	suggested	by	the	closer	position	of	stents	at	point	
b	 compared	 with	 a	 (Figure	 6.8)	 and	 by	 the	 -3.1mm	 change	 in	 the	 distance	
between	AGM	and	DGM	markers	(i.e.	M3).	There	is	also	no	discernible	change	in	
the	position	of	PGM	in	relation	to	AGM.	
	
Figure	6.8	First	and	last	available	images	for	fEVAR	35	
	
fEVAR	40	(M1:	+7.8mm):	No	component	distraction.		
An	isolated	7.8mm	increase	in	the	distance	between	the	first	appearance	of	two	
bare	metal	 stents	 and	 the	 proximal	 gold	marker	 (PGM)	of	 the	 distal	 body	was	
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observed	 for	 fEVAR	 40.	 Visual	 inspection	 of	 images	 shows	 remodelling	 of	 the	
visceral	aorta	with	reduction	in	aneurysm	size.	Although	further	expansion	of	the	
second	 sealing	 stent	between	 imaging	episodes	has	 straightened	 the	CLL	 there	
has	been	a	little	increase	in	the	distance	between	this	and	the	next	stent	at	point	
b	compared	with	point	a	(see	Figure	6.9).		
	
Figure	6.9	First	and	last	available	images	for	fEVAR	40	
This	slight	moving	apart	of	stent	rows	has	caused	all	other	reference	points	to	be	
slightly	 lower	 against	 their	 respective	 vertebral	 bodies	 whereas	 the	 proximal	
bare	metal	stent	remained	at	the	same	position.	The	lack	of	significant	change	in	
M1	and	M2	measurements	 and	 the	 constant	position	of	 anterior	 gold	markers	
(AGM),	 PGM	 and	 distal	 gold	 marker	 (DGM)	 confirmed	 that	 no	 distal	 body	
component	distraction	had	occurred.	
6.6.2.3.2 Cases	where	true	component	distraction	was	confirmed	
fEVAR	 22	 (M1:	 +6.7mm,	 M2:	 +5.6mm,	 M4:	 -5.1mm):	 Confirmed	 component	
distraction.		
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All	 three	 measurements	 for	 fEVAR	 22	 showed	 significant	 change	 between	
imaging	 episodes	 and	 the	 length	 of	 the	 proximal	 body,	 i.e.	 the	 M3	 distance	
between	the	anterior	gold	marker	(AGM)	and	the	distal	gold	marker	(DGM)	only	
changed	by	0.5mm.		
	
Figure	6.10	First	and	last	available	images	for	fEVAR	22	
Visual	 inspection	 (see	 Figure	6.10)	 shows	 that	 the	PGM	of	 the	distal	 body	was	
initially	proximal	to	the	AGM	in	2008	but	by	2012	had	moved	to	lie	just	distal	to	
the	 upper	 edge	 of	 the	 first	 AGM.	 Although	 the	 change	 in	 position	 of	 the	
components	in	relation	to	the	vertebral	bodies	was	suggestive	of	a	small	amount	
of	 proximal	 body	 migration	 the	 movement	 was	 not	 significant	 (0.5mm,	 see	
Appendix	 8.7.1).	 The	 observed	 changes	 in	 M1,	 2	 and	 4	 measurements	 in	 the	
absence	of	a	significant	change	 in	M3	measurement	confirmed	the	presence	of	
component	distraction.	
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fEVAR	 43	 (M1:	 +6.6mm,	 M2:	 +5.4mm,	 M4:	 -6.1mm):	 Confirmed	 component	
distraction.		
Anterior	 displacement	 of	 the	 stent-graft	 was	 observed	 between	 imaging	
episodes.	The	proximal	gold	marker	(PGM)	of	the	distal	body	was	proximal	to	the	
anterior	gold	markers	(AGM)	of	the	proximal	body	following	deployment	in	2009	
but	by	2012	had	moved	adjacent	 to	 the	most	proximal	of	 the	 three	AGM	 (see	
Figure	6.11).	Although	the	CLL	through	the	section	of	stent-graft	between	AGM	
and	distal	gold	marker	 (DGM)	appeared	to	straighten	over	 the	 imaging	 interval	
there	 was	 only	 -0.6mm	 change	 in	 M3	 measurement.	 This	 confirms	 that	 the	
reduction	 in	 M4	 (PGM	 to	 DGM)	 was	 due	 to	 component	 distraction	 and	 not	
concertinering.		
	
Figure	6.11	First	and	last	available	images	for	fEVAR	43	
fEVAR	 46	 (M1:	 +11.3mm,	M2:	 +13.7mm,	M4:	 -9.6mm):	 Confirmed	 component	
distraction.	
The	proximal	gold	marker	(PGM)	of	the	distal	body	moved	distally	in	relation	to	
the	anterior	gold	markers	(AGM,	see	Figure	6.12).	This	resulted	in	an	initial	three-
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stent	 overlap	 becoming	 only	 two-stents	 in	 the	 latter	 image.	 There	 was	 no	
significant	 proximal	 body	migration	 (1.7mm)	 or	 change	 in	 the	 proximal	 CLL	 to	
affect	 the	M1	measurements.	 The	 9.6mm	 reduction	 in	 distance	 between	 PGM	
and	 DGM	 remained	 significant	 even	 after	 allowing	 for	 the	 apparent	 4.2mm	
reduction	in	M3	measurement	(i.e.	length	of	proximal	body	or	AGM	to	DGM).		
	
Figure	6.12	First	and	last	available	images	for	fEVAR	46	
	
 Total	resultant	distraction	force	
There	 was	 no	 observed	 trend	 towards	 greater	 total	 RDF	 in	 the	 component	
distraction	group	versus	the	no	distraction	group	(see	Figure	6.13).	Total	RDF	was	
in	 fact	 non-significantly	 smaller	 in	 both	 complete	 stent-grafts	with	 evidence	 of	
component	 distraction	 (median	 total	 RDF	 4.8N,	 range	 4.2-5.1N	 vs	 5.5N,	 range	
2.1-13.1N)	 and	 distal	 bodies	 (median	 4.3N,	 range	 2.8-4.7N	 vs	 4.8N,	 range	 2.4-
8.0N).	
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Figure	6.13	Comparison	of	total	RDF	between	component	distraction	groups	
	
 Clinical	sequelae	
There	 were	 no	 clinical	 sequelae	 as	 a	 result	 of	 any	 of	 the	 three	 cases	 of	
component	distraction.	Two	patients	were	alive	at	five	and	four	years	of	follow-
up	 with	 no	 graft-related	 adverse	 events	 (fEVAR	 22	 and	 43).	 One	 patient	 died	
from	non-aneurysm	related	causes	after	three	years	of	follow-up	(fEVAR	46).	The	
distal	body	of	this	stent-graft	moved	13.7mm	caudally	in	relation	to	the	proximal	
body	between	imaging	episodes	and	although	the	initial	three	stent	overlap	was	
reduced	 to	 two	 stents,	 no	 type	 IIIa	 endoleak	 or	 other	 complication	 was	
identified.	None	of	these	patients	underwent	any	secondary	interventions.	There	
were	 no	 graft-related	 adverse	 events	 in	 relation	 to	 the	 proximal-distal	 body	
junction	within	the	‘no	component	distraction’	group	either.	A	full	description	of	
all	clinical	outcomes	is	included	in	Appendix	8.9.	
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 Limb	extension	migration	
 Exclusions	
One	 fenestrated	 stent-graft	 (fEVAR	 15)	 was	 excluded	 from	 the	 43	 used	 in	 the	
proximal	 body	 analysis	 due	 to	 the	 presence	 of	 a	 Wallstent	 (Boston	 Scientific,	
France)	in	the	contralateral	limb.	This	uncovered	stent	placed	at	the	time	of	the	
initial	repair	to	correct	a	stenosis	or	kink	in	the	limb	extension	would	have	had	an	
unknown	 effect	 on	 the	 distal	 fixation	 force.	 It	was	 not	 possible	 to	 identify	 the	
inlet	 and	 outlets	 of	 the	 limbs	 of	 one	 further	 stent-graft	 (fEVAR	 49)	 due	 to	 the	
overlapping	stents	of	three	limb	extensions	deployed	in	the	same	common	iliac	
artery.	Five	other	stent-grafts	were	excluded	due	to	no	available	migration	data	
(fEVARs	 40,	 55-57	 and	 59).	 Thirty	 six	 fenestrated	 stent-grafts	 were	 therefore	
included	 in	 the	analysis.	These	comprised	36	contralateral	 limb	extensions	plus	
an	additional	seven	ipsilateral	limb	extensions	(total	43	limb	extensions).		
	
 Migration	analysis	
Prior	central	luminal	line	analysis	had	identified	four	cases	of	migration	≥4mm	in	
a	 proximal	 direction	 from	 the	 distal	 seal-zone	 (194).	 There	 was	 also	 one	
migration	 of	 the	 distal	 body	 ipsilateral	 limb	 (fEVAR	 39)	 but	 this	 case	 was	 not	
analysed	 with	 the	 limb	 extension	 components	 because	 the	 distraction	 force	
results	were	obtained	for	the	entire	component	and	would	not	have	given	a	valid	
comparison.	 Likewise	 this	 case	 was	 not	 compared	 against	 other	 distal	 bodies	
without	 ipsilateral	 limb	migration	 as	 no	meaningful	 analysis	 could	 be	 achieved	
with	only	one	case.	Demographics	are	summarised	in	Table	6.4	and	were	similar	
between	those	patients	with	limb	extension	migration	versus	those	without.	The	
only	 significant	 difference	 was	 the	 duration	 of	 follow-up	 (i.e.	 the	 interval	
between	imaging	episodes).	This	was	significantly	higher	in	the	migration	group	
(see	Table	6.4).	Overall	median	time	between	imaging	episodes	was	26	months	
(range	4-72).	
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Table	6.4	Comparison	of	demographics	between	patients	with	limb	extension	
migration	versus	no	migration	
	 Migration	 No	Migration	 p	(MWU	except	
f:Fisher's	Exact)	
No.	of	limb	extensions	
(no.	of	complete	stent-grafts)	
4	(4)	 39	(32)	 	
Distance	migrated,	mm	 5.0	
(4.4-10.6)	
0.1	
(-3.42-2.38)	
	
Gender	(M:F)	 3:1	 29:3	 .390f	
Age	 79.5	
(72-86)	
74.5	
(62-85)	
.092	
BMI	 25.0	
	(20.3-33.9)	
27.0	
(19.7-40.9)	
.248	
Diabetes	 1	 3	 .390f	
Ischaemic	heart	disease	 2	 19	 .560f	
Heart	failure	 0	 1	 .889f	
Hypertension	 1	 18	 .260f	
Preoperative	systolic	blood	
pressure,	mmHg	
152.5	
(120-164)	
140	
(92-180)	
.421	
Preoperative	pulse	rate,	beats	
per	minute	
80	
(66-90)	
70	
(50-118)	
.315	
Chronic	renal	impairment	 1	 4	 .466f	
Current	smoker	 0	 7	 .800f	
Peripheral	vascular	disease	 0	 5	 .534f	
ASA	(1/2/3)	 0/1/3	 1/9/22	 1.000f	
Imaging	interval,	months	 46	
(26-52)	
24	
(4-72)	
.044*	
Maximum	preoperative	AAA	
diameter	(mm)	
72	
(57-85)	
64	
(55-86)	
.292	
XSA	of	limb	extension	outlet	
(mm2)	
183	
(123-380)	
95	
(25-254)	
	
.018*	
For	full	demographics	see	Appendix	8.8.	Continuous	variables	expressed	as	median	with	range	in	
parentheses,	n	given	for	categorical	variables,	ASA:	American	Society	of	Anaesthetists	grading,	
BMI:	Body	mass	index,	XSA:	Cross-sectional	area,	*denotes	significance	to	p<.05	
	
	
Migration,	total	RDF	and	imaging	interval	data	for	individual	patients	is	contained	
in	Appendix	8.7.3.	
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 Total	resultant	distraction	force	
Total	RDF	was	non-significantly	higher	in	the	complete	stent-grafts	whose	limbs	
were	 seen	 to	 undergo	migration	 compared	with	 those	without	 limb	migration	
(median	 total	 RDF	 6.0N,	 range	 2.4-13.1N	 vs	 5.4N,	 2.1-7.8N,	 p=.747).	 Limb	
extension	 components	 that	underwent	migration	were	exposed	 to	 significantly	
more	distraction	force	than	those	that	did	not	migrate	(median	2.9N,	range	2.7-
6.3N	vs	1.6N,	0.4-3.8N,	p=.003,	see	Figure	6.14).	
Chapter	five	showed	that	cross-sectional	area	of	outlet	was	the	most	important	
factor	contributing	to	total	RDF	in	limb	extensions	and	this	was	also	significantly	
larger	in	the	migration	compared	with	the	no	migration	group	(see	Table	6.4).	
	
Figure	6.14	Total	resultant	distraction	force	in	complete	stent-grafts	and	limb	
extensions	by	group	(**denotes	significance	to	p<.01)	
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 Clinical	sequelae	
Of	the	four	patients	within	the	migration	group,	one	contralateral	limb	extension	
developed	 a	 stenosis	 at	 14	months	 but	was	 treated	 conservatively	 (fEVAR	25).	
The	ipsilateral	limb	of	this	stent-graft	was	already	known	to	have	occluded	prior	
to	 the	 first	 imaging	 episode	 and	 the	 patient	 was	 alive	 at	 five	 years	 follow-up.	
Another	was	noted	to	have	poor	apposition	of	limb	extension	and	common	iliac	
artery	but	no	type	Ib	endoleak	(fEVAR	41).	This	patient	was	alive	at	three	years	
with	no	complications	attributable	 to	migration	of	 the	 limb	extension	however	
the	superior	mesenteric	artery	stent	had	dislocated	and	occluded	at	15	months.	
The	 other	 two	 cases	 of	 limb	 migration	 were	 free	 of	 complications	 and	 re-
interventions.	 One	 died	 from	 non-aneurysm	 related	 causes	 at	 four	 years,	 the	
other	was	still	alive	at	four	years.	
In	 the	no	migration	group	 there	were	 two	occlusions	 in	 the	 ipsilateral	 limbs	of	
distal	body	 components.	One	occurred	early	before	 the	 first	 follow-up	episode	
(fEVAR	28).	The	other	(fEVAR	39)	was	the	ipsilateral	limb	noted	to	have	migrated	
cranially	 at	 35	 months,	 it	 then	 occluded	 and	 the	 patient	 died	 from	 unrelated	
causes	shortly	afterwards.	There	appears	to	be	no	unusual	findings	with	regards	
to	 the	direction	or	magnitude	of	 the	distraction	 forces	acting	on	 this	particular	
distal	body	component	(x:	2.0N	y:	-0.9N	z:	 3.3N,	 Total	 RDF:	 4.0N,	 see	 Appendix	
8.7.2).	
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6.7 Discussion	
 Proximal	body	migration	
Proximal	 body	 migration	 is	 a	 serious	 and	 potentially	 fatal	 complication	 of	
endovascular	repair	therefore	the	incidence	was	expected	to	be	low.	There	was	a	
trend	 towards	greater	distraction	 forces	 in	both	proximal	bodies	and	complete	
stent-grafts	 that	 underwent	 migration	 in	 comparison	 with	 those	 that	 did	 not	
migrate	 but	 the	 difference	 lacked	 significance.	 This	 may	 be	 due	 to	 the	
heterogeneity	 in	 configuration	 of	 proximal	 bodies	 within	 the	 cohort	 (see	
Appendix	 8.5.2)	 or	 to	 a	 type	 two	 error.	 	 With	 a	 larger	 sample	 a	 significant	
difference	may	have	been	possible	to	prove.	
In	chapter	five	the	inlet	cross-sectional	area	of	the	proximal	body	was	shown	to	
be	the	most	important	morphological	determinant	of	distraction	force	acting	on	
this	 component.	 Analytical	 models	 and	 the	 predominance	 of	 pressure	 derived	
forces	also	show	that	blood	pressure	is	of	critical	 importance.	Neither	 inlet	XSA	
nor	 blood	 pressure	 was	 significantly	 different	 between	 migration	 and	 no	
migration	groups.		
Only	one	of	the	proximal	body	components	that	underwent	migration	developed	
a	target	vessel	problem	compared	with	nine	patients	in	the	no	migration	group.	
Statistical	analysis	of	visceral	vessel	complications	was	not	performed	due	to	the	
small	 numbers	 involved	 and	 the	 presence	 of	 other	 variables	 such	 as	 the	
configuration	of	 the	devices	 and	 the	 choice	of	 stents	used.	Of	note	 is	 that	 the	
only	custom-made	single-piece	bifurcated	fenestrated	main	body	(fEVAR	7)	was	
one	 of	 the	 nine	 components	 in	 the	 migration	 group.	 This	 device	 migrated	
caudally	6mm	over	72	months	of	follow-up.	A	contributory	factor	may	have	been	
the	 lack	of	proximal-distal	body	 junction	 that	would	have	 resulted	 in	 the	all	 of	
the	distraction	force	(apart	from	that	acting	on	the	limb	extension)	having	to	be	
resisted	 by	 the	 proximal	 fixation	 force.	 In	 this	 case	 the	 potential	 for	 a	 small	
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amount	 of	 component	 distraction	 may	 have	 been	 protective.	 Despite	 the	
migration	at	the	proximal	seal-zone	there	were	no	target	vessel	complications.		
In	 the	 no	 migration	 group,	 fEVAR	 25	 in	 particular	 was	 troubled	 with	
complications.	 It	 was	 a	 two	 scallop,	 one	 fenestration	 device	 that	 developed	
ipsilateral	limb	occlusion	prior	to	the	first	CT	scan	and	was	then	found	to	have	a	
stenosis	 in	 the	contralateral	 limb	at	14	months.	 It	developed	one	visceral	 stent	
fracture,	one	visceral	stent	dislocation	and	a	type	IIIa	endoleak.	A	fracture	of	the	
bare	metal	stent	was	also	found	at	14	months	(see	Figure	6.15).	Embolization	of	
the	 inferior	 mesenteric	 artery	 was	 performed	 at	 15	 months	 for	 aneurysm	
enlargement	in	the	presence	of	presumed	type	II	endoleak.		
	
Figure	6.15	3D	rendering	of	the	proximal	body	stents	of	fEVAR	25	showing	a	
fracture	of	the	bare	metal	stent	(white	arrow).	
	
Despite	 these	 complications	 no	 significant	migration	was	 noted.	 The	migration	
analysis	was	performed	52	months	after	the	first	follow-up	imaging	and	showed	
3.2mm	 of	 proximal	 movement.	 It	 is	 possible	 that	 the	 fracture	 made	 the	 bare	
metal	stent	appear	more	proximal	in	relation	to	the	SMA	and	therefore	affected	
the	validity	of	this	result.	Alternatively	migration	may	have	occurred	before	the	
		
148	
Chapter	6:	Distraction	Force,	Migration	and	Component	Distraction		
first	follow-up	imaging.	It	was	noted	that	the	proximal	body	of	fEVAR	25	showed	
poor	apposition	with	the	visceral	aorta.	This	may	explain	the	apparent	instability	
of	 the	 target	vessel/main	stent-graft	 interface.	Verhoeven	et	al.	 (67)	 suspected	
that	migration	of	<5mm	had	contributed	to	two	cases	of	target	vessel	occlusion	
in	 their	 cohort.	 Even	 if	 the	 method	 used	 for	 migration	 analysis	 was	 able	 to	
confirm	 less	 than	 4mm	 of	 movement,	 the	 direction	 would	 not	 have	 been	
consistent	with	the	large,	predominantly	caudal	direction	of	the	distraction	force	
(11.6N	and	 the	only	outlier	 to	 the	95%	confidence	 interval	 in	 the	no	migration	
group,	see	Figure	6.4).	The	results	of	Chapter	five	suggest	that	in	addition	to	the	
large	 inlet	 cross-sectional	 area	 of	 the	 proximal	 body	 in	 fEVAR	 25	 (907mm2),	
occlusion	 of	 the	 ipsilateral	 limb	 soon	 after	 deployment	 would	 also	 have	
contributed	 to	 the	 higher	 than	 average	 distraction	 force	 because	 of	 the	
increased	Inlet:Outlet	area	ratio.		
 Fixation	force	
All	nine	cases	of	migration	were	exposed	to	in	situ	distraction	forces	smaller	than	
the	 initial	 fixation	 force	 as	 determined	 by	 bovine	 pullout	 studies	 (123).	 This	
fixation	force	of	11.5N	+/-1.5N	was	determined	under	experimental	conditions	in	
perfectly	 straight,	 non-diseased	 bovine	 aorta	 using	 a	 truncated	 Zenith	
fenestrated	 proximal	 body	 with	 one	 stented	 fenestration.	 Only	 three	 of	 the	
proximal	bodies	included	in	this	analysis	had	one	stented	fenestration,	two	had	
no	fenestrations	(only	a	scallop).	These	devices	may	be	expected	to	have	a	lower	
fixation	force	but	none	were	among	the	nine	cases	of	migration.	 It	 is	uncertain	
how	much	the	 initial	 fixation	force	may	be	 increased	by	adding	further	stented	
fenestrations	to	the	Zenith	device.	As	the	target	vessels	were	usually	aligned	to	
the	 inferior	 aspect	 of	 the	 fenestration	 in	 anticipation	 of	 a	 small	 degree	 of	
‘settlement’	 it	 may	 be	 anticipated	 that	 more	 stented	 fenestrations	 would	 not	
add	to	this	 initial	fixation	force	but	may	add	to	the	total	fixation	force	once	full	
engagement	of	 the	barbs	had	occurred.	The	 initial	 in	situ	 fixation	 force	may	be	
less	 by	 differing	 amounts	 than	 11.5N	 in	 all	 patients	 depending	 on	 factors	
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affecting	 barb	 engagement	 such	 as	 the	 presence	 of	 thrombus,	 atherosclerosis	
and	angulation.		
	
 Proximal-distal	body	component	distraction	
In	 chapter	 five	 the	main	 determinant	 of	 total	 RDF	 acting	 on	 distal	 bodies	was	
inlet	 cross-sectional	 area.	 This	 alone	 predicted	 74%	 of	 distraction	 force	 at	 any	
given	blood	pressure.	Because	the	proximal	end	of	every	distal	body	was	24mm	
diameter	 the	 range	 of	 inlet	 XSA	 was	 limited.	 Values	 above	 380mm2	 (22mm	
diameter)	were	possible	if	the	distal	body	was	deployed	with	maximum	overlap	
within	 the	variable	 sized	 segment	of	proximal	body	above	 the	22mm	diameter	
overlap	 segment.	 Although	 this	 would	 increase	 the	 distraction	 force	 acting	 on	
the	 distal	 body,	 experimental	 evidence	 confirms	 that	 a	 longer	 overlap	 also	
conveys	greater	fixation	force	(144).		In	this	situation	a	greater	distraction	force	
may	be	effectively	counteracted	by	greater	fixation	force.	This	may	be	the	reason	
that	no	association	was	found	between	total	RDF	and	component	distraction.		
All	 three	 values	 of	 total	 RDF	 in	 the	 distal	 bodies	 that	 underwent	 component	
distraction	 (4.3,	 4.7	 and	 2.8N)	 were	 below	 the	 experimentally	 determined	
fixation	force	of	6.5N	(4.8-7.2N)	(195).	Three	distal	bodies	in	the	no	component	
distraction	group	were	exposed	to	total	RDF	above	this	figure.		
 Fixation	force	
Forty	of	 the	42	proximal	bodies	 included	 in	 the	component	distraction	analysis	
had	two	sealing	stents.	In	these	patients	it	may	be	expected	that	inlet	XSA	of	the	
distal	body	would	be	larger	when	the	M1	distance	(first	appearance	of	two	bare	
metal	 stent	 struts	 to	 the	proximal	 gold	 radiopaque	marker	 on	 the	distal	 body)	
was	shorter.	This	 is	because	deploying	the	distal	body	partly	within	the	visceral	
seal-zone	of	 the	proximal	body	may	allow	 the	proximal	 end	 to	open	out	 to	 its	
maximum	24mm	diameter.	No	correlation	was	found	between	M1	distance	and	
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distal	 body	 inlet	 XSA	 (Spearman’s	 rho,	 ρ	 0.143	 p=.367).	 Likewise	 there	was	 no	
correlation	 between	M1	 distance	 and	 total	 RDF	 acting	 on	 the	 distal	 bodies	 (ρ	
0.014,	 p=.928).	 Conversely	 deploying	 the	 distal	 body	within	 the	 22mm	overlap	
segment	of	proximal	body	may	 result	 in	 lower	distraction	 force	because	of	 the	
restricted	 maximum	 cross-sectional	 area	 but	 also	 -	 and	 perhaps	 more	
importantly	-	lower	fixation	force	due	to	less	overlap.	Initial	M3	distance	(i.e.	the	
CLL	 distance	 from	 the	 anterior	 gold	 radiopaque	 marker	 to	 the	 distal	 gold	
radiopaque	marker	on	the	proximal	body	component)	was	synonymous	with	the	
length	 of	 available	 appositional	 overlap.	 When	 this	 was	 compared	 between	
groups	 it	 was	 significantly	 shorter	 in	 the	 three	 stent-grafts	 that	 exhibited	
component	 distraction	 (Median	 M3	 53.2mm,	 range	 41.6-67.3mm	 vs	 73.3mm,	
range	53.8-119.9mm,	p=.012	MWU,	see	Figure	6.16).		
	
Figure	6.16	Comparison	of	available	and	actual	overlap	between	proximal	and	
distal	body	components	by	group	
	 	 	 	 	 *denotes	significance	to	p<.05	
		
151	
Chapter	6:	Distraction	Force,	Migration	and	Component	Distraction		
The	length	of	the	proximal	body	component	as	defined	by	the	manufacturer	was	
a	 less	 reliable	 surrogate	 for	 available	 overlap	 because	 two	 of	 the	 42	 proximal	
bodies	had	either	one	or	three	sealing	stents	that	would	have	given	them	longer	
lengths	 with	 no	 increase	 in	 available	 appositional	 overlap.	 Consequently	
although	the	overall	 length	of	proximal	body	component	(BL1,	Figure	5.10)	was	
shorter	 in	 the	 component	 distraction	 group	 (median	 BL1	 109mm,	 range	 94-
109mm	 vs.	 124mm,	 range	 99-183mm)	 this	 did	 not	 quite	 reach	 statistical	
significance	(p=.055	MWU).	
Initial	 M4	 distance	 (i.e.	 the	 CLL	 distance	 from	 the	 proximal	 gold	 radiopaque	
marker	on	the	distal	body	to	the	distal	gold	radiopaque	marker	on	the	proximal	
body)	 represented	 the	actual	 overlap	 between	 the	 two	 components	 (including	
appositional	 and	 non-appositional	 overlap).	When	 this	 was	 analysed	 by	 group	
there	 was	 a	 trend	 towards	 less	 overlap	 in	 the	 distal	 bodies	 that	 underwent	
distraction	 (median	 M4	 47.6mm,	 range	 46.3-71.7mm	 vs	 62.8mm,	 range	 36.7-
84.9mm)	but	this	did	not	reach	statistical	significance	(p=.166	MWU,	see	Figure	
6.16).	
Whilst	there	was	no	association	between	total	RDF	and	component	distraction,	
there	was	some	evidence	to	suggest	an	association	between	shorter	component	
overlap	and	the	risk	of	component	distraction.	This	would	point	towards	fixation	
force	 being	 the	most	 important	 factor	 governing	 the	 stability	 of	 the	 proximal-
distal	body	junction.		
There	were	no	graft-related	adverse	events	as	a	result	of	component	distraction	
even	 though	 the	 maximum	 length	 of	 distraction	 was	 13.7mm.	 This	 patient	
(fEVAR	46)	died	of	non-aneurysm	related	causes	at	40	months	postoperatively.	It	
is	uncertain	 therefore	whether	 the	 two	stent	overlap	would	have	continued	 to	
distract	or	remained	stable	in	the	longer	term.	A	small	amount	of	distraction	at	
this	 junction	 is	 probably	 useful	 in	 protecting	 the	 fenestrations	 above	 from	
migration.		
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 Limb	extension	migration	
The	 magnitude	 of	 total	 RDF	 acting	 upon	 limb	 extensions	 was	 significantly	
associated	with	limb	migration.	The	same	was	not	observed	for	total	RDF	acting	
upon	complete	stent-grafts.	 	Chapter	 five	showed	that	the	forces	acting	on	the	
complete	stent-graft	were	in	a	more	caudal	direction	with	less	contribution	from	
out-of-plane	 forces.	 All	 significant	 migration	 of	 limb	 extension	 components	
occurred	in	the	cranial	direction.	The	difference	between	the	direction	of	forces	
acting	 on	 the	 complete	 stent-grafts	 and	 the	 clinical	 observations	 suggests	 that	
overall	forces	on	the	complete	stent-graft	do	not	accurately	describe	the	 in	situ	
conditions	experienced	by	its	individual	components.		
Limb	extension	migration	occurred	at	 forces	much	 less	 than	 the	apparent	9.6N	
+/-1.5N	fixation	force	as	determined	by	experimental	models	(84).	This	suggests	
that	either	our	 in	 silico	model	underestimates	distraction	 force	or	 that	 fixation	
force	may	be	 less	 than	expected.	 Previous	published	work	 from	our	unit	 (123)	
suggests	that	steady	state	simulation	of	blood	flow	leads	to	an	approximate	10%	
underestimation	 of	 distraction	 force.	Use	 of	 pulsatile	 flow	 therefore	may	 have	
only	 increased	 the	 largest	 forces	 acting	 on	 the	 limb	 extension	 to	 7N.	 The	
experimentally	derived	figure	of	9.6N	+/-1.5N	was	taken	from	pullout	studies	in	
human	 cadaveric	 tissue.	 Attempts	 were	 made	 to	 classify	 the	 amount	 of	
atherosclerosis	in	the	vessel	wall	however	it	is	likely	that	the	actual	fixation	force	
in	situ	 is	 less	 than	that	measured	experimentally	under	more	 ideal	deployment	
conditions.	More	recent	pilot	study	data	using	porcine	aorta	has	suggested	that	a	
figure	of	2.32N	±0.56N	may	be	more	realistic	(198).		
It	is	possible	that	dilatation	of	common	iliac	arteries	during	the	follow	up	period	
may	 reduce	 the	 fixation	 force.	 The	 same	 process	 would	 also	 be	 expected	 to	
increase	 distraction	 force	 since	 outlet	 cross-sectional	 area	 was	 the	 main	
morphological	 determinant	 of	 force.	 The	 net	 effect	 of	 both	would	 be	 to	make	
migration	more	likely.	We	have	no	data	to	prove	a	significant	change	in	diameter	
		
153	
Chapter	6:	Distraction	Force,	Migration	and	Component	Distraction		
occurred	although	one	of	the	four	cases	of	 limb	migration	(and	the	one	case	of	
distal	body	ipsilateral	limb	migration)	was	noted	to	have	lost	apposition	with	the	
vessel	wall	 at	 the	 level	 of	 the	distal	 sealing	 stent.	Another	had	 a	CIA	diameter	
larger	than	the	original	limb	chosen	to	achieve	seal	within	it.	These	findings	are	
highly	suggestive	of	progressive	vessel	enlargement.		
Clinical	 observational	 studies	 looking	 specifically	 at	 the	 issue	 of	 stent-graft	
deployment	in	ectatic	iliac	vessels	have	shown	no	associated	increase	in	iliac	limb	
related	complications	(152)	or	re-interventions	(151).	There	were	however	only	
11	Zenith	stent-grafts	used	in	ectatic	 iliac	arteries	 in	these	studies,	the	majority	
being	either	Talent	(Medtronic)	or	Excluder	(Gore).		
Standard	Zenith	stent-grafts	accounted	for	1988	(29%)	of	the	6787	stent-grafts	in	
the	EUROSTAR	registry	by	2005	(199).		Of	these,	803	limbs	(40%)	were	deployed	
in	iliac	vessels	greater	than	or	equal	to	16mm.	The	annual	incidence	of	kinking	in	
Zenith	 limbs	 was	 twice	 that	 of	 the	 Excluder	 (Gore)	 at	 0.012%	 versus	 0.006%.	
Likewise	the	annual	incidence	of	occlusion	was	higher	than	other	modern	stent-
grafts	 (Zenith:	 0.035,	 Excluder:	 0.011,	 Talent,	 0.023%)	and	was	only	 favourable	
when	compared	to	outdated	devices	such	as	the	Vanguard	(0.053%)	(199).		
A	 recent	 analysis	 has	 shown	 that	 aorto-iliac	 tortuosity	 index	 was	 significantly	
reduced	 by	 EVAR	 deployment	 and	 that	 this	 reduction	was	maximal	 for	 Zenith	
limbs	 over	 Medtronic	 or	 Gore	 (190).	 The	 implication	 is	 that	 the	 Zenith	 limbs,	
similar	 to	 those	 used	 in	 this	 cohort	may	 be	 stiffer	 with	 less	 conformability	 to	
native	anatomy.	Furthermore	greater	pre	and	postoperative	aorto-iliac	tortuosity	
index	 was	 significantly	 associated	 with	 complications	 such	 as	 limb	 kinking,	
occlusion	 and	 type	 Ib	 endoleak.	 Zenith	 stent-grafts	 comprised	 59%	 of	 the	
endovascular	arm	of	the	EVAR	trial	(200)	where	the	incidence	of	limb	thrombosis	
was	more	 than	 three	 times	 that	 observed	 in	 Talent	 devices	 (3.5	 vs	 1.1%).	 This	
also	suggests	that	Zenith	limbs	may	be	less	resilient	to	kinking	caused	by	native	
vessel	 anatomy	 or	 movement	 at	 the	 distal	 seal-zone.	 	 All	 of	 the	 fenestrated	
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stent-grafts	 used	 in	 the	 current	 study	 included	 the	 ‘TFLE’	 limb	 as	 illustrated	 in	
Figure	6.17A.	More	recently	this	has	been	superseded	by	the	Spiral-Z	limb	(Figure	
6.17B).	The	proximal	and	distal	sealing	stents	are	still	of	the	same	‘z’	formation	
stainless	 steel	 construction	 but	 supporting	 the	 middle	 is	 a	 continuous	 spiral	
nitinol	 stent	 designed	 to	 improve	 its	 conformability	 and	 address	 some	 of	 the	
shortcomings	of	the	old	limb	as	detailed	above.		
	
Figure	6.17	Zenith	TFLE	limb	extension	(A)	and	Spiral-Z	ZSLE	limb	extension	(B).	
Adapted	from	Cook	Medical	Inc.	(72,	201)	
The	link	between	distraction	force	and	graft-related	adverse	events	could	not	be	
fully	 assessed	 because	 there	 were	 no	 type	 Ib	 endoleaks	 during	 the	 follow-up	
period.	There	were	 three	 late	 limb	occlusions,	one	was	 in	 the	migration	group,	
one	was	in	the	no	migration	group	and	one	in	the	ipsilateral	limb	of	a	distal	body.		
	
 Limitations	
A	major	limitation	in	this	analysis	was	the	small	number	of	stent-grafts	observed	
to	have	undergone	movement,	especially	component	distraction	and	migration	
of	the	distal	limb	extension	seal-zone.	Non-parametric	statistical	tests	were	used	
to	limit	the	possibility	of	false	positive	results.	The	number	of	clinically	significant	
complications	was	 smaller	 still	 and	 no	meaningful	 conclusions	 could	 be	 drawn	
from	linking	them	with	the	magnitude	of	the	total	RDF.	An	alternative	approach	
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would	 have	 been	 a	 case	 controlled	 study.	 Patients	 with	 proven	 migration,	
component	 distraction	 and	 graft-related	 adverse	 events	 could	 have	 been	
identified	 in	 advance	 and	 distraction	 force	 acting	 upon	 their	 stent-graft	
components	then	compared	with	a	cohort	of	patient	matched	for	demographics	
but	without	complications.	A	power	calculation	would	have	given	an	 indication	
of	 the	numbers	 required	 for	 such	a	 study.	 The	 same	patients	 could	have	been	
used	 for	 investigating	 the	 influence	of	morphological	 features	upon	distraction	
force	as	was	described	in	chapter	5.	
The	 definition	 of	 migration	 and	 component	 distraction	 was	 based	 on	 the	
accuracy	 of	 a	 validated	 technique.	 The	 figure	 of	 4mm	 may	 result	 in	 clinically	
significant	 problems	 in	 relation	 to	 the	 proximal	 seal-zone	 and	 target	 vessel	
compromise	but	 it	 is	probably	 insignificant	 in	the	context	of	the	proximal-distal	
body	junction	and	the	distal	seal-zone	of	the	limb	extension.	Within	the	confines	
of	 this	 study	 it	 was	 not	 possible	 to	 determine	 whether	 a	 small	 amount	 of	
movement	predicts	later,	larger	migration	or	distraction.		
6.7.4.1.1 Local	factors	
No	mechanical	properties	of	the	aorta	were	analysed	but	other	studies	suggest	
that	higher	pressure	 in	 the	aneurysm	sac	 such	as	 the	presence	of	 an	endoleak	
may	reduce	distraction	force	acting	on	the	stent-graft	and	thereby	convey	some	
protection	 against	 migration	 (162).	 Fifteen	 of	 the	 43	 patients	 included	 in	 the	
proximal	 body	migration	 analysis	 had	 an	 endoleak	 diagnosed	 during	 follow-up	
(14	 type	 II	 and	 two	 type	 IIIa	 with	 one	 patient	 having	 both).	 There	 was	 no	
difference	 in	 the	 incidence	 of	 endoleak	 between	 migration	 and	 no	 migration	
groups	(n=3	vs	12,	p=.619,	Fisher’s	exact	test).	
6.7.4.1.2 Boundary	conditions	
A	single	preoperative	systolic	blood	pressure	may	not	be	indicative	of	prevailing	
physiological	conditions	following	fenestrated	endovascular	aneurysm	repair	but	
a	 more	 robust	 measure	 of	 blood	 pressure	 was	 not	 available.	 An	 alternative	
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would	have	been	to	use	160mmHg	for	hypertensive	patients	and	120mmHg	for	
normotensive	 patients	 but	 this	 approach	 would	 not	 have	 taken	 into	
consideration	 those	 patients	 with	 well	 controlled	 hypertension	 or	 those	 with	
undiagnosed	 hypertension.	 The	 use	 of	 preoperative	 blood	 pressure	 in	
simulations	 may	 have	 resulted	 in	 either	 an	 increase	 or	 a	 decrease	 in	 the	
difference	between	total	RDF	 in	the	migration/component	distraction	and	non-
migration/component	distraction	groups.		
As	 discussed	 in	 chapter	 five,	 steady	 state	 CFD	 simulations	may	 underestimate	
distraction	 force	 by	 a	 small	 margin	 as	 compared	 with	 results	 obtained	 using	
pulsatile	flow	(see	Validation,	section	5.5.3).		
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6.8 Conclusion	
This	 chapter	 has	 examined	 the	 relationship	 between	 patient-specific	 total	
resultant	 distraction	 force	 and	 movement	 of	 stent-graft	 components.	 Results	
suggest	that	movement	at	all	three	sites	(caudal	migration	of	the	proximal	seal-
zone,	 component	 distraction	 at	 the	 proximal-distal	 body	 junction	 and	 cranial	
migration	at	the	distal	seal-zone)	may	occur	at	distraction	forces	lower	than	the	
experimentally	derived	fixation	force.		
Although	 there	was	 a	 trend	 towards	 greater	 distraction	 forces	 in	 the	 proximal	
bodies	 that	 underwent	 migration	 this	 lacked	 statistical	 significance.	 No	
association	was	 found	between	total	 resultant	distraction	 force	 in	distal	bodies	
and	 the	 incidence	 of	 component	 distraction.	 Shorter	 available	 appositional	
overlap	was	significantly	associated	with	component	distraction,	suggesting	that	
the	strength	of	fixation	may	be	more	important	than	distraction	force	at	this	site.	
Fixation	 force	 is	 increased	with	maximal	 overlap	 and	 the	 results	 support	 using	
the	longest	length	of	proximal	body	possible	with	maximum	component	overlap.		
In	 limb	 extension	 components	 greater	 distraction	 force	 was	 significantly	
associated	 with	 cranial	 migration	 at	 the	 distal	 seal-zone.	 Results	 suggest	 that	
caution	should	be	employed	when	planning	to	achieve	distal	seal	in	large	calibre,	
ectatic	 iliac	 vessels.	 It	 is	 likely	 that	 such	 morphology	 will	 be	 associated	 with	
greater	distraction	force	and	may	also	be	more	likely	to	continue	to	dilate	over	
time	with	subsequent	increases	in	distraction	force	and	compromise	of	fixation.	
With	regards	to	the	second	hypothesis,	only	in	limb	extension	components	was	
greater	 distraction	 force	 significantly	 associated	 with	 a	 higher	 incidence	 of	
migration.
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7 Discussion	
Device	 failure	 leading	 to	 reperfusion	 of	 the	 aneurysm	 is	 one	 of	 the	 biggest	
concerns	following	endovascular	aneurysm	repair.	Movement	of	the	stent-graft	
may	lead	to	device	failure	and	in	fenestrated	endovascular	aneurysm	repair	this	
may	carry	the	potentially	serious	added	consequence	of	visceral	vessel	loss.	
Fixation	 force	 resists	 movement	 of	 the	 stent-graft	 and	 hence	 protects	 against	
one	 mode	 of	 device	 failure.	 The	 strength	 of	 fixation	 is	 dependent	 upon	 the	
mechanical	properties	of	the	sealing	stents	and	the	presence	of	ancillary	features	
such	 as	 hooks	 or	 barbs.	 Acting	 against	 the	 fixation	 force	 is	 the	 haemodynamic	
distraction	 force	 generated	 by	 blood	 pressure	 and	 blood	 flow.	 A	 greater	
understanding	of	 the	factors	that	contribute	to	distraction	force	should	help	to	
inform	 the	 clinician	 during	 the	 planning	 stage	 and	 help	 to	 avoid	 high-risk	
solutions	that	might	predispose	to	device	failure.	
Chapter	three	set	out	the	rationale	for	choosing	the	approach	undertaken	in	this	
study	 both	 in	 terms	 of	 which	 factors	 to	 investigate	 and	 the	methods	 used	 to	
assess	them.	Morphological	features	were	investigated	based	on	evidence	from	
previous	experimental,	analytical	and	computational	fluid	dynamics	models.	The	
use	 of	 CFD	 enabled	 blood	 flow	 through	 complex	 patient-specific	 three-
dimensional	morphology	to	be	modelled	accurately	and	efficiently.		
To	enable	lumen	and	stent-graft	morphology	to	be	compared	with	force	results	a	
reliable	 and	 reproducible	 method	 of	 measurement	 had	 to	 be	 devised.	 Cross-
sectional	area	was	easily	measurable	using	 software	 tools	and	although	similar	
tools	existed	for	the	measurement	of	angulation,	there	was	no	common	agreed	
method	 for	 their	 deployment.	 Chapter	 four	 defined	 one	 method	 of	 angle	
measurement	 and	 assessed	 it	 against	 another	 common	 method	 used	 in	 the	
planning	 stage	 of	 endovascular	 aneurysm	 repair.	 This	 new	 method	 was	 then	
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developed	 further	 with	 previous	 analytical	 and	 computational	 analyses	 of	
distraction	force	in	mind	for	use	in	chapter	five.	
The	CFD	simulations	in	chapter	five	were	performed	at	constant	blood	pressure	
and	volumetric	flowrate.	They	confirmed	that	cross-sectional	area	was	the	major	
contributing	 factor	 to	 distraction	 force.	 This	 factor	 was	 by	 no	means	 the	 only	
important	 factor	 otherwise	 Figure	 7.1	would	 show	all	 the	data	points	 equal	 to	
unity.	 The	 significant	 variation	 from	 unity	 (up	 to	 600%)	 confirms	 that	 other	
parameters	do	indeed	influence	the	distraction	force.				
	
Figure	7.1	Plot	of	total	resultant	distraction	force	(RDF)	normalised	by	the	
product	of	inlet	pressure	(P1)	and	cross-sectional	area	(A1).	
	
The	Bernoulli	and	continuity	equations	relate	the	inlet	and	outlet	pressures	and	
velocities	of	blood	 flow	(43,	44,	202).	Together	 they	 form	the	basis	of	a	simple	
analytical	 model	 for	 determining	 distraction	 force	 (equation	 3.1).	 From	 this	
analytical	 model	 it	 can	 be	 seen	 that	 distraction	 force	 is	 determined	 by:	 Inlet	
		
160	
Chapter	7:	Discussion	
pressure	 (P1),	 inlet	 cross-sectional	 area	 (A1),	 blood	 density	 (ρ),	 inflow	 velocity	
(U1),	 outlet	 cross-sectional	 area	 (A2),	 and	 outlet	 angle	 (θ).	 The	 only	 term	 not	
represented	 is	 viscosity	 but	 since	 this	 –	 as	well	 as	 blood	 density,	 inlet	 volume	
flow	 rate	 (A1U1)	 and	 pressure	 –	 was	 kept	 constant	 for	 the	 CFD	 analysis,	 the	
remaining	 variables	 (all	 morphological	 terms	 A1,	 A2	 and	 θ)	 must	 have	 been	
responsible	for	the	variation	in	total	resultant	distraction	force.	
The	relative	importance	of	blood	pressure	was	highlighted	by	the	comparison	of	
CFD	results	from	chapter	five	at	21332Pa	(160mmHg)	with	the	same	simulations	
at	 18665Pa	 (140mmHg).	 By	 increasing	 the	 pressure	 by	 20mmHg,	 the	 total	
resultant	distraction	 force	was	 increased	by	a	 factor	of	1.14.	This	suggests	 that	
control	 of	 hypertension	 should	 remain	 an	 important	 objective	 even	 after	
aneurysm	exclusion.		
	
7.1 Limitations	of	the	current	study	
 Orthogonal	versus	resultant	distraction	force	
Both	 migration	 and	 component	 distraction	 occur	 along	 the	 vessel	 lumen	 (i.e.	
orthogonal	 to	 the	 seal-zones	of	 the	 stent-graft)	 yet	 only	 part	 of	 total	 RDF	 acts	
along	 this	 plane.	Might	 this	 component	 of	 total	 RDF	 be	more	 pertinent	 when	
considering	migration	and	component	distraction?	In	order	to	calculate	this	force	
the	x,	y	and	z	directional	 forces	have	to	be	translated	based	upon	the	angle	of	
each	component’s	seal-zone	from	the	vertical	in	coronal	and	sagittal	elevation.	In	
terms	of	the	proximal	body,	this	angle	would	be	identical	to	α	angle	if	the	lumen	
of	the	distal	thoracic	aorta	was	precisely	vertical	within	the	computer	generated	
model.	X	and	z	direction	forces	could	be	translated	first	using	equation	7.1.	This	
would	 give	 the	 component	 of	 distraction	 force	 acting	 along	 the	 seal-zone	 in	
coronal	elevation	(zI):		
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This	translation	has	been	applied	to	the	proximal	body	of	fEVAR	12	in	Figure	7.2	
where	the	axis	of	blood	flow	within	the	proximal	seal-zone	 is	35°	anticlockwise	
from	vertical.	Applying	equation	7.1	gives	a	coronal	distraction	force	orthogonal	
to	this	proximal	seal-zone	(zI)	of	4.4N.	
	
Figure	7.2	Translation	in	coronal	elevation	for	proximal	body	(blue)	of	fEVAR	
12.	Red=lumen	
	
zI	 could	 then	 be	 used	 to	 translate	 the	 sagittal	 forces	 and	 calculate	 total	
orthogonal	distraction	force	(zII)	using	equation	7.2:	
	
(7.2)	
	
Figure	 7.3	 shows	 equation	 7.2	 applied	 to	 the	 same	 proximal	 body	 in	 sagittal	
elevation.	The	total	orthogonal	distraction	force	(zII)	was	6.8N.		
													𝒛𝑰 = 𝒛 𝐜𝐨𝐬 𝝉 + 𝒙 𝐬𝐢𝐧 𝝉	 	 			 	 	 	 	 	 	 								 	 	 	 	 	 	 	 (7.1)	
	𝑧FF = 	−𝑦 𝑠𝑖𝑛 𝜑 + 𝑧F 𝑐𝑜𝑠 𝜑	
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Figure	7.3	Translation	in	sagittal	elevation	for	proximal	body	(blue)	of	fEVAR	
12.	Red=lumen	
	
A	similar	set	of	equations	can	be	applied	to	the	x,	y	and	z	directional	results	for	
fEVAR	12	to	show	the	magnitude	(z)	and	direction	(τ/𝜑)	of	the	resultant	forces	in	
each	elevation.	 Figure	7.4	 shows	a	 resultant	 force	 in	 coronal	 elevation	of	 4.5N	
acting	 at	 -22°	 from	 the	 z	 direction.	 These	 figures	 were	 obtained	 using	 the	
equations	7.3	and	7.4.	
(7.3)	
(7.4)	
	
Figure	7.4	Magnitude	and	direction	of	coronal	distraction	force	was	similar	to	
orthogonal	coronal	distraction	force	shown	in	Figure	7.2			
	
𝑧𝑐 = 	O𝑥Q + 𝑧Q	
	 𝜏 = tanUV W𝑥𝑧X	
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Using	the	following	two	equations	(7.5	and	7.6),	the	magnitude	and	direction	of	
the	total	resultant	distraction	force	can	be	resolved	in	the	sagittal	elevation.		
(7.5)	
	
(7.6)	
	
These	calculations	are	shown	in	Figure	7.5.	
	
Figure	7.5	Magnitude	and	direction	of	total	resultant	distraction	force	shown	in	
sagittal	elevation	was	similar	to	the	total	orthogonal	distraction	force	depicted	
in	Figure	7.3	
	
The	magnitude	and	direction	of	 resultant	distraction	 force	 (7N	acting	at	50°	 to	
the	 vertical	 z	 axis)	 was	 very	 similar	 to	 the	 orthogonal	 forces	 obtained	 with	
equations	7.1-7.2	(6.8N	at	43°).	This	confirms	that	most	of	the	distraction	force	
did	act	along	the	axis	of	blood	flow	at	the	seal-zone	of	the	proximal	body	as	was	
also	noted	by	Molony	et	al.	 (165).	The	use	of	total	orthogonal	distraction	force	
instead	of	 total	 resultant	distraction	 force	 therefore	may	not	have	made	much	
difference	to	the	results.			
	
	𝑧𝑠 = O𝑧𝑐Q + 𝑦Q	
𝜑 = tanUV W−𝑦𝑧𝑐 X	
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 Measurement	error	
Any	study	that	defines	vessel	angulation	as	a	variable	is	limited	by	the	method	it	
uses	 to	measure	 the	 angle	or	 angles.	 In	 the	 current	 study	 attempts	 to	 identify	
potential	weaknesses	in	the	current	methods	of	angle	measurement	were	made	
and	a	new	method	was	clearly	defined	before	comparison	with	the	old	one.	Error	
was	minimised	by	clear	definitions	of	angles	and	by	the	same	observer	taking	all	
measurements.	All	images	were	manipulated	in	exactly	the	same	way	and	there	
was	a	clear	protocol	for	application	of	computerised	calipers.	
Because	 a	 small	 change	 in	 the	 placement	 of	 calipers	may	 produce	 a	 relatively	
large	 variation	 in	 angle,	 all	 angles	 were	 compared	 in	 groups	 with	 relation	 to	
distraction	force	rather	than	as	a	continuous	variable.	
Sources	of	error	in	the	measurement	of	XSA	have	been	discussed	in	chapter	five	
(section	 5.8).	 These	 include	 the	 necessary	 use	 of	 a	 different	 method	 of	
measuring	limb	extension	inlet	XSA	due	to	the	close	proximity	of	the	other	limb;	
the	 potential	 influence	 of	metal	 artefact	 in	 underestimating	 the	 lumen	 XSA	 at	
this	position	and	the	potential	overestimation	of	lumen	XSA	due	to	the	modelling	
method	as	illustrated	in	Figure	5.17.	
 CFD	analysis	
Every	effort	was	made	 to	ensure	 realistic	boundary	 conditions	were	used.	 This	
included	 the	 use	 of	 supracoeliac	 flow	 data	 from	 the	 investigational	 work	
performed	 at	 Stanford	 University	 (191,	 192).	 The	 validity	 of	 a	 ‘snapshot’	
preoperative	systolic	blood	pressure	is	unknown	but	a	more	reliable	measure	of	
blood	pressure	was	not	available.	The	choice	of	a	standard	flow	rate	rather	than	
standard	 velocity	 (velocity	 was	 calculated	 from	 the	 average	 orthogonal	 cross-
sectional	 area	 at	 the	 model	 inlet	 divided	 by	 the	 flow	 rate)	 was	 intended	 to	
standardise	as	many	variables	as	possible	in	order	to	best	elucidate	the	effect	of	
vessel	geometry	upon	distraction	force.	
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Steady-state	blood	flow	was	used	rather	than	pulsatile	flow.	Previous	experience	
with	experimental	models	suggests	that	results	are	 less	than	10%	higher	at	any	
given	 time	along	a	pulse	wave	 in	pulsatile	 flow	models	 compared	with	 steady-
state	models.	The	difference	was	largest	at	peak	systole	due	to	the	inertial	effect	
of	the	pressure	waveform	(see	Validation,	section	5.5.3).		
The	 current	 results	 represent	 a	 flow	 analysis	 of	 the	 fluid	 domain	 only.	 No	
biomechanical	characteristics	of	the	aneurysm	sac	or	stent-graft	were	modelled.	
Previously	 published	 fluid/structure	 interactions	 have	 suggested	 a	 protective	
effect	of	type	II	endoleak	in	reducing	distraction	force		(41,	162)	and	a	negligible	
effect	with	the	addition	of	stent-graft	compliance	(158,	178).		
The	 use	 of	 a	 Newtonian	 fluid	 model,	 the	 assumption	 that	 all	 forces	 were	
transmitted	through	the	overlapping	parts	of	the	stent-graft	and	the	exclusion	of	
visceral	 stents	 from	 the	 stent-graft	 models	 due	 to	 limitations	 in	 CT	 imaging	
resolution	are	 limitations	 that	would	have	only	affected	 the	shear/viscous	 flow	
derived	 forces	 and	 therefore	would	not	 have	had	 a	 significant	 effect	 upon	 the	
results.	
	
7.2 Further	studies	
 Expanding	the	role	of	computer	models	
Previous	 work	 suggests	 that	 β	 angle	 and	 iliac	 tortuosity	may	 reduce	 following	
standard	EVAR	deployment	(190,	203).	Conversely	the	diameter	of	the	proximal	
seal-zone	 may	 increase	 by	 approximately	 2mm	 in	 the	 first	 two	 years	 (204).	
Confirmation	 of	 how	 fenestrated	 stent-graft	 deployment	 affects	 blood	 vessel	
morphology	could	be	obtained	 from	pre	and	post-deployment	CT	 images	using	
the	measuring	methods	 developed	 for	 the	 current	 study.	More	 complete	 data	
quantifying	 the	 effect	 of	 stent-graft	 deployment	 upon	 vessel	morphology	may	
facilitate	 the	 development	 of	 realistic	 ‘virtual’	 stent-graft	 models	 enabling	 a	
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clinician	to	plan	and	deploy	a	stent-graft	based	on	computerised	models	of	the	
preoperative	CT	images.	Recent	studies	have	simply	added	a	virtual	stent-graft	to	
a	 vessel	 lumen	 without	 taking	 into	 account	 what	 affect	 this	 may	 have	 on	
angulation	and	tortuosity	(205).	Simulator	practice	prior	to	undertaking	the	real	
intervention	 improves	performance	 in	 endovascular	procedures	 (206,	 207)	 and	
benefits	may	be	maximised	by	providing	the	most	realistic	simulator	possible.			
If	 the	 morphological	 changes	 following	 fEVAR	 can	 be	 anticipated	 it	 is	 also	
conceivable	 that	 CFD	 based	 upon	 these	 virtual	 models	 would	 allow	 accurate	
predictions	of	distraction	force	to	be	made	prior	to	deployment.	This	could	assist	
the	clinician	to	choose	alternative	treatment	modalities	in	high-risk	morphology	
or	ensure	close	follow-up	of	stent-grafts	exposed	to	greater	distraction	force.		
A	mechanical	solver	that	models	the	biomechanical	properties	of	the	aorta	and	
stent-graft	 could	 be	 linked	 to	 the	 fluid	 solver	 used	 in	 the	 current	 studies.	 This	
may	 lead	 to	 a	more	 accurate	 representation	 of	 patient-specific	 conditions	 but	
would	be	more	complex	to	perform	and	may	not	significantly	change	any	of	the	
results	obtained	via	fluid	simulation	alone	(158,	178).	
	
 Distraction	force	prediction	
Another	 option	 for	 prediction	 of	 distraction	 force	 would	 be	 to	 input	
morphological	 data	 in	 to	 the	 analytical	 model	 (equation	 3.1).	 In	 simplified	
geometry	the	error	between	this	approach	and	CFD	 is	 less	than	2%	however	 in	
complex	three-dimensional	anatomy	the	error	may	be	much	greater	due	to	out-
of-plane	forces.	To	address	this,	 the	one-dimensional	analytical	model	could	be	
developed	 further.	 Equations	 7.7-7.9	 represent	 a	 proposed	 three-dimensional	
analytical	 model	 for	 total	 distraction	 force	 (f),	 inclusive	 of	 pressure	 and	 flow	
derived	forces	in	x,	y	and	z	directions.	
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Chapter	7:	Discussion	fz	=	P1A1	-	P3A3cos(θ3x)	-	P2A2cos(θ2x)		+	ρ(U1A1)[-(U3cos(θ3x)	+	U2cos(θ2x))+U1]	 	 	 	 	 						 (7.7)	
	 fx	=	P2A2sin(θ2x)	-	P3A3sin(θ3x)	+	ρ(U1A1)(U2sin(θ2x)	-	U3sin(θ3x))	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 (7.8)	
	 fy	=	P2A2sin(θ2y)	-	P3A3sin(θ3y)		+	ρ(U1A1)(U2sin(θ2y)	-	U3sin(θ3y))	 	 	 	 	 	 	 	 	 	 	 	 (7.9)		
	
Where		 	𝑈2 = fghghiQ 		and		𝑈3 = fghghjQ 	and	 θ2	 and	 θ3	 refer	 to	 the	 left	 and	 right	
outlet	angles	in	the	coronal	(x)	and	sagittal	(y)	elevation	respectively.		
fz	can	be	solved	for	x	as	well	as	y	angles	and	the	difference	between	this	force	in	
each	elevation	is	greater	with	larger	differences	in	outlet	angulation.	Resolution	
of	 this	 problem	 was	 beyond	 the	 scope	 of	 this	 thesis	 and	 therefore	 a	
comprehensive	 comparison	 between	 3D	 analytical	 model	 and	 CFD	 was	 not	
performed.	An	additional	consequence	of	this	was	that	the	angle	measurement	
technique	 described	 in	 Chapter	 five,	 designed	 to	 allow	 comparison	 in	 three-
dimensions	became	obsolete.	One	angle	per	data	point	 (instead	of	 two)	would	
therefore	 have	 been	 sufficient.	 This	 would	 not	 have	 given	 any	 information	
regarding	 the	position	of	one	outlet	with	 regards	 to	 the	other	but	would	have	
made	data	analysis	simpler.	The	3D	caliper	used	in	the	initial	angle	measurement	
study	 (see	chapter	 four)	would	have	provided	this	 information	and	would	have	
removed	 the	 potential	 error	 introduced	 by	 image	manipulation	 prior	 to	 angle	
measurement	in	each	elevation.		This	error	was	reduced	in	the	current	study	by	
clearly	defining	the	method	to	be	used	(see	section	5.5.5.2).	
A	 much	 simpler	 analytical	 model	 could	 be	 derived	 by	 combing	 the	 regression	
analysis	 in	 section	5.7.4.	with	equation	6.2	 after	 first	 substituting	P1	 (18665Pa)	
for	 P2	 (21332Pa).	 The	 only	 patient-specific	 parameters	 required	 would	 be	 the	
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predicted	 post-deployment	 cross-sectional	 area	 of	 the	 inlet	 and	 outlets,	 the	
largest	outlet	angle	and	the	systolic	blood	pressure.		
	
 Expanding	the	current	CFD	methods	to	other	stent-grafts	
Since	the	start	of	this	project	other	manufacturers	have	developed	solutions	for	
aneurysms	with	necks	that	are	unsuitable	for	standard	endovascular	repair.	One	
such	device	 is	 the	Nellix	endovascular	aneurysm	sealing	system	from	Endologix	
Inc.,	 Irvine,	 USA.	 This	 consists	 of	 a	 polymer-filled	 endobag	 that	 sits	 within	 the	
aneurysm	sac	to	provide	fixation	for	two	ePTFE-covered,	cobalt	chromium	alloy	
balloon-expandable	stents,	each	with	little	or	no	tapering	between	proximal	and	
distal	ends	(see	Figure	7.6).	One	retrospective	review	showed	that	it	was	suitable	
for	 use	 in	more	 infrarenal	 aneurysms	 than	 any	 other	manufacturer’s	 standard	
stent-graft	system	(i.e.	Cook,	Zenith;	Medtronic,	Endurant	and	Gore,	C3	Excluder)	
(208).	 Although	 it	 was	 only	 applicable	 to	 8%	 of	 the	 aneurysms	 treated	 with	
fenestrated	stent-grafts	the	original	IFU	is	already	being	extended	(209,	210).	In	
the	 future	 it	may	offer	a	method	of	 treating	 juxtarenal	 aneurysms	without	 the	
need	for	complex	EVAR	planning	or	custom-made	stent-grafts.	
	
Figure	7.6	Nellix	endovascular	aneurysm	sealing	system.		
Image	from	Endologix	Inc.	(211)	
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The	design	of	the	Nellix	stent-graft	represents	a	major	change	in	approach	to	the	
issue	 of	 endovascular	 fixation	 and	 -	 given	 that	 the	 proximal	 inlet	 XSA	 of	 each	
conduit	 is	much	smaller	that	the	Zenith	device	-	 it	would	be	very	 interesting	to	
determine	the	distraction	force	acting	upon	its	components	and	compare	it	with	
the	current	work	on	the	Zenith	device.	The	modelling	and	CFD	method	described	
in	Chapter	five	could	be	applied	for	this	purpose.	
	
 Verifying	fixation	force	
Median	distraction	force	acting	on	limb	extension	components	was	2.9N	(range	
2.7-6.3N).	The	distal	fixation	force	was	9.6N	+/-1.5N	(84)	yet	four	limbs	migrated.	
Although	 all	 proximal	 and	 distal	 bodies	 that	 underwent	 migration	 and	
component	 distraction	 were	 also	 below	 the	 experimentally	 derived	 fixation	
forces,	 four	 components	 in	 the	 no	 migration	 groups	 (one	 proximal	 body	 and	
three	distal	bodies)	were	exposed	to	forces	higher	than	this.	In	these	two	other	
components	 the	discrepancy	between	distraction	and	 fixation	 force	was	not	as	
marked:	 Median	 total	 RDF	 in	 migrated	 proximal	 bodies	 5.6N	 (range	 1.7-8.6N)	
versus	 11.5N	 +/-1.5N	 fixation	 force	 (123)	 and	 median	 total	 RDF	 in	 distracted	
distal	 bodies	 4.3N	 (range	 2.8-4.7N)	 versus	 6.5N	 (4.8-7.2N)	 fixation	 force	 (195).		
This	 finding	 suggests	 that	 especially	 in	 regards	 to	 limb	 extension	 components,	
the	 reported	 fixation	 force	 may	 be	 too	 high	 and	 would	 support	 further	
investigation	with	additional	pullout	studies	in	porcine	or	cadaveric	arteries.		
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7.3 Conclusion	
 Hypothesis	1	
Larger	angulation	of	vessels	is	associated	with	greater	distraction	force.	
Only	 outlet	 (θ)	 angulation	 in	 complete	 stent-grafts	 and	 limb	 extension	
components	 was	 associated	 with	 greater	 distraction	 force.	 Inclusion	 of	 the	
largest	θ	angle	also	improved	the	predictive	power	of	the	regression	analysis	for	
distraction	force	acting	on	distal	bodies.	
The	work	outlined	in	this	thesis	is	the	first	time	that	individual	components	of	a	
stent-graft	have	been	considered	within	a	CFD	analysis	of	distraction	force.	The	
results	 from	 this	 study	 thus	 enable	 the	 precise	 elucidation	 of	 which	
morphological	 factors	 are	 important	 in	 the	 generation	 of	 distraction	 force	 in	
each	case.	This	comprehensive	approach	was	chosen	 for	 the	underlying	reason	
that	 movement	 is	 possible	 at	 all	 component	 junctions.	 By	 focusing	 on	 the	
components	in	this	way	and	defining	more	specific	angles	than	in	many	previous	
analyses,	hypothesis	one	has	been	tested	in	more	depth	than	has	hitherto	been	
possible	 in	 the	 literature.	This	method	provided	 the	detail	 to	be	able	 to	define	
inlet	 or	 outlet	 cross-sectional	 areas	 as	 the	 most	 important	 determinant	 of	
distraction	 force	depending	on	which	component	was	being	considered.	 It	also	
allowed	a	distinction	to	be	made	between	the	caudally	directed	forces	acting	on	
proximal	 and	distal	 bodies	with	 the	more	 out-of-plane	 and	 cranial	 direction	 of	
force	acting	on	limb	extensions.		
	
 Hypothesis	2	
Greater	 distraction	 force	 is	 associated	 with	 higher	 incidence	 of	 migration	 and	
component	distraction.	
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The	 results	 of	 chapter	 six	 show	 the	 link	 between	 greater	 distraction	 force	 and	
migration	 of	 limb	 extension	 components.	 This	 intuitive	 link	was	 not	 present	 in	
the	 migration	 of	 proximal	 body	 components	 perhaps	 due	 to	 the	 confounding	
effect	of	the	many	available	configurations	of	stented	fenestrations	and	scallops.	
Similarly	 it	was	not	present	 in	distal	body	components	where	 it	seems	that	the	
strength	of	 the	fixation	as	provided	by	overlap	of	components	may	be	of	more	
significance.	
This	 is	 the	 first	 time	that	 in	silico	distraction	 force	results	have	been	compared	
with	migration	 and	 distraction	 analyses.	 The	 approach	 has	 enabled	 the	 cranial	
direction	 of	 distraction	 force	 in	 limb	 extensions	 to	 be	 directly	 related	 to	 their	
migration	in	the	same	direction.	
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8 Appendices	
8.1 Planning	document	for	Zenith	fenestrated	endovascular	stent-
graft	
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8.2 Instructions	given	to	observers	for	α	angle	measurement	using	
ScanIP	
Terminology:	All	angles	are	made	up	of	 two	rays	 that	 intersect	at	a	vertex.	For	
accurate	 angle	measurement	 each	 ray	must	 have	 a	 specified	 endpoint	 and	 be	
measured	along	a	central	luminal	line	(CLL).	
	
Supplementary	 angles	 are	 used	 (as	 opposed	 to	 inner	 or	 outer	 angles)	 as	 they	
represent	blood	flow	in	terms	of	deviation	from	180°.		A	supplementary	angle	of	
30°	is	equivalent	to	an	inner	angle	150°	or	an	outer	angle	of	210°.	
For	the	purpose	of	this	study	only	α	angle	will	be	measured	i.e.	a	proximal	angle	
at	or	near	the	lowest	renal	artery	that	describes	the	angle	of	the	aneurysm	neck	
from	the	suprarenal	aorta.	In	a	post	EVAR	aorta	the	α	angle	would	be	at	or	just	
proximal	to	the	proximal	seal-zone.	
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The	following	points	should	be	observed:	
Proximal	endpoint	 Vertex	 Distal	endpoint	
Where	CLL	of	SMA	joins	
aortic	CLL	
Major	angulation	of	CLL	
nearest	the	lowest	renal	
artery	
Next	major	point	of	
angulation	or	most	
distal	extent	of	
aneurysm	neck	
	
Step	by	step	instructions	for	measuring	α	angle	using	ScanIP	
1. Use	 the	mouse	 to	manipulate	 the	model	 around	 the	 longitudinal	 axis	 of	 its	
lumen.	Try	to	identify	the	likely	position	of	the	α	angle	vertex.	
‘Left	click’:	rotates	image;	‘Scroll	wheel’:	 	zooms	in	or	out;	 ‘Middle	click’/clicking	
down	scroll	wheel	and	move:	moves	object	around	
The	 lumen	model	of	 ‘exampleAAA’	 is	shown	below.	The	α	angles	appears	quite	
small	 but	 there	 is	 a	 slight	 antero-(right)lateral	 deviation	of	 the	 infrarenal	 aorta	
from	 the	 course	 of	 the	 suprarenal	 aorta	 which	 in	 itself	 angles	 anteriorly.	 This	
occurs	at	 the	point	marked	by	 the	white	arrow	 (the	α	angle	vertex)	 just	below	
the	lowest	renal	artery.	
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2. Right	click	on	the	3D	model	to	bring	up	the	following	box:	
	
Hover	the	mouse	over	‘lumen’	and	left	click	over	‘visible’	to	turn	the	view	of	the	
lumen	off.	This	should	bring	the	Centre	Lumen	Line	(CLL)	into	view.	
3. Left	click	on	the	measurements	icon	 	in	the	second	row	from	the	top	of	
the	screen.	A	measurement	toolbox	should	appear	on	the	left	hand	side.	
4. Select	 the	 angle	measurement	 tool	 from	 the	measurement	 toolbox	 and	
the	select	3D	mode	 which	should	make	the	angle	measuring	tool	
visible	in	the	3D	pane.	
5. Right	click	on	‘Angle	(deg)’,	hover	over	‘Set	angle	type’	and	 left	click	to	select	
‘Supplementary	angle’		
	
	
The	 angle	measuring	 tool	 has	 proximal	 and	 distal	 endpoints	 plus	 a	 vertex	 that	
need	to	be	‘snapped’	onto	the	appropriate	points	along	the	aortic	CLL.	
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6. Drag	 the	 proximal	 endpoint	 to	 near	 the	 SMA	 origin	 then	 zoom	 in	 to	 make	
placement	more	accurate.	You	should	chose	a	point	on	the	aortic	CLL	that	best	
represents	the	origin	of	the	SMA	based	on	the	direction	of	the	SMA	CLL.		
In	the	diagram	below	the	direction	of	the	SMA	CLL	indicated	by	the	green	arrow	
suggests	that	either	point	1	or	2	would	be	appropriate	proximal	endpoints.	
	
	
7.	Drag	the	proximal	endpoint	marker	to	the	chosen	point	(in	the	diagram	below	
point	2	has	been	chosen).	Release	the	 left	mouse	button	and	the	crosshair	will	
change	from	red	to	green	if	it	has	been	successfully	‘snapped’	to	the	CLL.	
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8.	Zoom	out	to	locate	the	vertex	marker	(black	arrow)….	
	
	
….drag	it	close	to	the	lowest	renal	artery.		
9.	Zoom	in	and	chose	a	suitable	point	to	snap	the	vertex	marker	to.	Based	on	our	
initial	observations	of	the	lumen	model	the	α	angle	vertex	looked	to	be	just	distal	
to	 the	 lowest	 renal	artery.	 In	 the	diagram	below	the	point	has	been	chosen	 to	
mark	the	α	angle	vertex.	
Lf	RA	
Rt	RA	
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10.	Repeat	this	process	with	the	distal	endpoint.	You	may	need	to	right	click	on	
the	3D	image	and	set	 ‘visibility’	to	 ‘on’	for	the	 lumen	model	to	remind	yourself	
where	the	distal	endpoint	should	be.			
	
The	 rays	 (yellow	 lines)	of	 the	angle	measuring	 tool	 should	be	a	good	 fit	 to	 the	
course	of	the	aortic	CLL	but	do	not	have	to	exactly	overlie	every	green	marker.	
11.	 Record	 the	 supplementary	α	 angle	 (approx.	 17-18°	 for	 ‘exampleAAA’)	 then	
right	 click	 on	 the	 temporary	 angle	 name	 to	 rename	 using	 the	 following	
nomenclature	
EVAR/INITIALS/angle	
E.g.	I	would	rename	the	α	angle	measurement	from	EVAR	1	as	1SMJa	
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Angle	Measurement	with	Leonardo	
Consider	the	α	angle	in	exactly	the	same	way	as	above.	Use	your	usual	method	
for	angle	measurement	with	the	following	points	in	mind:	
1. Whilst	profiling	the	neck	in	the	usual	way	ensure	the	blue	box	(bottom	left)	is	
also	 enlarged	 and	 that	 the	blue	 crosshairs	 are	moved	 to	mark	 the	 level	 of	 the	
lowest	renal	artery.	
2. Identify	the	intended	site	of	the	α	angle	vertex		
3. Use	 the	 ‘Angle’	 tool	 found	 in	 the	 ‘Tools’	 menu.	 Ensure	maximum	 length	 of	
lumen	 is	demonstrated	proximal	and	distal	 to	 the	vertex	and	apply	 the	 tool	 to	
the	centre	of	the	lumen	in	either	red	or	green	boxes	depending	on	which	shows	
the	larger	angle.	 	The	proximal	endpoint	should	be	the	approximate	position	of	
the	SMA	and	the	distal	endpoint:	the	distal	extent	of	aneurysm	neck	or	the	next	
major	angulation	along	the	centreline.		
4. Record	the	angle:	Highlight	the	box	chosen	for	the	angle	measurement.	Go	to	
‘edit’	 and	 ‘copy’.	 	 Press	 the	windows	 key	 and	under	programmes	open	 ‘Paint’.	
Paste	the	image	and	save	as	file	name:	Number	of	EVAR/INITIALS/angle	
e.g.	1SMJa	
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8.3 Validation	of	multiple	stent-graft	territories	versus	single	
component	models		
 Aim	
Section	 5.5.1	 described	 the	 model	 making	 process	 in	 full.	 Section	 5.5.1.2.5	
outlined	 how	 the	 number	 of	 simulations	 could	 be	 reduced	 four-fold	 by	
representing	all	stent-graft	components	on	the	same	lumen.	To	confirm	that	this	
approach	did	not	introduce	bias	a	direct	comparison	was	made	between	the	two	
model	techniques.	
 Method	
Separate	models	for	each	component	of	fEVAR	18	were	constructed	in	the	same	
way	as	described	in	section	5.5.1.	This	approach	yielded	four	models:	A	complete	
stent-graft,	proximal	body,	distal	body	and	limb	extension	model	(see	Figure	8.1).		
One	further	model	was	constructed	using	the	combined	ROI	approach	described	
in	section	5.5.1.2.5	(see	Figure	8.1).	
	
	
Figure	8.1	Separate	models	for	each	stent-graft	component	and	combined	ROI	
model	
SG:	Complete	stent-graft,	PB:	Proximal	body,	DB:	Distal	body,	LE:	Limb	extension,	All:	All	
components	represented	in	combined	region	of	interest	approach.	
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CFD	was	performed	 for	each	model	using	 the	same	boundary	conditions	as	 for	
previous	simulations	(i.e.	blood	viscosity	0.0033Pa.s	and	density	1098	kg/m3	with	
a	flow	rate	of	1.323x10-4m3/s).	Blood	pressure	was	set	at	120mmHg	(18665Pa).	
 Results	
Table	8.1	shows	the	breakdown	of	all	forces	acting	upon	the	single	component	
and	combined	ROI	models.	
Table	8.1	Comparison	between	single	component	and	combined	ROI	models	
	 Complete	stent-
graft	
Proximal	body	 Distal	body	 Limb	extension	
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x	 pres	 -0.063	 -0.094	 0.029	 -0.020	 -0.418	 -0.400	 -0.237	 -0.226	
	 vis	 -0.004	 -0.004	 0.001	 0.001	 0.005	 0.005	 -0.009	 -0.009	
	 total	 -0.067	 -0.098	 0.030	 -0.019	 -0.413	 -0.395	 -0.247	 -0.236	
y	 pres	 0.824	 0.807	 1.869	 1.844	 -1.813	 -1.842	 -0.484	 -0.505	
	 vis	 -0.003	 -0.003	 0.004	 0.004	 0.001	 0.001	 -0.005	 -0.005	
	 total	 0.820	 0.804	 1.873	 1.848	 -1.811	 -1.841	 -0.489	 -0.509	
z	 pres	 2.968	 2.958	 1.545	 1.529	 3.587	 3.675	 0.911	 1.034	
	 vis	 -0.041	 -0.041	 -0.014	 -0.014	 -0.023	 -0.023	 -0.020	 -0.020	
	 total	 2.927	 2.917	 1.531	 1.515	 3.564	 3.652	 0.891	 1.014	
Total	RDF	
(N)	
3.04	 3.03	 2.42	 2.39	 4.02	 4.11	 1.05	 1.16	
Error	(%)		 	 0.42	 	 1.23	 	 -2.23	 	 -10.89	
	
All	of	the	difference	in	total	RDF	was	due	to	pressure	derived	forces.	Viscous	
friction	forces	were	the	same	between	all	models.	
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 Conclusion	
Use	 of	 combined	 ROI	 models	 instead	 of	 single	 component	 models	 does	 not	
significantly	 affect	 distraction	 force	 results.	 The	 combined	 approach	 enables	
force	results	for	all	components	of	a	fEVAR	to	be	obtained	with	one	simulation	as	
opposed	to	four	or	more	separate	simulations.	This	saves	a	minimum	of	12	hours	
of	computational	time	per	fEVAR.	These	results	justify	the	use	of	combined	ROI	
models.	
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8.4 Validation	of	model	mesh	complexity	
 Aim	
When	creating	computer	models	of	patient-specific	aorto-iliac	anatomy,	regions	
of	 interest	 (ROI)	 segmented	 from	 CT	 images	 were	 converted	 into	 computer	
models	 by	 the	 process	 of	 meshing.	 This	 process	 was	 performed	 by	 ScanIP	
software	(Simplware	Ltd)	and	resulted	 in	a	3-dimensional	representation	of	the	
ROI	built	 from	smaller	 tetrahedral	elements	based	on	pre-set	parameters.	Free	
mesh	 algorithms	 were	 recommended	 for	 irregular	 biological	 morphology	
because	 they	 automatically	 use	 small	 tetrahedral	 elements	 to	 preserve	 fine	
detail	and	larger	elements	in	areas	that	do	not	require	detail	to	be	preserved	i.e.	
the	centre	of	the	lumen.	Meshes	that	are	too	coarse	potentially	miss	fine	detail	
and	 may	 produce	 a	 poor	 representation	 of	 the	 actual	 anatomy.	 Meshes	 too	
complex	 require	 more	 processing	 power	 for	 both	 the	 meshing	 itself	 and	 the	
blood	flow	simulation.	A	balance	must	therefore	be	struck	between	accuracy	and	
efficiency.	 The	 aim	 of	 this	 validation	 experiment	 was	 to	 assess	 the	 effect	 on	
distraction	force	of	increasing	mesh	complexity.		
 Method	
A	patient-specific	aorto-iliac	ROI	prepared	using	the	method	described	in	section	
5.5.1	was	meshed	with	standard	settings	recommended	by	the	software	provider	
with	 ‘compound	 coarseness’	 set	 to	 -20	 and	 then	 again	 with	 finer	 mesh	
parameters	(compound	coarseness=0).		
Both	standard	and	complex	models	were	exported	into	FLUENT	v6.2	(ANSYS	Inc.)	
for	blood	flow	simulation	(see	section	5.5.2).	Mesh	parameters	were	requested	
for	 each	 model	 including	 number	 of	 tetrahedral	 elements,	 number	 of	 faces	
comprising	each	model	inlet	and	outlet	and	the	actual	surface	area	of	the	model	
inlet	 and	 outlets.	 Distraction	 force	 was	 determined	 for	 the	 distal	 body	
component	and	was	compared	between	models.		
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 Results	
Table	8.2	shows	mesh	parameters	for	both	the	standard	and	complex	model.	
Table	8.2	Mesh	parameters	
	 Standard	mesh	 Complex	mesh	
Total	no.	of	tetrahedral	elements	 703287	 2476618	
No.	of	tetrahedral	elements	in	lumen	ROI	 400882	 1882302	
No.	of	faces	at	model	inlet	
XSA	(mm2)	
1322	
381	
4996	
382	
No.	of	faces	at	right	IIA	outlet	
XSA	(mm2)	
48	
13	
266	
13	
No.	of	faces	at	right	EIA	outlet	
XSA	(mm2)	
124	
47	
873	
47	
No.	of	faces	at	left	IIA	outlet	
XSA	(mm2)	
33	
9	
215	
10	
No.	of	faces	at	left	EIA	outlet	
XSA	(mm2)	
124	
42	
802	
42	
No.	of	faces	at	right	RA	outlet	
XSA	(mm2)	
24	
6	
141	
7	
No.	of	faces	at	left	RA	outlet	
XSA	(mm2)	
37	
7	
166	
7	
No.	of	faces	at	SMA	outlet	
XSA	(mm2)	
44	
19	
431	
20	
No.	of	faces	at	CHA	outlet		
XSA	(mm2)	
26	
12	
271	
12	
No.	of	faces	at	SA	outlet	
XSA	(mm2)	
34	
15	
301	
16	
CHA:	common	hepatic	artery,	EIA:	external	iliac	artery,	IIA:	internal	iliac	artery,	SA:	splenic	
artery,	SMA:	Superior	mesenteric	artery,	RA:	Renal	artery	
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Table	8.3	Distraction	force	(N)	acting	on	standard	and	complex	models	
	 Standard	Model	 Complex	Model	
X			 Pressure	 0.968	 0.960	
	 Viscous	 0.006	 0.006	
	 Total	 0.974	 0.966	
Y	 Pressure	 -1.783	 -1.776	
	 Viscous	 -0.003	 -0.004	
	 Total	 -1.786	 -1.780	
Z	 Pressure	 1.506	 1.499	
	 Viscous	 -0.014	 -0.014	
	 Total	 1.492	 1.485	
Total	RDF	(N)	 2.523	 2.511	
	
	
 Discussion	
Although	 the	 complex	 model	 had	 over	 three	 times	 the	 total	 number	 of	
tetrahedral	 elements	 and	 a	maximum	of	 ten	 times	 the	number	of	 outlet	 faces	
(common	hepatic	 artery	outlet)	 the	maximum	difference	 in	 any	 cross-sectional	
area	 was	 only	 1mm2.	 Total	 resultant	 distraction	 force	 was	 2.523N	 for	 the	
standard	model	and	2.511N	for	the	complex	model	(see	Table	8.3).	The	error	was	
therefore	 0.48%.	 Increasing	 the	 complexity	 of	 the	 mesh	 above	 the	 standard	
setting	did	not	cause	any	significant	difference	in	total	RDF	and	this	supports	the	
use	 of	 standard	 mesh	 settings	 for	 determining	 distraction	 force	 in	 patient-
specific	anatomy.	
	
 Conclusion	
Standard	mesh	settings	are	adequate	to	model	patient-specific	anatomy	for	the	
purpose	of	investigating	distraction	force.		
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8.5 Morphological	features	of	stent-grafts	and	components	
 Complete	stent-grafts	
fE
VA
R	
Cross-sectional	area	
(mm2)	
Angulation	(degrees)	
Inlet	
XSA	
Left	
outlet	
XSA	
Right	
outlet	
XSA	
Cor	
α	
Sag	
α	
Cor	
β	
Sag	
β	
Left	
Cor	
θ	
Left	
Sag	
θ	
Right	
Cor		
θ	
Right	
Sag	θ	
Cor	
Bif	
Sag	
Bif	
1	 No	postoperative	CT	imaging	
2	 514	 101	 98	 8	 13	 29	 -10	 -58	 -63	 26	 -31	 84	 32	
3	 No	postoperative	CT	imaging	
4	 260	 117	 128	 6	 3	 -9	 -9	 -37	 -19	 52	 -48	 89	 29	
5	 675	 201	 278	 0	 0	 5	 -2	 -29	 -53	 29	 -60	 58	 7	
6	 355	 214	 165	 -17	 6	 13	 -28	 -62	 -35	 19	 -69	 81	 34	
7	 435	 115	 121	 -7	 7	 0	 0	 14	 -58	 18	 -67	 4	 9	
8	 345	 37	 65	 -5	 15	 8	 -13	 -48	 4	 36	 -86	 84	 90	
9	 275	 84	 254	 -2	 5	 4	 -4	 -18	 -57	 40	 -55	 58	 2	
10	 351	 76*	 72	 -22	 -1	 -13	 -21	 8	 -52	 36	 -58	 28	 6	
11	 485	 120	 78	 -21	 26	 14	 -34	 -34	 -82	 51	 -56	 85	 26	
12	 433	 229	 142	 -1	 24	 58	 -41	 13	 -60	 64	 -49	 51	 11	
13	 227	 65	 70	 -12	 18	 -6	 -15	 -66	 -62	 28	 -27	 94	 35	
14	 294	 70	 155	 -26	 38	 43	 -42	 -62	 -
140	
97	 -120	 159	 20	
15	 295	 71*	 118	 -8	 11	 14	 -15	 -53	 27	 51	 -66	 104	 93	
16	 264	 82	 49	 -14	 29	 41	 -29	 -4	 -61	 65	 -60	 69	 1	
17	 271	 124	 37	 -8	 18	 25	 -7	 -34	 -64	 30	 -48	 64	 16	
18	 209	 54	 25	 -2	 9	 5	 4	 -15	 -20	 52	 -51	 67	 31	
19	 389	 151	 106	 -12	 13	 9	 -13	 -37	 -44	 66	 -43	 103	 1	
20	 309	 33	 217	 4	 5	 24	 0	 -42	 -35	 36	 -37	 78	 2	
21	 214	 62	 156	 -2	 23	 4	 -13	 -23	 -87	 13	 -91	 36	 4	
22	 375	 87	 83	 -1	 16	 7	 -8	 -39	 -59	 32	 -53	 71	 6	
23	 272	 95	 114	 -19	 8	 13	 -8	 -14	 -53	 47	 -54	 61	 1	
24	 111	 72	 56	 -4	 4	 12	 -11	 -12	 -37	 19	 -27	 31	 10	
25	 907	 380	 *	 18	 2	 36	 -16	 -73	 -
114	
Occluded	limb	
26	 290	 78	 86	 3	 13	 0	 -26	 -2	 -97	 56	 -99	 58	 2	
27	 438	 95	 59	 -11	 21	 26	 -22	 -35	 -83	 66	 -69	 101	 14	
28	 407	 170	 -	 -11	 5	 23	 2	 -33	 -70	 Occluded	limb	
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	 Cross-sectional	area	 Angulation	
Inlet	
XSA	
Left	
outlet	
XSA	
Right	
outlet	
XSA	
Cor	
α	
Sag	
α	
Cor	
β	
Sag	
β	
Left	
Cor	
θ	
Left	
Sag	
θ	
Right	
Cor		
θ	
Right	
Sag	θ	
Cor	
Bif	
Sag	
Bif	
29	 335	 135	 113	 -15	 -5	 27	 17	 -13	 -80	 93	 -76	 106	 4	
30	 312	 59	 30*	 -1	 -3	 7	 -9	 -47	 -43	 46	 -31	 93	 12	
31	 451	 29	 60	 -8	 9	 15	 10	 6	 -15	 36	 -60	 30	 45	
32	 340	 125	 97	 -4	 9	 -11	 -19	 -80	 -91	 40	 -64	 120	 27	
33	 No	postoperative	CT	imaging	with	contrast	
34	 360	 114	 194	 -7	 2	 21	 -7	 -62	 -71	 4	 -74	 66	 3	
35	 242	 103	 87	 -4	 8	 10	 23	 3	 -26	 25	 -20	 22	 6	
36	 348	 70	 35	 -9	 2	 28	 -8	 -10	 -59	 40	 -61	 50	 2	
37	 227	 34	 62	 -14	 7	 18	 -15	 -28	 -56	 54	 -48	 82	 8	
38	 281	 28*	 57	 -22	 -4	 -3	 -4	 -7	 -46	 85	 -12	 92	 34	
39	 222	 91	 104	 -19	 17	 53	 -27	 -37	 -87	 45	 -58	 82	 29	
40	 371	 210	 242	 -24	 -18	 48	 15	 -5	 -37	 75	 -37	 80	 0	
41	 527	 96	 123	 2	 11	 -5	 -1	 -22	 -82	 26	 -67	 48	 15	
42	 No	postoperative	CT	imaging	
43	 230	 98	 74	 -13	 9	 -17	 11	 -44	 -57	 34	 -50	 78	 7	
44	 216	 41	 112	 -11	 8	 12	 -1	 -13	 -44	 40	 -38	 53	 6	
45	 364	 58	 81	 -12	 18	 19	 -21	 -22	 -67	 24	 -42	 46	 25	
46	 415	 33	 80	 1	 3	 13	 -7	 -83	 -92	 84	 -95	 167	 3	
47	 351	 84	 92	 6	 8	 -3	 -2	 -66	 3	 19	 -24	 85	 27	
48	 298	 209	 263	 -9	 2	 16	 6	 -63	 -80	 75	 -67	 138	 13	
49	 351	 131	 216	 11	 9	 -20	 -23	 -31	 -61	 38	 -73	 69	 12	
50	 270	 25	 64	 0	 6	 19	 -21	 1	 -65	 36	 -74	 35	 9	
51	 304	 356	 -	 -8	 22	 49	 -38	 22	 -47	 Tube	graft	only	
52	 363	 85	 25	 -9	 -8	 25	 -24	 -45	 -60	 77	 -16	 122	 44	
53	 403	 166	 136	 -19	 0	 24	 -3	 -34	 -51	 44	 -58	 78	 7	
54	 No	postoperative	CT	imaging	
55	 659	 132	 128	 -27	 0	 12	 -28	 -12	 -44	 57	 -43	 69	 1	
56	 548	 400	 393	 -3	 -4	 18	 -1	 -54	 -31	 56	 -33	 110	 2	
57	 393	 204	 178	 0	 5	 -12	 4	 -20	 -65	 27	 -53	 47	 12	
58	 509	 178	 233	 -31	 1	 -5	 -10	 -55	 -59	 58	 -74	 113	 15	
59	 465	 155	 52	 -15	 14	 26	 -3	 20	 -49	 64	 -60	 44	 11	
Cor/Sag	α:	α	angle	in	coronal	or	sagittal	elevation,	β:	β	angle,	θ:	outlet	angle,	Bif:	bifurcation	
angle	(see	Figure	5.9),	XSA:	cross-sectional	area	(mm2),	*:Wallstent	across	outlet	
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 Proximal	bodies	
fE
VA
R	
D1	
Inlet	
XSA	 BL1	
Seal	
stents	 Scal	 Fens	
Left	
Outlet	
XSA	
Cor		
θ	
Sag	
θ	
Right	
Outlet	
XSA	
Cor	
θ	
Sag	
θ	
1	 36	 -	 122	 2	 1	 2	 No	postoperative	CT	imaging	
2	 32	 514	 124	 2	 0	 2	 330	 29	 -15	 -	 -	 -	
3	 28	 -	 124	 2	 1	 2	 No	postoperative	CT	imaging	
4	 26	 260	 109	 2	 1	 2	 52	 -6	 -31	 84	 -15	 -14	
5	 36	 675	 122	 2	 1	 2	 105	 4	 -3	 78	 11	 -2	
6	 34	 355	 99	 1	 1	 0	 55	 2	 -30	 97	 10	 -27	
7	 32	 435	 181	 2	 1	 3	 115	 14	 -58	 70	 0	 -12	
8	 28	 345	 109	 2	 0	 3	 108	 9	 -28	 45	 18	 -47	
9	 28	 275	 109	 2	 1	 2	 45	 5	 -15	 92	 17	 -10	
10	 28	 351	 124	 2	 0	 3	 53	 -2	 -38	 57	 1	 -38	
11	 30	 485	 124	 2	 1	 2	 62	 15	 -44	 100	 16	 -44	
12	 34	 433	 122	 2	 1	 1	 89	 43	 -56	 132	 69	 -50	
13	 24	 227	 109	 2	 1	 2	 109	 -9	 -15	 100	 0	 -23	
14	 28	 294	 124	 2	 1	 2	 54	 36	 -48	 66	 58	 -47	
15	 26	 295	 109	 2	 1	 2	 39	 14	 -24	 42	 1	 -20	
16	 28	 264	 124	 2	 1	 2	 70	 39	 -25	 101	 49	 -41	
17	 30	 271	 124	 2	 0	 3	 76	 32	 -24	 97	 37	 -33	
18	 24	 209	 109	 2	 1	 2	 92	 13	 -11	 58	 6	 2	
19	 30	 389	 109	 2	 1	 2	 51	 10	 -37	 78	 11	 -16	
20	 28	 309	 124	 2	 1	 2	 113	 15	 -9	 65	 24	 -15	
21	 24	 214	 109	 2	 1	 1	 51	 7	 -39	 100	 16	 -32	
22	 28	 375	 109	 2	 1	 2	 70	 0	 -13	 123	 -2	 -11	
23	 28	 272	 109	 2	 1	 2	 57	 36	 -23	 54	 25	 -14	
24	 24	 111	 76	 1	 1	 1	 40	 10	 -15	 103	 20	 -10	
25	 36	 907	 137	 2	 1	 2	 57	 31	 -23	 Occluded	
26	 28	 290	 124	 2	 1	 2	 111	 2	 -32	 57	 10	 -32	
27	 30	 438	 124	 2	 1	 2	 48	 25	 -35	 103	 28	 -19	
28	 36	 407	 164	 2	 1	 3	 78ᶲ	 32	 -30	 Occluded	
29	 32	 335	 124	 2	 1	 2	 339	 39	 -8	 -	 -	 -	
30	 34	 312	 107	 2	 1	 2	 54	 8	 -14	 94	 13	 -12	
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fE
VA
R	
D1	
Inlet	
XSA	 BL1	
Seal	
stents	 Scal	 Fens	
Left	
Outlet	
XSA	
Cor	
θ	
Sag	
θ	
Right	
Outlet	
XSA	
Cor	
θ	
Sag	
θ	
31	 30	 451	 124	 2	 1	 3	 325	 3	 1	 -	 -	 -	
32	 30	 340	 124	 2	 1	 3	 71	 -17	 -33	 156	 -12	 -15	
33	 32	 -	 124	 2	 1	 3	 No	postoperative	CT	imaging	with	contrast	
34	 32	 360	 129	 3	 1	 3	 51	 14	 -25	 143	 36	 -18	
35	 28	 242	 124	 2	 1	 2	 77	 11	 16	 119	 11	 13	
36	 30	 348	 109	 2	 1	 2	 56	 22	 -23	 110	 28	 -14	
37	 26	 227	 139	 2	 1	 3	 253	 24	 -16	 -	 -	 -	
38	 28	 281	 124	 2	 0	 3	 50	 25	 -16	 224	 32	 -29	
39	 30	 222	 109	 2	 1	 0	 45	 45	 -31	 83	 50	 -16	
40	 34	 371	 152	 2	 1	 2	 153	 37	 0	 58	 53	 4	
41	 32	 527	 124	 2	 1	 3	 344	 -28	 -7	 -	 -	 -	
42	 36	 -	 107	 2	 1	 2	 No	postoperative	CT	imaging	
43	 24	 230	 94	 2	 1	 2	 71	 5	 -19	 116	 4	 -9	
44	 26	 216	 109	 2	 1	 2	 57	 8	 -25	 101	 15	 -16	
45	 28	 364	 109	 2	 1	 2	 62	 19	 -26	 97	 16	 -29	
46	 28	 415	 109	 2	 1	 3	 50	 16	 -24	 47	 16	 -29	
47	 30	 351	 109	 2	 1	 2	 50	 -1	 -22	 103	 0	 -21	
48	 26	 298	 124	 2	 1	 2	 65	 20	 -3	 107	 23	 -6	
49	 34	 351	 108	 2	 1	 1	 103	 -21	 -30	 35	 -15	 -22	
50	 28	 270	 109	 2	 1	 2	 54	 19	 -34	 86	 23	 -23	
51	 28	 304	 153	 2	 1	 3	 356ᶲ	 22	 -47	 Tube	graft	only	
52	 30	 363	 139	 2	 1	 2	 175	 17	 -29	 52	 30	 -29	
53	 28	 403	 139	 2	 1	 3	 79	 13	 -20	 56	 22	 -19	
54	 34	 -	 137	 2	 0	 3	 No	postoperative	CT	imaging	
55	 40	 659	 171	 2	 1	 2	 233	 2	 -36	 -	 23	 -36	
56	 36	 548	 183	 2	 0	 4	 51	 15	 -15	 100	 23	 -6	
57	 28	 393	 109	 2	 1	 2	 54	 1	 -31	 122	 8	 -32	
58	 36	 509	 174	 3	 1	 3	 56	 -9	 -20	 87	 -8	 -17	
59	 32	 465	 168	 2	 0	 4	 106	 28	 -14	 59	 47	 -21	
Data	obtained	from	supply	and	manufacturing	documents	shown	in	italics.	D1:	Actual	proximal	
diameter	(mm),	Inlet	XSA:	Inlet	cross-sectional	area	post	deployment	(mm2),	BL1:	Proximal	body	
length	(mm),	Seal	stents:	no.	of	sealing	stents,	Scal:	no.	of	Scallops,	Fen:	no.	of	Fenestrations,	
Outlet	XSA:	Outlet	cross-sectional	area	post	deployment	(mm2),	Cor/Sag	θ:	Coronal/Sagittal	
outlet	angle	(degrees),	ᶲ:	non-standard	distal	diameter	
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 Distal	bodies	
fE
VA
R	
Inlet	
XSA	 DBL	 DLL	
D3	
(R/L)	
Ipsilateral	outlet		 Contralateral	outlet		
Cor	
bif	
Sag	
bif	XSA	
Cor	
θ	
Sag	
θ	 XSA	
Cor	
θ	
Sag	
θ	
1	 -	 94	 62	 20	 No	postoperative	CT	imaging	
2	 420	 124	 62	 16	(R)	 101	 -3	 -22	 71	 -23	 -33	 20	 11	
3	 -	 109	 45	 12		 No	postoperative	CT	imaging	
4	 376	 94	 62	 20	(R)	 128	 61	 -36	 72	 9	 -29	 52	 7	
5	 453	 94	 62	 20	(L)	 202	 -30	 -54	 100	 9	 -13	 39	 41	
6	 412	 94	 45	 20	(R)	 166	 4	 -44	 76	 -13	 -10	 17	 34	
7	 Custom-made	single-piece	bifurcated	fenestrated	main	body		
8	 455	 94	 62	 12	(L)	 59*	 -75	 -57	 72	 5	 -35	 80	 22	
9	 390	 94	 28	 12	(L)	 84	 -26	 -51	 84	 19	 -26	 45	 25	
10	 342	 109	 28	 12	(R)	 50	 47	 -22	 77	 28	 -27	 19	 5	
11	 448	 94	 45	 16	(R)	 79	 39	 -26	 77	 5	 -13	 34	 13	
12	 447	 94	 28	 12	(R)	 90	 3	 -14	 81	 -11	 -21	 14	 7	
13	 194	 94	 45	 12	(L)	 63	 -61	 -48	 90	 4	 -19	 65	 29	
14	 327	 109	 28	 12	(R)	 79	 24	 -22	 78	 11	 -3	 13	 19	
15	 377	 94	 62	 20	(R)	 118*	 49	 -51	 27*	 12	 -16	 37	 35	
16	 416	 94	 45	 16	(R)	 49	 24	 -31	 84	 0	 -15	 24	 16	
17	 408	 94	 62	 16	(R)	 36	 6	 -39	 89	 6	 -22	 0	 17	
18	 342	 76	 62	 12	(L)	 55	 -20	 -23	 79	 1	 -8	 21	 15	
19	 385	 94	 62	 16	(R)	 105	 61	 -31	 82	 25	 -25	 36	 6	
20	 395	 94	 45	 16	(L)	 33	 -68	 -36	 62	 -1	 -21	 67	 15	
21	 276	 94	 28	 12	(R)	 95	 9	 -56	 72	 -4	 -31	 13	 25	
22	 414	 76	 62	 12	(R)	 124	 26	 -46	 87	 -6	 -7	 32	 39	
23	 429	 76	 28	 12	(L)	 62	 12	 -27	 68	 13	 -7	 1	 20	
24	 160	 76	 45	 12	(R)	 56	 7	 -16	 61	 4	 -8	 3	 8	
25	 399	 109	 62	 12	(R)	 Occluded*‡	 40	 -2	 -37	 -	 -	
26	 396	 94	 62	 12	(L)	 78	 -2	 -71	 57	 12	 -14	 14	 57	
27	 393	 76	 62	 12	(R)	 59	 37	 -45	 55	 -2	 -14	 39	 31	
28	 432ᶲ	 97	 30	 12	(R)	 Occluded‡	 65	 8	 -42	 -	 -	
29	 301	 109	 62	 20	(R)	 113	 63	 -89	 51	 8	 -49	 55	 40	
30	 410	 76	 62	 12	(R)	 30*	 41	 -24	 57	 2	 -4	 39	 20	
31	 285	 109	 62	 12	(L)	 109	 -38	 -30	 66	 -12	 -25	 26	 5	
32	 382	 109	 45	 20	(R)	 97	 53	 -44	 75	 -6	 -15	 59	 29	
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fE
VA
R	
Inlet	
XSA	 DBL	 DLL	
D3	
(R/L)	
Ipsilateral	outlet	
	
Contralateral	outlet	
	
Cor	
bif	
Sag	
bif	XSA	
Cor	
θ	
Sag	
θ	 XSA	
Cor	
θ	
Sag	
θ	
33	 -	 109	 28	 12	 No	postoperative	CT	imaging	with	contrast	
34	 387	 94	 62	 20	(R)	 194	 -16	 -67	 66	 -8	 -23	 8	 44	
35	 383	 76	 62	 12	(R)	 87	 16	 -42	 82	 2	 -10	 14	 32	
36	 253	 94	 62	 16	(R)	 35	 12	 -51	 69	 -7	 -17	 19	 34	
37	 318	 109	 45	 12	(R)	 62	 34	 -30	 61	 -15	 -4	 49	 26	
38	 320	 124	 45	 12	(R)	 57	 85	 -7	 23*	 58	 -37	 27	 30	
39	 425	 76	 62	 12	(R)	 104	 -8	 -31	 87	 -7	 -2	 1	 29	
40	 300	 94	 45	 22	(L)	 210	 -53	 -50	 70	 10	 -21	 63	 29	
41	 312	 109	 62	 12	(R)	 77	 57	 -81	 70	 -28	 -22	 85	 59	
42	 -	 76	 62	 12	 No	postoperative	CT	imaging	
43	 272	 76	 62	 16	(R)	 74	 50	 -58	 83	 19	 -31	 31	 27	
44	 338	 94	 45	 12	(R)	 53	 26	 -40	 66	 -4	 -34	 30	 6	
45	 394	 76	 62	 12	(R)	 82	 5	 -20	 70	 -3	 -4	 8	 16	
46	 340	 76	 28	 12	(R)	 61	 4	 -25	 57	 4	 -18	 0	 7	
47	 501	 76	 62	 16	(R)	 92	 21	 -23	 70	 -2	 -21	 23	 2	
48	 435	 94	 62	 20	(R)	 263	 59	 -71	 79	 5	 -11	 54	 60	
49	 379	 42	 63	 16	(L)	 131	 -13	 -40	 23	 6	 -3	 19	 37	
50	 253	 76	 45	 16	(R)	 64	 14	 -52	 82	 2	 -17	 12	 35	
51	 Fenestrated	tube	graft	only	
52	 318	 94	 62	 16	(R)	 25	 52	 -12	 96	 -4	 -13	 56	 25	
53	 335	 76	 45	 20	(R)	 102	 0	 -38	 68	 -13	 -17	 13	 21	
54	 -	 76	 62	 24	 No	postoperative	CT	imaging	
55	 358	 94	 45	 24	(R)	 128	 38	 -15	 72	 -3	 -27	 41	 12	
56	 312	 109	 62	 28	(R)	 393	 40	 -34	 41	 2	 -15	 38	 19	
57	 324	 76	 62	 16	(R)	 178	 38	 -55	 62	 14	 -33	 24	 22	
58	 418	 94	 62	 22	(R)	 233	 60	 -62	 70	 -3	 -16	 63	 46	
59	 329	 109	 45	 20	(L)		 155†	 -8	 -50	 69	 28	 -21	 36	 29	
Data	obtained	from	supply	and	manufacturing	documents	shown	in	italics.	Inlet	XSA:	Inlet	cross-
sectional	area	post	deployment	(mm2),	DBL:	Actual	distal	body	length	to	contralateral	gate	(mm),	
DLL:	Actual	ipsilateral	limb	length	(mm),	D3:	Actual	ipsilateral	limb	outlet	diameter,	(R/L):	denotes	
laterality	of	ipsilateral	limb,	Ipsilateral/Contralateral	XSA:	limb	outlet	cross-sectional	area	post	
deployment	(mm2),	Cor/Sag	θ:	Coronal/Sagittal	outlet	angle	(degrees),	Cor/Sag	bif:	
Coronal/Sagittal	bifurcation	angle	(degrees),	*:	Wallstent,	†:	Palmaz	stent,	‡:	Internal	iliac	artery	
coil	embolization,	ᶲ:	non-standard	inlet	
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 Limb	extensions	
	 Contralateral	limb	extension	 Other	limb	extension	
fEVAR	
Inlet	
XSA	
LL	 D2	 Outlet	
XSA	
Cor		
θ	
Sag	
θ	
Inlet	
XSA	
LL	 D2	 Outlet	
XSA	
Cor	
θ	
Sag	
θ	
1	 -	 71	 22	 No	postoperative	CT*	 	 	 	 	 	 	
2	 65	(L)	 71	 18	 100	 -74	 -20	 	 	 	 	 	 	
3	 -	 71	 12	 No	postoperative	CT*	 	 	 	 	 	 	
4	 57	(L)	 71	 16	 117	 -32	 15	 	 	 	 	 	 	
5	 87	(R)	 88	 22	 280	 16	 -56	 	 	 	 	 	 	
6	 79	(L)	 54	 20	 213	 -64	 -2	 	 	 	 	 	 	
7	 86	(R)	 71	 16	 121	 17	 -53	 	 	 	 	 	 	
8	 48	(R)	 54	 16	 65	 17	 -41	 96	(L)	 54	 12	 37*‡	 2	 60	
9	 79	(R)	 71	 16	 254	 21	 -44	 	 	 	 	 	 	
10	 60	(L)	 71	 16	 76	 16	 -12	 60	(R)	 54	 16	 68	 29	 -16	
11	 103	(L)	 71	 18	 120	 -45	 -35	 	 	 	 	 	 	
12	 60	(L)	 88	 24	 229	 -33	 -4	 73	(R)	 71	 24	 144	 25	 8	
13	 97	(R)	 54	 12	 70	 28	 -9	 	 	 	 	 	 	
14	 61	(L)	 71	 16	 69	 -116	 -94	 96	(R)	 88	 16	 156	 37	 -75	
15	 (L)	 88	
71	
12	
14	
Unable	to	identify	
inlet/outlet*‡	
	 	 	 	 	 	
16	 63	(L)	 71	 14	 82	 -45	 -21	 	 	 	 	 	 	
17	 72	(L)	 71	 22	 124	 -57	 -44	 	 	 	 	 	 	
18	 65	(R)	 88	 12	 25	 47	 -51	 	 	 	 	 	 	
19	 48	(L)	 71	 18	 148	 -53	 -5	 	 	 	 	 	 	
20	 69	(R)	 54	 24	 217	 14	 -31	 	 	 	 	 	 	
21	 45	(L)	 71	 14	 62	 -28	 -46	 62	(R)	 54	 20	 156	 4	 -57	
22	 68	(L)	 71	 12	 83	 -41	 -50	 	 	 	 	 	 	
23	 92	(R)	 71	 18	 114	 23	 -39	 75	(L)	 54	 16	 95	 -48	 -26	
24	 62	(L)	 71	 12	 61	 -23	 -17	 	 	 	 	 	 	
25	 66	(L)	 93	 28	 380	 -106	 -99	 (R)	 71	
71	
14	
12	 Occluded*‡	
26	 65	(R)	 71	 14	 86	 45	 -61	 	 	 	 	 	 	
27	 64	(L)	 71	 14	 95	 -58	 -46	 	 	 	 	 	
28	 75	(L)	 56	 24	 170	 -55	 -35	 (R)	 90	 12	 Occluded‡	
29	 61	(L)	 71	 18	 135	 -50	 -52	 	 	 	 	 	 	
30	 79	(L)	 54	 14	 59	 -53	 -28	 	 	 	 	 	 	
31	 83	(R)	 73	 12	 60	 31	 -45	 83	(L)	 90	 12	 29‡	 29	 13	
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fEVAR	
Inlet	
XSA	
LL	 D2	 Outlet	
XSA	
Cor	
θ	
Sag	
θ	
Inlet	
XSA	
LL	 D2	 Outlet	
XSA	
Cor	
θ	
Sag	
θ	
32	 58	(L)	 71	 24	 125	 -59	 -59	 	 	 	 	 	 	
33	 -	 54	
88	
16	
16	
No	postoperative	CT	
with	contrast	
	 	 	 	 	 	
34	 72	(L)	 90	 16	 114	 -71	 -45	 	 	 	 	 	 	
35	 90	(L)	 90	 14	 103	 -13	 -42	 	 	 	 	 	 	
36	 57	(L)	 71	 14	 70	 -35	 -32	 	 	 	 	 	 	
37	 72	(L)	 71	 12	 34	 -63	 -37	 	 	 	 	 	 	
38	 53	(L)	 88	 12	 28*	 -39	 -21	 	 	 	 	 	 	
39	 61	(L)	 73	 16	 91	 -80	 -55	 	 	 	 	 	 	
40	 79	(R)	 73	 24	 242	 22	 -41	 	 	 	 	 	 	
41	 55	(L)	 90	 16	 96	 12	 -60	 104	(R)	 88	 16	 123	 -54	 -55	
42	 -	 90	 12	 No	postoperative	CT*	 	 	 	 	 	 	
43	 70	(L)	 73	 14	 98	 -49	 -38	 	 	 	 	 	 	
44	 79	(L)	 90	 16	 41	 -23	 -18	 78	(R)	 71	 14	 112	 34	 -18	
45	 83	(L)	 90	 12	 58	 -42	 -42	 	 	 	 	 	 	
46	 54	(L)	 90	 16	 33	 -98	 -63	 62	(R)	 73	 16	 80	 68	 -63	
47	 87	(L)	 73	 14	 84	 -65	 17	 	 	 	 	 	 	
48	 84	(L)	 73	 20	 209	 -84	 -75	 	 	 	 	 	 	
49	 (R)	 56	
73	
90	
12	
24	
24	
Unable	to	identify	
inlet/outlet	
	 	 	 	 	 	
50	 60	(L)	 56	 14	 25	 -20	 -26	 	 	 	 	 	 	
51	 Tube	graft	only	 	 	 	 	 	 	
52	 53	(L)	 73	 16	 85	 -62	 -27	 	 	 	 	 	 	
53	 57	(L)	 73	 18	 166	 -48	 -29	 69	(R)	 90	 18	 136	 25	 -29	
54	 (L)	 73	 20	 No	postoperative	CT	 	 	 	 	 	 	
55	 64	(L)	 73	 22	 132	 -20	 13	 	 	 	 	 	 	
56	 69	(L)	 107	 28	 400	 -64	 -14	 	 	 	 	 	 	
57	 44	(L)	 73	 18	 204	 -20	 -38	 	 	 	 	 	 	
58	 77	(L)	 90	 18	 178	 -50	 -40	 	 	 	 	 	 	
59	 61	(R)	 73	 14	 52‡	 12	 -38	 	 	 	 	 	 	
Data	obtained	from	supply	and	manufacturing	documents	shown	in	italics.	Inlet	XSA:	Inlet	cross-
sectional	area	post	deployment	(mm2),	(L/R)	denotes	laterality,	LL:	Actual	length	of	limb	
extension	(mm,	not	including	22mm	proximal	seal-zone),	D2:	Actual	distal	diameter	of	limb	
extension	(mm),	Outlet	XSA:	Outlet	cross-sectional	area	post	deployment	(mm2),	Cor/Sag	θ:	
Coronal/Sagittal	outlet	angle	(degrees),	*:wallstent,	‡:	Internal	iliac	artery	coil	embolization.	
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8.6 Distraction	force	results	for	chapter	5	
 Complete	stent-grafts	
fE
VA
R	
Pressure	force	(N)	 Viscous	Force	(N)	 Total	Force	(N)	 Total
RDF	
(N)	x	 y	 z	 x	 y	 z	 x	 y	 z	
1	 No	results	
2	 0.335	 -3.245	 7.017	 0.001	 -0.002	 -0.018	 0.336	 -3.247	 6.998	 7.7	
3	 No	results	
4	 -0.439	 -0.139	 2.205	 0.001	 -0.005	 -0.019	 -0.438	 -0.145	 2.186	 2.2	
5	 2.464	 -7.018	 7.444	 -0.002	 -0.002	 -0.019	 2.462	 -7.020	 7.425	 10.5	
6	 5.372	 -3.480	 2.253	 0.003	 -0.005	 -0.016	 5.375	 -3.485	 2.237	 6.8	
7	 -0.437	 -1.700	 7.121	 0.002	 0.000	 -0.022	 -0.435	 -1.701	 7.099	 7.3	
8	 0.480	 -0.885	 6.424	 0.012	 -0.011	 -0.035	 0.492	 -0.896	 6.390	 6.5	
9	 -1.391	 -2.104	 0.890	 -0.002	 -0.002	 -0.019	 -1.393	 -2.106	 0.871	 2.7	
10	 -1.645	 -2.404	 4.462	 -0.002	 -0.003	 -0.049	 -1.647	 -2.407	 4.413	 5.3	
11	 1.198	 -3.473	 8.163	 0.000	 -0.006	 -0.021	 1.198	 -3.480	 8.142	 8.9	
12	 -0.618	 -7.192	 1.856	 -0.008	 -0.006	 -0.027	 -0.626	 -7.198	 1.829	 7.5	
13	 0.500	 0.253	 3.182	 0.004	 -0.004	 -0.021	 0.504	 0.249	 3.161	 3.2	
14	 -2.464	 -6.042	 3.819	 -0.004	 -0.007	 -0.023	 -2.468	 -6.048	 3.795	 7.6	
15	 0.193	 -0.139	 3.955	 0.008	 0.000	 -0.046	 0.200	 -0.139	 3.910	 3.9	
16	 -0.494	 -1.336	 3.092	 -0.003	 -0.004	 -0.029	 -0.496	 -1.340	 3.063	 3.4	
17	 1.175	 -1.600	 3.596	 -0.005	 -0.002	 -0.030	 1.171	 -1.602	 3.566	 4.1	
18	 -0.073	 0.940	 3.390	 -0.004	 -0.003	 -0.041	 -0.077	 0.937	 3.349	 3.5	
19	 -0.974	 -1.254	 5.663	 -0.004	 -0.010	 -0.024	 -0.977	 -1.264	 5.638	 5.9	
20	 -1.485	 -0.275	 2.062	 -0.001	 -0.002	 -0.021	 -1.486	 -0.277	 2.041	 2.5	
21	 0.609	 -3.369	 2.191	 0.000	 -0.006	 -0.028	 0.610	 -3.375	 2.163	 4.1	
22	 1.197	 -1.450	 6.270	 0.001	 -0.005	 -0.019	 1.197	 -1.455	 6.251	 6.5	
23	 -0.212	 -1.272	 2.794	 0.000	 -0.003	 -0.048	 -0.212	 -1.275	 2.746	 3.0	
24	 -0.279	 0.130	 -0.066	 0.002	 -0.006	 -0.037	 -0.278	 0.124	 -0.104	 0.3	
25	 2.081	 -9.641	 14.76	 0.008	 -0.028	 -0.052	 2.089	 -9.669	 14.71	 17.7	
26	 -1.009	 -4.473	 4.990	 -0.005	 -0.007	 -0.028	 -1.014	 -4.479	 4.962	 6.8	
27	 -1.459	 -2.670	 7.889	 -0.004	 -0.012	 -0.034	 -1.462	 -2.682	 7.855	 8.4	
28	 -0.988	 1.930	 7.368	 0.005	 -0.014	 -0.035	 -0.983	 1.915	 7.333	 7.6	
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	 Pressure	Force	(N)	x,y,z	 Viscous	Force	(N)	x,y,z	 Total	Force	(N)	x,y,z	 RDF	
29	 -1.593	 -5.896	 4.357	 -0.003	 -0.009	 -0.025	 -1.596	 -5.905	 4.332	 7.5	
30	 0.112	 -0.166	 5.470	 -0.004	 -0.007	 -0.041	 0.107	 -0.173	 5.429	 5.4	
31	 -1.149	 3.500	 7.444	 0.006	 -0.009	 -0.057	 -1.143	 3.491	 7.387	 8.2	
32	 2.594	 -2.413	 5.454	 0.001	 -0.007	 -0.031	 2.595	 -2.420	 5.423	 6.5	
33	 No	results	
34	 3.953	 -2.059	 5.779	 -0.003	 -0.005	 -0.024	 3.950	 -2.064	 5.755	 7.3	
35	 -0.814	 1.984	 2.255	 -0.005	 0.002	 -0.021	 -0.818	 1.986	 2.234	 3.1	
36	 0.610	 -1.220	 6.465	 -0.002	 -0.007	 -0.028	 0.607	 -1.227	 6.436	 6.6	
37	 -0.885	 0.111	 3.357	 0.002	 -0.006	 -0.044	 -0.883	 0.106	 3.313	 3.4	
38	 0.223	 -1.032	 4.915	 -0.008	 -0.009	 -0.048	 0.215	 -1.041	 4.867	 5.0	
39	 -1.587	 -2.294	 1.335	 -0.004	 -0.006	 -0.023	 -1.590	 -2.300	 1.312	 3.1	
40	 -0.761	 -1.702	 2.213	 -0.001	 -0.001	 -0.028	 -0.762	 -1.704	 2.185	 2.9	
41	 1.342	 -1.660	 9.713	 0.003	 -0.009	 -0.030	 1.345	 -1.668	 9.683	 9.9	
42	 No	results	
43	 1.210	 -1.261	 3.332	 -0.001	 -0.003	 -0.023	 1.209	 -1.264	 3.309	 3.7	
44	 0.173	 -0.829	 2.485	 -0.001	 -0.006	 -0.034	 0.172	 -0.835	 2.451	 2.6	
45	 0.862	 -1.697	 5.764	 0.001	 -0.007	 -0.037	 0.863	 -1.705	 5.727	 6.0	
46	 -0.717	 1.921	 8.749	 0.000	 -0.012	 -0.026	 -0.717	 1.909	 8.724	 9.0	
47	 2.446	 1.724	 5.261	 0.001	 -0.005	 -0.029	 2.447	 1.719	 5.231	 6.0	
48	 -0.185	 -4.852	 1.769	 -0.001	 -0.003	 -0.023	 -0.186	 -4.855	 1.746	 5.2	
49	 -3.101	 -3.693	 3.943	 -0.005	 -0.009	 -0.039	 -3.106	 -3.702	 3.903	 6.2	
50	 -0.449	 -1.460	 4.797	 -0.008	 -0.009	 -0.036	 -0.456	 -1.469	 4.761	 5.0	
51	 -3.287	 0.429	 0.743	 -0.001	 0.003	 -0.009	 -3.288	 0.432	 0.735	 3.4	
52	 -0.179	 1.442	 6.735	 -0.006	 -0.010	 -0.032	 -0.186	 1.432	 6.702	 6.9	
53	 2.094	 0.612	 5.376	 -0.003	 -0.003	 -0.034	 2.091	 0.609	 5.341	 5.8	
54	 No	results	
55	 0.589	 -0.714	 11.75	 0.004	 -0.010	 -0.020	 0.593	 -0.725	 11.73	 11.8	
56	 0.279	 -6.130	 0.019	 0.000	 -0.003	 -0.030	 0.279	 -6.134	 -0.011	 6.1	
57	 0.241	 -4.977	 1.711	 0.002	 -0.004	 -0.024	 0.244	 -4.981	 1.687	 5.3	
58	 3.600	 -4.208	 5.829	 0.006	 -0.005	 -0.027	 3.606	 -4.212	 5.802	 8.0	
59	 -3.202	 -2.005	 6.286	 -0.012	 -0.003	 -0.049	 -3.214	 -2.009	 6.238	 7.3	
N:	Newtons,	RDF:	Resultant	distraction	force,	negative	values	indicate	forces	acting	in	the	
opposite	direction	to	that	of	the	x,y	or	z	axis	
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 Proximal	bodies	
fE
VA
R	 Pressure	force	(N)	 Viscous	Force	(N)	 Total	Force	(N)	 Total	
RDF	
(N)	x	 y	 z	 x	 	 y	 z	 x	 y	 z	
1	 No	results	
2	 -2.557	 -2.068	 3.539	 -0.002	 0.003	 -0.003	 -
2.559	
-
2.064	
3.535	 4.8	
3	 No	results	
4	 0.213	 1.111	 3.196	 0.001	 -0.001	 -0.010	 0.214	 1.109	 3.187	 3.4	
5	 2.529	 -0.223	 11.794	 -0.002	 0.003	 -0.012	 2.526	 -
0.220	
11.782	 12.1	
6	 2.343	 -1.368	 4.444	 -0.001	 -0.002	 -0.009	 2.342	 -
1.370	
4.436	 5.2	
7	 0.010	 0.221	 7.890	 0.002	 0.002	 -0.018	 0.012	 0.224	 7.872	 7.9	
8	 -0.491	 0.134	 4.426	 -0.001	 0.001	 -0.013	 -
0.492	
0.135	 4.412	 4.4	
9	 0.948	 1.475	 3.560	 -0.001	 0.002	 -0.008	 0.947	 1.477	 3.552	 4.0	
10	 -0.567	 -1.373	 5.053	 0.006	 0.004	 -0.024	 -
0.562	
-
1.369	
5.029	 5.2	
11	 0.572	 -1.753	 7.804	 0.000	 0.000	 -0.011	 0.572	 -
1.753	
7.793	 8.0	
12	 -1.838	 -5.831	 4.615	 -0.005	 -0.001	 -0.010	 -
1.843	
-
5.832	
4.605	 7.7	
13	 0.859	 1.495	 0.829	 0.001	 0.002	 -0.011	 0.860	 1.497	 0.818	 1.9	
14	 -1.333	 -1.764	 3.056	 0.000	 0.002	 -0.009	 -
1.333	
-
1.762	
3.047	 3.8	
15	 0.291	 0.400	 4.911	 0.000	 0.001	 -0.015	 0.291	 0.401	 4.895	 4.9	
16	 -1.292	 0.250	 1.812	 -0.002	 0.002	 -0.016	 -
1.294	
0.252	 1.796	 2.2	
17	 -0.914	 0.611	 2.812	 -0.004	 0.004	 -0.015	 -
0.917	
0.615	 2.796	 3.0	
18	 0.032	 2.134	 1.766	 0.001	 0.004	 -0.014	 0.033	 2.138	 1.752	 2.8	
19	 -1.616	 0.895	 5.593	 0.000	 -0.001	 -0.010	 -
1.616	
0.895	 5.582	 5.9	
20	 -0.715	 1.028	 2.996	 -0.004	 0.001	 -0.014	 -
0.720	
1.029	 2.982	 3.2	
21	 0.088	 0.504	 2.509	 -0.001	 0.003	 -0.008	 0.087	 0.507	 2.500	 2.6	
22	 1.087	 1.338	 4.830	 0.000	 0.001	 -0.009	 1.087	 1.339	 4.820	 5.1	
23	 -0.266	 0.616	 4.063	 0.001	 0.005	 -0.024	 -
0.265	
0.620	 4.039	 4.1	
24	 -0.569	 1.672	 -0.322	 0.001	 0.001	 -0.012	 -
0.568	
1.673	 -0.334	 1.8	
25	 -3.544	 -3.721	 14.86	 -0.002	 0.002	 -0.021	 -
3.545	
-
3.719	
14.84	 15.7	
26	 -0.119	 -0.920	 3.273	 0.001	 0.002	 -0.012	 -
0.119	
-
0.917	
3.262	 3.4	
27	 -2.065	 -0.216	 6.306	 0.000	 0.001	 -0.018	 -
2.065	
-
0.215	
6.288	 6.6	
28	 -3.061	 3.965	 7.849	 0.000	 0.002	 -0.014	 -
3.060	
3.967	 7.835	 9.3	
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	 Pressure	Force	(N)	x,y,z	 Viscous	Force	(N)	x,y,z	 Total	Force	(N)	x,y,z	 RDF	
29	 -1.905	 -0.748	 -0.223	 0.000	 0.003	 -0.007	 -
1.905	
-
0.744	
-0.230	 2.1	
30	 -0.331	 0.663	 3.999	 0.000	 0.000	 -0.011	 -
0.331	
0.663	 3.989	 4.1	
31	 -0.362	 6.157	 2.666	 0.001	 0.004	 -0.012	 -
0.362	
6.162	 2.654	 6.7	
32	 2.295	 0.748	 3.283	 0.001	 0.002	 -0.013	 2.295	 0.749	 3.271	 4.1	
33	 No	results	
34	 1.729	 2.792	 5.525	 -0.003	 0.002	 -0.009	 1.727	 2.794	 5.517	 6.4	
35	 -0.426	 4.688	 2.082	 -0.001	 0.004	 -0.011	 -
0.427	
4.692	 2.072	 5.1	
36	 -0.538	 0.705	 4.757	 -0.002	 0.002	 -0.012	 -
0.540	
0.706	 4.745	 4.8	
37	 -1.112	 1.223	 -0.412	 0.000	 0.003	 -0.014	 -
1.112	
1.226	 -0.426	 1.7	
38	 0.975	 -0.768	 0.393	 0.006	 0.003	 -0.012	 0.981	 -
0.764	
0.381	 1.3	
39	 -3.228	 -0.132	 1.711	 -0.004	 0.000	 -0.011	 -
3.232	
-
0.132	
1.700	 3.7	
40	 -0.834	 4.058	 3.720	 0.002	 0.006	 -0.013	 -
0.833	
4.063	 3.707	 5.6	
41	 4.569	 3.962	 6.072	 0.001	 0.002	 -0.004	 4.570	 3.964	 6.068	 8.6	
42	 No	results	
43	 1.492	 1.718	 2.106	 0.002	 0.002	 -0.010	 1.494	 1.720	 2.096	 3.1	
44	 0.905	 0.999	 1.957	 0.000	 0.002	 -0.009	 0.905	 1.000	 1.948	 2.4	
45	 0.156	 -0.124	 4.955	 -0.002	 0.001	 -0.015	 0.154	 -
0.122	
4.940	 4.9	
46	 -0.252	 3.702	 7.345	 -0.001	 0.001	 -0.009	 -
0.254	
3.703	 7.336	 8.2	
47	 1.021	 1.861	 4.869	 -0.002	 -0.002	 -0.013	 1.019	 1.860	 4.856	 5.3	
48	 -0.047	 1.574	 2.927	 -0.001	 0.003	 -0.016	 -
0.047	
1.577	 2.911	 3.3	
49	 -0.145	 0.711	 5.006	 0.003	 0.002	 -0.020	 -
0.142	
0.713	 4.986	 5.0	
50	 -0.526	 0.332	 3.559	 -0.002	 0.002	 -0.012	 -
0.529	
0.334	 3.547	 3.6	
51	 -3.287	 0.429	 0.743	 -0.001	 0.003	 -0.009	 -
3.288	
0.432	 0.735	 3.4	
52	 -1.473	 1.998	 3.363	 0.000	 0.001	 -0.009	 -
1.473	
1.999	 3.354	 4.2	
53	 1.007	 3.815	 7.525	 -0.002	 0.004	 -0.019	 1.005	 3.820	 7.506	 8.5	
54	 No	results	
55	 0.726	 0.701	 10.54	 0.001	 -0.001	 -0.007	 0.728	 0.700	 10.54	 10.6	
56	 -0.921	 0.146	 8.311	 -0.002	 0.001	 -0.018	 -
0.923	
0.147	 8.293	 8.3	
57	 0.343	 -0.297	 4.709	 0.002	 0.002	 -0.015	 0.345	 -
0.296	
4.694	 4.7	
58	 4.013	 0.153	 8.187	 0.004	 0.002	 -0.017	 4.016	 0.155	 8.170	 9.1	
59	 -2.963	 0.376	 6.772	 0.001	 0.009	 -0.021	 -
2.963	
0.384	 6.751	 7.4	
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N:	Newtons,	RDF:	Resultant	distraction	force,	negative	values	indicate	forces	acting	in	the	
opposite	direction	to	that	of	the	x,y	or	z	axis	
	
	
 Distal	bodies	
fE
VA
R	 Pressure	force	(N)	 Viscous	Force	(N)	 Total	Force	(N)	 Total	
RDF	
(N)	x	 y	 z	 x	 y	 z	 x	 y	 z	
1	 No	results	
2	 1.834	 -3.088	 5.365	 -0.003	 -0.002	 -0.016	 1.831	 -3.091	 5.349	 6.4	
3	 No	results	
4	 -2.925	 -1.487	 4.554	 -0.001	 -0.005	 -0.013	 -2.927	 -1.492	 4.541	 5.6	
5	 1.241	 -5.094	 3.170	 0.000	 0.001	 -0.016	 1.242	 -5.093	 3.153	 6.1	
6	 0.613	 -1.989	 5.303	 -0.002	 -0.004	 -0.014	 0.611	 -1.993	 5.288	 5.7	
7	 No	distal	body	(custom-made	single-piece	bifurcated,	fenestrated	main	body)	
8	 1.053	 -3.445	 7.199	 0.004	 -0.010	 -0.023	 1.058	 -3.454	 7.177	 8.0	
9	 0.194	 -3.221	 4.870	 -0.001	 -0.002	 -0.017	 0.193	 -3.223	 4.853	 5.8	
10	 -2.486	 -2.675	 4.004	 -0.001	 -0.002	 -0.035	 -2.487	 -2.676	 3.969	 5.4	
11	 -0.431	 -0.993	 6.652	 -0.003	 -0.004	 -0.017	 -0.434	 -0.997	 6.635	 6.7	
12	 2.344	 -1.385	 5.327	 -0.007	 -0.006	 -0.024	 2.337	 -1.391	 5.303	 6.0	
13	 0.968	 -1.783	 1.506	 0.006	 -0.003	 -0.014	 0.974	 -1.786	 1.492	 2.5	
14	 -0.524	 -1.631	 3.515	 -0.004	 -0.001	 -0.018	 -0.528	 -1.632	 3.497	 3.9	
15	 -0.480	 -1.947	 5.334	 -0.006	 -0.003	 -0.030	 -0.486	 -1.951	 5.304	 5.7	
16	 0.473	 -1.914	 6.106	 -0.007	 -0.002	 -0.021	 0.466	 -1.916	 6.085	 6.4	
17	 0.247	 -3.997	 4.882	 -0.008	 -0.001	 -0.026	 0.239	 -3.998	 4.856	 6.3	
18	 -0.478	 -2.073	 4.100	 0.005	 0.001	 -0.023	 -0.472	 -2.072	 4.077	 4.6	
19	 -2.130	 -1.308	 5.504	 -0.008	 -0.007	 -0.020	 -2.138	 -1.315	 5.484	 6.0	
20	 2.246	 -1.868	 5.998	 0.001	 -0.001	 -0.018	 2.246	 -1.869	 5.979	 6.7	
21	 0.384	 -3.313	 2.087	 -0.001	 -0.001	 -0.020	 0.382	 -3.313	 2.067	 3.9	
22	 0.443	 -2.514	 5.265	 -0.002	 -0.001	 -0.013	 0.442	 -2.515	 5.252	 5.8	
23	 -0.843	 -1.813	 5.800	 -0.003	 0.002	 -0.036	 -0.845	 -1.811	 5.764	 6.1	
24	 -0.227	 -0.492	 0.846	 -0.001	 -0.003	 -0.025	 -0.228	 -0.494	 0.821	 1.0	
25	 0.728	 -1.927	 6.871	 -0.002	 -0.005	 -0.036	 0.726	 -1.932	 6.835	 7.1	
26	 -0.506	 -3.318	 5.954	 -0.001	 -0.005	 -0.022	 -0.507	 -3.323	 5.933	 6.8	
27	 -0.959	 -2.332	 6.556	 -0.008	 -0.005	 -0.026	 -0.967	 -2.338	 6.530	 7.0	
28	 0.244	 -1.638	 7.134	 -0.003	 -0.010	 -0.025	 0.241	 -1.647	 7.109	 7.3	
29	 -1.848	 -3.703	 4.035	 -0.006	 -0.005	 -0.020	 -1.854	 -3.708	 4.014	 5.8	
30	 -0.674	 -0.920	 6.628	 -0.009	 -0.005	 -0.034	 -0.683	 -0.924	 6.594	 6.7	
31	 0.920	 -2.283	 2.220	 0.008	 -0.003	 -0.028	 0.927	 -2.285	 2.191	 3.3	
32	 -0.859	 -2.005	 4.797	 -0.001	 -0.005	 -0.026	 -0.860	 -2.010	 4.771	 5.2	
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	 Pressure	Force	(N)	x,y,z	 Viscous	Force	(N)	x,y,z	 Total	Force	(N)	x,y,z	 RDF	
33	 No	results	
34	 0.750	 -4.900	 3.911	 -0.007	 -0.001	 -0.018	 0.743	 -4.901	 3.894	 6.3	
35	 -0.173	 -3.482	 3.937	 -0.004	 0.002	 -0.015	 -0.177	 -3.480	 3.923	 5.2	
36	 0.269	 -1.645	 3.173	 -0.005	 -0.003	 -0.020	 0.264	 -1.649	 3.153	 3.6	
37	 -0.427	 -1.176	 4.336	 -0.006	 0.002	 -0.019	 -0.433	 -1.173	 4.317	 4.5	
38	 -4.110	 -1.198	 4.912	 -0.016	 -0.002	 -0.029	 -4.126	 -1.199	 4.883	 6.5	
39	 2.544	 -1.201	 4.268	 -0.007	 -0.003	 -0.020	 2.537	 -1.204	 4.248	 5.1	
40	 2.118	 -3.514	 2.416	 -0.003	 -0.005	 -0.021	 2.115	 -3.520	 2.394	 4.8	
41	 -1.120	 -3.517	 3.633	 0.003	 -0.001	 -0.024	 -1.117	 -3.518	 3.609	 5.2	
42	 No	results	
43	 -1.887	 -2.825	 2.379	 -0.003	 -0.002	 -0.015	 -1.890	 -2.827	 2.363	 4.1	
44	 -0.231	 -2.801	 4.467	 -0.003	 -0.003	 -0.024	 -0.234	 -2.804	 4.443	 5.3	
45	 0.725	 -1.597	 5.077	 -0.004	 -0.001	 -0.024	 0.721	 -1.598	 5.052	 5.3	
46	 0.313	 -1.983	 4.500	 -0.003	 -0.002	 -0.017	 0.310	 -1.985	 4.484	 4.9	
47	 0.784	 -1.804	 6.869	 -0.006	 -0.005	 -0.023	 0.778	 -1.809	 6.846	 7.1	
48	 -3.333	 -5.591	 4.036	 -0.004	 0.000	 -0.018	 -3.337	 -5.591	 4.017	 7.7	
49	 -0.553	 -2.044	 4.815	 0.005	 -0.004	 -0.024	 -0.548	 -2.048	 4.792	 5.2	
50	 0.108	 -2.076	 2.316	 -0.008	 -0.005	 -0.023	 0.100	 -2.081	 2.293	 3.1	
51	 No	distal	body	(fenestrated	tube	graft	only)	
52	 0.493	 0.206	 4.193	 -0.012	 -0.008	 -0.025	 0.482	 0.197	 4.168	 4.2	
53	 0.583	 -3.089	 3.789	 -0.004	 0.000	 -0.021	 0.578	 -3.089	 3.768	 4.9	
54	 No	results	
55	 -1.645	 -0.840	 4.474	 -0.001	 -0.007	 -0.013	 -1.646	 -0.846	 4.461	 4.8	
56	 -4.507	 -3.750	 -0.038	 -0.004	 -0.002	 -0.021	 -4.511	 -3.752	 -0.060	 5.9	
57	 -2.127	 -3.931	 1.519	 0.001	 -0.002	 -0.018	 -2.127	 -3.933	 1.501	 4.7	
58	 -3.217	 -3.639	 3.831	 -0.001	 -0.003	 -0.018	 -3.218	 -3.641	 3.812	 6.2	
59	 -0.394	 -2.795	 2.442	 -0.008	 -0.001	 -0.030	 -0.402	 -2.797	 2.412	 3.7	
N:	Newtons,	RDF:	Resultant	distraction	force,	negative	values	indicate	forces	acting	in	the	
opposite	direction	to	that	of	the	x,y	or	z	axis	
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 Limb	extensions	
fE
VA
R	
Pressure	force	(N)	 Viscous	Force	(N)	 Total	Force	(N)	 Total	
RDF	
(N)	x	 y	 z	 x	 y	 z	 x	 y	 z	
1	 No	results	
2	
L	
1.767	 -0.293	 0.122	 0.004	 -0.004	 -
0.008	
1.771	 -0.296	 0.113	 1.8	
3	 No	results	
4	
L	
1.414	 0.140	 -
0.879	
0.003	 -0.004	 -
0.008	
1.417	 0.137	 -0.887	 1.7	
5	
R	
-1.041	 -4.103	 -
2.865	
-0.002	 -0.001	 -
0.009	
-1.043	 -4.104	 -2.874	 5.1	
6	
L	
3.541	 -0.436	 -
0.983	
0.006	 -0.003	 -
0.011	
3.547	 -0.439	 -0.994	 3.7	
7	
R	
-0.262	 -2.309	 -
0.358	
0.001	 0.000	 -
0.011	
-0.262	 -2.309	 -0.369	 2.4	
8	
R	
0.320	 -0.946	 0.196	 -0.003	 -0.008	 -
0.009	
0.317	 -0.954	 0.187	 1.0	
8	
L	
-0.585	 1.346	 0.818	 0.015	 -0.002	 -
0.010	
-0.570	 1.344	 0.808	 1.7	
9	
R	
-2.733	 -2.373	 -
2.781	
-0.003	 0.000	 -
0.006	
-2.736	 -2.373	 -2.787	 4.6	
10	
L	
-0.459	 -0.319	 -
0.195	
-0.001	 -0.004	 -
0.016	
-0.459	 -0.323	 -0.211	 0.6	
10	
R	
-0.689	 -0.225	 0.037	 -0.006	 -0.003	 -
0.016	
-0.695	 -0.228	 0.021	 0.7	
11	
L	
1.226	 -1.096	 0.502	 0.003	 -0.004	 -
0.009	
1.229	 -1.101	 0.493	 1.7	
12	
L	
1.263	 -1.207	 -
3.165	
-0.001	 -0.004	 -
0.011	
1.262	 -1.210	 -3.176	 3.6	
12	
R	
-1.217	 0.082	 -
1.164	
-0.002	 -0.002	 -
0.009	
-1.219	 0.079	 -1.173	 1.7	
13	
R	
-0.636	 -0.327	 0.580	 -0.002	 -0.002	 -
0.010	
-0.638	 -0.329	 0.570	 0.9	
14	
L	
0.669	 -1.442	 0.981	 0.000	 -0.004	 -
0.007	
0.669	 -1.446	 0.975	 1.9	
14	
R	
-1.050	 -2.854	 0.401	 -0.005	 -0.004	 -
0.010	
-1.055	 -2.858	 0.391	 3.1	
15	 No	results	(unable	to	identify	inlets/outlets)	
16	
L	
0.815	 -0.557	 -
0.119	
0.002	 -0.004	 -
0.012	
0.817	 -0.561	 -0.131	 1.0	
17	
L	
1.692	 -0.923	 0.444	 0.001	 -0.002	 -
0.014	
1.693	 -0.925	 0.430	 2.0	
18	
R	
-0.271	 -0.554	 1.038	 -0.009	 -0.005	 -
0.020	
-0.280	 -0.559	 1.018	 1.2	
19	
L	
2.435	 -1.153	 -
0.569	
0.002	 -0.007	 -
0.011	
2.438	 -1.160	 -0.579	 2.8	
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	 Pressure	Force	(N)	x,y,z	 Viscous	Force	(N)	x,y,z	 Total	Force	(N)	x,y,z	 RDF	
20	
R	
-1.712	 -1.141	 -
2.224	
-0.003	 -0.001	 -
0.008	
-1.716	 -1.143	 -2.231	 3.0	
21	
L	
0.424	 -0.711	 0.246	 0.003	 -0.006	 -
0.011	
0.427	 -0.717	 0.235	 0.9	
21	
R	
-0.209	 -2.109	 -
1.136	
-0.001	 -0.004	 -
0.009	
-0.211	 -2.112	 -1.145	 2.4	
22	
L	
0.944	 -1.171	 0.619	 0.003	 -0.003	 -
0.009	
0.947	 -1.174	 0.610	 1.6	
23	
R	
-0.482	 -1.178	 -
0.168	
-0.004	 -0.002	 -
0.020	
-0.485	 -1.180	 -0.188	 1.3	
23	
L	
1.272	 -0.853	 0.003	 0.001	 -0.005	 -
0.018	
1.274	 -0.858	 -0.015	 1.5	
24	
L	
0.182	 -0.506	 0.230	 0.002	 -0.004	 -
0.016	
0.184	 -0.511	 0.214	 0.6	
25	
L	
5.597	 -6.204	 0.512	 0.009	 -0.029	 -
0.047	
5.606	 -6.233	 0.465	 8.4	
26	
R	
-0.792	 -1.511	 0.999	 -0.005	 -0.003	 -
0.014	
-0.798	 -1.514	 0.985	 2.0	
27	
L	
1.147	 -1.740	 0.729	 0.003	 -0.009	 -
0.016	
1.150	 -1.748	 0.713	 2.2	
28	
L	
2.135	 -1.539	 -
0.112	
0.004	 -0.017	 -
0.025	
2.139	 -1.557	 -0.137	 2.6	
29	
L	
0.789	 -2.090	 0.131	 0.000	 -0.009	 -
0.013	
0.789	 -2.099	 0.119	 2.2	
30	
L	
0.693	 -0.538	 0.890	 0.005	 -0.002	 -
0.015	
0.698	 -0.541	 0.875	 1.2	
31	
R	
-0.501	 -0.548	 1.030	 -0.004	 -0.007	 -
0.016	
-0.505	 -0.556	 1.013	 1.3	
31	
L	
-0.891	 0.355	 0.681	 0.008	 -0.004	 -
0.024	
-0.883	 0.350	 0.657	 1.2	
32	
L	
1.272	 -1.892	 0.295	 0.003	 -0.005	 -
0.012	
1.275	 -1.897	 0.282	 2.3	
33	 No	results	
34	
L	
2.288	 -1.669	 1.089	 0.002	 -0.005	 -
0.012	
2.290	 -1.674	 1.076	 3.0	
35	
L	
0.091	 -1.378	 -
0.167	
-0.001	 0.000	 -
0.009	
0.090	 -1.378	 -0.176	 1.4	
36	
L	
0.820	 -0.683	 0.236	 0.002	 -0.005	 -
0.013	
0.822	 -0.688	 0.223	 1.1	
37	
L	
0.718	 -0.624	 1.371	 0.003	 -0.009	 -
0.027	
0.722	 -0.633	 1.345	 1.7	
38	
L	
0.198	 -0.593	 1.383	 -0.003	 -0.012	 -
0.027	
0.195	 -0.606	 1.355	 1.5	
39	
L	
1.596	 -1.292	 0.775	 0.002	 -0.004	 -
0.010	
1.598	 -1.295	 0.765	 2.2	
40	
R	
-1.680	 -3.004	 -
0.911	
-0.005	 -0.003	 -
0.011	
-1.685	 -3.007	 -0.921	 3.6	
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	 Pressure	Force	(N)	x,y,z	 Viscous	Force	(N)	x,y,z	 Total	Force	(N)	x,y,z	 RDF	
41	
L	
-0.513	 -2.266	 0.439	 0.005	 -0.006	 -
0.010	
-0.509	 -2.272	 0.429	 2.4	
41	
R	
-1.988	 -2.220	 0.409	 -0.003	 -0.005	 -
0.015	
-1.991	 -2.226	 0.394	 3.0	
42	 No	results	
43	
L	
0.971	 -1.118	 0.198	 0.002	 -0.003	 -
0.010	
0.973	 -1.122	 0.188	 1.5	
44	
L	
0.315	 -0.383	 1.325	 0.003	 -0.005	 -
0.014	
0.318	 -0.388	 1.311	 1.4	
44	
R	
-1.121	 -0.536	 -
0.331	
-0.004	 -0.003	 -
0.013	
-1.125	 -0.539	 -
0.345	
1.3	
45	
L	
0.532	 -0.605	 1.323	 0.004	 -0.006	 -
0.020	
0.536	 -0.612	 1.303	 1.5	
46	
L	
0.592	 -0.337	 1.237	 0.006	 -0.007	 -
0.010	
0.598	 -0.344	 1.227	 1.4	
46	
R	
-0.970	 -0.915	 0.884	 -0.005	 -0.006	 -
0.010	
-0.976	 -0.921	 0.874	 1.6	
47	
L	
1.568	 0.336	 0.909	 0.005	 -0.002	 -
0.014	
1.573	 0.334	 0.895	 1.8	
48	
L	
3.065	 -2.685	 0.543	 0.001	 -0.003	 -
0.011	
3.066	 -2.688	 0.532	 4.1	
49	 No	results	(unable	to	identify	inlets/outlets)	
50	
L	
0.370	 -0.257	 0.754	 -0.001	 -0.007	 -
0.016	
0.369	 -0.263	 0.739	 0.9	
51	 No	results	(fenestrated	tube	graft	only)	
52	
L	
1.074	 -0.506	 0.449	 0.004	 -0.007	 -
0.012	
1.078	 -0.513	 0.437	 1.3	
53	
L	
2.020	 -1.620	 -
0.930	
0.002	 -0.004	 -
0.013	
2.021	 -1.624	 -
0.943	
2.8	
53	
R	
-1.023	 -1.046	 -
0.429	
-0.004	 -0.003	 -
0.010	
-1.027	 -1.049	 -
0.440	
1.5	
54	 No	results	
55	
L	
1.373	 -0.423	 -
0.557	
0.004	 -0.007	 -
0.009	
1.376	 -0.430	 -
0.566	
1.5	
56	
L	
5.840	 -2.621	 -
3.832	
0.003	 -0.004	 -
0.016	
5.844	 -2.625	 -
3.848	
7.5	
57	
L	
0.880	 -2.893	 -
1.714	
0.002	 -0.003	 -
0.010	
0.882	 -2.896	 -
1.724	
3.5	
58	
L	
2.024	 -1.791	 -
0.100	
0.004	 -0.005	 -
0.010	
2.029	 -1.796	 -
0.110	
2.7	
59	
R	
0.024	 -0.308	 0.555	 -0.013	 -0.009	 -
0.021	
0.012	 -0.316	 0.533	 0.6	
L/R	in	fEVAR	column	refers	to	laterality	of	limb	extension	(Ipsilateral	limbs	in	iltalics),	N:	Newtons,	
RDF:	Resultant	distraction	force,	negative	values	indicate	forces	acting	in	the	opposite	direction	
to	that	of	the	x,y	or	z	axis	
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8.7 Detailed	patient-specific	results	for	chapter	6	
 Patient-specific	total	distraction	force,	migration	distance	and	imaging	
interval	for	complete	stent-grafts	and	proximal	bodies	
fE
VA
R	
Sy
st
ol
ic
	B
P	
	 Total	distraction	force	acting	
on	Complete	stent-graft	(N)	
Total	distraction	force	
acting	on	Proximal	body	(N)	
Proximal	
Body	
Migration	
(mm)	
Im
ag
in
g	
In
te
rv
al
		
x	 y	 z	 Total	
RDF	
x	 y	 Z	 Total	
RDF	
1	 No	postoperative	CT	imaging	
2	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
3	 No	postoperative	CT	imaging	
4	 150	 -0.4	 -0.1	 2.0	 2.1	 0.2	 1.0	 3.0	 3.2	 0.4	 21	
5	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
6	 140	 4.7	 -3.0	 1.9	 5.9	 2.0	 -1.2	 3.9	 4.5	 1.8	 26	
7	 167	 -0.5	 -1.8	 7.4	 7.6	 0.0	 0.2	 8.2	 8.2	 6.0	 72	
8	 160	 0.5	 -0.9	 6.4	 6.4	 -0.5	 0.1	 4.4	 4.4	 2.6	 19	
9	 134	 -1.2	 -1.8	 0.7	 2.2	 0.8	 1.2	 3.0	 3.3	 3.1	 45	
10	 100	 -1.0	 -1.5	 2.7	 3.3	 -0.3	 -0.8	 3.1	 3.2	 2.0	 17	
11	 112	 0.8	 -2.4	 5.7	 6.2	 0.4	 -1.2	 5.4	 5.6	 1.3	 4	
12	 147	 -0.6	 -6.6	 1.7	 6.8	 -1.7	 -5.3	 4.2	 7.0	 2.8	 12	
13	 150	 0.5	 0.2	 3.0	 3.0	 0.8	 1.4	 0.8	 1.8	 0.6	 26	
14	 129	 -2.0	 -4.8	 3.0	 6.0	 -1.1	 -1.4	 2.4	 3	 2.7	 13	
15	 134	 0.2	 -0.1	 3.2	 3.3	 0.2	 0.3	 4.1	 4.1	 0.6	 49	
16	 122	 -0.4	 -1.0	 2.3	 2.6	 -1.0	 0.2	 1.4	 1.7	 4.6	 51	
17	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
18	 145	 -0.1	 0.8	 3.0	 3.2	 0.0	 1.9	 1.6	 2.5	 5.0	 52	
19	 164	 -1.0	 -1.3	 5.8	 6.0	 -1.6	 0.9	 5.7	 6.0	 4.1	 47	
20	 160	 -1.5	 -0.3	 2.0	 2.5	 -0.7	 1.0	 3.0	 3.2	 1.8	 45	
21	 137	 0.5	 -2.9	 1.8	 3.5	 0.1	 0.4	 2.1	 2.2	 2.0	 26	
22	 117	 0.9	 -1.1	 4.6	 4.8	 0.8	 1.0	 3.5	 3.7	 0.5	 49	
23	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
24	 Only	1	available	postoperative	CT	(poor	renal	function)	
25	 120	 1.6	 -7.2	 10.8	 13.1	 -2.6	 -2.7	 10.9	 11.6	 -3.2	 52	
26	 130	 -0.8	 -3.6	 4.0	 5.5	 -0.1	 -0.7	 2.6	 2.7	 9.5	 44	
27	 135	 -1.2	 -2.3	 6.6	 7.1	 -1.7	 -0.2	 5.3	 5.6	 12.5	 10	
28	 140	 -0.8	 1.6	 6.3	 6.6	 -2.6	 3.4	 6.7	 8.0	 0.8	 22	
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fE
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R	
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	B
P	 Total	distraction	force	acting	
on	Complete	stent-graft	(N)	
Total	distraction	force	
acting	on	Proximal	body	(N)	
Proximal	
Body	
Migration	
(mm)	 Im
ag
in
g	
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al
	
x	 y	 z	 Total	
RDF	
x	 y	 z	 Total	
RDF	
29	 145	 -1.4	 -5.3	 3.9	 6.8	 -1.7	 -0.7	 -0.2	 1.9	 2.6	 41	
30	 142	 0.1	 -0.1	 4.7	 4.7	 -0.3	 0.6	 3.4	 3.5	 3.6	 35	
31	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
32	 150	 2.4	 -2.3	 5.1	 6.1	 2.1	 0.7	 3.1	 3.8	 0.5	 4	
33	 No	postoperative	CT	imaging	with	contrast	
34	 172	 4.2	 -2.2	 6.2	 7.8	 1.9	 3.0	 5.9	 6.9	 3.5	 38	
35	 148	 -0.8	 1.8	 2.1	 2.9	 -0.4	 4.3	 1.9	 4.7	 0.0	 36	
36	 143	 0.5	 -1.1	 5.8	 5.9	 -0.5	 0.6	 4.2	 4.3	 0.4	 34	
37	 125	 -0.7	 0.1	 2.6	 2.7	 -0.9	 1.0	 -0.3	 1.3	 -1.5	 35	
38	 Only	1	available	postoperative	CT	(died	at	1	month)	
39	 125	 -1.2	 -1.8	 1.0	 2.4	 -2.5	 -0.1	 1.3	 2.8	 2.6	 35	
40	 120	 -0.6	 -1.3	 1.6	 2.1	 -0.6	 3.0	 2.8	 4.1	 -2.0	 5	
41	 145	 1.2	 -1.5	 8.7	 8.9	 4.1	 3.6	 5.5	 7.7	 1.3	 26	
42	 No	postoperative	CT	imaging	
43	 180	 1.4	 -1.4	 3.7	 4.2	 1.7	 1.9	 2.4	 3.5	 3.3	 23	
44	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
45	 165	 0.9	 -1.8	 5.9	 6.2	 0.2	 -0.1	 5.1	 5.1	 7.8	 11	
46	 92	 -0.4	 1.1	 5.0	 5.1	 -0.1	 2.1	 4.2	 4.7	 1.7	 21	
47	 140	 2.1	 1.5	 4.6	 5.3	 0.9	 1.6	 4.2	 4.6	 1.9	 21	
48	 100	 -0.1	 -3.0	 1.1	 3.2	 0.0	 1.0	 1.8	 2.1	 0.2	 22	
49	 185	 -3.6	 -4.3	 4.4	 7.1	 -0.2	 0.8	 5.7	 5.8	 3.3	 25	
50	 Only	1	available	postoperative	CT	
51	 Only	1	available	postoperative	CT	
52	 150	 -0.2	 1.3	 6.2	 6.4	 -1.4	 1.9	 3.1	 3.9	 -0.5	 11	
53	 135	 1.8	 0.5	 4.5	 4.8	 0.8	 3.2	 6.3	 7.1	 8.5	 18	
54	 No	postoperative	CT	imaging	
55	 130	 0.5	 -0.6	 9.5	 9.5	 0.6	 0.6	 8.5	 8.6	 6.1	 11	
56	 123	 0.2	 -4.7	 0.0	 4.7	 -0.7	 0.1	 6.4	 6.4	 -2.0	 5	
57	 130	 0.2	 -4.0	 1.4	 4.3	 0.3	 -0.2	 3.8	 3.8	 3.8	 11	
58	 Only	1	available	postoperative	CT	(died	at	1	month)	
59	 137	 -2.7	 -1.7	 5.3	 6.2	 -2.5	 0.3	 5.7	 6.3	 2.3	 4	
Imaging	interval	in	completed	months,	Systolic	BP:	Preoperative	systolic	blood	pressure	(mmHg),	
x,y,z	forces	and	Total	RDF	include	both	pressure	and	viscous	forces	
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 Patient-specific	total	distraction	force,	interval	change	in	M1,	2,	3	and	4	
measurements	and	imaging	interval	for	distal	bodies	
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Total	distraction	force	
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x	 y	 z	 Total	
RDF	
1	 No	postoperative	CT	imaging	
2	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
3	 No	postoperative	CT	imaging	
4	 150	 2.1	 -2.7	 -1.4	 4.2	 5.2	 -0.1	 1.4	 0.1	 -0.8	 No	 21	
5	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
6	 140	 5.9	 0.5	 -1.7	 4.6	 5.0	 3.9	 2.5	 1.2	 -1.3	 No	 26	
7	 Custom	made	hybrid	proximal/distal	body	component	
8	 160	 6.4	 1.1	 -3.4	 7.2	 8.0	 1.3	 1.7	 1.1	 0.5	 No	 19	
9	 134	 2.2	 0.2	 -2.7	 4.1	 4.9	 -0.5	 -0.3	 -0.3	 0.1	 No	 45	
10	 100	 3.3	 -1.5	 -1.7	 2.5	 3.3	 1.6	 -0.2	 0.2	 0.3	 No	 17	
11	 112	 6.2	 -0.7	 -0.9	 3.8	 4.0	 0.4	 -0.8	 -0.3	 0.5	 No	 4	
12	 147	 6.8	 2.1	 -1.3	 4.9	 5.5	 2.7	 -1.0	 -1.7	 -0.5	 No	 12	
13	 150	 3.0	 0.9	 -1.7	 1.4	 2.4	 0.7	 0.9	 -1.4	 -2.3	 No	 26	
14	 129	 6.0	 -0.4	 -1.3	 2.8	 3.1	 -0.2	 -1.0	 -2.7	 -1.6	 No	 20	
15	 134	 3.3	 -0.4	 -1.6	 4.4	 4.7	 0.6	 -1.0	 -2.3	 -0.7	 No	 49	
16	 122	 2.6	 0.4	 -1.5	 4.6	 4.9	 -1.0	 0.4	 1.0	 0.7	 No	 51	
17	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
18	 145	 3.2	 -0.4	 -1.9	 3.7	 4.2	 2.2	 1.0	 0.5	 -0.5	 No	 52	
19	 164	 6.0	 -2.2	 -1.3	 5.6	 6.2	 2.9	 -1.6	 -6.2	 -4.6	 No	 47	
20	 160	 2.5	 2.2	 -1.9	 6.0	 6.6	 2.1	 -1.6	 1.1	 2.7	 No	 45	
21	 137	 3.5	 0.3	 -2.8	 1.8	 3.3	 6.6	 3.0	 -2.3	 -5.3	 No	 26	
22	 117	 4.8	 0.3	 -1.8	 3.8	 4.3	 6.7	 5.6	 0.5	 -5.1	 Yes	 49	
23	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
24	 Only	1	available	postoperative	CT	(poor	renal	function)	
25	 120	 13.1	 0.5	 -1.4	 5.0	 5.3	 1.9	 -0.2	 -1.7	 -1.5	 No	 52	
26	 130	 5.5	 -0.4	 -2.7	 4.8	 5.5	 4.4	 2.6	 2.3	 -0.3	 No	 44	
27	 135	 7.1	 -0.8	 -2.0	 5.5	 5.9	 -0.3	 -0.3	 -2.7	 -2.2	 No	 10	
28	 140	 6.6	 0.2	 -1.4	 6.1	 6.3	 1.3	 0.1	 1.1	 1.2	 No	 23	
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Total	distraction	force	
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x	 y	 z	 Total	
RDF	
29	 145	 6.8	 -1.7	 -3.4	 3.6	 5.2	 0.4	 2.6	 3.4	 0.7	 No	 41	
30	 142	 4.7	 -0.6	 -0.8	 5.7	 5.8	 0.7	 0.5	 -0.6	 -1.3	 No	 35	
31	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
32	 150	 6.1	 -0.8	 -1.9	 4.5	 4.9	 -1.3	 -0.4	 0.6	 1.3	 No	 5	
33	 No	postoperative	CT	imaging	with	contrast	
34	 172	 7.8	 0.8	 -5.3	 4.2	 6.8	 0.2	 1.2	 2.4	 1.0	 No	 38	
35	 148	 2.9	 -0.2	 -3.2	 3.6	 4.8	 1.9	 0.9	 -3.1	 -4.4	 No	 36	
36	 143	 5.9	 0.2	 -1.5	 2.8	 3.2	 0.3	 -0.1	 -2.4	 -2.4	 No	 34	
37	 125	 2.7	 -0.3	 -0.9	 3.4	 3.5	 2.8	 2.5	 1.7	 -0.9	 No	 35	
38	 Only	1	available	postoperative	CT	(died	at	1	month)	
39	 125	 2.4	 2.0	 -0.9	 3.3	 4.0	 3.3	 2.7	 0.3	 -2.5	 No	 35	
40	 120	 2.1	 1.6	 -2.6	 1.8	 3.5	 7.8	 1.3	 0.9	 -0.7	 No	 5	
41	 145	 8.9	 -1.0	 -3.2	 3.3	 4.7	 -1.7	 1.7	 2.1	 1.0	 No	 24	
42	 No	postoperative	CT	imaging	
43	 180	 4.2	 -2.1	 -3.2	 2.7	 4.7	 6.6	 5.4	 -0.6	 -6.1	 Yes	 23	
44	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
45	 165	 6.2	 0.7	 -1.6	 5.2	 5.5	 -1.8	 -1.8	 -1.2	 0.6	 No	 11	
46	 92	 5.1	 0.2	 -1.1	 2.6	 2.8	 11.3	 13.7	 4.2	 -9.6	 Yes	 21	
47	 140	 5.3	 0.7	 -1.6	 6.0	 6.2	 -1.3	 -0.2	 0.3	 0.5	 No	 21	
48	 100	 3.2	 -2.1	 -3.5	 2.5	 4.8	 2.4	 1.3	 0.5	 -0.9	 No	 22	
49	 185	 7.1	 -0.6	 -2.3	 5.5	 6.0	 0.3	 2.8	 0.4	 -2.2	 No	 25	
50	 Only	1	available	postoperative	CT	
51	 Only	1	available	postoperative	CT	
52	 150	 6.4	 0.4	 0.2	 3.9	 3.9	 0.7	 1.3	 0.3	 -1.0	 No	 11	
53	 135	 4.8	 0.5	 -2.6	 3.2	 4.1	 -2.6	 -1.4	 -3.9	 -2.5	 No	 8	
54	 No	postoperative	CT	imaging	
55	 130	 9.5	 -1.3	 -0.7	 3.6	 3.9	 -2.7	 -3.2	 -2.9	 0.3	 No	 11	
56	 123	 4.7	 -3.5	 -2.9	 -0.1	 4.5	 -0.6	 -2.7	 -2.1	 0.7	 No	 5	
57	 130	 4.3	 -1.7	 -3.2	 1.2	 3.8	 3.7	 0.4	 0.8	 0.8	 No	 4	
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Total	distraction	force	
acting	on	distal	body	(N)	
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x	 y	 z	 Total	
RDF	
58	 Only	1	available	postoperative	CT	(died	at	1	month)	
59	 137	 6.2	 -0.3	 -2.4	 2.0	 3.2	 -2.9	 0.4	 1.9	 1.3	 No	 4	
Imaging	interval	in	completed	months,	M1-4:	component	distraction	measurements	(see	6.5.2.4),	
Systolic	BP:	Preoperative	systolic	blood	pressure	(mmHg),	x,y,z	forces	and	Total	RDF	include	both	
pressure	and	viscous	forces.	*for	full	description	of	forces	acting	on	complete	stent-graft	see	
8.7.1	
	
 Patient-specific	total	distraction	force,	migration	distance	and	imaging	
interval	for	limb	extensions	
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Total	RDF	
complete	
stent-
graft*	
R/L	 Total	distraction	force	acting	on	limb	
extensions	(N)	
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x	 y	 z	 Total	
RDF	
1	 No	postoperative	CT	imaging	
2	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
3	 No	postoperative	CT	imaging	
4	 150	 2.1	 L	 1.3	 0.1	 -0.8	 1.6	 0.1	 21	
5	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
6	 140	 5.9	 L	 3.1	 -0.4	 -0.9	 3.3	 -1.3	 26	
7	 167	 7.6	 R	 -0.3	 -2.4	 -0.4	 2.5	 -0.1	 72	
8	 160	 6.4	 R	 0.3	 -1.0	 0.2	 1.0	 -0.1	 19	
9	 134	 2.2	 R	 -2.3	 -2.0	 -2.3	 3.8	 1.6	 45	
10	 100	 3.3	 L	 -0.3	 -0.2	 -0.1	 0.4	 2.4	 17	
R	 -0.4	 -0.1	 0.0	 0.5	 0.2	 17	
11	 112	 6.2	 L	 0.9	 -0.8	 0.3	 1.2	 2.2	 4	
12	 147	 6.8	 L	 1.2	 -1.1	 -2.9	 3.3	 -1.8	 12	
R	 -1.1	 0.1	 -1.1	 1.6	 1.0	 12	
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Total	RDF	
complete	
stent-
graft*	
R/L	 Total	distraction	force	acting	on	limb	
extensions	(N)	
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x	 y	 z	 Total	
RDF	
13	 150	 3.0	 R	 -0.6	 -0.3	 0.5	 0.9	 1.2	 26	
14	 129	 6.0	 L	 0.5	 -1.2	 0.8	 1.5	 1.1	 13	
R	 -0.8	 -2.3	 0.3	 2.5	 1.6	 13	
15	 Wallstent	
16	 122	 2.6	 L	 0.6	 -0.4	 -0.1	 0.8	 -3.4	 51	
17	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
18	 145	 3.2	 R	 -0.3	 -0.5	 0.9	 1.1	 -0.6	 52	
19	 164	 6.0	 L	 2.5	 -1.2	 -0.6	 2.8	 -5.0	 47	
20	 160	 2.5	 R	 -1.7	 -1.1	 -2.2	 3.0	 -10.6	 45	
21	 137	 3.5	 L	 0.4	 -0.6	 0.2	 0.7	 -1.2	 26	
R	 -0.2	 -1.8	 -1.0	 2.1	 -2.2	 26	
22	 117	 4.8	 L	 0.7	 -0.9	 0.4	 1.2	 0.3	 49	
23	 Only	1	available	postoperative	CT	(follow-up	elsewhere)		
24	 Only	1	available	postoperative	CT	(poor	renal	function)	
25	 120	 13.1	 L	 4.2	 -4.7	 0.3	 6.3	 -4.4	 52	
26	 130	 5.5	 R	 -0.6	 -1.2	 0.8	 1.6	 -0.3	 44	
27	 135	 7.1	 L	 1.0	 -1.5	 0.6	 1.9	 0.2	 10	
28	 140	 6.6	 L	 1.9	 -1.4	 -0.1	 2.3	 -1.9	 22	
29	 145	 6.8	 L	 0.7	 -1.9	 0.1	 2.0	 -0.9	 41	
30	 142	 4.7	 L	 0.6	 -0.5	 0.8	 1.1	 -1.6	 35	
31	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
32	 150	 6.1	 L	 1.2	 -1.8	 0.3	 2.2	 1.1	 4	
33	 No	postoperative	CT	imaging	with	contrast	
34	 172	 7.8	 L	 2.5	 -1.8	 1.2	 3.3	 -3.4	 38	
35	 148	 2.9	 L	 0.1	 -1.3	 -0.2	 1.3	 -2.1	 36	
36	 143	 5.9	 L	 0.7	 -0.6	 0.2	 1.0	 -0.7	 34	
37	 125	 2.7	 L	 0.6	 -0.5	 1.0	 1.3	 0.5	 35	
38	 Only	1	available	postoperative	CT	(died	at	1month)	
	
		
211	
Chapter	8:	Appendices	
fE
VA
R	
Sy
st
ol
ic
	B
P	
	
Total	RDF		
complete	
stent-
graft*	
R/L	 Total	distraction	force	acting	on	limb	
extension(N)	
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x	 y	 z	 Total	
RDF	
39	 125	 2.4	 L	 1.2	 -1.0	 0.6	 1.7	 2.0	 35	
40	 120	 2.1	 R	 -1.3	 -2.2	 -0.7	 2.7	 No	Data	
41	 145	 8.9	 L	 -0.5	 -2.1	 0.4	 2.1	 -1.0	 26	
R	 -1.8	 -2.0	 0.3	 2.7	 -4.9	 26	
42	 No	postoperative	CT	imaging	
43	 180	 4.2	 L	 1.1	 -1.3	 0.2	 1.7	 -2.9	 23	
44	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
45	 165	 6.2	 L	 0.6	 -0.6	 1.3	 1.6	 -0.9	 11	
46	 92	 5.1	 L	 0.3	 -0.2	 0.7	 0.8	 -1.2	 21	
	 R	 -0.6	 -0.5	 0.5	 0.9	 1.2	 21	
47	 140	 5.3	 L	 1.4	 0.3	 0.8	 1.6	 -0.1	 21	
48	 100	 3.2	 L	 1.9	 -1.7	 0.3	 2.6	 0.7	 22	
49	 Unable	to	identify	inlet/outlets	
50	 Only	1	available	postoperative	CT	
51	 Only	1	available	postoperative	CT	
52	 150	 6.4	 L	 1.0	 -0.5	 0.4	 1.2	 -3.3	 11	
53	 135	 4.8	 L	 1.7	 -1.4	 -0.8	 2.3	 1.4	 18	
R	 -0.9	 -0.9	 -0.4	 1.3	 -0.4	 18	
54	 No	postoperative	CT	imaging	
55	 130	 9.5	 L	 1.1	 -0.4	 -0.5	 1.3	
No	Data	56	 123	 4.7	 L	 4.5	 -2.0	 -3.0	 5.8	
57	 130	 4.3	 L	 0.7	 -2.4	 -1.4	 2.8	
58	 Only	1	available	postoperative	CT	(died	at	1	month)	
59	 137	 6.2	 R	 0.0	 -0.3	 0.5	 0.5	 No	Data	
Imaging	interval	in	completed	months,	Systolic	BP:	Preoperative	systolic	blood	pressure	(mmHg),	
*for	full	description	of	forces	acting	on	complete	stent-graft	see	8.7.1,	x,y,z	forces	and	Total	RDF	
include	both	pressure	and	viscous	forces,	negative	values	in	Migration	column	indicate	migration	
in	proximal	direction	
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8.8 Patient	demographics	
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1	 No	postoperative	CT	imaging	
2	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
3	 No	postoperative	CT	imaging	
4	 M	 76	 29.1	 Yes	 Yes	 No	 Yes	 Yes	 Yes	 No	 3	 150	 99	 76	
5	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
6	 M	 78	 25.4	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 140	 70	 65	
7	 M	 76	 34.3	 No	 Yes	 No	 Yes	 No	 No	 No	 3	 167	 60	 80	
8	 M	 85	 27.4	 No	 Yes	 No	 Yes	 No	 Yes	 Yes	 3	 160	 76	 76	
9	 M	 83	 28.8	 No	 Yes	 No	 Yes	 No	 No	 No	 3	 134	 94	 61	
10	 F	 65	 28.3	 No	 Yes	 Yes	 No	 No	 Yes	 No	 3	 100	 60	 55	
11	 M	 66	 30.6	 No	 Yes	 No	 No	 No	 Ex	 No	 3	 112	 70	 67	
12	 M	 77	 25.3	 No	 Yes	 No	 Yes	 No	 Yes	 Yes	 3	 147	 71	 57	
13	 M	 81	 21.8	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 150	 82	 68	
14	 M	 73	 25.2	 No	 No	 No	 No	 No	 Yes	 No	 3	 129	 118	 79	
15	 M	 81	 25.7	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 134	 67	 57	
16	 M	 71	 25.1	 Yes	 Yes	 No	 No	 No	 Ex	 No	 3	 122	 84	 60	
17	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
18	 M	 65	 25.3	 No	 Yes	 No	 Yes	 No	 Yes	 Yes	 2	 145	 50	 55	
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19	 F	 86	 25.0	 No	 Yes	 No	 No	 No	 Yes	 No	 3	 164	 90	 57	
20	 M	 81	 20.3	 No	 No	 No	 No	 No	 Yes	 No	 3	 160	 75	 70	
21	 M	 70	 27.2	 No	 Yes	 No	 Yes	 No	 No	 No	 2	 137	 85	 57	
22	 M	 62	 26.3	 No	 Yes	 No	 No	 No	 Ex	 No	 3	 117	 65	 62	
23	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
24	 Only	1	available	postoperative	CT	(poor	renal	function)	
25	 M	 78	 24.9	 No	 No	 No	 No	 No	 No	 No	 2	 120	 66	 85	
26	 M	 78	 23.7	 No	 Yes	 No	 No	 Yes	 Ex	 No	 3	 130	 68	 68	
27	 M	 76	 24.5	 No	 No	 No	 No	 No	 No	 No	 3	 135	 65	 57	
28	 M	 75	 25.1	 No	 No	 No	 Yes	 No	 Yes	 No	 2	 140	 70	 64	
29	 M	 65	 40.9	 No	 No	 No	 Yes	 No	 Ex	 No	 3	 145	 90	 80	
30	 M	 68	 26.8	 No	 No	 No	 Yes	 No	 No	 No	 2	 142	 62	 56	
31	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
32	 M	 76	 25.1	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 150	 66	 65	
33	 No	postoperative	CT	imaging	with	contrast	
34	 M	 68	 28.0	 No	 No	 No	 Yes	 No	 Yes	 No	 3	 172	 82	 62	
35	 M	 71	 35.1	 No	 No	 No	 No	 No	 Yes	 No	 2	 148	 88	 75	
36	 M	 75	 29.9	 No	 No	 No	 No	 No	 No	 Yes	 3	 143	 80	 68	
37	 M	 64	 28.4	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 125	 69	 64	
38	 Only	1	available	postoperative	CT	(died	at	1	month)	
39	 M	 74	 26.4	 No	 No	 No	 No	 No	 Ex	 No	 1	 125	 64	 58	
40	 F	 83	 24.2	 No	 Yes	 No	 No	 No	 No	 No	 3	 120	 82	 61	
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41	 M	 72	 33.9	 Yes	 Yes	 No	 Yes	 Yes	 Yes	 No	 3	 145	 85	 74	
42	 No	postoperative	CT	imaging	
43	 F	 76	 27.6	 No	 No	 No	 No	 No	 No	 No	 3	 180	 90	 59	
44	 Only	1	available	postoperative	CT	(follow-up	elsewhere)	
45	 M	 74	 22.6	 No	 No	 No	 Yes	 Yes	 Yes	 No	 3	 165	 65	 64	
46	 M	 78	 19.7	 No	 No	 No	 No	 No	 Ex	 No	 2	 92	 62	 57	
47	 M	 85	 26.8	 No	 Yes	 No	 No	 No	 Yes	 Yes	 2	 140	 69	 62	
48	 F	 64	 28.3	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 100	 53	 66	
49	 M	 77	 35.4	 No	 Yes	 No	 Yes	 No	 Yes	 No	 3	 185	 70	 71	
50	 Only	1	available	postoperative	CT	
51	 Only	1	available	postoperative	CT	
52	 M	 82	 31.4	 Yes	 Yes	 No	 Yes	 Yes	 Yes	 No	 2	 150	 60	 86	
53	 M	 71	 28.6	 No	 No	 No	 No	 No	 Yes	 No	 2	 135	 75	 58	
54	 No	postoperative	CT	imaging	
55	 M	 76	 23.9	 No	 No	 No	 Yes	 No	 Ex	 No	 3	 130	 75	 59	
56	 M	 68	 30.6	 No	 No	 No	 No	 No	 Ex	 No	 2	 123	 68	 70	
57	 M	 82	 28.6	 No	 No	 No	 Yes	 No	 Yes	 No	 3	 130	 76	 55	
58	 Only	1	available	postoperative	CT	(died	at	1	month)	
59	 M	 76	 30.4	 No	 Yes	 No	 Yes	 No	 Yes	 No	 2	 137	 62	 58	
Demographics	for	all	patients	included	in	chapter	6.	BMI:	Body	mass	index,	IHD:	Ischaemic	heart	
disease,	CRF:	Chronic	renal	failure,	PVD:	Peripheral	vascular	disease,	ASA:	American	Association	
of	Anaesthetists,	Systolic	BP:	Preoperative	systolic	blood	pressure	(mmHg),	Pulse	rate:	
Preoperative	pulse	rate	(beats	per	minutes),	D3:	Maximum	preoperative	aneurysm	diameter	
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8.9 Clinical	outcomes	
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1	 Not	assessed	 	 	 MI	4	days	
post	fEVAR	
Died	 0	
2	 Not	assessed	 SMA	stenosis	
(mesenteric	
ischaemia)	
Angioplasty
1mnth.	
REIA	to	
SMA	
bypass,	
8mnts	
	 Lost	to	follow-
up	
28	
3	 Not	assessed	 	 Left	hemi-
colectomy	
within	30	
days	
Perforated	
colon	due	
to	fibro-
matosis	
Died	NARC	 18	
4	 No	 No	 No	 	 	 type	II,	
2yrs	
Died	NARC	 32	
5	 Not	assessed	 	 	 type	II,	0-
6yrs	
Lost	to	follow-
up	
75	
6	 No	 No	 No	 	 	 	 Died	NARC	 37	
7	 Ye
s	
-	 No	 	 None	 	 Alive	 74	
8	 No	 No	 No	 	 	 	 Died	NARC	 44	
9	 No	 No	 No	 	 	 	 Alive	 80	
10	 No	 No	 No	 	 	 	 Alive	 43	
11	 No	 No	 No	 	 	 	 Died	NARC	 19	
12	 No	 No	 No	 	 	 	 Died	Unknown	 39	
13	 No	 No	 No	 	 	 	 Declined	further	
follow-up	
26	
14	 No	 No	 No	 	 	 	 Died	NARC	 18	
15	 No	 No	 -	 	 	 	 Died	NARC	 59	
16	 Ye
s	
No	 No	 	 None	 	 Declined	further	
follow-up	
53	
17	 Not	assessed	 	 	 	 Lost	to	follow-
up	
6	
18	 Ye
s	
No	 No	 	 None	 	 Alive	 65	
19	 Ye
s	
No	 Yes	 	 None	 type	II,	
4yrs	
Died	NARC	 57	
20	 No	 No	 Yes	 	 None	 	 Alive	 59	
21	 No	 No	 No	 Stenosis	of	
RRA(scallop)	AAA	
Expansion	
RRA	stent	
8mnths	
type	II	
1-27mnths	
Alive	 27	
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22	 No	 Ye
s	
No	 	 None	 	 Alive	 63	
23	 Not	assessed	 	 	 	 Lost	to	follow-
up	
11	
24	 Not	assessed	 Early	RRA	stent	
stenosis	
RRA	stent	
angioplasty	
in	1st	
month	
type	II,	0-
5yrs	
Alive	 61	
25	 No	 No	 Yes	 Early	occlusion	Rt	
limb.	Lf	limb	
stenosis	+	BMS	#,	
14mnths.	AAA	
expansion.	RRA	
stent	#,	LRA	stent	
dislocation	+	IIIa,	
50mnths		
IMA	
emboli-
sation	
15mnths	
type	II	
2-14mnths	
Alive	 63	
26	 Ye
s	
No	 No	 	 None	 	 Died	NARC	 49	
27	 Ye
s	
No	 No	 	 None	 	 Died	NARC	 20	
28	 No	 No	 No	 Early	occlusion	Rt	
limb	
	 	 Lost	to	follow-
up	
24	
29	 No	 No	 No	 RRA	occlusion	
43mnths	
Ureteric	
stent	
Transient	
type	II,	
1month.	
Ureteric	
obstructio
n	due	to	
fibrosis	
Lost	to	follow-
up	
43	
30	 No	 No	 No	 	 	 transient	
type	II	
1mnth	
Alive	 49	
31	 Not	assessed	 	 	 	 Died	NARC	 52	
32	 No	 No	 No	 type	IIIa	from	RRA	 RRA	stent	
angioplasty
12mnths	
	 Lost	to	follow-
up	
15	
33	 Not	assessed	 	 	 type	II	0-
4yrs	
Alive	 50	
34	 No	 No	 No	 SMA	stent	#	 SMA	re-
stented	
27mnths	
type	II	
0-3yrs	
Alive	 39	
35	 No	 No	 No	 SMA	stenosis	
(scallop)	
SMA	stent	
42mnths	
	 Alive	 49	
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36	 No	 No	 No	 RRA	stent	#	and	
occlusion	
Diagnostic	
angiogram	
39mnths	
transient	
type	II	
1-8mnths	
Alive	 48	
37	 No	 No	 No	 	 	 Pre-
existing	
native	REIA	
occlusion	
with	fem-
fem	xover		
Alive	 36	
38	 Not	assessed	 Postoperative	
bleeding	
Re-
exploration	
of	right	
groin	
MI,	MSOF	 Died	 1	
39	 No	 No	 No
†	
Ipsilateral	limb	
occlusion,	36mnths	
None	 transient	
type	II	
1-12mnths	
Died	NARC	 38	
40	 No	 No	 No	 	 	 	 Died	NARC	 13	
41	 No	 No	 Yes	 SMA	stent		
dislocation	+	
occlusion,	15mnths	
None	 	 Alive	 38	
42	 Not	assessed	 Expanding	AAA	 	 transient	
type	II,	
2mnths	
Lost	to	follow-
up	
9	
43	 No	 Ye
s	
No	 	 None	 	 Alive	 39	
44	 Not	assessed	 	 	 	 Died	NARC	 13	
45	 Ye
s	
No	 No	 High	velocity	in	SMA	 Diagnostic	
angiogram	
10mnts	
(NAD)		
transient	
type	II	
2mnts	
Died	NARC	 24	
46	 No	 Ye
s	
No	 	 None	 	 Died	NARC	 40	
47	 No	 No	 No	 	 	 	 Alive	 23	
48	 No	 No	 No	 	 	
	
transient	
type	II	
2mnths	
Alive	 36	
49	 No	 No	 -	 	 None	 type	II	
0-2yrs	
Alive	 25	
50	 Not	assessed	 	 	 	 	 24	
51	 Not	assessed	 	 	 	 	 16	
52	 No	 No	 No	 SMA	stent	#	 SMA	re-
stented	
13mnths	
	 Alive	 24	
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*as	determined	by	CLL	analysis,	Comp.	distraction:	Component	distraction	of	the	distal	body	from	
the	proximal	body,	Limb	migration:	Proximal	migration	of	the	distal	iliac	limb	extension	seal-zone,	
†only	incidence	of	proximal	migration	of	ipsilateral	limb	(distal	body),	L/RRA:	Left/Right	renal	
artery,	MI:	Myocardial	infarction,	MSOF:	Multisystem	organ	failure,	NAD:	No	Abnormality	
Detected,	NARC:	Non-aneurysm-related	causes,	SMA:	Superior	mesenteric	artery,	type	I/II/III:	
endoleak	classification,	#:	fracture	
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53	 Ye
s	
No	 No	 type	IIIa	from	LRA	 LRA	stent	
angioplasty
14mnths	
transient	
type	II	
6mnths	
Alive	 26	
54	 Not	assessed	 	 	 	 	 4	
55	 Ye
s	
No	 -	 	 None	 	 Alive	 13	
56	 No	 No	 -	 	 	 	 Alive	 13	
57	 No	 No	 -	 	 	 	 Alive	 5	
58	 Not	assessed	 	 	 	 Died	NARC	 1	
59	 No	 No	 -	 	 	 type	II	
1-12mnths	
Alive	 11	
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